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Petroleum refineries emit a variety of airborne substances which may be harmful to 
human health. HEIDI II (Health Effects Indicators Decision Index II) is a computer-based 
decision analysis tool which assesses airborne emissions from Canada’s oil refineries for 
reduction, based on ordinal ranking of estimated health impacts. The model was designed 
by a project team within NERAM (Network for Environmental Risk Assessment and 
Management) and assembled with significant stakeholder consultation. HEIDI II is 
publicly available as a deterministic Excel-based tool which ranks 31 air pollutants based 
on predicted disease incidence or estimated DALYS (disability adjusted life years). The 
model includes calculations to account for average annual emissions, ambient 
concentrations, stack height, meteorology/dispersion, photodegradation, and the 
population distribution around each refinery. Different formulations of continuous dose-
response functions were applied to nonthreshold-acting air toxics, threshold-acting air 
toxics, and nonthreshold-acting CACs (criteria air contaminants). An updated 
probabilistic version of HEIDI II was developed using Matlab code to account for 
parameter uncertainty and identify key leverage variables. Sensitivity analyses indicate 
that parameter uncertainty in the model variables for annual emissions and for 
concentration-response/toxicological slopes have the greatest leverage on predicted 
health impacts. Scenario analyses suggest that the geographic distribution of population 
density around a refinery site is an important predictor of total health impact. Several 
ranking metrics (predicted case incidence, simple DALY, and complex DALY) and 
ordinal ranking approaches (deterministic model, average from Monte Carlo simulation, 
test of stochastic dominance) were used to identify priority substances for reduction; the 
results were similar in each case. The predicted impacts of primary and secondary 
particulate matter (PM) consistently outweighed those of the air toxics. Nickel, PAH 
(polycyclic aromatic hydrocarbons), BTEX (benzene, toluene, ethylbenzene and xylene), 
sulphuric acid, and vanadium were consistently identified as priority air toxics at 
refineries where they were reported emissions. For many substances, the difference in 
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1 Part 1: Introduction, Background, and Methods 
1.1 Introduction 
 Over the past decades, there has been recognition that many of the industries and 
products upon which our society depends may negatively affect the environment and 
human health. Although many industrial processes are essential, they may be associated 
with effects such as resource depletion, loss of wildlife habitat, and emission of toxic 
pollutants. Scientists, policymakers, and other stakeholders are making an effort to 
understand what the specific impacts are and to identify those with the greatest 
consequences. In Canada in 2003/2004, a unique national, multi-stakeholder effort was 
undertaken to identify the best ways to reduce airborne oil refinery emissions. One of the 
products of this process was HEIDI II (Health Effects Indicators Decision Index II) a 
computer-based tool designed to prioritize airborne emissions from Canadian petroleum 
refineries on the basis of estimated health impacts. HEIDI II was designed with extensive 
consultation with a multi-stakeholder committee which included representatives from 
government, industry, NGOs, and the academic community.  
Currently, HEIDI II is available as a publicly available tool which uses 
deterministic values to rank groups of substances emitted from each of Canada’s 20 oil 
refineries. The following project presents a new and updated version of HEIDI II: the 
model has now been extensively tested and validated, and incorporates knowledge about 
the uncertainty and variability associated with many of the model’s inputs. A comparison 
of the distributions for predicted health impacts at Canadian refineries inform about 
priority substances for reduction in the face of uncertainty and hint at the range of 
potential risk which may be associated with each emission in each location. A 
comparison of various methods of ranking the probabilistic results confirms that the 
appropriate substances are being identified as high priority while allowing exploration of 
the implications of stochastic results for interpreting rank orders in general. The report 
also explores the possibility of adapting HEIDI II to other contexts, such as other 
industries, and emissions from several refineries simultaneously affecting one population. 
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1.2 Background 
1.2.1  HEIDI is born 
It is now universally recognized that poor air quality has adverse impacts on 
human health (Cohen, Anderson et al. 2004), and Canadians are becoming more 
concerned about the impact of industrial emissions (Corporate Research Associates Inc. 
1997). One source of airborne pollutants is the petroleum refining industry. Currently, 
there are 18 petroleum refineries operating across Canada, some of which are located in 
highly populated areas (see Figure 1 and  
Table 1)1. The types and amounts of emissions created by these refineries are 
publicly available through Canada’s NPRI (National Pollutant Release Inventory) 
(Environment Canada 2005). 
In 2001, the Canadian Petroleum Products Institute (CCPI), representing the 
refiners of Canada, approached provincial and federal departments of environment and 
energy with a proposal to establish and co-fund a new approach to reducing emissions 
from the petroleum refining sector. The NFPRER (National Framework for Petroleum 
Refinery Emissions Reductions) was conducted as a multi-stakeholder process with the 
ultimate goal of providing facility emissions caps for key pollutants and air toxics 
(McColl, Hicks et al. 2003; CCME (Canadian Council of Ministers of the Environment) 
2005). One component of the framework required the formation of a Health Prioritization 
Subgroup. 
The responsibilities of the Health Prioritization Subgroup included providing 
information on the health impacts of exposure to pollutants, either alone or as mixtures, 
making recommendations on addressing knowledge gaps, establishing a prioritized list of 
pollutants of concern, and participating in the development of principles and methods 
used by jurisdictions to establish performance-based facility emission caps that are 
protective of human health and the environment (McColl, Hicks et al. 2003; CCME 
(Canadian Council of Ministers of the Environment) 2005). 
 
                                                 
1 At the project inception, 20 refineries were operating in Canada; two have since been closed down. 
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Figure 1: Geographic locations of Canada's 20 petroleum refineries 
 
Table 1: List of the 20 Canadian refineries included in HEIDI 
Canadian Refineries (Corporation and location) 
Chevron Canada Limited - Burnaby Refinery Parkland Refining Ltd. - Bowden Refinery (closed in 2001) 
Consumer's Co-operative Refineries 
Ltd./NewGrade Energy Inc., Regina Petro-Canada - Edmonton Refinery 
Husky Oil Operations Limited - Prince George 
Refinery Petro-Canada - Mississauga Lubricant Center 
Imperial Oil - Dartmouth Refinery Petro-Canada - Raffinerie de Montreal 
Imperial Oil - Nanticoke Refinery Petro-Canada - Oakville Refinery (closed in 2004) 
Imperial Oil - Sarnia Refinery Plan Produits Shell Canada - Raffinerie de Montreal-est 
Imperial Oil - Strathcona Refinery Shell Canada Products - Sarnia Manufacturing Centre 
Irving Oil Ltd. Refining – Saint John Shell Canada Products - Shell Scotford Refinery 
North Atlantic Refining - North Atlantic 
Refinery, Come-by-Chance Sunoco Inc. - Sarnia Refinery 
Nova Chemicals (Ltd.) - Nova Chemicals 




NERAM (the Network for Environmental Risk Assessment and Management) 
was engaged by the Health Prioritization Subgroup to provide a critical analysis of 
available prioritization schemes. In their extensive review, NERAM determined that a 
new tool would be needed to appropriately prioritize the refinery emissions, and 
developed a prototype of the tool, called HEIDI (Health Effects Indicators Decision 
Index) (McColl, Hicks et al. 2003). 
As a prototype, HEIDI provided proof-of-concept, ranking six substances for four 
refinery scenarios (three “real” refineries plus a hypothetical “worst-case” refinery). The 
rankings were carried out for various levels of model complexity, and were used to 
identify an appropriate base-case for expansion into a comprehensive screening-level 
prioritization tool.  
1.2.2 Model development: HEIDI II introduction 
HEIDI II was designed by NERAM in consultation with the NFPRER Health 
Prioritization Subgroup as an expansion of the HEIDI 1 prototype (Model 4c) previously 
developed by NERAM in 2002-03 (McColl, Hicks et al. 2003) 2. The level four prototype 
represented a model-based approach of relatively high complexity, and ranked substances 
using emission mass, toxicity weighting, physicochemical characteristics, and exposed 
population. The approach to model development was stakeholder-driven: throughout the 
development process all significant conceptual and methodological issues were reviewed 
on a periodic basis by the entire Health Effects Subgroup (HSP), or by delegated 
members of the HSP. The members of the NFPRER HSP included representatives from 
industry, NGOs, regulatory jurisdictions, and consultants. HEIDI II exists as a screening-
level tool designed to assist policymakers in prioritizing reductions of air emissions from 
each Canadian petroleum refinery on the basis of estimated risk to human health.  
Broadly, HEIDI II is a Microsoft Excel (Microsoft 2000) workbook3 which 
produces facility-level rankings of the potential health impacts associated with three 
classes of air emissions: (1) non-threshold-acting air toxics (carcinogens), (2) threshold-
                                                 
2 The HEIDI I prototype explored five levels of complexity for prioritization ranking schemes.  
3 As a major requirement of HEIDI II was that it be completely transparent to potential users, it was created 
using Microsoft Excel software Microsoft (2000)., which is widely used and allows tracking of equations 
and data. Additionally, no elements of the program use visual basic code of any kind, as this was found to 
cause difficulties for users whose computer security settings are controlled by the larger organizations by 
whom they are employed. 
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acting air toxics (non-carcinogens), and (3) criteria air contaminants (CACs)4 for each of 
the 20 refineries in Canada. As inputs to its calculations, HEIDI II considers the site-
specific annual pollutant emission data, location-specific background (ambient) air 
concentrations, degradation properties of the emitted substances, substance-specific 
toxicity data for each emission, and site-specific population densities. HEIDI II predicts 
health impacts for three different health effects endpoint types: cancer, non-cancer 
illnesses, and cardiorespiratory illnesses and death, employing a specific concentration-
response function for each class of health effects. 
HEIDI II provides three sets of relative rankings of the estimated health impacts 
associated with the substances emitted from each facility, based on (i) predicted 
incidence of health effects, (ii) a simplified disability-adjusted life year (DALY) measure, 
and (iii) a more complex DALY measure. The DALYs represent summary measures of 
health impacts that allow for a comparative ranking of the incidence and severity of 
health effects within each of the three classes of air emissions (or across classes if desired 
by the user).  
The following section provides a brief description of HEIDI II. For a more 
complete description of the input variables, data sources, and mathematical relationships 
between variables included in HEIDI II, please see Appendix B. Appendix C includes 
discussion of some of the limitations of the variable choices and justifications for their 
use. Decisions made about key parameters and a complete list of assumptions made 
during design of HEIDI along with the associated limitations and advantages are fully 
documented in the final technical report that accompanies the currently available version 
of the model (McColl, Gower et al. 2004).  
1.2.2.1 A description of HEIDI II – the deterministic version 
HEIDI II is best described as a modular tool (See Figure 2) that can be applied for 
any refinery in Canada. 
 
                                                 
4 The term “criteria air contaminants” was defined by the US Clean Air Act amendments of 1970 and refers 
to ambient pollutants that are widespread and reasonably expected to present a danger to public health or 
welfare (National Research Council, 2004). Although “CAC” was initially an American term, its use is 
now widespread in Canada. Ontario provincial documents may also refer to “common air contaminants” 
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Figure 2: General Structure of HEIDI II model. Note modular structure, with three main modules: 
(i) Air exposure module, (ii) Health effects module, (iii) Health impacts module. 
 
 Substances included in HEIDI II 
HEIDI II considers selected air pollutants that are reported annually to 
Environment Canada’s National Pollutant Release Inventory (NPRI) database 
(Environment Canada 2005). HEIDI II assesses 29 air toxics including two mixtures: 
polycyclic aromatic hydrocarbons (PAHs), and BTEX (benzene, toluene, ethylene, and 
xylene). The air toxics were selected for inclusion in consultation with the CCME's 
NFPRER Health Prioritization Sub-group based on the following criteria: quantity of 
emissions reported in NPRI, CEPA-toxic substances, substances included on Health 
Canada Priority Substance List (PSL2), and PSL scores for toxicity, persistence and 
bioaccumulation.  
The selection and characterization of the CACs was also accomplished in 
consultation with the Health Prioritization Sub-group. PM2.5 (fine particulate matter) was 
assumed to be an indicator of overall ambient air quality, and the concentration-response 
Air Exposure Module 
Health Effects Module 
Health Impacts Module 
NPRI annual emissions  
- air toxics 
- PM and PM precursors (NOx, SOx),  
Refinery-related air concentrations 
- carcinogenic air toxics 
- non-carcinogenic air toxics 
- PM2.5  
Meteorology 
Concentration-Response  







Predicted population case-incidence rates  
(sum across radial zones, by age groups) 
- cancer 
- non-cancer 
- cardiorespiratory illness related to CACs 










sex-age group apportionment of 
disease morbidity and mortality 
Air degradation
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functions chosen accounted for the health impacts of gaseous co-pollutants. PM10 and O3 
were not modeled HEIDI II in order to avoid “double-counting”, although the authors 
recognized the importance of O3 in particular for formation of photochemical smog. 
 
Data used to develop model predictions (deterministic version of HEIDI II) 
The HEIDI II tool is comprised of three modules:  
(1) The Air Exposure Module uses a USEPA air dispersion computer model 
(AERMOD) to estimate ambient concentrations of carcinogenic and non-carcinogenic air 
toxics and particulate matter (PM) in the airshed impacted by each refinery. Specifically, 
air concentrations are estimated for 20 zones (defined by five radii, each subdivided into 
four geographical quadrants, within a 25 km boundary (See Figure 3)).  
Refinery emissions data for the air toxics were retrieved from Environment 
Canada’s NPRI database (2001) (Environment Canada 2005), and emissions of criteria 
air contaminant (CAC) emissions were drawn from 2001 data provided by Environment 
Canada in 2003 for the HEIDI I project. This CAC data was collected from CPPI member 
refineries and from publicly available information for non-CPPI refineries. HEIDI II also 
estimates in a simplified manner the formation of secondary particulate matter from PM 
precursors (NO2 and SO2) using conversion factors found in the research literature. The 
air pollutants are assumed to be emitted continuously at a constant average annual rate 
from a single stack in the centre of the refinery property. It is assumed that each 
substance is emitted at a constant rate over the period of one year. A generic 
meteorological profile representing southwestern Ontario is used as the default scenario, 
and the terrain is assumed to be flat, resulting in physical air distribution patterns being 
generic and not site-specific. 
(2) The Health Effects Module estimates, for each refinery location, the 
predicted cancer incidence, systemic disease incidence, and cardiopulmonary disease 
incidence associated with the refinery’s contribution to the ambient air concentration of 
each substance. Health effects are first estimated for each of 20 “zones” around each 
refinery (See Figure 3) and then summed to obtain a total estimate of the impact of the 
refinery’s airborne emissions within 25 km of the facility. 
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To determine the population at risk, the Geographical Information System (GIS) 
software ArcMap (ESRI Inc. 1999-2002) was used to map site-specific population 
density profiles and Canadian age/sex distribution profiles extracted from 2001 Statistics 
Canada Census Data (Statistics Canada 2002). Environment Canada data for background 
air levels of pollutants from anthropogenic and natural sources collected in the vicinity of 
each of the refineries (Environment Canada 2003) was used to estimate the facilities’ 




Figure 3: Example of a refinery (Chevron refinery, located in Burnaby, B.C.) and the 20 "zones" for 
which (a) ambient concentrations of each substance and (b) population at risk were determined. 
Underlying polygons represent census dissemination areas from which population density 
information was derived using ArcMAP software. 
 
For estimating population health effects of air toxics, HEIDI II uses 
concentration-response parameter values based on standardized measures of 
concentration-response derived primarily from Health Canada source materials 
(Environmental Health Directorate Health Protection Branch 1996; Toxicology 
Excellence for Risk Assessment (TERA) & Concurrent Technologies Corporation 2004), 
or where Health Canada values are not available, from USEPA (Toxicology Excellence 
for Risk Assessment (TERA) & Concurrent Technologies Corporation 2004; U.S. 
Environmental Protection Agency 2004) or CalEPA sources (i.e., (California Air 
Resources Board 2005))(California Air Resources Board 2004). HEIDI II estimates 
chronic health effects associated with exposure to particulate matter (PM) based on the 
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extensively peer-reviewed American Cancer Society (Pope, Thun et al. 1995) and 
Harvard Six-City chronic epidemiology studies (Dockery, Pope et al. 1993), or values 
from their reanalyses (Health Effects Institute 2000) where appropriate. In these and 
other studies, the population health impacts associated with chronic exposure to PM are 
estimated to be as large as or greater than those from acute exposure. However, HEIDI II 
likely underestimates the health effects associated with acute (daily) PM exposure to 
some extent. Although acute endpoints for CAC exposure (such as visits to the 
emergency room due to asthmatic episodes) arise from exacerbation of an underlying, 
chronic disorder in most cases, an assessment of other potential short-term effects of PM 
exposure is not included in HEIDI. HEIDI also does not characterize the acute effects of 
exposure to photochemical smog. 
(3) The Health Impacts Module aggregates diverse health effects of varying 
severity using a common metric. Two variations of Disability Adjusted Life Years 
(DALYs) are applied for this purpose. In the first, a series of simplified DALYs is 
calculated based on an approach developed by ILSI which accounts for three basic levels 
of severity (Burke, Doull et al. 1996). The more complex form of DALYs, based on the 
World Health Organization’s 'global burden of disease' approach (Murray and Lopez 
1996), uses 140 illness categories representing fatal and non-fatal outcomes according to 
age, sex and other demographic factors.  
The final output of HEIDI II is a priority ranking of those NPRI substances in 
order of preference for emissions reduction, according to either the predicted health 
effects case-incidence rates (which do not consider severity of health effects) or the 




Several aspects of the HEIDI II program were designed to allow the user to set the 
scenario for analysis. The user-controlled options include stack height, hours of sunlight 
(which affects photodegradation) and an option to include substances in the ranking even 
if their emissions were reported as falling below the reporting guideline. 
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• Stack height - The default stack height is 30 metres, but HEIDI II can also 
perform rankings using stack heights of 5 metres or 15 metres.  
• Photodegradation time - The default setting for photodegradation time (important 
for predicting the amount of decay that a given chemical will undergo) is 12 
hours, but HEIDI II can also perform rankings using any photodegradation time 
from 0-24 hours (for Class I and Class II air toxics only).  
• Refinery emissions reported to be zero5 - Because many of the emissions fall 
below reporting guidelines set out by the NPRI, they are reported in the NPRI as 
being zero. In order to assess the rank order that might occur for substances if 
they are emitted at levels below the reporting guideline level, an alternate ranking 
scenario is available within the HEIDI II model. The user may choose a 
percentage value (1-99%) of the NPRI reporting threshold for substances that are 
reported in the NPRI as zero emissions. (The default setting for percent of the 
reporting threshold is 50%, if the user elects to include substances reported as 
zero emissions). With this scenario, all substances reported as being emitted at the 
zero level are evaluated at the same percent of their reporting guideline value (i.e, 
the user cannot select different percentages of the reporting guidelines for 
different substances). 
 
Outputs created by HEIDI II 
HEIDI provides the following three health impact ranking outputs for each facility: 
1) Ranking of pollutants based on predicted number of annual incident cases of 
health effects. This ranking does not take into consideration differences between 
types of health effects i.e. temporary, chronic, and fatal conditions.  
2) Ranking of pollutants based on simplified Disability Adjusted Life Years 
(DALYs) that provide a common measure for comparing the severity of different 
health endpoints (e.g. (i) irreversible/life-shortening, (ii) may be reversible, could 
be life-shortening, (iii) generally reversible, generally not life-threatening) across 
                                                 
5 This scenario was later removed from the probabilistic version. As described in the Methods chapter, 
using a percentage of the reporting guideline did not appear to be a realistic approximation of possible 
emissions for these substances, since emissions documentation was frequently provided for many 
substances which were emitted at levels below these guidelines. 
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the three classes of air emissions. The DALY calculation is based on years of life 
lost due to death and loss of quality of life due to illness.  
3) Ranking of pollutants based on more complex Disability Adjusted Life Years 
(DALYs) that consider type of cancer, type of systemic disease, or type of 
cardiopulmonary health effects.  
Note that the predicted numbers of incident cases and predicted numbers of 
DALYs are useful only for purposes of making risk-related comparisons between 
chemicals and do not represent actual risk. 
Application of HEIDI II results 
The purpose of HEIDI II is to provide a screening-level risk-based ranking of 
refinery NPRI emissions, to help inform users in prioritizing emissions reductions at 
petroleum refinery emissions. Screening analysis models are purposefully based on 
simple models that will not underestimate exposure, and are used for identifying 
scenarios of concern (Cullen and Frey 1999). There are considerable uncertainties in the 
data inputs and modeling assumptions within each of the three HEIDI II modules, and 
care is advised when comparing health impacts between cancer, non-cancer effects, and 
the criteria air contaminants. The rankings rely on rough statistical estimates of predicted 
incidence rates for a variety of health endpoints of widely differing severity. As the 
technical report points out,  
“The statistical models used to calculate priority rankings can provide useful 
guidance in relative terms by comparing estimated health impacts associated with annual 
emissions at the facility level, but they cannot adequately represent absolute estimates of 
health risk in the exposed populations.”  (McColl, Gower et al. 2004) 
1.2.3 Model Evaluation 
Development, testing, and validation of models should occur in an integrated way 
(Saltelli, Tarantola et al. 2004), where results of model testing may influence decisions 
about model design. McKay (McKay 1988) suggests that model evaluation involves three 
main objectives: (i) exploration and investigation of model calculations, (ii) sensitivity 
analysis, and (iii) uncertainty analysis. Initially, this involves basic testing of the model to 
identify errors in its structure and inspecting the structure and results for validity. 
However, full evaluation of a model requires a structured method for testing models 
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which allows for flexible analysis. Saltelli (Saltelli, Tarantola et al. 2004) sets out a 
specific framework for conducting sensitivity analyses (See Table 2). Applying these 
steps more broadly to include uncertainty analysis in the goals and methods of the 
analysis provides a useful framework on which to base model evaluation in general.  
1.2.3.1 Sensitivity Analysis 
Sensitivity analysis (SA) is used to determine to what degree model predictions 
are affected by variation in input values. The interpretation of SA varies depending on the 
reason for varying the input, including uncertainty, inherent variability, or manipulation 
by a modeler to represent alternate scenarios. SA identifies variables that matter to the 
model predictions; sources and ranges of variation for these variables ought to be well-
characterized where possible. Using SA to test the upper and lower-bound estimates for 
uncertain or variable inputs can also identify cases where variation in input does not 
affect model predictions in a significant way. These variables can be characterized by 
point estimates without any loss of information, allowing development of models that 
maximize information in model output without introducing unnecessary model 
complexity. Testing various methods of representing data or relationships within the 
model allows comparison of various modeling approaches and can determine whether 
simple representations of ideas are adequate. SA is also useful in providing a sense of the 
range of possible outputs that might be observed across a variety of scenarios. 
A common complaint regarding computer models is that, if manipulated in certain 
ways, they can be made to produce any output desired. According to Saltelli (Saltelli, 
Tarantola et al. 2004), sensitivity analysis can provide a valuable quality check and be 
carried out in a way that is unambiguous and defensible. She stresses the importance of 
defining the focus and setting for any sensitivity analysis that is carried out.  
Best practice for sensitivity analysis suggests that models should create only 
relevant outputs that address the object of the analysis, and not be clouded by excess 
complexity and outputs. As well, patchy or piece-wise sensitivity analysis should be 
avoided. Finally, sensitivity analysis should be used in the process of model development 
(Saltelli, Tarantola et al. 2004). 
 13
Table 2: Steps for conducting a sensitivity analysis (Saltelli, Tarantola et al. 2004) 
Step Action 
1 Establish the goal of the analysis and use it to define the form of the output function such that it 
answers your question. The question should be stated in a top-level form rather than in terms of the 
actual model output. 
2 Decide which input factors should be included in the analysis. Trigger parameters (which sample 
across model structures) may be defined 
3 Choose distribution functions for each of the input factors. These functions may derived from 
various sources: 
1. literature 
2. by fitting empirical distributions to empirical data 
3. expert opinion 
4. normal distributions truncated to avoid sampling outliers 
5. in the case of triggers, weights may be applied to the different values of the triggers if prior 
information is available about the relative likelihood of possible model structures 
6. correlation structures may be defined if appropriate 
4 Choose a sensitivity analysis method based on: 
1. the questions being addressed. (Is the issue a screening problem or is quantitative 
methodology required?) 
2. the number of affordable model evaluations (if the number of input factors is high, either 
the method of Morris or grouping of factors may be required) 
3. presence or absence of correlation structure between input factors (for screening, 
correlation can initially be dropped and subsequently reintroduced for the quantitative 
analysis of the few remaining important factors) 
5 Generate input sample (follows from method chosen for the sensitivity analysis) 
6 Evaluate the model on the generated sample and produce the output 
7 Analyze the model outputs, draw conclusions, possibly start a new iteration of the analysis 
 
Two broad types of sensitivity analysis include (i) a perturbative (or ‘local’) 
approach, which assesses the effect of varying one factor while all others are kept 
constant, typically by calculating partial derivatives, and (ii) a global approach, which 
evaluates the effect of the factor while all others are also varying (Saltelli 2002).  
McKay suggests that the local approach can provide a complete description of 
importance (McKay 1988). He identifies two specific methods for assessing importance 
with local measures: (i) using partial rank correlation coefficients, to measure the degree 
of strength of association between input and output (after the spread in variable values 
has been normalized), and (ii) using regression coefficients to measure the intensity of the 
relationship; i.e., change in output per unit change in input. Both of these methods could 
be used to assess the relationship between any input variable and model predictions. 
Those with the strongest relationship would be deemed most important to predicting 
output. 
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Saltelli advocates use of the global approach (Saltelli 2002; Saltelli 2004) and 
identifies several focused settings for sensitivity analysis. In the “factors prioritization 
setting”, the objective is to determine the most important factor, where this is defined as 
being the one which, if its “true value” was known, would most reduce the variance in the 
model output. This method is used to identify priorities in research. The “factors fixing 
setting” is designed to simplify complex models through identification of non-influential 
factors whose values can be fixed anywhere within their range of uncertainty without 
significantly reducing the variance in output. In the “variance cutting setting”, the 
objective is to reduce the variance of the target function from its unconditional value to a 
lower pre-established threshold value. Finally, the “factors mapping setting” is used to 
determine which factors are responsible for creating output in a region of specific 
interest.  
Variables, model parameters, or model formulations that are most responsive to 
changes in input are said to be more “sensitive”, and thus may play an important role in 
predicting outputs if they are naturally subject to variation or if they are highly uncertain. 
Thus, in the case of factors prioritization setting, sensitivity analysis is often also called 
“importance analysis”. 
Sensitivity analysis may be particularly important in the context of a ranking 
model such as HEIDI II since small changes in sensitive input variables could 
dramatically alter the output ranking order. The interpretation and communication of the 
meaning of a rank order relative to its sensitivity to changes in input must be considered, 
where the meaning of an alteration in rank based on a subtle change in predicted impact 
should perhaps be differentiated from alterations in rank due to larger changes in 
predicted impact. 
1.2.3.2 Uncertainty analysis 
Modelers of health impacts acknowledge that use of point estimates to represent 
model parameters limits the value of model output, and are moving away from purely 
deterministic methods (Pennington, Norris et al. 2000). Various levels of uncertainty 
have been described (Gough 1997). These include (i) risk, which exists where the 
behaviour or character of the parameter or system is reasonably well-known, and 
distributions can be assigned, (ii) scientific uncertainty, where significant parameters 
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have been identified, but their distributions are not known (iii) ignorance – about what is 
not known, and (iv) indeterminacy, where causal links, networks, and processes cannot 
be predicted. 
Probabilistic analysis allows propagation of uncertainties in model estimates to 
yield quantitative information about both the range and relative likelihood of model 
predictions (Cullen and Frey 1999). Bailar and Bailar (Bailar and Bailar 1999) and others 
have identified various types of uncertainty that are relevant to modeling environmental 
health impacts, including parameter uncertainty, model uncertainty, and scenario 
uncertainty. Parameter uncertainty, which is associated with either a lack of knowledge 
about specific variables in the model, or inherent variability in the factors, is typically 
addressed using traditional statistical techniques such as calculation of standard 
deviations for each variable or Monte Carlo Simulation, which includes the probability of 
observing each value in the uncertain range calculated for the output (Morgan and 
Henrion 1990). These methods are well-established, and while they cannot reduce the 
uncertainty inherent in a given set of data, they allow appropriate description of the 
possible variation in outcome that could result from it. Model and scenario uncertainty 
are more difficult to assess. Model uncertainty refers to the construction of the model and 
how various elements are related to each other. An example of a gap in knowledge that 
creates model uncertainty is the controversy about whether linear, non-threshold models 
are sufficiently accurate to set conservative limits for exposure to carcinogens. Sensitivity 
analysis, in which changes in output are monitored as various input parameters (including 
functional relationships such as dose-response functions) are changed, is one method of 
assessing model uncertainty. It is also possible to include alternate formulations of a 
model in a simulation designed to assess the extent of uncertainty in outputs that could 
result from model uncertainty. Scenario uncertainty refers to the relevance of the model 
output, and may be partly addressed through formulation of alternative scenarios to see 
how well the model performs in a variety of related situations (Pruss, Corvalan et al. 
2001). Some attempts have also been made to address scenario uncertainty through use of 
cultural theory, which distinguishes value systems which may be helpful in explaining 
peoples’ attitudes (Hofstetter 1998; Goedkoop and Spriensma 1999). In general, current 
methods to address model and scenario uncertainty are inadequate, and disciplinary 
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perspective can often colour how uncertainty is viewed and treated by scientists (Bailar 
and Bailar 1999). This may be important for communicating about how to use HEIDI II 
and how to interpret the results since users may include risk assessors, toxicologists, 
policy-makers, or interested members of the public. 
Uncertainty analysis may be helpful in identifying key sources of uncertainty and 
variability that can focus future research activity (Cullen and Frey 1999). Dominici and 
Burnett confirm that providing uncertainty estimates for predictions relating air pollution 
to health effects is necessary to prioritize future research initiatives, and for more 
effective communication with regulators and the public (Dominici and Burnett 2003). 
Industrial representatives agree that uncertainties must be explicitly identified and 
communicated in order to prevent the development of inappropriate or untimely policies 
(Granville 2003). 
There are various methods for identifying key contributors to uncertainty in a 
model. Before a simulation is carried out, the magnitude of the variation of each input 
can be compared. For linear models in particular, the magnitude of the estimated 
variation indicates potential to contribute to output uncertainty. Coefficients of variation 
(determined by dividing the variable variance by its mean value) can also be used to 
identify a priori potentially important inputs for linear models. Sensitivity analysis 
techniques are also appropriate, since the uncertainty about a highly influential variable is 
more likely to propagate through the model and affect model predictions. For example, 
after the simulation has been carried out, scatterplots of inputs versus the corresponding 
model outputs provide a visual sense of whether one influences the other. The input and 
output values can be regressed against each other in multivariate regression, and 
correlation coefficients6 can be calculated, where coefficients >0.5 indicate substantial 
dependence (Cullen and Frey 1999). The specific methods used to evaluate uncertainty in 
HEIDI II are described in the methods section (Chapter 3). 
Numerical methods for probabilistic analysis are useful for several reasons: they 
accommodate a wide variety of assumptions, can evaluate the effects of correlation and 
dependencies, and their accuracy increases as the sample size is increased. LHS (Latin 
                                                 
6 The type of correlation coefficient may depend on the function under study, i.e. for nonlinear monotonic 
functions, use of rank correlation may be most appropriate. 
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Hypercube sampling) may perform better than Monte Carlo simulation for a given 
sample size (number of iterations). However, LHS may have limitations with respect to 
estimating higher moments such as variance, skewness, or higher percentiles, which are 
more sensitive to extreme values (Cullen and Frey 1999). In both sensitivity and 
uncertainty analysis, it is important to consider the possibility that variables may be 
correlated, and to account for this in the analysis. 
The importance of including uncertainty analyses in HEIDI II cannot be 
overstated. HEIDI II is designed as a ranking tool – and it must be clear how sure the 
predictions are that any given substance is ranked higher than the next. Both the degree of 
separation between the rankings and the level of certainty about whether adjacent 
rankings are distinct will be important for policy decisions which are informed through 
use of this tool. 
1.2.3.3 A note on variability 
 It is important to distinguish between uncertainty and variability. Uncertainty 
denotes a lack of knowledge – about the true value of a parameter, the correct way to 
structure a model, or the most appropriate scenario construction, and is typically 
characterized using probability distributions. Variability is an inherent, empirical 
distribution of values for a given parameter within a population sample, and is most often 
characterized using frequency distributions. Variability is irreducible, and may occur in 
various dimensions: across space, time, geographic area, age, gender, or other specific 
population subgroups (Hattis and Anderson 1999).  
Bailar and Bailar note that heterogeneity (inherent variability) must be 
distinguished from uncertainty (highlighting the specific cases of differences between 
children and adults, sensitive subpopulations, and synergies with prior, concurrent, or 
later exposures to other agents) (Bailar and Bailar 1999). Hoffman and Hammonds 
(Hoffman and Hammonds 1994) also note the need to distinguish whether uncertainty in 
a model is due to lack of knowledge or variability, indicating that the presence of both in 
a single model may require two-dimensional Monte Carlo simulation to produce 
alternative distributions of output. Carrying out Monte Carlo analyses using distributions 
that describe both variability and uncertainty may complicate interpretation of the results 
(Cullen and Frey 1999). 
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1.2.3.4 Choosing Ranges and Distributions 
 Model evaluation should occur concurrently with model development, with 
iterations of analyses being performed as knowledge about the behaviour of the model 
increases. As a result, progressive “runs” may use various degrees of knowledge about 
the input variables. Initial runs may be designed to assess which variables are influential 
to the model output and which do not have to be specified with a high degree of 
knowledge. The range of variation selected to describe each input value in such a case 
may be based on informed guesses or intuition, and be revised at a later time (McKay 
1988).  The selection of appropriate parametric information must consider the purpose 
and type of information being conveyed by each model component. Morgan and Henrion 
identify several types of quantities that may exist within a model, including empirical 
quantities, defined constants, decision variables, value parameters, and model domain 
parameters (Morgan and Henrion 1990).  
 Where possible, selection of probability distributions should be informed – 
perhaps by a review of the literature, from empirical data, or through expert knowledge. 
Some common probability distributions are described in Appendix A. 
In practice, selecting probability distributions may sometimes be a somewhat 
arbitrary process. However, the effect of selecting certain probability distributions can be 
explored either by repeating the simulations using alternate probability distributions, or 
by using the original simulations to approximate a response surface and studying it under 
different distributions (McKay 1988). If significant differences in model output are 
observed when alternative plausible input distributions are used, it may be beneficial to 
spend more time identifying the best representation for inputs.  
1.2.4 Purpose and Objectives 
• To test and validate HEIDI II   
• To evaluate the model through application of  sensitivity analysis, importance 
analysis, and uncertainty analysis 
o To identify appropriate ways of characterizing both uncertainty and 
variability within the model 
o To identify an appropriate form of the model which incorporates the 
maximum amount of information while maintaining parsimony 
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o To identify variables which have a large influence on model predictions 
o To identify variables which contribute the most uncertainty to the 
predictions 
o To examine how uncertainty and variability affect our understanding of the 
rankings produced by HEIDI II 
• To use HEIDI II to make predictions about important emissions for health impacts 
at Canadian refineries 
• To use HEIDI II to explore how predictions change under various scenarios 
• To use HEIDI II to explore the implications of uncertainty for predictions 
• To explore methods of ranking stochastic data 
• To discuss interpretation of predicted ranking under various scenarios 
• To identify limitations of HEIDI II and possible areas for improvement 
1.2.5 Rationale 
 A great deal of effort on the part of many stakeholders, and in particular, on the 
part of NERAM, was involved in the conceptualization and creation of HEIDI II. This 
tool was designed with the intent that it should be used (in conjunction with other tools 
and methods) by regulators, industry, NGOs, and other stakeholders for determining 
realistic and useful emissions reductions for the petroleum refining industry in Canada. 
The additional work completed here (a) increases the capabilities of HEIDI II and its 
usefulness to the stakeholders, (b) identifies the most important variables for achieving 
high rankings, (c) explores the effects of uncertainty on the model predictions, (d) using 
up-to-date information, provides clear, comprehensive summaries of HEIDI II’s 
predictions for each of Canada’s refineries alongside thoughtful discussion of the 
implications of these predictions, and (e) explores predictions that could emerge from 




 Much of the testing and validation of HEIDI II was done using predicted case 
incidence as an endpoint. This is in no way intended to suggest that the case incidence 
values predicted from HEIDI II are representative of real numbers of cases of illness 
caused by airborne emissions from petroleum refineries. The values predicted by HEIDI 
II are intended to be used for comparative purposes only. They have not been ground-
truthed and are based on several assumptions inherent to the model, which are 
documented elsewhere in this thesis (see especially, Appendix C) and in the technical 
report accompanying the publicly available version of HEIDI II (McColl, Gower et al. 
2004). In particular, generic meteorology and geography were used to describe vastly 
different geographic locations across Canada. 
 HEIDI II should be used as a screening-level tool, with predicted health impacts 
(predicted case incidence, or predicted DALYs) to be used for ranking emitted substances 




The starting point for this project is considered to be a lightly tested deterministic 
version of HEIDI II coded in Excel (McColl and Gower 2004; McColl, Gower et al. 
2004). The methods describe further testing and validation of the deterministic version, 
and development, testing, and validation of a probabilistic version of HEIDI II, coded in 
a more sophisticated computing environment, Matlab (Mathworks 2002). Methods for 
identifying sources of uncertainty in model predictions and important variables for 
predicting priority substances for reduction are described. Once an acceptable model was 
developed, it was used to make predictions and explore implications about priority 
emissions from refineries across Canada.  
1.4.1 Development, Testing, and Validation 
 Development, testing, and validation must occur in an integrated way (Saltelli, 
Tarantola et al. 2004), where the purpose and scope of the model determines model 
design, model formulation sets up how the model is assembled in order to achieve the 
model’s goals, and correct computation ensures that appropriate numbers and coding is 
used to produce error-free predictions that accurately reflect the formulation of the model 
(See Figure 4). As the figure implies, errors can be introduced in any of these three 
aspects of the model, at any stage of model development; it is crucial that they be 
evaluated continuously throughout the development and testing process. 
 The general approach followed to develop the HEIDI II probabilistic model 
included the following steps: 
1. Catalogue and describe all model variables 
2. Test and validate deterministic model 
3. Assign probability distributions to each model variable where possible 
4. Conduct sensitivity analysis to assess impact of different variable values 
a. For uncertain/variable inputs 
b. To assess various possible scenarios  
5. Conduct uncertainty analysis to determine possible range /distributions of 
predictions 
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6. Test and validate probabilistic model; make recommendations about final form of 




Biological Realism and Relevance
Heuristic Value
Utility for extraploation to other conditions
MODEL FORMULATION
Structure reflects model objectives
Robustness under extreme inputs
Sensitivity to changing inputs
Agreement with other models







Figure 4: Aspects of the model which must be considered in an integrative and ongoing way during 
development, testing and validation.  See Table 3 for specific testing methods 
1.4.1.1 Model Inventory 
 An inventory of all model variables, including original data source, type of 
variable, and mathematical relationship(s) to other variables was compiled (See 
Appendix B). This allowed ordered testing of each variable to ensure appropriate 
representation in the model according to the model design.  
1.4.1.2 Testing and Validation of the deterministic Excel version 
The process described in Figure 5 was applied iteratively by the researcher as the 
model gained complexity. It was initially used to test the deterministic version of the 
model and later used for testing and validation during development of the probabilistic 
version. Following the approach depicted in Figure 5, and using the tabulation of model 
variables as a guide, each variable was examined within the module where its 
functionality resides. Module-by-module testing was completed first, and then HEIDI II 
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Figure 5: Basic Testing and Validation Approach for HEIDI II. This approach was used for each 
module individually, and then for the model as a whole. 
 
 
The individual variables were classified as being subject to variation as a result of 
mainly (i) variability, (ii) uncertainty, or (iii) scenario choices. The uncertain and/or 
variable inputs were first tested while keeping the scenario variables at pre-selected 
default values. Once the functional relationships and variable values were confirmed as 
being reasonable for the model, the effects of applying the various scenarios available to 
the user (i.e., different refineries, stack heights, photodegradation times, emission year 
data etc.) were tested.  The specific criteria and methods used to complete the testing and 
validation (for both the deterministic and probabilistic versions) are described in Table 3. 
The validation process also requires documentation of all assumptions made during 






Table 3: Criteria and methods used for testing and validation of HEIDI II throughout the development process for the probabilistic model 
Validity Criterion Definition Methods used to test whether HEIDI II met this criterion 
Computation   
Internal Consistency 
How each model item independently relates to each 
other model variable and how they are related 
overall (i.e., populations in each zone add up to 
total population, total of fraction of PM observed in 
each zone adds up to one) 
• Determine how each variable in HEIDI II relates to each other variable 
(tabulations, flow charts). If more than one method of calculating a 
variable is possible, values are similar from each calculation method. 
• Redesign HEIDI with (n-1) degrees of freedom to redefine variables in 
terms of each other 
Absence of numerical 
(computational) artifacts 
Examples: rounding-off errors which may affect 
non-monotonic functions (such as the ranking 
procedure), true 0 vs. notional 0, overflow and 
underflow effects, dealing with ties in the ranking, 
missing values handling 
• Visual/graphical inspection of results at each stage along the model 
pathway to ensure realism of results 
• Documenting software handling of relevant issues such over-/underflow 
• Programming of HEIDI II in second environment (i.e., Matlab) to ensure 
predictions are the same 
Computational 
Correctness 
Model does not contain mathematical mis-
specifications or oversights 
• Visual inspection of results to assess realism 
• Disaggregation of HEIDI II into component modules to test inputs and 
outputs 
• Dimensional analysis – ensure that formulas predict correct units 
• Programming of HEIDI II in second environment (i.e., Matlab) to ensure 
predictions are the same 
Model Formulation   
Model form is correct 
Overall structure and equations, regardless of 
parameter values, accurately reflects model 
objectives 
• Literature review to summarize current practice, knowledge, and thought 
re processes being characterized in HEIDI II, especially wrt thresholds 
and linear vs. nonlinear dose-response relationships 
• Document simplifying modeling assumptions 
• Annotation/documentation of reference sources 
Robustness to changing 
input parameters 
Model does not break down under differing input 
and exposure scenarios 
• Apply emissions across a wide range of values to ensure that predicted 
case incidence reflects the dose-response form of the model selected. 
• Apply a wide range of values in place of each input variable 
• Visual inspection of results to assess realism under this range of 
emissions scenarios, also under each input/scenario selection option 
Sensitivity to changing 
input parameters 
Changes to key input parameters result in 
appropriate changes in model outcomes 
• Sensitivity analysis  – assess whether changes in inputs result in 
reasonable changes in outputs 




Parsimony Model is not over-parameterized or unduly complex 
• Sensitivity analyses should indicate which variables are most/ least 
important in output predictions. 
• This identifies which variables need to be characterized in terms of 
uncertainty/variability and which do not 
• If any of the scenarios available to the user do not actually alter 
predictions, they should be removed, and documentation provided to 
explain the change in model formulation. 
Model Design   
Generalizability The model is suitable for more than one application or use 
• Determine whether HEIDI II could be adapted to (i) other industries (ii) 
include more substances (iii) other geographical areas, such as the U.S. 
context 
• What steps would be involved, complexity of achieving this, scenarios 
that could not be included (i.e., exposure other than inhalation?) 
Biological realism and 
relevance 
Underlying biological mechanisms are correctly 
specified 
Assess limitations of dose-response methodology used, impact on 
predictions of HEIDI II. Compare to other methodologies, such as EPA’s 
linear dose-response models; use of RfD rather than ED05 




characterizing the same 
process 
 
Comparison to rankings that would be obtained using TRACI 
characterization factors 
 
Possible comparison to rankings obtained by HEIDI I for those chemicals 
that were assessed in the original prototype 
Heuristic value Model provides useable indicator variables that inform policy decisions 
Discussion of CCME/NFPRER requirements, value of priority ranking 
strategies 
Capacity to deal with 
dose-dependent biological 
responses 
 Discussion of approaches used for each different substance class (linear for carcinogens and CACs, Mantel-Bryant for air toxics) 
Useful in extrapolation to 
other conditions  
• Identify various scenarios for which HEIDI II can be used. Identify other 
scenarios which might be useful; assess difficulty of addressing with 
HEIDI 
• Assess utility of HEIDI II in low-dose situation. Is there an emissions 
level below which HEIDI II is unable to effectively prioritize (i.e., 
below-threshold predictions?) or a population level below which 




In preparation for upgrading HEIDI II to probabilistic format, it was recoded in 
Matlab, a computational environment that allows greater flexibility in implementing and 
testing various model formulations. The program offers the additional advantage that 
evaluation time during Monte Carlo simulations was reduced compared to the 
Excel/Crystal Ball approach7. Once the deterministic model output from the two software 
programs (Excel and Matlab) was shown to match, the model development steps required 
to extend the Matlab model were undertaken.  
1.4.2 Model Development: Probabilistic adaptation of HEIDI II. 
 Once HEIDI II was recoded in Matlab and predictions from the Excel and Matlab 
environments were in perfect agreement, probabilistic elements were introduced. 
Adapting HEIDI II into a probabilistic model essentially constituted a series of 
adjustments in model design. As development proceeded, at each update to the model 
(i.e., with new data, implementation of mathematical relationships or computations, or 
design elements), the process depicted in Figure 5 was re-initiated.  
Distributions were identified to represent model variables where possible. For 
each variable, sources of uncertainty, the level of uncertainty, and the level of evidence 
were catalogued (see Appendix C). Specific (extra) sensitivity analyses deemed to be of 
interest for any individual variable were documented, and possible correlations with other 
model variables were identified. For each variable, justifications, notes, and comments 
about the parameterization of the variables, data sources, and limitations of the variable 
representation were also recorded. In cases where probability distributions could not be 
established, the implications of using point values were also assessed and recorded.  
The default model for testing and analysis of the probabilistic model was selected 
to be a hypothetical worst-case scenario, using a stack height of 30 metres and a 
photodegradation time of 12 hours. This scenario uses the maximum annual emission 
observed across all Canadian refineries to represent each individual substance emitted, 
and therefore incorporates an emission for every substance included in the model (which 
is not the case for any individual Canadian refinery). It also uses high enough emissions 
                                                 
7 Crystal Ball (Decisioneering 2000) is a forecasting and risk analysis software add-in for Microsoft Excel, 
and allowing probability distributions to be assigned to spreadsheet values. It was used in preliminary 
analyses but is not referred to further in this document as Matlab was used for all results presented. 
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that some predicted incidence of disease might be expected, but uses realistic emissions 
levels – as they are levels that have been recorded at real refineries. A political 
motivation for employing this as a default scenario was that it does not single out one real 
refinery for more in-depth analysis than the others. A stack height of 30 metres was 
chosen since it was thought to be most representative of the stack heights that exist at 
Canadian refineries (Hicks 2005), and 12 hours was selected as an annual average of the 
amount of daylight that might be expected during the day8. 
1.4.2.1 Focused settings for conducting Sensitivity Analysis  
 
Although each variable in HEIDI II is likely subject to both uncertainty and 
variability, given the data available, it is not possible to sufficiently distinguish the two to 
enable assigning two separate probability distributions. However, it is usually apparent 
whether uncertainty or inherent variability dominates the reasons why a variable may 
take on a range of values. Distinguishing the variables by predominant “source” of 
variation informs the interpretation of the results of the sensitivity analysis (see Table 4 ).  
1.4.2.2 Sensitivity Analysis (SA) 
Although HEIDI II’s final output is a rank order, full-model SAs were performed 
using predicted incident cases as the output of interest. Because rank order is a 
categorical rather than continuous output, using rank as the output for SA results in a loss 
of information (i.e., variation in input could change predicted case incidence for at least 
one substance but not alter rank order, or where only one substance in a class is 
associated with any predicted case incidence, rank order would not change no matter 
what variation occurred in inputs for that substance). Predicted health impact may be a 
more relevant indicator of how well the model performs. Although DALYs are intended 
to be the health impact measure upon which ranking/prioritization is based, in HEIDI II 
they are simplistically operationalized as point values (in terms of DALYS per person per 
year), and no relevant information about uncertainty in DALYs is available. Focusing on 
                                                 
8 The amount of time for photodegradation might be more properly estimated based on annual average 
amounts of “sunlight”; in any case, the amount of either daylight or sunlight depends on the geographic 
location within Canada, and the assumption of 12 hours may not be appropriate for all locations. It does 
provide a useful base-case however, and sensitivity analysis addresses whether the amount of sunlight is an 
important predictor of the amount of each substance delivered to populations near refineries.  
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predicted case incidence rather than DALYs as an output is thus unlikely to result in a 
loss of information from the sensitivity analysis, and additionally, may be a more 
intuitive metric for the reader.  
Table 4: The major contribution to variability (i.e., parametric uncertainty vs. inherent variability) 
for inputs used in HEIDI II directs the interpretation of the sensitivity analysis results  
Dominant reason to perform SA Variables/formulations 
tested 
Assess impact of parametric uncertainty (the true value of a variable is 
not known, perhaps because of  technological limitations in 
measurement, lack of data, human error, or systematic uncertainty) :  
 
(a) for variables that appear to be influential in the sensitivity analysis, the 
uncertainty of the parameter value is an important factor in limiting the 
predictive ability of the model. Improved datasets for these variables 
would enhance the model’s predictive precision. 
 
(b) for variables that appear to be non-influential in the SA, the extent of 
the uncertainty manifested in the model predictions is likely small relative 
to that resulting from other variables, and better precision in characterizing 
the variable will not improve the model’s predictive ability. 
• k – substance-specific 
photodegradation rate 
constants 
• Atmospheric [OH]9 
• C-R (concentration-
response data) 
• Class 1: unit risk 
• Class 2: threshold 
        Mantel-bryan slope 
• Class 3: RR 
• Specific analysis for 
especially uncertain values 
Assess implications of inherent variability (where a variable may truly 
take on a range of values  within a given population or dataset; 
improved measurement techniques will not reduce variability): 
 
(a)  for variables that appear to be influential in the SA, the inherent 
variability is an important determining factor in predictions. Gaining a 
better sense of the true extent of the variability through improved 
monitoring or more frequent measurements may be useful. For contexts 
where data might be locally gathered and available, and less variable than 
the more broad data used in HEIDI II, substitution of this data into HEIDI 
II may result in more precise predictions. For variables that can be affected 
by policy decisions (i.e., background levels of airborne pollutants), HEIDI 
II may offer a method of assessing the extent of health improvements that 
could potentially be achieved.  
 
(b) for variables that appear to be non-influential in the SA, the different 
values the variables may take on do not affect the model predictions. 
Attempts to adjust the factor through policy or other intervention will 
likely not improve health of the affected population 
• Annual emissions 
• Background 
concentrations 
Compare predictions from different model formulations (model 
uncertainty) 
 
Assesses whether different formulations of the model affect the 
predictions; if not, then the most parsimonious formulation is desirable.  
• Different values for 
Mantel-Bryan slope 
• Approaches for 
characterizing 
background data 
• Calculation of 
photodegradation 
Assess implications of scenario uncertainty 
 
• High vs. low dose 
• Stack height 
                                                 
9 [OH] may also be inherently variable since it depends in part on ambient pollution levels and local 
meteorology and geographic conditions 
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Provides information about the range of predictions that might be expected 
under alternate sets of conditions which may occur at any given refinery. 
• Amount of time for 
photodegradation 
• Population distribution 
around refinery 
 
1.4.2.2.1 Local Sensitivity Measures 
 Various measures of sensitivity may be calculated when performing local 
sensitivity analysis (which is where the values assigned to only one variable are altered to 
determine the effect on model predictions). The measures used to explore the sensitivity 
of inputs in HEIDI are described below: 
SR – Sensitivity Ratio 
 
 The sensitivity ratio (SR) measures percent change in output relative to percent 

















 This measure normalizes the amount of change in output (here, in predicted 
incident cases) by the amount of variation in the particular input variable. For HEIDI II, 
this measure was useful for assessing the effect of uncertainty in variables that 
functionally acted on all substances in the same way but had substance-specific 
probability distributions (i.e., concentration-response parameters for a particular class of 
substances, where the same type of function was applied to calculate incidence for all 
class 2 substances, but the probability distribution of the toxicity data which determined 
where the function was anchored was different for each substance). 
Percent change in output 
 
The percent change in output alone can be assessed for two input values, x1 and 
x2:  
% change = (y2-y1)/y1 
 The x1 and x2 values selected to test the sensitivity of the model can either be a 
fixed percentage of themselves (i.e., what is the effect of changing an input by 5%?), or 
be determined by the standard deviations of the inputs. Some inputs are inherently likely 
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to take on a wider range of values than others, so when the standard deviation is used to 
determine y1 and y2, the percent change in output accounts for the impact of anticipated 
“realistic” variability in an input on predicted incidence. This is a simpler metric that was 
useful in HEIDI II for comparing the relative importance of inputs whose distributions 
are not substance-specific (such as [OH]), since the x1 and x2 values would remain 
unchanged for each substance-specific evaluation.  
Absolute change in output value 
 
 The absolute change in predicted incidence provides information about whether a 
large or small relative change in predicted incidence that was observed in the SA might 
be meaningful. In some cases, large percent changes in predicted incidence were related 
to absolute changes on the order of 10-12 or smaller. Given the limitations of HEIDI II, 
values this small cannot be reasonably interpreted as representing real variation, and do 
not represent a meaningful difference in predicted incidence in a regulatory or policy 
context in any case. 
Local SA for substances subject to uncertainty or variability 
 
For examining inputs that are subject to uncertainty or variability, the local 
sensitivity measures were calculated based on the change in predicted case incidence for 
each substance associated with a change of 1 standard deviation (both increases and 
decreases) in input. For each calculation, only one variable of interest was altered at a 
time; the others were held constant. The variables of interest were:  
• emissions 
• rate constant for photodegradation (k) 
• atmospheric concentration of hydroxyl radical 
• background (ambient) concentration of each substance  
• concentration-response (C-R) parameter for each substance.  
For some substances, the SR could not be calculated. This occurred when either 
the input value or the predicted value was zero (resulting in a value of infinity being 
calculated for either the numerator or denominator of the SR), or when the input was not 
a single number. For example, the C-R value of BTEX was a complex combination of the 
C-R parameters for benzene, toluene, xylene, and ethylbenzene, and the concentration-
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response values for class 3 substances were complicated amalgamations of relative risk 
values for children, adults and seniors. To evaluate the sensitivity of these inputs, the 
other local measures of sensitivity plus results from the global sensitivity analyses were 
considered. 
Extra sensitivity analyses were performed for C-R values for several individual 
substances including Ni, PAH, and V as a result of particularly high uncertainty 
surrounding their toxicity values. 
Local SA for various scenarios possible within HEIDI II 
 Local measures of sensitivity were also applied to estimate the implications of 
selection various scenarios for the HEIDI II model: 
 
Inputs that define model scenarios and have user toggles: stack height and 
photodegradation time 
 For user-selected inputs such as stack height and photodegradation time, the range 
of model predictions was explored across the range of allowed inputs. The interaction of 
stack height and photodegradation was assessed using response surfaces for total 
predicted case incidence at various distances from the refinery. The absolute and percent 
change in predicted case incidence for each alternate scenario was compared to the 
default scenario. 
 
Inputs that define model scenarios without user toggles: population and background  
The effect on predicted case incidence of altering the population distribution 
around the refinery was investigated. For the hypothetical refinery scenario, a standard 
population of 1 000 000 was manipulated to create the following population 
density/dispersion scenarios  
a) homogeneous 
b) heterogeneous outward – where population density increases moving from 
zone to zone away from the refinery (using 1x, 2x, 3x, 4x, 5x population 
density for each subsequent "circular slice" moving away from refinery) 
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c) heterogeneous inward – where population decreases with distance from 
the refinery (similar to the refinery being situated at the centre of an urban 
area),  
d) all population in the north  
e) all population in the south 
f) all population in the east  
g) all population in the west 
 
Sensitivity analysis was used to compare two different background scenarios. The 
first, which was used in the deterministic version of HEIDI II, employed site-specific 
values for ambient concentrations of each substance modeled. Many of the values were 
based on incomplete data or data from monitors that were not directly adjacent to the 
refineries. An alternate, “low/medium/high” background scenario was proposed, where 
the divisions between each category were determined based on the population of each 
community and the imperfect location-specific background data that was used in the 
original HEIDI II model. The method and values used to choose the low/medium/high 
scenarios are detailed in Appendices C, G, and H. 
Response Surfaces 
Response surfaces may be created to investigate the possibility of interaction 
between model inputs. These are “maps” of model predictions in three dimensions: 
output is on the vertical axis (z-axis), and each of two inputs are varied along x and y 
axes. These provide good visual representations of whether two variables may interact to 
affect the model output, and provide focus for further (numerical) investigations, if 
needed. 
 
Possible interactions with class 2 “estimated threshold” 
For class 2 substances which were assumed to be threshold-acting, response 
surfaces were plotted to investigate the possibility of interaction between the 
concentration-response parameter (estimated threshold) selected for each of the class 2 
substances with (i) background concentration of each of the substances (ii) mantel-bryan 
slope factor used to anchor the concentration-response curve. 
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1.4.2.2.2 Global Sensitivity Analyses 
In global sensitivity analysis, the effect on model predictions of simultaneous 
variation of all variables is explored. Monte Carlo simulations were run where the values 
of all probabilistically-defined inputs were simultaneously allowed to vary according to 
their probability distributions. According to Cullen and Frey (Cullen and Frey 1999), a 
good way of identifying influential variables in a Monte Carlo Simulation is to create a 
scatterplot of input values vs. the associated outputs. Scatterplots of input vs. predicted 
case incidence were created for each substance to determine the influence of the input 
variables of (i) OH atmospheric concentration, (ii) k values (which determine rate 
constant of reaction with OH), (iii) background concentration, and (iv) toxicity values, on 
the output of predicted case incidence.  
Spearman rank correlation coefficients were calculated for each input/substance 
combination. Calculating the correlation coefficients between inputs and output (using 
predicted case incidence as the output of interest) helps to identify significant 
contributors to variance in the output (Cullen and Frey 1999). The rank correlation 
coefficient is useful in cases where scale may be very different, as in HEIDI II where k is 
on the order of 10-12, while ED05 values can be on the order of 105.   
The number of iterations used for the simulation was initially varied to ensure that 
an adequate number of runs were being used to assess trends and correlation. Final 
analyses were run with 100,000 iterations which was sufficient to show trends where they 
existed without overburdening the computational time and resources required. 
1.4.2.2.3 SA in general 
 The sensitivity analysis results were used to identify which variables are and are 
not influential for predicting case incidence. SA results were used throughout the model 
development and validation process to determine which variables most needed to be 
characterized in terms of uncertainty or variability (or both) for the model output to 
accurately reflect the current level of knowledge about the variables and processes 
included in the model. The information obtained from the sensitivity analyses was also 




 Finally, the sensitivity analyses (especially identification of influential variables) 
were also important to help interpret model results for policy applications. 
1.4.3 Model Predictions (Uncertainty Analysis Results) 
Frequency distributions for predicted case incidence from exposure to each 
emission at the hypothetical worst-case refinery were created using Monte Carlo 
simulations with 100 000 iterations. For class 1 and class 2 substances, the proportion of 
the frequency distribution curve below the de minimis risk level of 10-6 was identified, 
and substances for which the entire frequency distribution was below the de minimis risk 
level were documented. The distributions were truncated at the 99th percentile to improve 
graphical representations of the distributions, but the full distribution was used for the 
numerical analysis. For class 3 substances the whole distribution was above the de 
minimis risk level, so this type of analysis was not relevant. Instead, the 5th, mean, and 
95th percentile values for predicted case incidence were extracted, along with the mean 
risk level. 
The same approach was followed for each of the 20 real refineries in Canada. A 
list of class 1 and class 2 substances for which a proportion of the predicted case 
incidence frequency distribution was above the de minimis level was retained to enable 
identification of common substances of concern. The 5th percentile, mean, and 95th 
percentile values for predicted case incidence and the mean risk level were calculated for 
class 3 substances at each refinery. 
1.4.4 Ranks at the Hypothetical Refinery 
 The distribution of ranks predicted for each substance during the simulation was 
determined on a within-class basis. The number of times each substance was assigned 
each possible rank during the simulation was determined and extracted for each class. For 
class 2 substances, 25 ranks were possible, but only the top ten ranks are presented, to 
improve clarity. 
 These frequency distributions indicated that there was overlap in which 
substances were identified as being highest priority. As a result, various methods for 
ranking the substances both within each class and across classes were compared. The 
methods used were  
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a) rank from the deterministic model  
b) rank based on the mean value predicted in the Monte Carlo Simulation,  
c) test of second-degree stochastic dominance (described in chapter 5), and  
d) rank based on proportion of cumulative probability distribution exceeding 10-6 for 
substance-specific predicted case incidence.  
Each of these values was determined separately using predicted case incidence, predicted 
simple DALYs and predicted complex DALYs (except method (d)). 
 The top three ranked substances were identified within each class, and also from 
the across-class rankings. This enabled determination of whether the priorities were 
consistent across ranking methods. This (i) allowed assessment of the utility of different 
ranking methodologies and (ii) provided evidence about whether the model was capable 
of identifying high priority substances.   
 Correlation coefficients comparing the ranks predicted for each substance using 
each of the within-class ranking approaches were calculated to check how similar the 
results were across ranking methods. 
1.4.5 Further Analysis 
1.4.5.1 Impact Equivalents 
 As an alternate way to compare and communicate the relative impact of the 
different substances within each class, impact equivalents were calculated for class 1 and 
class 2 substances. Predicted case incidence, simple DALY, and complex DALYs were 
calculated in terms of benzene equivalents for class 1 substances and mercury equivalents 
for class 2 substances. 
1.4.5.2 Exposure from multiple refineries 
Because there are four refineries in close proximity in Sarnia, predictions from 
individual refineries in the area may not be relevant for the population. An ad hoc 
analysis was conducted to determine whether HEIDI II could be useful in this situation 
where the population is exposed to emissions from more than one refinery. To check that 
the populations within the 25 km zone captured by HEIDI II’s analysis for each 
individual refinery were roughly the same set of people, the number of adults, children, 
senior, and total population surrounding each refinery was compared across refineries. 
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Analysis indicated that roughly the same population is captured when looking within 25 
km of each refinery (i.e., the refineries are close enough together that the same people are 
living within 25 km of any of the four facilities). When the populations were compared 
by quadrant, the variation was much higher (up to 2), indicating that the location of 
highest population density relative to the location of each refinery was not consistent. 
 A theoretical refinery was imagined to be located at the geographic location 
which minimized the distance from each actual refinery, and the theoretical emissions 
were represented by the sum of all the emissions emitted from each of the four refineries. 
The “average” population distribution was calculated by averaging the actual population 
of children, adults, and seniors living in each quadrant around the real refineries. 
 The predicted case incidence at this theoretical Sarnia refinery was compared to 
that predicted at individual refineries in the Sarnia area and to the predictions for a 
hypothetical worst-case refinery, to assess whether the priorities identified in each case 
were similar and to investigate any obvious differences between the results for predicted 
case incidence.  
1.4.5.3 Comparison of HEIDI II to another model 
 An effort was made to compare results from HEIDI II to those predicted by 
another available model. TRACI is a stand-alone, Windows-based tool that was 
developed by the U.S. EPA. It uses a run-time version of Microsoft Access to 
characterize the potential impacts of a variety of environmental stressors, including 
human health cancer effects, human health noncancer effects, and human health criteria-
related effects (Bare, Norris et al. 2003). TRACI is one of few available impact analysis 
tools that explicitly distinguishes human health cancer and noncancer effects and also 
allows for assessment of airborne emissions only, as HEIDI II does. Currently, TRACI is 
offline for updating, but the characterization factors used in TRACI were available and 
enabled a comparison between the results predicted by the two models. 
 
TRACI 
 The characterization factors developed for TRACI were obtained from Jane Bare, 
one of the model’s authors (Bare 2004). TRACI includes a wide range of impacts, 
including the following relevant human health (HH) impact categories: HH Cancer Air 
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(kg benzene eq /kg), HH Noncancer Air (kg toluene eq /kg), and HH Criteria Air-Point 
Source (kg PM2.5 eq / kg). 
 The characterization factors for the relevant impact/substance combinations were 
extracted from TRACI, applied to the hypothetical worst-case emissions scenario, and 
then ranked within impact categories and across impact categories. The priority order was 
compared to the rankings produced by the deterministic version of HEIDI II, since 
TRACI is itself deterministic and the rankings produced by HEIDI II as a probabilistic 
model were often similar to those produced by the deterministic version. 
1.4.5.4 Application of HEIDI II to another industry 
 In order to test the generalizability of HEIDI II, an attempt was made to apply the 
model to emissions from another industry. The Nanticoke power generation facility was 
selected since it was in a similar geographic area as that assumed by the meteorology of 
HEIDI II, and adjacent to a refinery that was included in HEIDI II, which allowed re-use 
of population data. Coal-fired power generation was selected because as in the case of 
petroleum refineries, the predominant route of exposure for most emissions is by 
inhalation.  
Emissions data was obtained from the NPRI database, and for the substances not 
already included in HEIDI II, data on background, photodegradation potential, 
concentration-response, and health impact was gathered from similar sources as those 
used when data was initially compiled for HEIDI II. HEIDI II was first reprogrammed for 
the Nanticoke power generation facility as a deterministic model in Excel, and then as a 
probabilistic model in Matlab. 
 The difficulties in adapting the model were recorded, and the results of HEIDI II’s 
predictions for the facility presented. 
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2 Part 2: Results 
2.1 Model Validation and Analysis 
Computational validation techniques involve mathematical and dimensional 
“double-checking”, model formulation techniques are best done through adept use of 
techniques such as sensitivity analysis and model design questions are often best 
addressed through thought and discussion. General comments, results, and issues which 
arose during the validation process are addressed in Table 5. The bulk of testing and 
validation of the HEIDI II model was performed using techniques of sensitivity analysis 
(SA), and is addressed in the remainder of the chapter. Issues that require thoughtful 
consideration rather than mathematical analysis are addressed in either the discussion 
section of this chapter or this document’s final discussion. 
2.1.1 Basic Validation 
Following on from Table 3, which was presented in the Methods chapter, the 
results and comments which resulted from some of these efforts are presented below and 
are addressed in the comments in Table 5. 
2.1.2 Sensitivity Analysis 
In HEIDI II, SA was used to help provide recommendations about the most 
parsimonious and information-rich model form, identify scenarios potentially associated 
with greatest predicted health impacts, and provide an initial sense of the range of 
predicted health impacts from refinery airborne emissions. 
In order to conduct a complete SA, an inventory of the model variables and 
associated uncertainty and variability was compiled. Distributions for the model variables 
were proposed and justified where possible, and possible correlations identified. This 
inventory served as the basis for designing both local and global sensitivity analyses (See 
Appendix C). Distributions could not be assigned to some input variables due to lack of 




Table 5: Results and comments arising from basic validation efforts 
Validity Criterion Comments 
Computation  
Internal Consistency Consistency in predictions was found when variables were calculated via alternate possible methods and compared. There was very little need to redesign with (n-1) degrees of freedom as most of the functions were linear. 
Absence of numerical 
(computational) artifacts 
Inspection of results ensured realistic predictions, predictions from two software programs (excel and matlab) match. In excel 
the number precision is 15 digits; all values predicted fell in between the largest and smallest allowable values which are on 
the order of 10308 and 10-308 for both excel and matlab. (The Mathworks 2002; Microsoft Office online Excel 2003) 
Computational Correctness - Dimensional analysis predicted appropriate units for the excel version - Perfect agreement of Excel and Matlab predictions was achieved for the deterministic models 
Model Formulation  
Model form is correct See discussion and Appendix C regarding simplifying model assumptions 
Robustness to changing input 
parameters 
- Functional relationships were tested using values ranging from 0.0001*central value – 1000*central value for each variable 
to confirm functional relationships.  
- Probabilistic model did not break down under conditions of varying inputs. 
Sensitivity to changing input 
parameters 
- Local sensitivity analysis were carried out for all variables except meteorological variables 
- All SA was done using hypothetical refinery central values. Low dose SA used (hypothetical refinery emissions)/100 
Parsimony 
- Sensitivity ratios were calculated, local and global sensitivity analyses were carried out 
- Some aspects of the model were identified for potential removal to improve parsimony (see discussion and 
recommendations) 
Model Design  
Generalizability - An attempt was made to adapt HEIDI II to a coal-fired power plant (Nanticoke). Which addresses (i) and (ii) - See also discussion 
Biological realism and 
relevance See discussion 
Agreement between different 
models characterizing the same 
process 
- Predictions were compared to priorities using TRACI characterization factors 
- Comparisons to the prototype were invalid since the theoretical population and emissions scenarios are not comparable 
Heuristic value See discussion – especially with respect to cost-benefit of reductions in priority substances 
Capacity to deal with dose-
dependent biological responses See discussion 
Useful in extrapolation to other 
conditions 
- A theoretical “Sarnia refinery” was tested to see how well HEIDI II could predict impacts from multiple refineries in one 
geographic area/affecting one population 
- Low dose sensitivity analysis indicated that predicted incidence tends to zero for most class 2 substances at lower doses 
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HEIDI II and was operationalized in the model through a series of “adjustment factors” 
such as the generic multipliers applied to annual emissions of each substance to predict 
concentration in each of 20 locations surrounding any given refinery. These restrictions 
are also documented in Appendix C. 
Sensitivity analyses in HEIDI II were phased. Initially, local sensitivity analysis 
(where one input is varied and all others are held constant) was performed for each input 
variable and substance. As described in the methods section, within-module local SAs 
were performed first, followed by variable and substance-specific local sensitivity 
analysis for the model as a whole. Scenarios and functional relationships were also tested 
by module and model using local SA. The module-by-module local SA results served 
mainly as validity checks and will not be presented here. Global sensitivity analysis 
(where all inputs are allowed to vary simultaneously) was used to confirm conclusions 
made based on local SAs and to investigate the anticipated range of outputs from HEIDI 
II. 
 
2.1.3 Local Sensitivity Analysis Results 
Sensitivity was calculated based on change in predicted case incidence for the 
hypothetical worst-case refinery scenario. For many substances, predicted case incidence 
was zero across all tested input values. For others, while predicted case incidence was 
zero at the base case, adjusting inputs resulted in a positive predicted case incidence for 
some input values tested. The direction and magnitude of change in predicted output 
depended on whether the input variables were increased or decreased from their central 
values.  
2.1.3.1 Uncertain Inputs 
2.1.3.1.1 k and OH 
 k (atmospheric OH rate constant) and OH (atmospheric concentration) are 
mathematically related to predicted output in exactly the same way: they are multiplied 
by each other to generate the first-order rate constant used in the function used to 
describe photodegradation. However, while the distributions defined for k were 
substance-dependent, the value used to describe the distribution for OH was not. As 
 
41 
shown in Table 6, the importance of the uncertainty in k and OH was greater for class 1 
than class 2 substances (class 3 substances were assumed not to photodegrade). Any 
reduction in delivered concentration would directly affect predicted incidence for class 1 
substances (since a linear, non-threshold dose-response was applied for class 1 
substances), while for class 2 substances variation in k would only affect predicted 
incidence to the extent that the delivered concentration breached the substance-specific 
C-R threshold. In general, the impact of uncertainty in k appears to outweigh the 
importance of the uncertainty in OH on predicted incidence in absolute terms. 
Uncertainty in either k or OH alone does not alter the absolute predicted incident cases by 
one in a million. The impact of uncertainty in OH on predicted incidence is greatest for 
substances which photodegrade fastest.  
The greatest impact on predicted incidence appears to result from uncertainty in 
the k value for PAH: varying k across the range defined by ±1 stdev results in ~50% 





Table 6: Sensitivity of predicted incidence to k and OH using several sensitivity measures. Local sensitivity analyses were conducted using +/- 1 stdev 
from the variables’ central values. * represents substances for which predicted incidence was zero at baseline, or both before and after the SA, 
preventing calculation of some sensitivity measures. ‘N/A’ indicates that the measure was not relevant, i.e., metals do not photodegrade, therefore k and 
OH do not affect the model predictions for these substances. 
Substance k OH 
 Sensitivity Ratio 
% change 




output Absolute change 
Increase or decrease 
in stdev + - + - + - + - + - + - 
Class 1 
1,3-Butadiene -0.03 -0.50 -6.8 34 4.2E-03 -2.1E-02 -0.14 -0.24 -3.0 5.5 1.9E-03 -3.4E-03 
Benzene -0.02 -0.02 -5.0 1.6 9.7E-03 -3.1E-03 -0.02 -0.02 -0.5 0.5 9.5E-04 -9.6E-04 
Ethylene (as oxide) -0.08 -0.13 -22 10 1.7E-02 -7.4E-03 -0.11 -0.12 -2.6 2.7 1.9E-03 -2.0E-03 
Nickel (and its 
compounds) N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A 
PAH (as 
benzo(a)pyrene) -0.05 -0.53 -12 38 1.7E-01 -5.2E-01 -0.20 -0.31 -4.4 6.9 6.0E-02 -9.3E-02 
Formaldehyde -0.10 -0.17 -23 15 1.5E-02 -9.4E-03 -0.14 -0.15 -3.1 3.4 1.9E-03 -2.1E-03 
Acetaldehyde -0.12 -0.26 -25 17 1.6E-03 -1.1E-03 -0.20 -0.22 -4.4 5.0 2.8E-04 -3.1E-04 
Class 2 
1,2,4-
Trimethylbenzene * * * * * * * * * * * * 













-9.8 4.4 3.0E-08 -1.3E-08 0.0 0.0 -1.3 1.4 3.8E-09 -4.1E-09 
                                                 
10 Because the input variables for BTEX are a combination of the values of B,T,E,X, the sensitivity ratio can be calculated to assess percent change in predicted 





X -0.05 -0.07 
Cyclohexane * * * * * * * * * * * * 
Dicyclopentadiene * * * * * * * * * * * * 
Diethanolamine (and 
its salts) * * * * * * * * * * * * 
Hydrogen sulphide -0.24 -0.44 -54 31 1.7E-09 -9.8E-10 -0.36 -0.39 -8.2 8.8 2.5E-10 -2.8E-10 
Isoprene * * * * * * * * * * * * 
Mercury (and its 
compounds) N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A 
Methanol * * * * * * * * * * * * 
Methyl ethyl ketone * * * * * * * * * * * * 
Methyl isobutyl 
ketone * * * * * * * * * * * * 
Methyl tert-butyl 
ether * * * * * * * * * * * * 
Naphthalene -0.01 -2.09 -1.7 140 5.1E-14 -4.0E-12 0.0 0.0 0.0 0.0 0.0 0.0 
n-Hexane -0.27 -1.54 -58 110 4.0E-12 -7.3E-12 0.0 -0.01 0.0 0.26 0.0 -1.8E-14 
Phenol -0.09 -0.10 -18 7.0 1.5E-09 -5. 9E-10 -0.14 -0.03 -3.2 0.65 2.7E-10 -5.5E-11 
Propylene * * * * * * * * * * * * 
Styrene * * * * * * * * * * * * 
Sulphuric acid -0.02 -0.02 -4.5 1.4 4.3E-05 -1.3E-05 -0.02 -0.02 -0.43 0.43 4.1E-06 -4.2E-06 
Vanadium and its 
compounds N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A 
Zinc (and its 
compounds) N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A 
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2.1.3.1.2 Toxicity data 
Table 7 shows that adjusting the C-R (concentration-response parameter) by 1 
standard deviation has a dramatic impact on predicted incidence, especially for class 2 
substances where percent changes of up to 1015 were observed and absolute numbers of 
predicted cases increased by as much as 4600 (in the case of PAH). The values observed 
for class 1 and class 3 substances for SR reflect the linear no-threshold functions used to 
characterize dose-response. For class 2 substances, the large increases in predicted 
incidence that occur for a reduction in threshold suggest that overestimation of threshold 
values could be an important source of error.  A change of 1 standard deviation in relative 
risk (RR) estimates for class 3 substances appears to result in important changes in 
predictions for mortality and morbidity, particularly for sulfur dioxide, which is 
associated with the largest emissions of the three CACs. Considering that the effects 
attributable to each of the three CACs would be additive under a linear no-threshold 
assumption, this is cause for concern. 
Table 7: The sensitivity of predicted incidence to uncertainty in the C-R values used (unit risk for 
class 1 substances, TC05/NOAEL/LOAEL for class 2 substances, and RR for class 3 substances). * 
indicates values for which zero incidence was predicted 
Substance C-R value 
 Sensitivity Ratio % change output Absolute change 
Increase or decrease in stdev + - + - + - 
1,3-Butadiene 1.0 1.0 3.4E5 -100 -210 0.06 
Benzene 1.0 1.0 3.4E5 -100 -640 0.19 
Ethylene (as oxide) 1.0 1.0 3.4E5 -100 -250 0.08 
Nickel (and its compounds) 1.0 1.0 3.4E5 -100 -1.7E05 52 
PAH (as benzo(a)pyrene) 1.0 1.0 3.4E5 -100 -7.5E04 22 
Formaldehyde 1.0 1.0 3.4E5 -100 210 0.06 
Acetaldehyde 1.0 1.0 3.4E5 -100 210 0.01 
1,2,4-Trimethylbenzene * * * * 0.0 -4.3E02 
















-1.0 1.2E10 3.0E-07 -3.5E03 
Cyclohexane * * * * 0.0 -2.5E-01 
                                                 
11 Because the input variables for BTEX are a combination of the values of B,T,E,X, the sensitivity ratio 
can be calculated to assess percent change in predicted incidence relative to percent change in ED05 for 
each component of the mixture 
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Dicyclopentadiene * * * * 0.0 -3.0E01 
Diethanolamine (and its salts) * * * * 0.0 -3.8E+00
Hydrogen sulphide -4.2E-03 -7.4E12 -1.0 7.4E12 3.1E-09 -2.3E04 
Isoprene * * * * 0.0 -1.3E-04 
Mercury (and its compounds) -4.2E-03 -1.8E11 -1.0 1.8E11 4.1E-09 -7.3E02 
Methanol * * * * 0.0 -3.0 
Methyl ethyl ketone * * * * 0.0 -5.4E-01 
Methyl isobutyl ketone * * * * 0.0 -4.3E-02 
Methyl tert-butyl ether * * * * 0.0 -6.3E-02 
Naphthalene -4.2E-03 -7.5E13 -1.0 7.5E13 2.9E-12 -2.2E02 
n-Hexane -4.2E-03 -5.7E13 -1.0 5.7E13 6.9E-12 -3.9E02 
Phenol -4.2E-03 -8.4E10 -1.0 8.4E10 8.5E-09 -7.1E02 
Propylene * * * * 0.0 -5.5E01 
Styrene * * * * 0.0 -1.2E01 
Sulphuric acid -4.2E-03 -9.0E08 -1.0 1.3E09 9.6E-04 -8.6E05 
Vanadium and its compounds -3.7E-03 -1.0E07 -1.0 1.0E07 1.0E-01 -1.1E06 
Zinc (and its compounds) -1.0E-01 -6.0E06 -1.0 5.8E06 4.4E-09 -2.5E-02 
SOx chronic mortality * * 28 -28 91 -91 
SOx chronic bronchitis * * 36 -36 200 -200 
SOx asthma hosp * * 43 -43 3 -13 
SOx asthma ER * * 43 -43 22 -22 
NOx chronic mortality * * 28 -28 9.00 -9.0 
NOx chronic bronchitis * * 36 -36 19 -19 
NOx asthma hosp * * 43 -43 1.20 -1.2 
NOx asthma ER * * 43 -43 2.10 -2.1 
primary chronic mortality * * 28 -28 7.90 -7.9 
primary chronic bronchitis * * 36 -36 17 -17 
primary asthma hosp * * 43 -43 1.10 -1.1 
primary asthma ER * * 43 -43 1.90 -1.9 
 
 Together with Table 6, these results suggest that to improve predictions of the 
health impacts resulting from exposure to these refinery emissions, it would be most 
effective to plan research that would reduce uncertainty in the toxicity values used rather 
than the uncertainty in estimates for k and OH. 
2.1.3.2 Variable inputs 
2.1.3.2.1 Annual Emissions 
Fluctuations in annual emissions that were observed between 2001-2003 were 
sufficient to alter the predicted incidence by 100 % for some substances including PAH, 
ammonia, naphthalene, sulphuric acid, and zinc. As Table 8 shows, the results suggest 
 
46 
that the potential change in predicted incidence might exceed the de minimis risk level for 
nickel, PAH, formaldehyde, and most of the class 3 substances, but would be extremely 
small in absolute terms for class 2 substances. 
These results suggest that accurate and up-to-date knowledge about the emissions 
at a particular refinery is required for HEIDI II to provide useful predictions, and that 
actions taken to reduce many emissions from petroleum refineries, particularly of class 1 
and class 3 substances, would result in large relative decreases in predicted health impact.  
Table 8: Sensitivity of predicted incidence to fluctuations in annual emissions. Substances for which 
predicted incidence was zero in all cases are omitted.  
Substance Annual emissions value 
 Sensitivity Ratio % change output Absolute change 
Increase or decrease 
in stdev + - + - + - 
1,3-Butadiene 1.00 -1.00 28 -28 -0.02 0.02 
Benzene 1.00 -1.00 61 -61 -0.12 0.12 
Ethylene (as oxide) 1.00 -1.00 55 -55 -0.04 0.04 
Nickel (and its 




emissions  173 -31 -38 1.00 


















51 -51 -1.6E-07 1.5E-07
Hydrogen sulphide 5.3 4.0 40 -31 -1.3E-09 9.6E-10
Mercury (and its 
compounds) 1.7 0.27 7.0 -1.1 -2.9E-10 4.5E-11
Naphthalene 3.6 2.0 180 -98 -5.2E-12 2.8E-12
n-Hexane 0.78 2.8 16 -58 -1.1E-12 4.0E-12
Phenol 0.89 1.2 7.7 -11 -6.5E-10 8.9E-10
Sulphuric acid 5.9 2.0 260 -88 -2.5E-03 8.5E-04
Vanadium and its 
compounds 3.2 2.8 22 -19 -2.3E-02 2.0E-02
Zinc (and its 
compounds) 2.5 1.1 200 -85 -8.9E-09 3.7E-09
SOx chronic mortality 1.00 -1.00 9.2 -9.2 30 -30 
SOx chronic bronchitis 1.00 -1.00 9.2 -9.2 50 -50 
SOx asthma hosp 1.00 -1.00 9.2 -9.2 2.80 -2.80 
                                                 
12 Because the input variables for BTEX are a combination of the values of B,T,E,X, the percent change in 
predicted incidence from the mixture relative to changes in each of the individual substance-specific inputs 
was calculated.  
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SOx asthma ER 1.00 -1.00 9.2 -9.2 4.70 -4.70 
NOx chronic mortality 1.00 -1.00 2.4 -2.4 0.77 -0.77 
NOx chronic bronchitis 1.00 -1.00 2.4 -2.4 1.30 -1.30 
NOx asthma hosp 1.00 -1.00 2.4 -2.4 0.07 -0.07 
NOx asthma ER 1.00 -1.00 2.4 -2.4 0.120 -0.120 
primary chronic 
mortality 1.00 -1.00 40.9 -40.9 12 -12 
primary chronic 
bronchitis 1.00 -1.00 40.9 -40.9 19 -19 
primary asthma hosp 1.00 -1.00 40.9 -40.9 1.10 -1.10 
primary asthma ER 1.00 -1.00 40.9 -40.9 1.80 -1.80 
 
 Ambient levels of each of the substances included in HEIDI II fluctuate over time 
and from location to location. Table 9 suggests that the largest relative changes in 
predicted incidence observed throughout the local SAs were precipitated by adjusting the 
background concentration for some substances. The associated absolute change in 
predicted incidence is expected to be very small however. Potential increases in 
background concentrations are much more important for predicting large relative 
increases in incidence than equivalent decreases are for predicting relative decreases in 
incidence – although this may often be an artifact since background concentrations 
cannot extend below zero. 
Table 9: Sensitivity of predicted incidence to fluctuations in ambient concentrations. Substances for 
which predicted incidence was zero in all cases are omitted. ‘--‘ indicates results could not be 
calculated 
Substance Background concentration 
 SR % change output Absolute change 
Increase or decrease in stdev + - + - + - 
1,2,4-Trimethylbenzene -- -- -- -- -6.2E-10 0.0 
















9800 -100 -3.0E-05 3.0E-07 
Hydrogen sulphide 0.02 0.02 4.0 -1.5 -1.2E-10 4.7E-11 
Mercury (and its compounds) 26.68 1.44 5800 -100 -2.4E-07 4.1E-09 
Naphthalene 500.64 1.45 1100 -100 -3.1E-09 2.9E-12 
n-Hexane 557.73 1.18 2300 -100 -1.6E-08 6.9E-12 
                                                 
13 Because the input variables for BTEX are a combination of the values of B,T,E,X, the percent change in 
predicted incidence from the mixture relative to changes in each of the individual substance-specific inputs 
was calculated.  
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Phenol 17.54 1.57 3000 -100 -2.6E-07 8.4E-09 
Propylene -- -- -- -- -1.6E-12 0.0E+00 
Sulphuric acid background = 0 0.0 0.0 -3.7E-04 0.0E+00 
Vanadium and its compounds 0.42 0.22 -15 -1.6 1.6E-02 -1.60E-02
Zinc (and its compounds) 37.77 1.22 -97 -4.3E-05 4.2E-09 -4.20E-09
 
 The SR could not be calculated for many substances throughout the local SAs –
often because the predicted case incidence values were zero in the base case. In order to 
gain a sense of the extent of increase in predicted case incidence that could occur with 
variations in each of the input variables, the absolute change in predicted case incidence 
must be considered. 
2.1.3.3 Class-by-class 
 Since substance class determines the function used for dose-response in HEIDI II, 
it is helpful to compare the importance of each input variables to predicted incidence 
within classes. Figure 6 and Figure 7 confirm that variability in emissions and uncertainty 
in the unit risk values are the greatest contributors to variation in predicted incidence for 






2.1.3.3.1 Class 1 
Sensitivity Ratio (SR) for increase by 1 stdev to various 






















Sensitivity Ratio (SR) for decrease by 1 stdev to various 
























Figure 6: Sensitivity ratios confirm that linear relationships exist between the emissions level and predicted incidence, and between unit risk and 
predicted incidence. SR evaluates percent change in output relative to percent change in input: for these two variables the percent change is directly 
related through the slope value so SR = 1. The negative SR values for OH and k indicate an inverse relationship between each of the variables and 
predicted incidence. (A decrease in photodegradation rate through either smaller k or less ambient OH would result in some increase in predicted case 
incidence from exposure to 1,3-butadiene, Ethylene oxide, PAH, acetaldehyde, and formaldehyde.) The figures above suggest that decreases in k or OH 
relative to central value have more of an effect on predicted incidence than increases.  Lower value of either k or OH is associated with higher exposure 
and therefore higher predicted incidence. Therefore, overestimation of either k or OH might be more important in underpredicting incidence 
(compared to an underestimation of k or OH which would have a smaller effect on overpredicting incidence).  Background was excluded from the 






Percent change in output value for increase by 1 stdev to 









































Percent change in output value for decrease by 1 stdev to 









































Figure 7: Percent change in predicted case incidence with a one standard deviation change in input. The effect of increasing the unit risk value 
overwhelms the effect of increasing any other input variable for class 1 substances.  For decreases from the central estimate, the maximum possible 
percent change is 100% since negative values for predicted incidence cannot occur. The relative differences in the effect of emissions of predicted 
incidence stem from the baseline level of predicted incidence (i.e., nickel and PAH were associated with larger initial predicted incidence, so the increase 
that occurred by altering the emissions input was smaller relative to the increase which was observed for substances whose baseline predicted incidence 
was very low. In general, C-R seems to be the most influential variable, followed by emissions, k, and [OH]. In absolute terms, the largest changes in 
predicted incidence are observed for nickel – as a result of the relatively large unit risk value associated with its toxicity. Altering the value by 1 stdev 




2.1.3.3.2 Class 2 
 Because of extremely large differences in absolute predicted incidence and even 
percent change in predicted incidence for class 2 substances, the SR appears to be the 
best indicator for comparing the effects of varying the different inputs that affect 
predicted incidence for these systemic toxins. Figure 8 (A) suggests that variation in 
background levels of some substances (in particular, naphthalene and n-hexane) may 
have a large relative impact on predicted incidence. Once background is removed from 
the figure, it is possible to see that emissions also play a large role in influencing 
predicted incidence, as shown in Figure 8 (B). Figure 8 (C) shows the relative effects of 
increasing the remaining inputs: OH, k, and C-R (which is an ED05 for these class 2 
substances). An increase in the ED05 does not have a large effect on predicted incidence 
for any substance, suggesting that underestimation of ED05 is not usually an important 
source of error. 
 The patterns of importance by input variable are different when a decrease from 
the central value occurs: C-R becomes an important predictor of incidence, where a small 
decrease in ED05 can result in a large increase in predicted incidence (the inverse 
relationship results in negative values of SR) See Figure 9. 
 For all variations in input, predicted incidence as a result of exposure to 
naphthalene and n-hexane seems to be most influenced by changes in inputs, especially 
background, emission, and C-R. This may be because the baseline predicted incidence is 
very low (on the order of 10-12) such that any change appears to be large when compared 




Sensitivity Ratio (SR) for increase by 1 stdev to various inputs 




























































































































































8(A)  Background becomes an important predictor of incidence for several substances when its input 
value is increased from the base case by 1 stdev. 
Sensitivity Ratio (SR) for increase by 1 stdev to various inputs 
































































































































































Sensitivity Ratio (SR) for increase by 1 stdev to various inputs 



























































































































































8(C)  With background and emissions removed from the figure, k and OH seem to have the most 
influence on incidence when their values are increased from baseline 
Figure 8: Sensitivity ratio for case incidence with one standard deviation increase in input values for 





Sensitivity Ratio (SR) for decrease by 1 stdev to various inputs 






























































































































































9 (A)  Concentration response (ED05) has the greatest influence on predicted incidence when values 
are decreased from baseline 
Sensitivity Ratio (SR) for decrease by 1 stdev to various inputs 




























































































































































9 (B)  With C-R removed from the figure, emissions seem to have the largest influence on predicted 
incidence has the greatest influence on predicted incidence when values are decreased from baseline.  
Figure 9: Sensitivity Ratio for case incidence with one standard deviation decrease in input vlaues 
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2.1.3.3.3 Class 3 
 The class 3 substances are assumed to act according to a linear non-threshold 
dose-response function, so background is not considered to affect predicted incidence. As 
well, the class 3 substances do not photodegrade, so k and OH do not affect predicted 
incidence. Figure 10 shows that the emission level and the C-R value relative risk values 
have a regular and predictable effect on predicted incidence for class 3 substances, with 
emissions affecting all outcomes from a particular “type” of PM2.5 to the same degree, 
regardless of “outcome type”, and the C-R value affecting each “outcome type” to the 
same degree, regardless of PM2.5 “type”. 
 
Percent change in output value for increase by 1 stdev to 






























































































































Percent change in output value for decrease by 1 stdev to 


























































































































Figure 10: Predicted case incidence for Class 3 substances depends only on emissions and C-R data. 
Because the Class 3 C-R inputs depended on the population breakdown, a simple SR could not be 
calculated. Thus, the percent change in predicted case incidence rather than the SR is graphed. 
Because the degradation of Class 3 substances was calculated outside HEIDI II and the dose response 
relationship used was linear non-threshold, the predicted case incidence would not be expected to 
depend on k, OH, or background. The regular patterns above reflect the consistent input for 
emissions for each Class 3 substance, the consistent input for C-R for each Class 3 outcome type, and 
the linear dose-response function. 
 
 While the percent change in predicted case incidence and the SR are useful for 
identifying the extent of relative change incurred by variation in input variables, they do 
not inform about levels of predicted case incidence. For some substances, the predicted 
case incidence fluctuates by a large relative amount but remains below the de minimis 
level. Because HEIDI II compares across substances and uses substance-specific data for 
each of the input variables, it is helpful to examine the absolute changes in predicted case 
incidence. The tables presented above indicate that while some input variables may have 
a large influence on the relative change in predicted case incidence, the sensitivity of 
predicted case incidence to variation in the inputs is more important for Class 1 and class 
3 substances, in terms of actual predicted number of cases. 
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For increases in input variables affecting class 2 substances, the most influential 
variable for predicted case incidence is either background or ED05 value, depending on 
the direction of variation. However, even the greatest changes in predicted case incidence 
do not typically reach one case.  
2.1.3.3.4 Toxicity values for V, Ni, PAH 
 Several substances may be subject to greater than average uncertainty in their 
toxicity values. As a result, it is prudent to check the model using alternate possibilities 
for the toxicity values. Although not all the endpoints are identical, these values are 
selected in an effort to place limits on the upper and lower bounds of toxicity that might 




The ED05 values used in HEIDI II was based on a LOAEL devised by the WHO 
and published in 2000. Very few agencies have published reference values for either 
vanadium or vanadium pentoxide, citing a lack of adequate qualitative data. This includes 
Health Canada, EPA (IRIS), and CalOEHHA (RAIS), and the ASTDR, hindering 
development of an appropriate suite of values to test in HEIDI II. The recently released 
IARC monograph on vanadium pentoxide (IARC (International Agency for Research on 
Cancer) 2006) confirms that while there is sufficient evidence for carcinogenicity in 
animals, there is not enough evidence to confirm carcinogenic effects in humans (IARC 
(International Agency for Research on Cancer) 2006). Vanadium’s classification as 
Group 2B – possibly carcinogenic to humans, remains unchanged for the moment. There 
is currently little ability to distinguish various forms of V or V2O5 in terms of either their 
toxicity or predominance in the environment. Table 10 summarizes the available data14. 
The distribution (mean, 5th percentile, 95th percentile) used to describe V in the 
probabilistic model was (20, 9.8E-2, 70.6).  
                                                 
14 Agencies such as the OSHA, ACGIH, NIOSH also provide PEL values for Vanadium fume and dust and 
pentoxide. Using these PELs to back-calculate C-R values which might be useful in HEIDI II results in 
values which fall within the range described by the data presented here. 
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Table 10: Predicted case incidence from Vanadium exposure using alternative inputs for C-R data 
(shading indicates values that were actually used for all analyses of HEIDI II) 






WHO, 2000 20μg/m3 as LOAEL 
Suggest 1 μg/m3 as 
a reference level, 
safety factor of 20 is 
based on no 
susceptible 
subpops identified 
and minimal nature 






clinical signs of subtle 
chronic intoxication (green 
tongue, cough, 
vascularization of the 
cornea, conjunctivitis, colic, 
respiratory tract irritation, 
mucus, and rhinorrhea) at 
concentrations of about 100 
µg/m3 or less 
vanadium pentoxide ≤ 100 
4.11E-04 
 






intoxication resulting in 
metabolic disorders 
occurred at about 1-20 
µg/m3 
vanadium pentoxide 1-20 
440 
 
(using 1μg/m3 ) 
 
Nickel: 
The unit risk value used in HEIDI II was based on oxidic, sulphidic and soluble 
nickel compounds (combined). The actual composition of the nickel compounds to which 
populations around refineries are exposed is not known and may fluctuate with the 
composition of other substances which are emitted simultaneously. Possible alternate 
values for unit risk are: 
Table 11: Predicted case incidence from Nickel exposure using alternative inputs for Ni C-R data 
Source Value and type Notes 
Predicted case incidence (all 
other model parameters at 
default) 
Based on Health 
Canada TC05 
1.25E-3 per μg/m3  
(Unit Risk) 




EPA 2.4E-3 per μg/m
3  
(Unit Risk) Refinery dust 99 
EPA 4.8E-4 per μg/m
3  




The distribution (mean, 5th percentile, 95th percentile) used to describe Ni in the 
probabilistic model was (1.25E-3, 1.3E-6, 3.6E-3). 
 
PAH 
There are also several available values for PAH unit risk.  PAH is a mixture of 
individual chemicals which fall under the classification of polycyclic aromatic 
hydrocarbons – each with its own toxicity value. The values presented here all follow the 
convention of expressing PAH toxicity in BaP equivalents, as this was the method 
selected for describing the mixture’s toxicity in HEIDI II. 
Table 12: Predicted case incidence for PAH using alternative inputs for C-R data. All methods are 
based on some estimation based on the amount of  BaP in the PAH mixture (i.e., BaP equivalents). 
Source Value and type Predicted case incidence (all 
other model parameters at 
default) 
MOE 2.3*10
-2   per μg/m3 
(Unit Risk) 1.4 
WHO 8–10×10-2 per μg/m3 (Unit Risk) 5.9 (using 10*10-2) 
RIVM (1986) 1*10
-2 per μg/m3 
(Unit Risk) 0.59 
 
The distribution (mean, 5th percentile, 95th percentile) used to describe PAH in the 
probabilistic model was (2.3E-2, 2.5E-5, 6.8E-2). 
Inspection of these alternate values indicate that for each substance identified, 
these “reasonable alternate C-R values” do not necessarily fall within the 95th percentile 
range defined by the distributions that will be applied to the C-R data for the probabilistic 
values.  For vanadium, the upper bound C-R value of 100 proposed by the IIEQ is above 
the 95th percentile of V’s probability distribution as used in HEIDI II. Higher thresholds 
would reduce the predicted incident cases for Vanadium, so the impact of not including 
this upper-bound estimate of toxicity for V could be overprediction of incidence and an 
underestimate of the variation in predicted incidence. For PAH, the upper bound value of 
10*10-2 per μg/m3 proposed by WHO exceeds the 95th percentile value defined for PAH 
unit risk in HEIDI II, which could result in underprediction of cases.  
Using the individual “reasonable alternate C-R values” suggested above in local 
SA at the worst-case hypothetical refinery results in predicted case incidence values from 
4*10-4 up to ~400 for the range of values used to test Vanadium, from 20-99 cases for 
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values tested for Nickel, and from <1 - ~6 cases for PAH. These potential variations 
confirm how little is known about the specific toxicity of many substances, and also that 
the impact on humans, especially in the case of Ni and PAH, where the potential health 
outcome is cancer, could be considerable. Additionally, the values tabulated here 
represent results of limited experimentation and do not represent the true range of 
uncertainty about the toxicity of these substances 
2.1.3.3.5 Potential interaction of background and C-R for class 2 substances 
The C-R values used for class 2 substances were “derived threshold estimates” 15 
values used to anchor the Mantel-Bryan C-R formulation. Local sensitivity analyses 
indicated that predicted case incidence was dependent on background exposure for 
selected substances. The total exposure of a population surrounding a refinery may 
depend highly on the background levels, especially if emissions of specific substances are 
low relative to background concentrations. If the background levels approach the model’s 
“derived threshold estimates” for class 2 substances, additional exposure contributed by a 
refinery emission could cause additional predicted case incidence of disease. However, if 
the background levels are far below the toxicity threshold, emissions contributed by the 
refinery are unlikely to push exposure levels over the threshold, and so disease is unlikely 
to be predicted. 
There could be an interaction between substance-specific background levels and 
the toxicity values selected to represent their “derived threshold estimates”. To better 
understand this phenomenon, response surfaces were created depicting the interaction 
between background and the “derived threshold estimate” values. These response 
surfaces investigate the range of values from 1-99th percentile of the distributions used in 
HEIDI II for background and threshold. The response surfaces indicated that even at 
combined extreme values for background and threshold (all other inputs held at central 
values), the de minimis risk level was exceeded for only five substances (See Table 13).  
                                                 
15 Although they are being used to anchor the Mantel-Bryan distribution, they are variously based on TC05, 
LOAEL, and NOAEL values, some of which are extrapolated from animal experiments. It is probably not 
appropriate to label them as “thresholds” when they are only approximations in any case. Additionally, the 
terminology “threshold” suggests a definite cutoff point, whereas the Mantel-Bryan function allows for a 
continuous, sublinear function to represent dose-response for class 2 substances. 
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Table 13: Approximate number of predicted incident cases per million people at the hypothetical 
refinery for extreme values of background and C-R 
Substance 
Cases predicted per million people at 1st 
percentile for C-R16 and 99th percentile for 
background 
1,2,4-trimethylbenzene ~2 
BTEX ~680 000 
naphthalene ~1 
n-hexane ~5 
Vanadium ~100 000 
 
The two cases of particular concern appear to be Vanadium and BTEX. For V, the 
relevant outcome is relatively mild (nasal and upper airway irritation). High values of 
predicted case incidence for BTEX occur only at extreme values for background and 
toxicity, but given the relevant outcome of CNS toxicity, may be of concern. For all 
substances, most of the predicted incidence was at or close to zero as shown in Figure 11 
and Figure 13.  
                                                 
16 Because C-R is an ED05 value, it predicts higher incidence for lower values. Thus, the first percentile of 




Figure 11: BTEX – predicted incidence across the range of values allowed for C-R and background. 
Relevant equivalent human health outcome is moderate CNS neurotoxicity 
 
Figure 11 shows the predicted incidence associated with BTEX across the 99th 
percentile of values in the distributions for ED05 and background, and indicates that the 
majority of predicted incidence is zero. However, it is difficult to tell anything about the 
highest percentiles on this figure. A closer look at the first 20th percentile for C-R and the 
top 20th percentile for background (i.e., “zooming in” on the area of highest predicted 
incidence) provides a better sense of how fast predicted incidence of CNS neurotoxicity 





Figure 12: BTEX – predicted incidence across the 20th percentile of values for C-R and background 
leading to highest predicted incidence. Relevant equivalent human health outcome is moderate CNS 
neurotoxicity 
 
A similar response surface is produced for Vanadium: most of the response 
surface is at zero with high predicted incidence for low toxicity value inputs as shown in 
Figure 13. A closer look at the first 20th percentile for C-R and the top 20th percentile for 
background (i.e., “zooming in” on the area of highest predicted incidence) provides a 
better sense of how fast predicted incidence of upper airway irritation due to Vanadium 




Figure 13: Vanadium. Predicted incidence across the range of values allowed for C-R and 




Figure 14: V – predicted incidence across the 20th percentile of values for C-R and background 
leading to highest predicted incidence. Relevant equivalent human health outcome is upper airway 
irritation. 
 
2.1.3.3.6 Potential interaction of Mantel-Bryan slope and C-R values 
 The C-R values used for class 2 substances were “derived threshold estimate”, or 
ED05 values used to anchor the Mantel-Bryan C-R formulation. The Mantel-Bryan 
formulation for dose-response also relies on a slope value (for the probits per dose 
increase). In HEIDI II, the central value used was 1.5, which was found to provide good 
dose-response across the range of possible air concentration values, and to provide results 
that align well with the de minimis risk level calculated with the conventional threshold 
formula (See Appendix C for more details). The values used for these two substances 
could interact when predicting incidence. A sample graphic is provided for Vanadium in 
Figure 15. It includes the 1-99th percentile of toxicity data for Vanadium and shows that 
at most toxicity values the value of the slope selected has little impact on predicted 
incidence, and that at the slope value used in the model (1.5), there might be a slight 
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increase in predicted incidence from baseline only for the lowest 2 percentiles of possible 
threshold values. 
 
Figure 15: Vanadium. Predicted incidence across the range of values allowed for C-R and Slope. 
Relevant equivalent human health outcome is nasal and upper airway irritation 
2.1.3.4 Alternate Model Formulations 
 There are various ways to “assemble” a model and select data to represent the 
model variables. It is appropriate to test alternative formulations of the model – to find 
the most parsimonious representation that adequately represents the data. 
 
(i) Background scenarios 
 The original incarnation of HEIDI II used site-specific data for background 
concentrations. However, much of the data was incomplete or from monitors that were 
not ideally sited to collect background levels (i.e., not directly in the community, or 
located downwind from the refinery). Thus, a general division of background levels into 
“high”, “medium”, and “low” was proposed, with refineries assigned to each level based 
on population surrounding the refinery and whatever site-specific background data was 
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available. The values used to represent the background concentrations were derived from 
combining the site-specific data for refineries assigned to each of three categories 
(high/medium/low - See Appendix C).  
Sensitivity analysis indicated that for most substances, the change in predicted 
case incidence (or DALYs) was small with the new background scenario. The largest 
changes in predicted incidence were observed for styrene and isoprene, followed by zinc, 
1,2,4-trimethylbenzene, and MEK. It is worth noting that these were differences in 
absolute values on the order of 10-14 and smaller (in some cases, changes are at the level 
of 10-28). With this change in predicted population health impact, the rank order of each 
of these substances remained low, and often did not change. Thus the simpler 
high/medium/low background scenarios were retained for the probabilistic version of 
HEIDI II. 
(ii) Mantel-Bryan Slope 
A component of the C-R function for class 2 substances is the slope selected for 
the Mantel-Bryan formulation. 1.5 was used as the default, but possible values ranging 
from 1-5 were evaluated. When the Mantel-Bryan slope is decreased to 1 from 1.5, the 
percent increase in predicted population health impact is large, especially for those 
substances with the highest ED05 values. However, it is worth noting that the original 
predicted impacts for those substances were so small that increasing them even several 
million-fold does not affect their rank order (i.e. ranked at a tie in last place)! Where the 
slope was increased, the changes in predicted population health incidence tended towards 
zero.  
(iii) Application of photodegradation in HEIDI II 
A shortcoming of HEIDI II is its approach to photodegradation of class 1 and 
class 2 substances: the photodegradation equation, which was intended mainly to reflect 
the average amount of sunlight daily, is uniformly applied to concentrations delivered to 
each quadrant. However, substances take more time to reach the more distant locations, 
and so may undergo more photodegradation as they travel. At the closest locations, 
exposures are likely being underpredicted by HEIDI II, since the emissions may have 
very limited time to photodegrade before exposure occurs, while at the more distant 
locations, exposures are potentially overpredicted by HEIDI II.   
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Table 14: Percent change in predicted incidence at 25 km from the refinery for two 
photodegradation times: 8 hours and 16 hours. Only substances that had predicted incidence>0 for 
the 25 km zone are included 
Substance Stack Height (m) 
 30 15 5 
1,3-Butadiene 51.1% 51.1% 51.1% 
Benzene 5.1% 5.1% 5.1% 
Ethylene (as 5% Ethylene Oxide) 27.3% 27.3% 27.3% 
Nickel (and its comps) 0.0% 0.0% 0.0% 
PAHs (BaP surrogate class) 51.5% 51.5% 51.5% 
Formaldehyde 29.1% 29.1% 29.1% 
Acetaldehyde 39.7% 39.7% 39.7% 
Mercury 0.0% 0.0% 0.0% 
Phenol 26.5% 17.6% 26.5% 
Sulphuric Acid 5.6% 5.4% 5.6% 
Vanadium 0.0% 0.0% 0.0% 
Zinc (and its compounds) 0.0% 0.0% 0.0% 
 
Table 15: Percent change in predicted incidence at 1 km from the refinery for two photodegradation 
times: 8 hours and 16 hours. Only substances that had predicted incidence>0 at 1 km for at least one 
of the stack height scenarios are included.  (Val = 0 indicates that the percent change could not be 
calculated since one of the predicted incidence values was zero.) 
Substance Stack Height (m) 
 30 15 5 
1,3-Butadiene 51.1% 51.1% 51.1% 
Benzene 5.1% 5.1% 5.1% 
Ethylene (as 5% Ethylene Oxide) 27.3% 27.3% 27.3% 
Nickel (and its comps) 0.0% 0.0% 0.0% 
PAHs (BaP surrogate class) 51.5% 51.5% 51.5% 
Formaldehyde 29.1% 29.1% 29.1% 
Acetaldehyde 39.7% 39.7% 39.7% 
1,2,4-Trimethylbenzene Val=0 100.0% 85.1% 
Ammonia 0.0% 0.0% 0.0% 
Dicyclopentadiene Val=0 100.0% 96.6% 
Diethanolamine (and its salts) Val=0 Val=0 97.0% 
Hydrogen Sulphide 0.0% 0.0% 0.0% 
Mercury 0.0% 0.0% 0.0% 
Naphthalene 47.3% 48.1% 59.6% 
n-Hexane 50.0% 53.1% 75.0% 
Phenol 19.8% 20.1% 21.3% 
Sulphuric Acid 4.2% 3.8% 3.0% 
Vanadium 0.0% 0.0% 0.0% 
Zinc (and its compounds) 0.0% 0.0% 0.0% 
To test the effect of this error, two photodegradation times were selected, and the 
difference in predicted incidence at a location far from the refinery and a location close to 
the refinery were assessed. Table 14 and Table 15 show the percent change in predicted 
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incidence at two distances from the refineries with different photodegradation times. The 
potential for error is consistent across stack heights for class 1 substances, but differs 
across stack heights for class 2 substances. For the 5 metre stack height the potential error 
is greatest at closer locations and for the 30 metre stack height, it is marginally greater at 
distant locations. The results suggest that the relative error in predicted incidence could 
be large. Also – because it is different for each substance, it could potentially alter the 
rank order that HEIDI II produced to identify priority substances. Unfortunately the 
complexity required to incorporate photodegradation difference by time traveled away 
from the refinery is prohibitive. 
A second shortcoming of the method by which photodegradation was applied is 
that the breakdown products of the photodegradation process are not accounted for. 
Accounting for this would require a complex alternate model formulation and raises the 
problem of “double-counting” when estimating toxicity.  
2.1.3.5 Scenario Uncertainty 
“User-selected inputs” 
These include stack height input, which can be 5, 15, or 30 metres, and time 
allowed for photodegradation, which can theoretically vary between 0-24 hours. The 
following figures explore the range of possible outputs associated with different input 
values for these variables. The first few figures explore the effect of stack height and 
photodegradation on delivered concentration (Module 1 alone), since this helps to 
understand how changes in stack height or photodegradation affect exposure and 
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Figure 16: HEIDI II predicts that low stack heights deliver a much higher concentration to nearby 
locations, while intermediate stack heights deliver larger concentrations to intermediate distances. 
The stack height has a similar impact on class 3 substances (not shown) although the actual delivered 





 Figure 16 shows that the highest concentrations of each substance are delivered to 
the nearby locations, and with the lowest stack heights. Although this figure does not 
display it well, absolute concentrations of each substance also decrease with increasing 
distance from the refinery. The stack height affects every emission in the same way. 
Figure 17 shows how the effect of photodegradation is substance-specific, depending on 
the rate constant for the reaction of each emission with ambient OH. Figure 17 provides 
an assessment of the proportion of each substance remaining after a variety of allowed 








The extent to which photodegradation time affects delivered concentration will depend 





Proportion of delivered concentration remaining 




































Nickel (and its comps)















Methyl Ethyl Ketone (MEK)
Methyl Isobutyl Ketone (MIBK)










Zinc (and its compounds)
 
Figure 17: The proportion of each substance remaining at any given location around the refinery depends on the degradation rate constant of the 
substance and the time available for photodegradation. Some substances, such as the metals, do not photodegrade at all. Class 3 substances are not 
considered to undergo photodegradation reactions. 
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Ethylene, which has an intermediate photodegradation rate constant, is used as an 
example substance to explore the interaction between photodegradation time and stack 
height (See Figure 18. and Figure 19). These figures indicate that the overall relationship 
between stack height, photodegradation time, and delivered concentration around the 
refinery is complex. The summary value of predicted case incidence that emerges from 
the various combinations for these inputs values is thus likely to be complex as well. In 
general, a larger value of k (faster degradation) results in a steeper curved slope along the 
photodegradation time axis, and in all cases, more photodegradation time results in less 
exposure). Figure 18 explores the interaction for zones closest to the refinery: at this 
location, the combination of low stack height and little time for photodegradation results 
in the highest delivered concentrations – about 2.5 times higher than what would be 
observed with a 30 metre stack height and 0 hours of photodegradation. Figure 19 
indicates that at all distances, the impact of different photodegradation times on delivered 
concentration with a 30 metre stack is minor. Since 30 metres is the most realistic 
representation of stack height for most Canadian refineries (Hicks 2005), the amount of 
time available for photodegradation may not be relevant for determining exposure to 
most substances. Examining predictions results across a range of rate constants suggests 
that these results are generalizable to all class 1 and class 2 air toxics (class 3 substances 
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Figure 18: Ethylene (as oxide) (in the 1 km NE quadrant) is used as an example. In this quadrant, at 
high stack heights, the time available for photodegradation does not affect the delivered 
concentration. However, at low stack heights, the delivered concentration depends more strongly on 
photodegradation time.  
 
Figure 1917 looks at a specific quadrant at various distances from the refinery. It 
shows that the 30 metre stack is associated with the lowest exposure at any 
photodegradation time and distance from the refinery, but that the relative contributions 
to exposure for stack heights of 5 m or 15 m depend on a combination of 
photodegradation time and distance from the refinery. The highest exposure occurs for 
the shortest photodegradation times combined with the shortest stack height.
                                                 
17 The model can only be run for three specific stack heights: 5m, 15m, or 30m. The discontinuity that 






















































































































































































































































































































Figure 19: The interaction between stack height and photodegradation time. Here, the set of interactions across all NE quadrants with increasing 
distance from the refinery demonstrates how the delivered concentration is greatest for the 5 metre stack close to the refinery, but at farther distances, 




 Table 16 shows the predicted case incidence values for ethylene, under various 
stack height/photodegradation time scenarios (and using a homogeneous population of 
one million people). The greatest predicted case incidence occurs with the least amount 
of sunlight and with the 15 metre stack height. The only scenario that predicts lower 
incidence than the default scenario is the 16 hours, 30 metres scenario. This indicates that 
the default scenario used for most analyses may not be the most conservative scenario. 
However, it is probably the most realistic. 
Table 16: Predicted case incidence of leukemia from ethylene (class 1 substance) exposure at the 
worst-case refinery. Note that reporting values to three decimal places may not be appropriate as it 
provides a false sense of precision and accuracy associated with these values.  Also note that for no 
scenario is there likely to be even one predicted case in a population of one million. 
Predicted case incidence (leukemia) from 
Ethylene at worst-case refinery  
Percent change in predicted case incidence 
relative to default (30 metres, 12 hours) 
Stack height Hours of sunlight Hours of sunlight 
 8 12 16 8 12 16 
5 0.10 0.09 0.07 180% 150% 100% 
15 0.10 0.09 0.08 180% 150% 110% 
30 0.04 0.04 0.03 
 
14% 0% -17% 
 
Table 17: Predicted case incidence from exposure to sulphuric acid and phenol, class 2 substances. 
The extent to which incidence is altered with changes in stack height and photodegradation inputs 
depends on the individual substance. This is a function of the interaction of the nominal “threshold” 
and the total changes in exposure around the refinery resulting from various stack height/ 
photodegradation time scenarios. Although there is a large percent increase in predicted case 
incidence for many of the scenarios relative to default, the absolute value for predicted case incidence 
remains low (predicted case incidences are in a population of one million). Sulphuric acid has one of 
the lowest photodegradation constants, while phenol has a relatively high photodegradation constant. 
Predicted case incidence (benign nasal and 
upper airway tumors from Sulphuric Acid at 
worst-case refinery 
 Percent change in predicted case incidence relative to default (30 metres, 12 hours) 
Stack 
height Hours of sunlight Hours of sunlight 
 8 12 16 8 12 16 
5 4.2E-08 4.1E-08 4.0E-08 16000000% 16000000% 16000000% 
15 3.0E-11 3.0E-11 2.9E-11 11000% 11000% 11000% 
30 2.7E-13 2.7E-13 2.7E-13
 
0% 0% 0% 
Predicted case incidence (mild CNS 
neurotoxicity) from Phenol at worst-case 
refinery 
 Percent change in predicted case incidence relative to default (30 metres, 12 hours) 
 Hours of sunlight  Hours of sunlight 
Stack 
height 8 12 16  8 12 16 
5 9.7E-10 9.2E-10 7.4E-10  170% 160% 110% 
15 9.6E-10 9.1E-10 7.6E-10  170% 160% 110% 




 Table 16 and Table 17 show that the stack height is much more important for 
determining impacts of refinery emission than the amount of photodegradation 
time/sunlight available. 
Class 3 substances do not undergo photodegradation but rather transformation by 
chemical reactions. These were predicted as a part of the external dispersion modeling. 
Because the dose-response function for class 3 substances is linear non-threshold, a sense 
of the change in predicted case incidence with stack height can be inferred by considering 
the general effect of stack height on delivered concentrations (see Figure 16) in 
combination with the distribution of population around the refinery. 
 The populations (numbers and geographical distribution of people) associated 
with each refinery were selected based on Canadian census data (Statistics Canada 2002). 
However, populations may fluctuate and the distribution around any specific refinery 
may have important implications for total predicted case incidence. The influence of the 
following population scenarios on total predicted case incidence around a refinery (with 
all other variables held at the default) was assessed: 
• homogeneous 
• heterogeneous outward – population density increases linearly moving from zone 
to zone away from the refinery 
• heterogeneous inward – population decreases with distance from the refinery 
(similar to the refinery being situated at the centre of an urban area) 
• All population in the north 
• All population in the south 
• All population in the east  
• All population in the west 
 
The general trends in predicted case incidence were the same for class 1 and class 2 
substances, (although the absolute predicted case incidence values were different for each 
substance). Figure 20 uses nickel as an example to describe the pattern: 
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indicates population density 
increasing as a function of 
distance from the refinery - 
an unlikely scenario
"Heterogeneous inward" 
indicates population density 
decreasing as a function of 
distance from the refinery - 
as if the refinery was directly 
in the centre of an urban 
area
 
Figure 20: Nickel, like all class 1 and class 2 substances, decreases in concentration with distance 
from the refinery.  For class 1 and two substances, having the refinery at the centre of a heavily 
populated area would result in highest predicted case incidence. 
 
The greatest predicted case incidence is observed for “heterogeneous inward” – 
this makes sense since delivered concentrations are higher closest to the refinery. 
Heterogeneous outward places most of the population farther from the refinery where 
concentrations should be lower – this is reflected in the lower relative predicted case 
incidence. Prevailing winds were set as being from the SW to the NE – the patterns of 
predicted case incidence reflect this with higher predicted case incidence observed in the 
north and east scenarios where delivered concentration is likely to be higher. 
Looking at the percent change in incidence that would be predicted compared to 
the homogeneous population distribution around the refinery, the following points are 
noted: (i) predicted case incidence is higher in areas where delivered concentration 
should be higher, and (ii) the “heterogeneous inward” scenario results in the largest 
magnitude of altered predicted case incidence compared to the base case. 
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The pattern for the secondary PM (NOx and SOx) is somewhat different, with 
relatively similar predicted case incidence for homogeneous, heterogeneous inward, 
heterogeneous outward, or all in north or south scenarios. The only population scenarios 
that elicit notably different predicted case incidences than the homogeneous scenario are 
the all in east or all in west scenarios. This is likely a function of how 
degradation/transformation was calculated for class 3 substances. For primary and 
secondary PM, the calculation of transformation and degradation accounted for the 
reduced amount of primary PM and increased amounts of SOx and NOx at each 
successive distance from the refinery. The strong increase in SOx concentrations with 
distance from the refinery essentially overwhelms the reductions in predicted case 
incidence that might be expected for a heterogeneous inward scenario (due to fewer 
people living farther from the refinery) as compared with the “homogeneous” scenario. 



































density increasing as a 
function of distance from 




density decreasing as a 
function of distance from 
the refinery - as if the 
refinery was directly in the 
centre of an urban area
 
Figure 21: Concentration of SOx increases with distance from the refinery, in contrast to all class 1 
and 2 substances. In this case, only the “All in East” and “All in West” scenarios produce different 
predicted case incidence than the “homogeneous population” scenario.  Siting of refinery that is 
protective for SOx exposure is therefore not the same as siting which would be protective for class 1 
and class 2 substance exposures. 
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The local sensitivity analyses were followed by global analyses, where all 
uncertain or variable inputs were allowed to vary simultaneously according to 
predetermined probability distributions. 
2.1.4 Global Sensitivity Analysis Results 
2.1.4.1 Parametric uncertainty and Variability 
 In a global sensitivity analysis, the effects of allowing all input variables to vary 
at the same time is investigated, typically using a technique such as Monte Carlo 
simulation. 
The scatterplots of inputs/outputs created after initial Monte Carlo simulations 
indicated that there were always one or two extreme values predicted for both inputs and 
outputs. Truncating the distributions of values predicted at the 99th percentile eliminated 
the most extreme (and unlikely values) and provides a better sense of the scatter in 
values. Table 18 was created using 50 000 iterations. With this number of iterations, the 
correlation coefficients were stable.  
 Cullen and Frey suggest that correlation values of > |0.5| between model inputs 
and outputs indicate substantial correlation, while values > |0.2| may be of interest. For 
input/output combinations in HEIDI II, only correlation between predicted incidence and 
toxicity values exceeds either of these cutoff points for any substance. Correlations 
between predicted case incidence and background often exceeded |0.1|. 
 Table 18 confirms that the toxicity parameters are the most influential variables 
(of those that are either variable or uncertain or both) for predicted case incidence for 
class 1 and two substances. Background concentration becomes mildly important for 
some substances (BTEX, cyclohexane, n-hexane, propylene, and styrene). The 
background levels used do not appear to be significantly higher (relative to amount 
emitted) for these substances as compared to other substances, and the toxicity values do 
not appear to be particularly low. However, the GSD used to characterize the 
distributions for the background for these particular substances was relatively high. The 
higher degree of skew in the lognormal distributions used to represent ambient 
concentrations may have resulted in the total delivered concentration exceeding the 
threshold for these substances more often. 
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 Table 18 indicates that there are varying levels of correlation between the ED05 
values and the predicted impact for class 2 substances. In general, substances with lower 
thresholds exhibit greater correlation with predicted incidence. This likely reflects the 
greater proportion of times that the delivered concentration value exceeds the threshold 
during a simulation with multiple iterations - and therefore exerts an effect on predicted 
incidence values. In contrast, each time a delivered concentration value below the 
threshold is predicted for a given substance, regardless of the C-R value, zero case 
incidence would be predicted, leading to a low correlation.  
 For a select few substances (BTEX, cyclohexane, n-hexane, propylene and 
styrene), background becomes important. This suggests that the delivered concentration 
from refinery emissions rarely reaches the threshold concentration without the addition of 
background levels. Background is likely to have the greatest influence in cases where its 
presence routinely causes the threshold to be exceeded. With the exception of BTEX, the 
(absolute) predicted impacts for these substances are negligible. However, in the case of 
BTEX, this indicates that the combined presence of benzene, toluene, ethylbenzene, and 
xylene in the ambient environment and from individual industries poses a threat to health. 
 
Table 18: Spearman (rank) correlation coefficients for inputs values and predicted incidence 
calculated with distributions truncated at 99th percentile and using 50000 iterations. Correlation 
coefficients > |0.1| are highlighted. This data highlights the overwhelming importance of the C-R data 















Class 1      
1,3-Butadiene -2.6E-02 -1.1E-02 N/A 1.0 N/A 




-9.8E-03 -2.2E-02 N/A 1.0 N/A 
Nickel (and its 
compounds) -6.7E-04 N/A N/A 1.0 N/A 
PAHs -2.7E-02 -2.4E-02 N/A 1.0 N/A 
Formaldehyde -3.3E-03 -1.5E-02 N/A 1.0 N/A 
Class 2      
1,2,4-
Trimethylbenzene -7.0E-03 8.3E-04 7.2E-02 -7.0E-01 -0.59 
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Cyclohexane -1.8E-03 -3.8E-03 0.11 -0.45 -0.59 
Dicyclopentadiene -2.8E-03 -7.2E-03 N/A -0.88 -0.41 
Diethanolamine 
(and its salts) -3.0E-03 -4.4E-03 N/A -0.87 -0.44 
Hydrogen 
sulphide -8.6E-03 5.0E-03 4.2E-03 -0.93 -0.30 
Isoprene 2.0E-03 -2.0E-03 7.9E-02 -0.37 -0.49 
Mercury -2.4E-03 N/A 4.0E-02 -0.92 0.01 
Methanol -6.0E-03 -4.3E-03 N/A -0.59 -0.61 
Methyl ethyl 
ketone -5.0E-03 -3.5E-03 2.9E-02 -0.47 -0.62 
Methyl isobutyl 
ketone -3.8E-03 -1.2E-04 7.1E-03 -0.45 -0.60 
Methyl tert-butyl 
ether -4.6E-03 4.0E-03 N/A -0.55 -0.64 
Naphthalene -8.0E-03 -2.4E-03 3.5E-02 -0.77 -0.55 
n-Hexane 9.0E-04 5.6E-03 0.12 -0.74 -0.56 
Phenol (and its 
salts) 2.2E-04 -2.5E-04 N/A -0.83 -0.48 
Propylene -6.4E-03 -3.2E-03 0.15 -0.59 -0.62 
Styrene 3.8E-03 8.1E-04 0.13 -0.60 -0.61 
Sulphuric acid -5.3E-03 1.1E-04 N/A -0.95 -0.23 
Vanadium (except 
when in an alloy) 
and its 
compounds 
-3.2E-03 N/A 1.4E-02 -0.86 -0.46 
Zinc (and its 
compounds) 3.1E-03 N/A 6.4E-02 -0.58 -0.73 
Table 19 shows the correlation for class 3 substances, calculated after truncating 
distributions at 99th percentile. 
 
 
Table 19: Correlation between age-group and outcome-specific specific annual average mortality 
coefficient values with predicted case incidence.  The predicted case incidence is highly correlated 
                                                 
18 The first correlation coefficient listed is for a weighted background concentration for the BTEX mixture. 
Each of the following coefficients is for the background concentrations of the individual components of the 
mixture. 
19 The toxicity value used for BTEX was a weighted combination of the toxicity values for B, T, E, X 
which depended on the relative amounts delivered to each zone around the refinery and thus changed with 
the geographic space around the refinery. The correlation coefficients shown here are for the toxicity 
assigned to each of the components, suggesting that the toxicity of benzene contributes most to the overall 
toxicity of the mixture. The correlation of the individual components appears to be low relative to other 
substances. This may be because BTEX is the only substance for which the toxicity depended on the zone, 
which also determined delivered concentration and population. 
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with the epidemiological coefficients in HEIDI II. This is expected, since there are few other variables 
that predict class 3 incidence which are described probabilistically, and the dose-response 
relationship is assumed linear. N/A is used in the table where risk coefficients do not apply (i.e., 
children are not considered to be at risk of mortality from air pollution; this assumption is routinely 
made since the epidemiological studies on which the coefficients are based did not include children). 
Substance Input (toxicity RR) Population Sample Rank Correlation 
Spearman Rank 
Correlation 
PM from NOx mortality child N/A N/A 
  adult 0.96 0.96 
  senior 0.96 0.95 
 chronic bronchitis child N/A N/A 
  adult 0.98 0.98 
  senior 0.97 0.97 
 Asthma hospitalization child 0.96 0.97 
  adult 0.98 0.98 
  senior N/A N/A 
 Asthma ER visit child 0.96 0.97 
  adult 0.98 0.98 
  senior N/A N/A 
PM from SOx mortality child N/A N/A 
  adult 0.96 0.96 
  senior 0.96 0.95 
 chronic bronchitis child N/A N/A 
  adult 0.98 0.98 
  senior 0.97 0.97 
 Asthma hospitalization child 0.96 0.97 
  adult 0.98 0.98 
  senior N/A N/A 
 Asthma ER visit child 0.96 0.97 
  adult 0.98 0.98 
  senior N/A N/A 
Primary PM mortality child N/A N/A 
  adult 0.98 0.97 
  senior 0.97 0.97 
 chronic bronchitis child N/A N/A 
  adult 0.98 0.98 
  senior 0.98 0.98 
 Asthma hospitalization child 0.97 0.98 
  adult 0.99 0.99 
  senior N/A N/A 
 Asthma ER visit child 0.97 0.98 
  adult 0.99 0.99 
  senior N/A N/A 
 
Table 19 indicates high correlation between the relative risk values used for each 
population/outcome combination with predicted case incidence. This is expected due to 
the highly linear nature of the functions used to predict health impact from CACs. 
The datapoints selected during a simulation can be plotted as scatterplots to 
complement the correlation coefficients data, as shown in these examples: Figure 22, 




Figure 22: Sample scatterplot showing a strong linear relationship between C-R value and the 
predicted case incidence for 1,3-butadiene. This relationship was present for all class 1 substances.  
 
Figure 23: Sample scatterplot (for Mercury)  showing the relationship typical of that observed 
between ED05 and predicted case incidence for class 2 substances where lower thresholds are more 





Figure 24: There is a clear linear relationship between C-R value and predicted case incidence for all class 3 substances, as illustrated in this figure.  




Predicted case incidence for class 3 substances are not mathematically related to 
[OH], k, or background concentrations, and class 1 substances are not mathematically 
related to background. Scatterplots generated for these combinations confirmed this (for 
purposes of validation) and are not presented here. 
2.1.5 General conclusions about variables that are and are not 
important 
 Of the scenario variables under the user’s control, the stack height appears to be 
most influential in determining delivered concentration, and the degree to which each 
stack height delivers a small or large concentration to a particular area around the refinery 
depends on the distance from the refinery. The stack height variable could potentially 
interact with the population variable, where a refinery with a 30 metre stack would be 
associated with a greater health impact if the population was mainly located at 25 km 
downwind than if the same number of people were clustered within 5-10 km of the 
refinery. Based on predictions using a 5 metre stack height, fugitive emissions are likely 
to be important for people living with 5-10 km of the refinery, but do not appear to affect 
the health of people living farther away. 
The evidence presented above indicates that despite large uncertainty and 
variability in many input variables, predicted case incidence depends mainly on the 
concentration-response data selected for each substance. The uncertainty in background 
may play the most important role in predicting incidence for some class 2 substances, but 
the absolute difference in predicted case incidence in a population of 2.5 million is still 
less than one even if the background is being underpredicted at the 95th percentile of its 
uncertainty distribution. Additionally, the influence of even a minor overprediction of C-
R values overwhelms the effect of background on predicted case incidence for any 
substance. There is an interaction effect between background levels and ED05 value for 
class 2 substances, where if the background is high and the threshold is low in a 
particular iteration of the model, the predicted case incidence is high. However, predicted 
case incidence values of note only appear to occur at extreme combinations for both, 
which would typically be unlikely to occur together in practice. The potential variability 
and uncertainty in k and OH is not important for predicting incident cases, thus these 
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variables could be represented as point estimates in the model without any significant 
loss of information. 
 It appears that at certain combinations of variables at their 95th percentile levels, 
high levels of predicted case incidence can occur in the model for BTEX, Vanadium, HS, 
and Zn. The potential for predicted case incidence when all variables are simultaneously 
varying throughout the simulation will be investigated in the next chapter which provides 
the results of the Monte Carlo simulation. For now it is sufficient to note these substances 
for further investigation. For most class 2 substances, the predicted case incidence values 
are very low; well below a de minimis risk level of 10-6 even when values for at least two 
inputs are selected from the tails of their distributions – the most influential region. 
2.1.5.1 Alternate model formulations? 
 Sensitivity analysis should assess not just the effect of varying individual input 
variable, but also the predictions of plausible alternate model formulations. This was 
partially addressed by changing the slope in the Mantel-Bryan formulation of the C-R for 
class 2 substances. There was a clear dependence of predicted case incidence on this 
value, suggesting that if this characterization of the dose-response relationship is 
inappropriate, the model predictions for predicted case incidence are also invalid. 
However, the HEIDI II model was developed as a screening tool. Under the assumption 
that all class 2 substances are subject to equivalent dose response relationships (just 
anchored at substance-specific ED05 values), use of a likely dose response relationship is 
probably sufficient to enable comparison of substances. The interaction between Mantel-
Bryan slope and ED05 value was investigated and the results indicated that high values of 
predicted case incidence occurred only for slope values of 1 or less and that for slopes of 
1.5 and greater, predicted case incidence was effectively zero across the range of 
potential ED05 values. 
 By analyzing three separate classes of substances with three distinct C-R 
characterizations, the model contains a type of internal sensitivity analysis. The general 
characteristics of model behaviour for each of the three classes can be compared to 
understand how different types of C-R characterizations affect output. 
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Table 20: Comparing how three different types of dose-response relationships (selected to represent 
different “types” of substances) affected the model output and behaviour 















evidence (relative risk 
values) 
Type of health 
outcome Cancer 
Systemic; range from 
mild (i.e., nasal 





Magnitude range of 
emissions ~0-52 tonnes/year ~0-300 tonnes/year ~0-23000 tonnes/year 
Magnitude range of 
predicted case 
incidence  
~0.006 - 52 < 10-14 – 0.1 2-539 
Effect of background 
on predictions None 
Marginal for certain 
substances None 
Complexity of model medium complex simple 
2.1.6 Discussion 
 Truncating the output distributions in the global sensitivity analysis had the effect 
of eliminating the most extreme predictions from the distributions.  A lognormal 
distribution was assumed for many of the variables’ probability distributions. For the C-R 
data especially, the lognormal distributions were quite skewed. The result is that where 
high values of predicted case incidence are predicted (relative to the central estimates), 
the degree to which predicted case incidence becomes more extreme increases rapidly at 
the tail end of the distribution. 
 The predicted case incidence results presented in this chapter all resulted from 
inputs for a hypothetical worst-case scenario, where high emissions were being modeled 
for all substances – an unlikely scenario for any individual refinery. Most substances 
would be emitted at lower levels at any given refinery. In this way, the hypothetical 
refinery provides a conservative scenario, allowing assessment of impact at the highest 
likely emissions scenario. However, substance-specific results were independent, and the 
worst-case refinery was developed using the maximum emissions observed for each 
substance from across the refineries, so each substance-specific predicted incidence 
distribution could apply to at least one refinery in Canada. It might be useful to extend 
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the validation to a “catastrophic” refinery scenario, where emissions are modeled as 
being significantly higher than what has been observed in practice.  
The impact of stack height and photodegradation time on predicted case incidence 
is clear. The default scenario of 30 metres and 12 hours of degradation time is associated 
with the second-lowest predicted case incidence of all the possible stack 
height/photodegradation scenarios. The subsequent sensitivity analyses were all 
conducted at the default scenario. However, if the stack height (or “average stack height”, 
which could be conceptualized as the combination of all onsite emissions from multiple 
stacks of various heights plus fugitive emissions) was lower than 30 metres, the predicted 
case incidence across all distributions would increase. For substances such as BTEX, HS, 
V, and Zn which were already identified as potentially having relatively higher predicted 
incidence at the tails of the probability distribution, this could be important at a particular 
refinery if the stack is actually lower than 30 metres.  
The impact of stack height is important with respect to the physical distribution of 
the population around any given refinery. If the stack height in the model is changed, the 
location of maximum delivered concentration is also changed. The SAs provided above 
were done using the distribution of population close to the Imperial Sarnia refinery, 
which has the greatest number of people living within 25 km of any Canadian refinery. 
However, this distribution is not representative of all refineries. Policies for siting 
refineries can optimize (minimize) the impact of emissions on nearby densely populated 
areas through careful consideration of meterology, relative locations of the refinery and 
the population, and stack height. Improved mitigation should also be a component of risk 
management for refinery emissions. 
The sensitivity analyses described above overlooked many factors which could 
influence the predictions of HEIDI II. SA was unable to assess the effect of uncertainty in 
the dispersion modeling results, the effect of variable meteorological conditions, or the 
cumulative health impact from simultaneous exposure to all refinery emissions.  
HEIDI II assumed that airborne concentrations are representative of each 
individual’s exposure, which is not realistic, since most Canadians spend most of their 
time indoors (Leech and Laporte 1996), which reduces their exposure to ambient airborne 
pollutants. As well, Canadians living near a refinery are unlikely to spend all of their time 
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in the same location relative to the refinery, but will move further and closer in various 
directions as they travel to work and school, conduct errands, or meet social obligations. 
There is no adequate way to test the impact of neglecting “individual-level exposure” in 
HEIDI II. 
2.1.6.1 So what should HEIDI II look like as a probabilistic model? 
It appears that little information is likely gained in HEIDI II by retaining 
probability distributions (rather than point estimates) for variables such as k, [OH], and 
often, background levels for chemicals. The EPA points out that when deciding whether 
to use point values or probability density functions (PDFs) to characterize these types of 
variables, the risk communication process might be facilitated by focusing in on key 
variables and this is facilitated by quantifying only those variables using PDFs. However, 
they also point out that issues of perception and trust are important, and concerns exist 
that elimination of multiple small sources of variability would reduce the variability in 
the final output predictions (Office of Emergency and Remedial Response 2001). A key 
goal of NERAM’s original approach to HEIDI was to retain the maximum amount of 
transparency in the model. The run time of the model was not significantly increased by 
retaining the PDFs for these variables, and so there was no practical reason to use point 
estimates. Therefore, although the sensitivity analyses indicated that the variation in 
variables k, [OH], and sometimes background have little impact on the predicted case 
incidence, the PDFs for these variables were retained and allowed to fluctuate during the 
simulations.  
 To assess probable impacts, HEIDI should be run at the default, i.e. 30 metres and 
12 hours. 30 metres is likely representative of most refineries and 12 hours is the best 
compromise across seasons in Canada. However, to assess worst-case possibilities, the 
model could be run with a 15 metre stack height and no photodegradation. 
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2.2 Model/Analytical Findings 
2.2.1 Introduction 
 The sensitivity analyses conducted in the previous section provided some 
indication of specific substances which might be associated with predicted case incidence 
levels of concern, and the uncertain or variable inputs that would be related to the high 
predictions. In the following probabilistic analysis, Monte Carlo simulations were run 
with a high number of iterations to predict distributions of incidence for all substances. 
Each of the uncertain/variable inputs was allowed to vary simultaneously according to its 
selected probability distribution (See Appendix C). Distributions of predicted case 
incidence (or DALY years, if using DALY weights) allow comparison of the possible 
range of potential health impacts due to emissions from Canadian refineries, given both 
uncertainty and variability in the input data. The upper tails of the distributions could be 
thought of as describing a conservative scenario (given the amount of uncertainty in some 
inputs). This might include a sensitive population (since uncertainty in C-R values 
appears to be particularly influential), or where unusually high levels of background 
concentrations exist, or both. The distributions of predicted case incidence are first 
presented for the hypothetical worst-case refinery default scenario. Some predictions of 
annual incidence based on real emissions from Canadian refineries are also provided. 
These should be interpreted with caution and used mainly to compare substances with 
each other, as HEIDI II was developed as a screening tool and was not intended to be 
used to predict absolute incidence from exposure near specific refineries.  
 The original design for HEIDI II was to compare predicted health impacts based 
on a measure such as DALYs, which accounts for years and quality of life lost due to 
disease or disability, allowing comparison of endpoints with varying severity. However, 
most of the testing and validation of the model was carried out using predicted 
incidence20. The current operationalization of DALY weights in HEIDI II is fairly 
unsophisticated: they are expressed in terms of “DALYs per person” averaged over a 
population assumed to be equivalent to the Canadian population. The health impacts 
predicted by the model can be expressed in three ways: (i) predicted incidence, (ii) 
                                                 
20 For reasons described in Chapter 3 - Methods (“Sensitivity Analysis” section). 
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predicted DALYs using a set of “simple DALY” weights which differentiate health 
conditions only into three levels of severity, and (iii) predicted DALYs using a set of 
“complex DALY” weights which assigns a distinct weight to each disease state. The 
different methods of predicting health impact allow comparison of model rankings 
generated using DALYs vs. those using predicted case incidence. 
 HEIDI II is ultimately intended to be a prioritization tool; the most relevant output 
of HEIDI II is a rank order intended to identify the substances having the highest impact 
on populations living close to refineries in Canada. Various approaches to ranking 
probabilistic outputs are explored in an attempt to determine which approaches work best 
and whether there is any consistency across refineries in predictions about which 
substances should be highest priority for reduction. 
Unless otherwise specified, all simulations were run using the default stack height 
and photodegradation time parameters (30 metres and 12 hours).  
2.2.2 Predicted case incidence at the hypothetical worst-case 
refinery 
2.2.2.1 Classes 1 and 2 
 Frequency distributions for predicted case incidence were created using Monte 
Carlo simulations with 100 000 iterations, and the proportion of the cumulative frequency 
distribution curve below a lifetime (70 years) de minimis risk level of 10-6 was identified. 
For the purpose of creating legible plots, values above the 99th percentile were discarded 
during plotting.  
 Figure 25 provides an example cumulative probability distribution for predicted 
case incidence of lung cancer from exposure to Nickel at the hypothetical worst-case 
refinery. For nickel in this worst-case scenario, about 40% of the predicted case incidence 
values that emerged from the Monte Carlo simulation were above the de minimis risk 
level of 10-6, suggesting a high probability that this scenario is associated with more 
cancer than is typically deemed acceptable by many regulatory agencies. The upper tail 
of the distribution suggests that there is a small chance that as many as 100 cases of lung 
cancer could be predicted per year within 25 km of the hypothetical worst-case refinery 

































































Cumulative probability distribution of predicted incidence for Nickel 
(and its compounds) at the Hypothetical Worst-case refinery
AUC below the de minimis risk level = 0.60
↑
de minimis risk level
 
Figure 25: Cumulative probability distribution for predicted case incidence of lung cancer from 
Nickel (and compounds) at the hypothetical worst-case refinery. AUC = area under the curve, where 
total area equals 1. 
 Table 21 summarizes the percentage of the cumulative probability distribution 
exceeding the de minimis risk levels for each emitted substance in the default 
hypothetical worst-case scenario. The relevant human outcomes for those with the 
highest values are disparate, including lung cancer, CNS neurotoxicity, and nose 
irritation. It is difficult to compare chemicals on the basis of such diverse types of health 
outcomes; this table highlights the disadvantages of not including quality of life measures 
in determining health impact from exposure to diverse chemicals. Incidence above 10-6 
was sometimes predicted during the simulations for substances related to serious health 
impacts such as cancer and CNS neurotoxicity (i.e., Ni, PAH, BTEX). This indicates that 
analysis at individual refineries is important to determine whether high potential level of 
risk exists with “real” emissions/population distribution combinations. 
 Table 21 also provides a sense of which substances were not predicted to be 
associated with any risk above the de minimis level at the hypothetical worst-case 
refinery. Many substances were associated with zero predicted case incidence in all 
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simulations, including ammonia, isoprene, mercury, methanol, MEK, MIBK, MTBE, and 
phenol. This suggests that refinery emissions of these substances are not likely to be a 
health concern at any refinery in Canada. Depending on the substance, this is likely 
related to either very low emissions (i.e., mercury) or very low toxicity (i.e., MIBK) or a 
combination of both.  
Table 21: Proportion of predicted case incidence above the 10-6 de minimis level for all class 1 and 
class 2 substances for the hypothetical worst-case refinery. This tabulation in conjunction with the 
relevant human outcomes provides a sense of why DALYs (or some sort of weighting scheme) is 
useful for prioritization of risk.  Values greater than 0 are highlighted 
Substance Proportion of predicted 
case incidence above 
10-6 
Relevant outcome (for reference) 
Class 1   
1,3-Butadiene 0.00 Leukemia 
Benzene 0.00 Leukemia 
Ethylene (as 5% ethylene 
oxide) 0.00 
Leukemia 
Nickel 0.40 Lung Cancer 
PAH (using Benzo[a] 
pyrene) 0.38 
Lung Cancer 
Formaldehyde 0.00 Nasal and lung cancer 
Class 2   
1,2,4-trimethylbenzene 0.01 Moderate anemia 
Ammonia 0.00 Skin and nose irritation 
BTEX  0.20 CNS neurotoxicity 
Cyclohexane 0.00 Reduced bodyweight 
Dicyclopentadiene 0.00 Chronic renal disease 
Diethanolamine 0.00 Throat irritation 
Hydrogen sulphide 0.03 Nose irritation 
Isoprene 0.00 Benign lung tumours 
Mercury 0.00 Severe CNS neurotoxicity 
Methanol 0.00 Physical teratogenesis 
MEK 0.00 Developmental retardation 
MIBK 0.00 Developmental retardation 
MTBE 0.00 PNS neurotoxicity 
Naphthalene 0.00 Benign lung tumors 
n-hexane 0.00 PNS neurotoxicity 
Phenol 0.00 Mild CNS neurotoxicity 
Propylene 0.00 Benign nasal & upper airway tumours 
Styrene 0.00 Mild developmental retardation 
Sulphuric Acid 0.32 Benign nasal and upper airway tumors 
Vanadium 0.46 Nasal and upper airway irritation 
Zinc 0.00 Moderate anemia 
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2.2.2.2 Class 3 substances 
 Recall that the predictions of incidence for class 3 substances are different by 
virtue of (i) how they were generated (no accounting for photodegradation and the 
interdependence of concentrations of secondary PM on primary PM concentrations), and 
(ii) the type of C-R data used to predict incidence. For class 3 substances, 
epidemiological relative risk values for four separate outcomes per substances was used, 
whereas toxicity of class 1 and class 2 substances was based on unit risk or ED05 values 
which were estimated for the most critical endpoint, and often based on toxicological 
experiments on animals. The general characteristics of the predictions are also distinct. In 
particular, 100% of the cumulative probability distributions for predicted case incidence 
for class 3 substances is above the de minimis risk level for all outcomes, and this 
measure therefore does not distinguish the relative potential impact of SOx, NOx, and 
primary PM. Cumulative probability distributions are presented in Figure 26, Figure 27, 
and Figure 28 for predicted case incidence from exposure to PM from SOx, PM from 
NOx, and primary PM at the hypothetical refinery. Results for each of the four health 
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Predicted annual incidence for PM (NOx) 
(in a population of 2.5 million)
Predicted incidence for mortality for PM (NOx) 
at the Hypothetical Worst-case refinery
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Predicted annual incidence for PM (primary) 





































Predicted incidence for mortality for PM (primary) 
at the Hypothetical Worst-case refinery
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Predicted incidence for chronic bronchitis for PM (primary)
at the Hypothetical Worst-case refinery
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Predicted incidence for asthma hospitalizations PM (primary)
at the Hypothetical Worst-case refinery
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Predicted incidence for asthma ER visits PM (primary)
at the Hypothetical Worst-case refinery
 
Figure 28: Cumulative probability for predicted case incidence of each outcome associated with exposure to primary PM2.5 
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 The probability distributions for predicted case incidence from PM were normal 
in character. These cumulative distribution functions (CDFs) suggest that significant 
morbidity and mortality may be associated with PM emissions from Canadian refineries 
at nearby locations. Table 22 describes the distributions predicted for the hypothetical 
refinery.  
Table 22: Predicted case incidence for mortality, chronic bronchitis, asthma hospitalization and 






cases per person 
annually 
Refinery: Hypothetical Worst-Case (population = 2 612 269) 
PM from SOx - Mortality 35 350 660 1.3E-04 
          Chronic bronchitis 71 710 1300 2.7E-04 
          Asthma hospitalizations 3.8 38 72 1.4E-05 
          Asthma ER visits 6.5 65 120 2.5E-05 
PM from NOx - Mortality  3.3 33 63 1.3E-05 
         Chronic bronchitis 6.5 65 120 2.5E-05 
         Asthma hospitalizations 0.4 3.8 7.2 1.5E-06 
         Asthma ER visits 0.6 6.5 12 2.5E-06 
Primary PM - Mortality 2.8 28 53 1.1E-05 
        Chronic bronchitis 5.4 54 100 2.1E-05 
        Asthma hospitalizations 0.3 3.2 6.2 1.2E-06 
        Asthma ER visits 0.6 5.5 11 2.1E-06 
 For each outcome and PM combination, the mean rate of annual predicted case 
incidence exceeded 10-6. Exposure to SOx is associated with the highest rates of predicted 
case incidence. The upper 95th percentiles of predicted case incidence are associated with 
exceptionally high numbers of predicted cases of mortality and respiratory morbidity. 
 These probability distributions were created under the assumption of no threshold 
for health impact from PM. To date, large-scale studies have not been able to identify a 
specific threshold for the health impacts of PM2.5, but the possible existence of such a 
threshold is still contentious (World Health Organization (WHO) 2004).  
It is not practical to compare the exposures to CACs from refineries to any kind of 
“policy-based” threshold21. In Canada, Canada-wide standards are set at 30 μg/m3, and 
apply to ambient levels of PM2.5 contributed from all sources. Inspection of the delivered 
concentrations predicted by HEIDI II reveals that the concentration of PM delivered by 
                                                 
21 Because the dose-response function for CACs is linear, the effect of introducing any kind of threshold 
into the model is easily predicted: it reduces the predicted case incidence by the amount predicted using the 
threshold alone. For example, applying an arbitrarily selected threshold of 1μg/m3 has the expected effect 
of narrowing and shifting the cumulative probability distributions for predicted case incidence to the left. 
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the refineries to any given quadrant around them is predicted not to reach even half that 
value.  
2.2.3 Predicted case incidence at actual refineries in Canada 
 The actual emissions from “real” Canadian refineries differ at each location in 
terms of which substances are emitted, and in what quantities. As well, the number and 
geographic dispersion of people potentially affected differs at each refinery. Although (as 
the disclaimer prior to the methods chapter explains) predicted case incidence cannot be 
taken at a true estimate of the annual number of cases at each refinery, comparing the 
distributions of predicted case incidence values for different emissions still facilitates 
identification of (i) which substances are typically of concern at refineries across Canada 
using data relevant for individual communities, (ii) which refineries emit multiple 
substances of concern, and  (iii) whether there is a meaningful difference between 
predicted incidence values that are associated with adjacent ranks.  
2.2.3.1 Class 1 and 2 substances 
Table 23 indicates that predictions of incidence above the de minimis risk level 
were consistently associated with a limited set of substances. The table identifies only 
emitted substances where a portion of the cumulative probability distribution exceeded 
the de minimis risk level of 10-6 at each refinery. These include PAH, Nickel, BTEX, 
Sulphuric acid, hydrogen sulphide, and vanadium. The relevant human health outcomes 
for each of these substances are disparate, encompassing lung cancer, CNS neurotoxicity, 
nose irritation and benign nasal and upper airway tumors, and upper airway irritation. 
These outcomes are clearly not directly comparable. 
The Imperial Sarnia refinery is associated with predictions of incidence above the 
de minimis level for the highest number of substances (6). This may be of particular 
concern since there are other refineries located nearby, all of which contribute to 
exposure of the same population. This includes the Shell Sarnia refinery, which emits 
four substances of concern. The Petro Canada refinery in Montreal also has four 
emissions of concern, while the rest have either three, two, or one. 
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Table 23: Class 1 and class 2 substances emitted from each refinery for which the proportion of 
predicted case incidence above the de minimis risk level was greater than zero. A complete list 






Relevant outcome (for 
reference) 
BTEX 0.20 CNS neurotoxicity 
Chevron-Burnaby Vanadium 0.14 Nasal and upper airway irriatation 
BTEX 0.10 CNS neurotoxicity Consumer’s Co-
operative Hydrogen Sulphide 0.04 Nose irritation 
Prince George BTEX 0.09 CNS neurotoxicity 
BTEX 0.09 CNS neurotoxicity Imperial 
Dartmouth Sulphuric Acid 0.22 Benign nasal and upper airway tumors 
BTEX 0.09 CNS neurotoxicity 
Hydrogen Sulphide 0.01 Nose irritation Imperial Nanticoke 
Sulphuric Acid 0.17 Benign nasal and upper airway tumors 
Nickel 0.50 Lung cancer 
PAH (using Benzo[a] 
pyrene) 0.08 Lung cancer 
BTEX 0.09 CNS neurotoxicity 
Hydrogen Sulphide 0.01 Nose irritation 
Sulphuric Acid 0.39 Benign nasal and upper airway tumors 
Imperial Sarnia 
Vanadium 0.55 Nasal and upper airway irriatation 
BTEX 0.20 CNS neurotoxicity Imperial 
Strathcona Sulphuric Acid 0.19 Benign nasal and upper airway tumors 
Nickel 0.01 Lung cancer Irving Saint John BTEX 0.09 CNS neurotoxicity 
Nickel 0.36 Lung cancer 
BTEX 0.10 CNS neurotoxicity North Atlantic 
Refining Vanadium 0.44 nasal and upper airway irritation 
BTEX 0.10 CNS neurotoxicity 
Nova Corunna Sulphuric Acid 0.24 Benign nasal and upper airway tumors 
Parkland Bowden BTEX 0.09 CNS neurotoxicity 
BTEX 0.20 CNS neurotoxicity 
Sulphuric Acid 0.14 Benign nasal and upper airway tumors Petro-Canada - Edmonton 
Vanadium 0.01 Nasal and upper airway irriatation 
BTEX 0.09 CNS neurotoxicity Petro-Canada - 
Mississauga Sulphuric Acid 0.05 Benign nasal and upper airway tumors 
Nickel 0.40 Lung cancer 
BTEX 0.20 CNS neurotoxicity 
Sulphuric Acid 0.16 Benign nasal and upper airway tumors 
Petro-Canada - 
Montreal 




PAH (using Benzo[a] 
pyrene) 0.34 Lung cancer 
BTEX 0.20 CNS neurotoxicity 
Sulphuric Acid 0.20 Benign nasal and upper airway tumors 
Petro-Canada - 
Oakville 
Vanadium 0.12 Nasal and upper airway irritation 
BTEX 0.20 CNS neurotoxicity 
Shell-Montreal Sulphuric Acid 0.16 Benign nasal and upper airway tumors 
Nickel 0.22 Lung Cancer 
BTEX 0.10 CNS neurotoxicity 
Sulphuric Acid 0.38 Benign nasal and upper airway tumors Shell Sarnia 
Vanadium 0.33 Nasal and upper airway irritation 
PAH (using Benzo[a] 
pyrene) 0.04 Lung Cancer Shell Scotford 
BTEX 0.20 CNS neurotoxicity 
BTEX 0.09 CNS neurotoxicity 
Sunoco Sulphuric Acid 0.17 Benign nasal and upper airway tumors 
BTEX 0.09 CNS neurotoxicity Ultramar St. 
Romuald Sulphuric Acid 0.07 Benign nasal and upper airway tumors 
2.2.3.2 Class 3 substances 
Predicted case incidence for class 3 substances was determined for four separate 
outcomes per substance. For brevity, results are presented in Table 24 only for the Shell 
Montreal refinery, which was associated with the highest total predicted cases overall, 
and the Shell Scotford refinery, which was among the refineries with the lowest predicted 
case incidence from PM emissions. These results suggest that a significant health impact 
is associated with PM emissions from some refineries in Canada.  They also suggest that 
total number of cases predicted is heavily influenced by the total population exposed: 
while there are about 2.6 million people living within 25 km of the Montreal refinery, 
there are only ~62 000 people living near the Scotford refinery. The predicted incidence 
per person may be a better metric that total incidence to assess the implications of 
emissions at any particular site. A table containing predictions for all refineries can be 




Table 24: Predicted case incidence from exposure to primary and secondary PM at the Shell 
Montreal refinery (where highest impact was predicted) and Shell Scotford refinery (where lowest 






cases per person 
annually 
Refinery: Shell Montreal (population = 2 612 269) 
PM from SOx - Mortality 8.7 87 165 3.3E-05 
          Chronic bronchitis 16 160 310 6.2E-05 
          Asthma hospitalizations 1.1 11 21 4.3E-06 
          Asthma ER visits 1.6 17 31 6.3E-06 
PM from NOx - Mortality  2.5 25 47 9.4E-06 
         Chronic bronchitis 4.5 45 85 1.7E-05 
         Asthma hospitalizations 0.3 2.6 5.0 1.0E-06 
         Asthma ER visits 0.4 4.4 8.4 1.7E-06 
Primary PM - Mortality 1.5 15 28 5.7E-06 
        Chronic bronchitis 2.5 26 48 9.6E-06 
        Asthma hospitalizations 0.2 1.5 2.9 5.8E-07 
        Asthma ER visits 0.3 2.6 4.9 9.9E-07 
Refinery: Shell Scotford (population = 31 231) 
PM from SOx - Mortality 0.0 0.0 0.1 8.8E-07 
          Chronic bronchitis 0.0 0.0 0.1 1.6E-06 
          Asthma hospitalizations 0.0 0.0 0.0 1.2E-07 
          Asthma ER visits 0.0 0.0 0.0 1.8E-07 
PM from NOx - Mortality  0.0 0.1 0.2 2.5E-06 
         Chronic bronchitis 0.0 0.2 0.3 5.0E-06 
         Asthma hospitalizations 0.0 0.0 0.0 3.1E-07 
         Asthma ER visits 0.0 0.0 0.0 5.5E-07 
Primary PM - Mortality 0.0 0.0 0.0 3.1E-07 
        Chronic bronchitis 0.0 0.0 0.0 5.5E-07 
        Asthma hospitalizations 0.0 0.0 0.0 4.0E-08 
        Asthma ER visits 0.0 0.0 0.0 6.2E-08 
 
 Large differences in predicted cases per million people are observed when 
comparing across refineries and likely stem mainly from the amount of emissions at each 
individual refinery. However, the geographic distribution of people relative to the 
refinery is also important. The northeast quadrants are subject to the highest predicted 
exposures as a result of the generic meteorology scenario used throughout HEIDI. As 
Table 25 shows, the Imperial Sarnia refinery seems to have especially high rates of 
annual predicted case incidence for all outcomes – as high as one in 1000 for mortality 
from SOx. Imperial Sarnia has the highest PM emissions of all the Canadian refineries, 
and as Figure 29 shows, the majority of the population density is located to the northeast 
of the refinery, the quadrant that would be subject to the highest exposure given the 
meteorology used (which includes winds predominantly from the southwest).  
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Table 25: Predicted case incidence – annual rates per person at the Imperial Sarnia Refinery 
Outcome PM from SOx PM from NOx Primary PM 
Mortality 1.0E-04 1.1E-05 2.0E-05 
Chronic bronchitis 2.0E-04 2.0E-05 3.7E-05 
Asthma hospitalizations 1.2E-05 1.2E-06 2.2E-06 
Asthma ER visits 2.0E-05 2.0E-06 4.2E-06 
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Figure 29: Distribution of population in each of 20 "quadrants" around the Imperial Sarnia Refinery 
Different demographic composition of the populations in each area could also 
affect predicted rates of incidence - high rates would be observed where more of the 
population is “at-risk” (i.e, a greater proportion of adults and seniors relative to children 
puts a greater proportion of the population at risk for mortality from PM exposure, which 
HEIDI II assumes to be relevant for only adults and seniors). 
2.2.4 HEIDI II as a Ranking Tool 
HEIDI II was developed as a screening tool and is intended to be used to identify 
those refinery emissions associated with the greatest health impacts. The output of the 
deterministic model was a rank ordering of substances where a high rank indicated 
greater health impacts. The ranking information, however, did not provide any 
information about the absolute difference between impacts of different substances – an 
issue which may be important for policy decisions. 
 
 105
As part of the Monte Carlo simulation, a rank was generated at each iteration for 
each substance, allowing construction of a probability distribution for “rank” for each 
emission from the refinery. The distributions of rank provide insight about the level of 
separation that exists between ranked substances – information that is not available when 
using the ranks from the deterministic version of HEIDI II. However, there are some 
difficulties in interpreting probabilistically generated ranks when there is overlap in the 
CDFs for the health impact outputs. 
2.2.4.1 Ranks within classes – Hypothetical Refinery 
 Because predicted case incidence was calculated differently for each class of 
substances (i.e., as a result of the concentration-response functions used), ranks are most 






















































































Histogram indicating probability that each substance will achieve a 
rank from 1-7 for the Hypothetical Worst-case refinery
Number of times reanked #1
Number of times reanked #2
Number of times reanked #3
Number of times reanked #4
Number of times reanked #5
Number of times reanked #6
Number of times reanked #7
 
Figure 30: Probability that class 1 substances will be assigned a rank from 1-7 based on predicted 
incident cases. Nickel and PAH are most likely to be ranked as having the greatest health impact . 
Figure 30 shows the distribution of ranks for class 1 substances based on 
predicted case incidence, showing how often each of the seven class 1 substances was 
assigned each possible rank (from 1-7). (Although acetaldehyde is included in the figure, 
no emissions were actually recorded for acetaldehyde at any Canadian refineries, so there 
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was no data available to rank.) The figure clearly identifies Nickel and PAH as being 
priorities based on predicted health incidence, as they are most frequently ranked as the 
first or second priority among class 1 substances. Identifying a predominant rank for 1,2-
butadiene, ethylene, and formaldehyde is particularly difficult from this figure, as they all 
appear to fall within the same level of priority. This suggests that there is probably not 










































































































































































Histogram indicating probability that each class two substance 
will achieve a rank from 1-10 for the Hypothetical Worst-case refinery
Number of t imes ranked #1
Number of t imes ranked #2
Number of t imes ranked #3
Number of t imes ranked #4
Number of t imes ranked #5
Number of t imes ranked #6
Number of t imes ranked #7
Number of t imes ranked #8
Number of t imes ranked #9
Number of t imes ranked #10
 
Figure 31: Probability that class 2 substances will be assigned a rank from 1-10 based on predicted 
incident cases. Vanadium is usually highest priority, followed by sulphuric acid and BTEX (ranks 11-
25 are omitted for clarity). 
 
Figure 31 indicates that of the class 2 substances, Vanadium, Sulphuric Acid, and 
BTEX are most often accorded the highest priority based on predicted case incidence. In 
this figure only the top ten ranks are presented for clarity, although there are a possible 25 
ranks. As a result, the total frequency across all rank orders is unequal for each substance. 
Those substances with “short” frequency bars for all ranks are thus primarily associated 
with ranks of 10 or higher. Including all 25 ranks indicates that most often the ranks 
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greater than 10 are ranks of 25, which would result from zero predicted case incidence 
(and could therefore occur coincidentally among multiple substances in any iteration). 
These figures showing  probabilistic ranks provides immediate visual information 
about which substances are generally related to higher predicted case incidence relative to 
the others, and about the relative difficulty of distinguishing priority orders for 
substances. These figures may be a useful way to present the results from HEIDI II to 




























































Histogram indicating probability that each class two substance 
will achieve a rank from 1-3 
Number of t imes ranked #1
Number of t imes ranked #2
Number of t imes ranked #3
 
Figure 32: PM from SOx is always ranked as having the greatest impact on health effects based on 
predicted case incidence. PM from NOx  is more likely to be ranked as the second-most important in 
terms of health impacts, and primary PM usually falls into third place 
 Figure 32 indicates that there is little ambiguity about which class of PM is 
associated with the greatest total predicted case incidence: PM from SOx. This is a 
reflection of the greater amount of SOx delivered to most quadrants around each refinery. 
The relative rankings of secondary PM from NOx and primary PM2.5 is highly dependent 
on the relative amounts of NOx and pM2.5 emitted from the refinery – alternate scenarios 
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using emissions data from different years show that PM from NOx can sometimes be 
ranked third. 
2.2.4.2 Ranking probabilistic data – overlapping CDFs 
Some difficulties arise when prioritizing parametric outputs where the 
distributions overlap. In the case of HEIDI II, the distributions of predicted case 
incidence overlap significantly in some cases, which means that the rank order assigned 
to each substance (which is intended to convey relative importance of the substance for 
health impacts in the population surrounding the refinery) could change with each 
iteration of the model. As well, the ranks are interdependent: in any given iteration, each 
rank order can only occur once, which means that any change in rank by one substance 
necessitates a change in rank for at least one other substance. 
In order to properly communicate the prioritization results, it is important to 
specify which rank a substance achieves most often (i.e., the most probable rank) and 
whether the rank can be thought of as distinct from other substances (i.e., how much do 
the output distributions overlap) - both of these pieces of information inform any 
declaration about which substances are “higher priority”. 
Figure 33 indicates why different ranking methods might result in different rank 
orders when comparing incidence. BTEX, sulphuric acid, and Vanadium were frequently 
among the top three ranked class 2 substances based on predicted case incidence. At the 
de minimis level and above, the ranks for these substances are distinct. However, Figure 
33 suggests that extrapolation down to predited incidence for probabilities below ~0.4, 
the order might change, with sulphuric acid becoming less important than BTEX22. 
 
                                                 
22 Limitations of the program do not allow easy extrapolation to lower probabilities: these distributions are 
based on binning predicted values from the Monte Carlo simulation, and most predicted values were 
observed at low predicted case incidence, and therefore fell into the first few bins, meaning that the first 
data point on the cumulative curve is at a relatively high probability. (This might be rectified in the code by 











Predicted annual incidence for Vanadium (except when in an alloy) 










































Cumulative probability distribution of predicted incidence for 
selected class 2 substances at the Hypothetical Worst-case refinery
AUC below the de min imis risk level 
= 0.80 (BTEX)
= 0.68 (Sulphuric Acid)
= 0.55 (Vanadium)
↑




(denotes de minimis risk level)
 
Figure 33: Cumulative probability for predicted case incidence of CNS neurotoxicity from BTEX, 
nasal irritation from Vanadium, and benign nasal tumors from sulphuric acid. The de minimis line 
crosses each curve at y = 0.80, 0.69, and 0.55 for each substance, respectively. 
 
2.2.4.3 Health impact priorities – does application of DALYs alter the 
interpretation? 
DALYs are intended to enable comparison of disparate health endpoints by 
accounting for the differences in the way each endpoint affects years of life lost and 
quality of life with disease of disability. It may therefore be more appropriate to conduct 
rankings on the basis of the DALYs incorporated in HEIDI, regardless of how 
unsophisticated the implementation of these values may be. Performing rankings this way 
may provide information on the utility of applying currently available DALYs in future 
health risk assessments. 
Applying a measure of health impact such as DALYs does alter the interpretation 
of the cumulative probability distributions. Figure 34 indicates that using complex 
DALYs, BTEX is the highest priority substance at y=0.5 and below, and that at no point 
would sulphuric acid be considered a higher priority emission. Since sulphuric acid is 
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related to benign nasal and upper airway tumors while BTEX is related to CNS 
neurotoxicity, a more severe outcome, this shift makes sense. Vanadium does not become 
relatively more important; this is expected since its health effects are relatively mild. 
 








1.1Cumulative probability distribution of complex DALYs for selected 
class 2 substances at the Hypothetical Worst-case refinery










































Figure 34: Applying DALY values to the predicted case incidence numbers changes the perception of 
which substance is “high priority”.  
 
2.2.4.4 Ranks across Classes 
 Because of the way the data was generated and the types of health endpoints, it 
may not be appropriate to compare outcomes across classes using predicted case 
incidence. However, a comparison using DALYs was attempted to determine whether 
specific substances or any class generally is consistently identified as being high priority. 
 Figure 35 shows that distinguishing the probability distributions for predicted 
health impact (calculated using the complex DALYs formulation) is not straightforward. 
The narrow distribution predicted for primary PM and 1,3 butadiene illustrates that there 
is less uncertainty associated with predicting health impact of class 1 and class 3 
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substances as compared with class 2 substances. However, the overlapping nature of all 
of the distributions, particularly around the mean values (i.e., between y=0.4 and y=0.6) 
precludes identification of a clear “priority substance”. 
 The figure suggests that it may be difficult to rank health impacts predicted by 
HEIDI II across classes, even using DALYs. This may be partially a function of the 
different types of outcomes: class 1 substances are associated with cancer development – 
a rare but severe health outcome. In contrast, vanadium emissions are associated with 
upper airway and nasal irritation – a far milder, but potentially more common, health 
effect. The overlapping and different shapes of CDFs in Figure 35 likely result from 
uncertainty in the toxicity values coupled with a lack of certainty about how to compare 
disparate endpoints.  
















































Cumulative probability distribution of predicted 







Figure 35: Comparing probability distributions for predicted health impact across classes 
2.2.4.5 Numerical approaches to ranking probabilistic data 
Visual inspection of the CDFs for predicted case incidence or predicted health 
impact (such as those presented above) can sometimes identify substances which 
generally have greater health impact at a specific refinery. The approach has been used 
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before: a group prioritizing groundwater management strategies (Lytton, Howe et al. 
2003) found that plotting risk and uncertainty on the same histogram allowed 
classification of outputs into three categories for prioritizing. However, numerical 
methods are also available and may be more informative in cases such as those depicted 
in Figure 35, where several CDFs overlap at a cumulative probability of around 0.5, and 
where arbitrary choice of a “point of comparison” along the x-axis or along the y-axis 
could result in several alternative rank orders. Duchesne et al (Duchesne, Beck et al. 
2001) suggest four potential ranking methods: (i) using the lowest mean predicted after 
running a Monte Carlo Simulation, (ii) Using the lowest maximum value obtained after 
running a Monte Carlo Simulation, (iii) using the sum of the lowest mean and the 
standard deviation obtained over all simulations, or (iv) using tests of stochastic 
dominance. The first-degree stochastic dominance test checks whether the CDF of a 
given probability distribution is higher than another for all input values. For example, in 
Figure 35, SOx meets this criterion for dominance over 1,3-butadiene. The second-degree 
test of stochastic dominance addresses instances where CDFs may cross within the range 
of possible input values. This test calculates the difference in value between two 
alternative CDFs (say i-j) across all input values. If the cumulative difference is positive, 
it suggests that the CDF for option i is dominant and should be ranked more highly. Steen 
(Steen 1997) offers a similar interpretation, suggesting that creating a cumulative 
distribution of the difference between two options can identify the probability with which 
each is likely to be the better alternative.  
Table 26 compares the within-class rank orders that are predicted by HEIDI II 
under a variety of ranking approaches, using three different impact measures: I = 




Table 26: Comparing (within-class) ranks for substances using different ranking methods. Rank is 
based on predicted case incidence, simple DALYs, or complex DALY. Low rank numbers indicate 
high priority. Emissions from the hypothetical worst-case refinery default scenario are used. 
Multiples of the same rank order indicate that the health impact was predicted to be zero for more 

























Class 1 I24 S24 C24 I S C I S C Incidence 
1,3-Butadiene 5 5 5 6 5 6 5 6 5 4 
Benzene 3 3 3 3 3 3 3 3 3 3 
Ethylene (as oxide) 4 4 4 4 6 5 6 4 6 6 
Nickel (and its 
compounds) 1 1 1 1 1 1 1 2 1 1 
PAH (as 
benzo(a)pyrene) 2 2 2 2 2 2 2 1 2 2 
Formaldehyde 6 6 6 5 4 4 4 5 4 5 
Class 2           
1,2,4-
Trimethylbenzene 11 11 11 7 10 8 9 8 11 19 
Ammonia (Total) 10 10 10 18 19 19 18 20 19 18 
BTEX 3 3 3 1 1 1 1 1 1 3 
Cyclohexane 11 11 11 16 15 14 19 17 13 9 
Dicyclopentadiene 11 11 11 11 8 10 8 10 7 15 
Diethanolamine 
(and its salts) 11 11 11 12 12 12 11 13 18 14 
Hydrogen sulphide 5 6 6 4 5 6 4 5 5 4 
Isoprene 11 11 11 20 21 21 20 18 20 7 
Mercury (and its 
compounds) 7 4 4 6 4 4 5 4 4 10 
Methanol 11 11 11 21 20 20 21 21 21 6 
Methyl ethyl 
ketone 11 11 11 13 17 13 15 19 17 10 
Methyl isobutyl 
ketone 11 11 11 19 16 15 17 15 14 8 
Methyl tert-butyl 
ether 11 11 11 17 18 18 16 16 16 13 
Naphthalene 9 9 9 5 7 7 6 7 6 20 
n-Hexane 8 8 8 8 6 5 7 6 8 5 
Phenol 4 5 5 15 14 16 14 14 10 10 
Propylene 11 11 11 10 9 9 10 9 12 17 
Styrene 11 11 11 14 13 11 13 11 9 16 
Sulphuric acid 2 2 2 3 3 3 3 3 3 2 
                                                 
23 The median would provide a better sense of where most of the predicted values lie along the distribution, 
while the mean value can be highly influenced by skew of a distribution, and may better reflect the 
potential for high values of predicted health impact.  
24 I = rank based on predicted case incidence; S = rank based on predicted simple DALYs; C = rank based 
on predicted complex DALYs 
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Vanadium and its 
compounds 1 1 1 2 2 2 2 2 2 1 
Zinc (and its 
compounds) 6 7 7 9 11 17 12 12 15 21 
Class 3           
PM from SOx 1 1 1 1 1 1 1 1 1 
PM from NOx 2 2 2 2 2 2 2 2 2 
Primary PM 3 3 3 3 3 3 3 3 3 
N/A entire 
distribution is above 
10-6 
 
 These hypothetical refinery results indicate that for class 1 substances, the top priority 
substances are consistently identified as being Nickel, PAH, and benzene, regardless of ranking 
approach. For class 2 substances, BTEX, Vanadium, and sulphuric acid are consistently identified as 
the three most important substances. Rank order for the other substances fluctuates somewhat as a 
result of various ranking approaches, but the general trend of priorities is relatively consistent. For 
class 3 substances, the order of priority is clear: it is consistently the same cross each possible 
ranking method. 
Table 27 shows that there is high correlation for the ranks achieved by each 
substance across ranking approaches. The results of Table 26 and Table 27 together 
suggest that the (much simpler) deterministic version of HEIDI II might be sufficient to 
obtain good ranking information. 
 
Table 27: Correlation coefficients between different ranking methods for within-class rankings. The 
test of using the proportion of the cumulative incidence curve beyond 10-6 does not correlate well 
with the other ranking methods for class 2 substances. 
  





based on mean 
value predicted 
in Monte Carlo 
Simulation 







Class 1  I S C I S C I S C Incid. 
I 1.00 1.00 1.00 0.83 0.83 0.94 0.83 0.66 0.77 0.83 
S 1.00 1.00 1.00 0.83 0.83 0.94 0.83 0.66 0.77 0.83 
Rank from 
deterministic 
model C 1.00 1.00 1.00 0.83 0.83 0.94 0.83 0.66 0.77 0.83 
I 0.83 0.83 0.83 1.00 1.00 0.77 1.00 0.83 0.77 0.83 







C 0.94 0.94 0.94 0.77 0.77 1.00 0.77 0.77 0.89 0.77 
I 0.83 0.83 0.83 1.00 1.00 0.77 1.00 0.83 0.77 0.83 






C 0.77 0.77 0.77 0.77 0.77 0.89 0.77 0.94 1.00 0.60 
Exceeding 
10-6 Incid. 0.83 0.83 0.83 0.83 0.83 0.77 0.83 0.66 0.60 1.00 
            
Average 




            
            
Class 2            
I 1.00 0.99 0.99 0.79 0.83 0.76 0.82 0.79 0.76 0.68 
S 0.99 1.00 1.00 0.75 0.82 0.80 0.79 0.78 0.77 0.69 
Rank from 
deterministic 
model C 0.99 1.00 1.00 0.75 0.82 0.80 0.79 0.78 0.77 0.69 
I 0.79 0.75 0.75 1.00 0.97 0.80 1.00 0.93 0.85 0.37 







C 0.76 0.80 0.80 0.80 0.86 1.00 0.83 0.95 0.97 0.54 
I 0.82 0.79 0.79 1.00 0.98 0.83 1.00 0.94 0.86 0.38 






C 0.76 0.77 0.77 0.85 0.89 0.97 0.86 0.97 1.00 0.53 
Exceeding 
10-6 Incid. 0.68 0.69 0.69 0.37 0.41 0.54 0.38 0.48 0.53 1.00 




 0.84 0.84 0.84 0.82 0.85 0.83 0.84 0.86 0.84 0.58 
 
 Table 28 shows the numerical rank results for an across-class comparison. 
Although the previously identified within-class priorities are consistently selected as 
higher-priority emissions in the across-class scenario, the order is not consistent across 
ranking approaches. BTEX and PM from SOx are most frequently accorded the number 
one rank, with vanadium, primary PM, PM from NOx, sulphuric acid or nickel following. 
Benzene and PAH are not identified as being among the top three overall priorities for 
emissions reduction. The lack of convergence among these results suggest that across-
class rankings may not be appropriate, but that primary and secondary PM deserve 
special attention. 
Table 28: Comparing across-class ranks for substances using different ranking methods. Low rank 
numbers indicate high priority. Emissions from the hypothetical worst-case refinery default scenario 
are used. Multiples of the same rank order indicate that the health impact was predicted to be zero 






Rank based on mean value 




 I24 S24 C24 I S C I S C 
1,3-Butadiene 9 8 8 15 13 13 18 13 12 
Benzene 6 6 6 12 10 10 13 10 10 
Ethylene (as oxide) 8 7 7 17 11 11 17 12 11 
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Nickel (and its 
compounds) 4 2 2 7 6 7 8 6 6 
PAH (as 
benzo(a)pyrene) 5 5 5 9 8 6 7 7 7 
Formaldehyde 10 9 9 14 12 12 14 11 13 
1,2,4-
Trimethylbenzene 20 20 20 13 19 17 16 17 20 
Ammonia (Total) 19 19 19 27 28 28 27 29 28 
BTEX 12 12 12 1 1 1 1 1 1 
Cyclohexane 20 20 20 25 24 23 28 26 22 
Dicyclopentadiene 20 20 20 20 17 19 15 19 16 
Diethanolamine (and 
its salts) 20 20 20 21 21 21 20 22 27 
Hydrogen sulphide 14 15 15 8 14 15 9 14 14 
Isoprene 20 20 20 29 30 30 29 27 29 
Mercury (and its 
compounds) 16 13 13 11 9 9 10 9 9 
Methanol 20 20 20 30 29 29 30 30 30 
Methyl ethyl ketone 20 20 20 22 26 22 24 28 26 
Methyl isobutyl 
ketone 20 20 20 28 25 24 26 24 23 
Methyl tert-butyl ether 20 20 20 26 27 27 25 25 25 
Naphthalene 18 18 18 10 16 16 11 16 15 
n-Hexane 17 17 17 16 15 14 12 15 17 
Phenol 13 14 14 24 23 25 23 23 19 
Propylene 20 20 20 19 18 18 19 18 21 
Styrene 20 20 20 23 22 20 22 20 18 
Sulphuric acid 11 11 11 4 7 8 3 8 8 
Vanadium and its 
compounds 7 10 10 2 3 3 2 3 3 
Zinc (and its 
compounds) 15 16 16 18 20 26 21 21 24 
PM from SOx 1 1 1 3 2 2 4 2 2 
PM from NOx 2 3 3 5 4 4 5 4 4 
Primary PM 3 4 4 6 5 5 6 5 5 
 
2.2.5 Discussion 
Ranks depend strongly on emissions. Thus the priorities identified for the 
hypothetical worst-case refinery do not necessarily apply to all refineries or emission 
years. For example, there are refineries where vanadium might not be considered the 
highest priority for reduction from among the class 2 substances. It is important to 
examine the rankings for refineries individually. However, there are similarities in 
priority substances across all refineries (nickel, PAH, BTEX, sulphuric acid, and 
vanadium), and these may be used in making general recommendations about refinery 
emissions of concern.  
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2.2.5.1 The high priority substances  
 Where nickel is emitted, it appears that a large proportion of the probability 
distribution is often above the de minimis level. Given the severity of the health outcome 
(lung cancer), this makes Ni a substance of concern. Ni emissions are reported in the 
NPRI for only 8 of the 20 refineries, suggesting that the source of the crude oil may have 
a large impact on its Ni content and subsequent emissions during refining. PAH was also 
identified as an important class 1 substance – also with an endpoint of lung cancer. These 
are two substances with the same endpoint: further analysis of the combined impact of 
the class 1 substances could be important. 
 While the deterministic version of HEIDI II ranked BTEX fairly low during 
across-class comparison, the stochastic version tended to rank it much higher. This is 
likely because the lognormal distributions used for each of the BTEX components 
increased the overall skewness of the distribution for the substances combined, meaning 
that there was a long tail at the upper end of the distribution. This may be an example of 
statistical compounding. The toxicity associated with each of the mixture components 
was assigned a probability distribution, and the toxicity for the mixture was based on 
values selected from those distributions during the simulations. It might have been more 
appropriate to use the individual toxicity estimates for each mixture component to 
estimate the toxicity of BTEX, and then assign a probability distribution to the mixture. 
For all class 2 substances where the ED05 was developed in the absence of 
epidemiological data, a GSD of 7.5 was selected (for rationale, see Appendix C). By 
assigning this GSD of 7.5 to the toxicity values of the individual components of BTEX 
rather than to the mixture as a whole, the distribution for BTEX toxicity may have 
become artificially skewed. However, each of the component substances could have a 
higher toxicity than is suggested by the point estimate for the (uncertain) ED05 value, in 
which case this approach may be appropriate. The potential for high predicted case 
incidence with exposure to BTEX at each of the Canadian refineries suggests that other 
groups of substances with similar health endpoints should be considered as mixtures. 
While this would require a detailed evaluation of whether the mechanisms of toxicity are 
similar, there are several outcomes that are associated with exposure to more than one 
substance, including developmental and neurotoxic effects. 
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Exposure to sulphuric acid has been associated with laryngeal cancer in an 
occupational setting (Soskolne, Jhangri et al. 1992; Sathiakumar, Delzell et al. 1997), and 
IARC has defined sulphuric acid when contained in strong inorganic mists as a suspected 
human carcinogen (International Agency for Research on Cancer 1997). Because 
sulphuric acid is repeatedly identified as a high priority substance from among the class 2 
substances, the possibility that it should be treated as a class 1 substance was considered. 
However, regulatory agencies such as the EPA and Health Canada have not determined 
reference values for carcinogenicity from sulphuric acid. The health council of the 
Netherlands reviewed the genotoxocity and carcinogenicity of sulphuric acid in strong 
inorganic mists and concluded that it was a carcinogen in humans and that it acted by a 
non-stochastic genotoxic mechanism (Dutch Expert Committee on Occupational 
Standards 2003). This means that laryngeal cancer is probably related to regenerative cell 
proliferation that would occur after local irritation caused by exposure to sulphuric acid 
mists. Genotoxic effects (where damage to the DNA is involved) are assumed to play no 
(or a very minor) role. The Dutch Committee therefore recommended that a threshold 
approach to determining reference levels was more appropriate than the traditional linear 
no-threshold approach used for carcinogens (Dutch Expert Committee on Occupational 
Standards 2003). Given the lack of data about a potential threshold for carcinogenicity for 
sulphuric acid and the probability that it acts via a genotoxic mechanism, sulphuric acid 
is best treated as a class 2 substance in HEIDI II. 
In HEIDI II, the critical endpoint identified for sulphuric acid is bronchial 
hyperplasia. According to a review by Agency for Toxic Substances and Disease 
Registry (ATSDR) (Agency for Toxic Substances and Disease Registry (ASTDR) 1998), 
ambient levels of sulphuric acid are also associated with respiratory effects including 
asthma admissions, airway obstructive disease and decreased respiratory function. Since 
sulphuric acid is frequently emitted in large quantities from Canadian refineries, the 
possibility that it may compound effects observed with PM should be considered. 
Vanadium was often identified as a priority. There is high uncertainty associated 
with the toxicity data selected to represent Vanadium, especially since the NPRI – the 
source of emissions data - defines vanadium as “vanadium and its compounds (except 
when in alloy)”, which could include a variety of agents. Pentavalent vanadium appears 
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to be more toxic than other forms, but it is unclear from the inventory data which forms 
are predominantly emitted by the refineries. The toxicity value used in HEIDI II was for 
pentavalent vanadium – which may be a very conservative estimate. The priority ranking 
must be considered within the limitations of this toxicological data. 
2.2.5.2 Issues about looking at the absolute predictions for incidence 
 The limitations of using the absolute values of predicted incidence generated by 
HEIDI II are explained elsewhere. However, looking at the values may be useful in 
broadly characterizing the model result and in planning future research. 
The absolute predictions of incidence at the hypothetical refinery and at several 
refineries for several substances – especially the CACs - are worrying. Many of the 
limitations of HEIDI II have been identified in previous sections of this document. Given 
those limitations, to what extent should these predictions be considered representative of 
the possible effects of refinery emissions? HEIDI II is intended to be used as a screening 
tool in conjunction with other methods to set priorities. The results suggest that CACs 
should be high priority for emissions reduction and that a more thorough assessment of 
the health effects of CACs emitted from Canada’s refineries may be warranted. If any 
results from HEIDI II were to be reported, those in southwest Ontario would have the 
most validity since the meteorology should be appropriate to that region. 
Secondary PM is generated as the nitrate and sulphate pollutants travel away from 
the point source (stack). A 2003 analysis of power plants in the U.S. showed that using 
even a 500 km radius significantly underestimated population exposure and risks from 
PM2.5 (Levy, Wilson et al. 2003). Although power plants typically have higher stacks 
than refineries (which would induce emissions to travel further from the source), this 
implies that the mortality and morbidity predicted by HEIDI II may represent only a 
small portion of the health impacts of primary and secondary PM emitted from refineries. 
This issue is of particular importance for refineries located in southern Ontario, where the 
population density is consistently high over a large extent of the geography. HEIDI II 
currently estimates effects only within 25 km of each refinery, but a large number of 
people would be expected to be exposed to secondary PM formed beyond 25 km from 
each refinery.  
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 PM is emitted from many point and mobile sources including other industry such 
as coal-fired power plants and vehicles. Because PM is usually considered as a 
nonthreshold-acting substance, additional emissions from any sector add to the health 
burden of exposed populations. 
2.2.5.3 Issues about ranking 
 The frequency histograms comparing the number of times each substance 
achieved a particular rank during a simulation appear to be a useful way to visually 
represent information about which substances are important and the extent to which the 
impacts of various substances are distinct. This type of analysis might be most 
appropriate for presenting information to policy and decision-makers, who may have less 
familiarity with probability distributions than many scientists. 
 Using the proportion of the probability distribution that is below the de minimis 
level is another useful prioritization measure, as it provides a sense of how often an 
unacceptable (by typical regulatory standards) number of cases are predicted. However, 
the proportion of the distribution likely to exceed the de minimis risk level is directly 
associated to the input distributions used to characterize uncertainty and variability in the 
inputs, especially for the C-R relationships. The GSD selected to represent the C-R data 
is itself uncertain. A value of 7.5 was used for class 2 threshold data, but values of up to 
11 have been proposed. If a GSD of 11 had been used, the overall distributions would 
have been broader, and a greater proportion of the predicted case incidence may have 
been above the de minimis risk level for substances that were associated with predicted 
case incidence>0. 
Comparing impacts across classes may have limited validity; however, the 
implications of the overlapping distributions presented in Figure 35 should be considered. 
The figure suggests that the health impacts of several high-priority substances that are 
emitted from Canadian refineries may have similar extent of impact on the surrounding 
population; that attempting to identify priority substances may not be possible. Several 
alternate emissions reductions strategies are suggested by this figure. Emissions reduction 
for all substances deemed “high-priority” could be undertaken, but this would require 
some arbitrary definition of “high priority” – for example, “top three”, and does not 
consider cost of reduction. Alternately, reduction of the priority emissions most 
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easily/cheaply reduced could be unertaken, since no single substances appears to be 
dramatically more harmful. However, the issue of communication with stakeholders 
should also be considered. They may respond more favorably towards reduction of the 
emission with the most severe health effect, even if the estimated total benefit is the same 
as for a lesser reduction of emissions of a different substance. 
A disadvantage of using a prioritization approach is that ranks do not 
communicate about absolute impact. While a substance may be listed as high priority, the 
impact may actually be predicted to be incidence less than the de minimis risk level (i.e., 
if all emissions from a particular refinery are low). In this case it may not be appropriate 
to take action to reduce emissions of the substance. Ranks also do not inform about the 
benefits of reducing emissions. Cost-benefit of emissions reductions is an important 
consideration from both a technological and public health standpoint. A similar reduction 
in mass of emissions for two distinct substances may result in different extent of benefits. 
2.2.5.4 Limitations 
The different patterns of predicted case incidence according to population 
distribution indicate that consideration of the local meteorology is important for decisions 
regarding siting of refineries. In general, refineries should be sited downwind from the 
majority of the population to minimize health impacts. HEIDI II uses a generic 
meteorology which does not apply to all locations across Canada -  the predicted impacts 
at most real refinery locations are therefore inaccurate; the predicted case incidence 
values should in no way be taken literally, especially for locations outside Southern 
Ontario.  
The generic meteorology used in HEIDI II is one reason that ground-truthing of 
the predictions was not carried out. Another is that it would be very difficult to 
distinguish cases due to refinery emissions from cases due to other emissions in 
communities near to refineries. 
The ranks produced by HEIDI II are particular to each refinery. This is 
inappropriate for regions such as Sarnia which have several refineries in close proximity 
to each other. A better approach might be to determine the impact of the cumulative 
emissions from all of the refineries in the region on the local population. 
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The analysis of the Imperial Sarnia refinery showed that high impacts are 
expected where most people live (to the northeast of the refinery). The northeast 
quadrants were also associated with greatest delivered concentration as a result of the 
meteorology selected. This also suggests that the worst-case scenario might have been 
better designed – it was chosen to maximize the total number of people living around the 
refinery, without considering where people were living relative to where the greatest 
exposures might be occurring.  
2.2.5.5 Recommendations 
 Future prioritizations of health impacts from industries would benefit from 
including a valuation of reduction. The ranking alone is insufficient to determine whether 
a given substance is a health concern, or whether reducing emissions would result in a net 
public health benefit. Cost-benefit analysis of reducing emissions would be a welcome 
addition to any tool intended to identify priority substances for emissions reduction. 
 Unless the magnitude of emissions increases dramatically (unlikely), there are 
some substances for which the refinery contributions to the atmosphere are unlikely to 
ever pose a health risk to the public: these were identified as being associated with zero 
predicted case incidence in the hypothetical worst-case scenario.  
 Urban planners should consider information about population density and 
potential exposure, including predominant wind direction) when siting refineries, or 
planning for broadly residential and/or industrial areas. Refineries which are located 
upwind of densely populated areas are associated with much greater health impacts in the 
population, ultimately affecting individual quality and length of life. This could have 
downstream effect on economic productivity and social capital of the community. 
2.2.5.6 Sarnia – another analysis required? 
HEIDI II’s predictions suggest that there may be a particular problem for refinery 
emissions in Sarnia. Sarnia is a highly industrial region, and there are four refineries in 
close proximity to one another in the area. Although HEIDI II does not account for it, 
each of the people living in the area may be subject to exposures from all four refineries. 
The combined predicted impacts may therefore be much higher that those from each 
refinery alone. The analyses suggest that in Sarnia, there are two refineries where 
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predicted case incidence for six (Imperial Sarnia) and four (Shell Sarnia) of the class 1 
and class 2 emissions exceeds the de minimis level at least occasionally. The Imperial 
Sarnia refinery has the most CAC emissions of all refineries included in HEIDI II – 
which were associated with some of the highest rates of predicted mortality (up to 10-4) 
and morbidity.  
HEIDI II does not appropriately assess exposure or health impact from refinery 
emissions for this population; a more complex analysis incorporating emissions from all 
refineries and the geographic distribution of people relative to each of the refineries 
would be required. Assigning priorities for reduction at each refinery would be fraught 
with difficulties however, as assigning responsibility to each refinery for a portion of 
health impacts – particularly for impacts above a threshold level, would be technically 
(and politically!) difficult.   
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2.3 Further Analysis – what else can HEIDI II do or tell us? 
2.3.1 Impact Equivalents 
In order to examine predicted health impact in a relative sense, values for 
predicted incidence and predicted DALYs were converted into benzene equivalents (for 
class 1 substances) and mercury equivalents (for class 2 substances)25. These two 
substances have been well-characterized in terms of their toxicity which allows them to 
be useful as a basis for comparison. For anyone familiar with the toxicity/potential health 
impacts of benzene and mercury exposure, the values below provide a sense of the 
importance of other refinery emissions. (Because the class 3 substances are not treated 
using toxicologic data, and the predicted values from each CAC are of similar 
magnitudes, this exercise was not completed for class 3 substances.) 
The simple calculation was based on each health impact measure, i.e., (i) 
predicted incidence, (ii) predicted simple DALY, (iii) predicted complex DALY. Table 
29 indicates that nickel and PAH have a much greater impact than most other class 1 
substances emitted from the hypothetical refinery. 
Table 29: Class 1: benzene equivalent = (substance-specific predicted health impact score) / 
(predicted benzene impact score). TRACI characterization factors are provided for comparison, 
although they are not directly analogous: TRACI’s factors are per mass of emissions, while impacts 





















(kg benzene eq /kg) 
1,3-Butadiene leukemia 0.21 0.21 0.21 0.41 
Benzene leukemia 1.00 1.00 1.00 1.00 
Ethylene (as 
oxide) leukemia 0.45 0.45 0.45 11.02 
Nickel (and its 
compounds) lung cancer 240 240 150 1.51 
PAH (as 
benzo(a)pyrene) lung cancer 11 11 7.2 914 
Formaldehyde nasal and lung cancer 0.25 0.25 0.16 0.00 
Acetaldehyde nasal and lung cancer 0.02 0.02 0.01 0.00 
                                                 
25 TRACI, a popular screening tool developed by the EPA ((Bare, Norris et al. 2003) uses toluene 
equivalents rather than mercury equivalents, but because the toluene values are “wrapped up” into BTEX in 




Table 30: Class 2: Mercury equivalent = (substance-specific predicted health impact score)/(predicted mercury impact score) 
NPRI substance equivalent human endpoints predicted population health impact (Mercury equivalents) 
 primary human endpoint predicted incident cases simple DALYs total complex DALYs total 
1,2,4-Trimethylbenzene moderate anemia 0.00 0.00 0.00 
Ammonia (Total) skin and nose irritation 8.58E-06 8.58E-08 5.25E-08 
Benzene (as BTEX component) moderate CNS neurotoxicity See BTEX Mixture See BTEX Mixture See BTEX Mixture 
BTEX moderate CNS neurotoxicity 8.82 8.82 7.46 
Cyclohexane reduced bodyweight 0.00 0.00 0.00 
Dicyclopentadiene chronic renal disease 0.00 0.00 0.00 
Diethanolamine (and its salts) throat irritation 0.00 0.00 0.00 
Ethylbenzene (as BTEX 
component) moderate CNS neurotoxicity See BTEX Mixture See BTEX Mixture See BTEX Mixture 
Hydrogen sulphide nose irritation 8.99E-01 8.99E-03 5.50E-03 
Isoprene benign lung tumours 0.00 0.00 0.00 
Mercury (and its compounds) severe CNS neurotoxicity 1.00 1.00 1.00 
Methanol physical teratogenesis 0.00 0.00 0.00 
Methyl ethyl ketone developmental retardation 0.00 0.00 0.00 
Methyl isobutyl ketone developmental retardation 0.00 0.00 0.00 
Methyl tert-butyl ether PNS neurotoxicity 0.00 0.00 0.00 
Naphthalene benign lung tumours 7.02E-04 7.02E-05 7.90E-05 
n-Hexane PNS neurotoxicity 1.67E-03 1.67E-04 1.05E-04 
Phenol mild CNS neurotoxicity 2.39E-01 2.39E-02 2.02E-02 
Propylene benign nasal & upper airway tumours 0.00 0.00 0.00 
Styrene mild developmental retardation 0.00 0.00 0.00 
Sulphuric acid benign nasal & upper airway tumours 8.60E+03 86 53 
Toluene (as BTEX component) moderate CNS neurotoxicity See BTEX Mixture See BTEX Mixture See BTEX Mixture 
Vanadium and its compounds nasal and upper airway irritation 2.02E+07 2.02E+05 1.24E+05 
Xylene (as BTEX component) moderate CNS neurotoxicity See BTEX Mixture See BTEX Mixture See BTEX Mixture 
Zinc (and its compounds) moderate anemia 2.16 2.16E-02 2.27E-03 
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As with the base model, the values presented in Table 29 and Table 30 depend 
strongly on the emissions chosen. These values were created using the “hypothetical 
worst-case” refinery, but if a different refinery (with a different set of emissions) were 
chosen, different health impacts would be predicted. For example, many refineries do not 
have substantial nickel emissions and so for those cases, nickel would not appear to be as 
important as it does above. Note also that this method of comparison will not work for 
refineries where either benzene or mercury are not emitted (i.e., mercury is not a reported 
emission for the Chevron-Burnaby refinery). 
2.3.2 Several refineries in one area 
 
In Sarnia, the population is exposed to emissions from four separate petroleum 
refineries. HEIDI II was used to model a “composite” refinery where the emissions from 
the four individual refineries were summed, and the population distribution was created 
by averaging the population distributions around each of the four individual refineries. (A 
comparison of the populations living within 25 km of each individual refinery with the 
“average population” determined for the “composite” indicated that approximately the 
same urban population of the region is captured in each case). 
Table 31 shows that using the deterministic version of HEIDI II, the predicted 
cumulative impacts of the four refineries is much greater than the impact of any 
individual refinery. The table also highlights the main problem with using a “composite” 
refinery: the location of the population relative to the refinery and the dispersion of 
emissions is incorrect. If the location of the population was properly accounted for, the 
sum of all the DALYs from the class 1 and three substances should be the same as the 
DALYs predicted by the composite (since the concentration-response function used is 
linear). This suggests that a summed value for class 1 and class 3 substances (which were 
modeled as “non-threshold”) is probably more reliable than that of the composite. The 
results also suggest that emissions from the Imperial refinery have a strong influence on 




Table 31: Comparison of simple DALYs predicted for individual refineries in Sarnia, the sum of the 
individual effects, and predicted impacts from a "composite" refinery where the emissions input was 










Sunoco Sum of impacts 








DALYs 28 0.1 3.9 0.1 32 23 
Class 2 




data 6.3 16 140 210 
Total 
DALYs 150 0.1 10 16 170 240 
 
For class 3 substances, predictions were much lower at the Sarnia facility, mainly 
because of the much smaller at-risk population. The following comparison was made 
using the deterministic version of HEIDI II. 
Table 32: Predicted health impact at the hypothetical worst-case refinery as compared to the 
hypothetical Sarnia refinery. Recall that the Sarnia hypothetical refinery uses the summed emissions 
from all the refineries in the region. Note that the impacts are similar to those predicted for the 
worst-case scenario. I = impact based on predicted case incidence; S = impact based on predicted 
simple DALYs; C = impact based on predicted complex DALYs 
 Hypothetical Worst-Case Sarnia Composite 
 I S C I S C 
1,3-Butadiene 5.8E-02 3.9E-01 1.4 3.0E-03 2.0E-02 7.1E-02 
Benzene 1.9E-01 1.3 4.4 2.1E-02 1.4E-01 5.0E-01 
Ethylene (as oxide) 6.7E-02 4.5E-01 1.6 4.2E-03 2.8E-02 9.7E-02 
Nickel (and its compounds) 5.2E+01 3.5E+02 7.6E+02 3.3 2.2E+01 4.9E+01
PAH (as benzo(a)pyrene) 1.2 8.2 1.8E+01 5.8E-02 3.9E-01 8.5E-01 
Formaldehyde 5.7E-02 3.8E-01 8.3E-01 N/A N/A N/A 
Acetaldehyde 5.5E-03 3.7E-02 8.0E-02 N/A N/A N/A 
1,2,4-Trimethylbenzene 0.0 0.0 0.0 4.6E-15 3.1E-16 5.5E-17 
Ammonia (Total) 1.8E-14 1.2E-15 1.2E-15 7.6E-17 5.1E-18 5.3E-18 
BTEX 2.9E-07 2.0E-07 2.8E-07 3.7E-08 2.5E-08 3.6E-08 
Cyclohexane 0.0 0.0 0.0 5.9E-25 4.0E-25 8.3E-25 
Dicyclopentadiene 0.0 0.0 0.0 7.4E-17 4.9E-17 7.0E-17 
Diethanolamine (and its salts) 0.0 0.0 0.0 7.3E-19 4.9E-20 5.1E-20 
Hydrogen sulphide 4.6E-09 3.1E-10 3.2E-10 1.6E-11 1.1E-12 1.1E-12 
Isoprene 0.0 0.0 0.0 9.3E-32 6.2E-32 8.8E-32 
Mercury (and its compounds) 4.1E-09 2.8E-08 4.7E-08 1.0E-09 6.8E-09 1.2E-08 
Methanol 0.0 0.0 0.0 2.6E-18 1.8E-17 9.1E-17 
Methyl ethyl ketone 0.0 0.0 0.0 6.1E-22 4.1E-22 8.5E-22 
Methyl isobutyl ketone 0.0 0.0 0.0 3.2E-25 2.1E-25 4.4E-25 
Methyl tert-butyl ether 0.0 0.0 0.0 N/A N/A N/A 
Naphthalene 2.8E-12 1.9E-12 3.7E-12 1.4E-12 9.1E-13 1.8E-12 
n-Hexane 5.6E-12 3.8E-12 4.0E-12 4.1E-14 2.8E-14 3.0E-14 
Phenol 7.9E-09 5.3E-09 7.6E-09 4.8E-10 3.2E-10 4.7E-10 
Propylene 0.0 0.0 0.0 5.8E-17 3.9E-18 4.1E-18 
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Styrene 0.0 0.0 0.0 2.3E-20 1.6E-20 3.3E-20 
Sulphuric acid 5.8E-04 3.9E-05 4.1E-05 3.8E-03 2.6E-04 2.7E-04 
Vanadium and its compounds 1.0E-01 7.0E-03 7.3E-03 2.1E-02 1.4E-03 1.5E-03 
Zinc (and its compounds) 4.4E-09 2.9E-10 5.2E-11 1.1E-08 7.4E-10 1.3E-10 
PM from SOx 950 2600 3800 58 160 240 
PM from NOx 93 250 380 9 24 36 
Primary PM 82 220 330 11 30 45 
 
As shown in Table 33, the comparison of the summed emissions from the four 
refineries in the Sarnia area to the hypothetical worst-case scenario revealed that the 
prioritization order for the emitted substances was identical for class 1 substances and for 
the first four class 2 substances and very similar for subsequent emissions for class 2 
substances. For class 3 substances there is a switch in priority, where primary PM 
becomes more important than NOx at the composite Sarnia refinery. In this contrived 
scenario, this is likely due to the relative emissions of primary PM2.5 and NOx. In reality, 
the dispersion patterns would have to be considered more carefully: the emissions from 
the four refineries do not actually originate at one location, and the true dispersion pattern 
in Sarnia is likely to be much more complex. 
Table 33: Predicted priority (within-class rankings) of health impact from emissions at the 
hypothetical worst-case refinery as compared to the composite Sarnia refinery. Recall that the Sarnia 
composite refinery uses the summed emissions from all the refineries in the region. Priority order is 
similar in each case. (“N/A” indicates no reported emissions at any of the Sarnia facilities). I = rank 
based on predicted case incidence; S = rank based on predicted simple DALYs; C = rank based on 
predicted complex DALYs 
 Hypothetical Worst-Case Sarnia Composite 
 I S C I S C 
1,3-Butadiene 6 6 5 5 5 5 
Benzene 3 3 3 3 3 3 
Ethylene (as oxide) 4 4 4 4 4 4 
Nickel (and its compounds) 1 1 1 1 1 1 
PAH (as benzo(a)pyrene) 2 2 2 2 2 2 
Formaldehyde 5 5 6 N/A N/A N/A 
Acetaldehyde 7 7 7 N/A N/A N/A 
1,2,4-Trimethylbenzene 11 11 11 10 10 12 
Ammonia (Total) 10 10 10 11 13 13 
BTEX 3 3 3 3 3 3 
Cyclohexane 11 11 11 18 18 18 
Dicyclopentadiene 11 11 11 12 11 11 
Diethanolamine (and its salts) 11 11 11 15 15 15 
Hydrogen sulphide 6 7 6 7 7 8 
Isoprene 11 11 11 20 20 20 
Mercury (and its compounds) 5 4 4 5 4 4 
Methanol 11 11 11 14 12 10 
Methyl ethyl ketone 11 11 11 17 17 17 
Methyl isobutyl ketone 11 11 11 19 19 19 
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Methyl tert-butyl ether 11 11 11 N/A N/A N/A 
Naphthalene 9 9 9 8 8 7 
n-Hexane 8 8 8 9 9 9 
Phenol 7 5 5 6 6 5 
Propylene 11 11 11 13 14 14 
Styrene 11 11 11 16 16 16 
Sulphuric acid 2 2 2 2 2 2 
Vanadium and its compounds 1 1 1 1 1 1 
Zinc (and its compounds) 4 6 7 4 5 6 
PM from SOx 1 1 1 1 1 1 
PM from NOx 2 2 2 3 3 3 
Primary PM 3 3 3 2 2 2 
2.3.3 Using other models to predict priorities for petroleum 
emissions 
 TRACI is a stand-alone, windows-based tool that was developed by the U.S. EPA 
(Bare, Norris et al. 2003). It uses a run-time version of Microsoft Access to characterize 
the potential impacts of a variety of environmental stressors, including human health 
cancer effects, human health noncancer effects, and human health criteria-related 
effects(Bare, Norris et al. 2003).  
 The within-class priorities identified in the deterministic version of HEIDI II were 
compared to the predictions that result from application of TRACI’s characterization 
factors to the emissions used for the hypothetical worst-case refinery. The 
characterization factors were applied to emissions to predict impacts, which were then 
ranked within and across classes. The class 1 substances were compared to the rankings 
that resulted from applying TRACI’s HH (human health) cancer air characterization 
factors, the class 2 substances were compared based on the ranking that resulted from 
applying TRACI’s HH noncancer air characterization factors, and the class thee 
substances were compared based on the rankings that resulted from applying TRACI’s 
HH criteria – air point source characterization factors. 
2.3.3.1 Within-class comparisons based on rank 
 
Regardless of the ranking method or metric used with HEIDI II, the top priority 
substances for class 1 are consistently identified as being nickel, PAH, and benzene. This 
is consistent with the results from TRACI shown in Table 34. 
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Table 34: Rank order resulting from application of TRACI's characterization factors to class 1 
substances at the hypothetical worst-case refinery.  
Rank Order from Deterministic version of HEIDI II 
(using simple DALYs) 
Order from TRACI based on HH 
cancer air 
1 Nickel PAH (as benzo(a)pyrene) 
2 PAH (as benzo(a)pyrene) Benzene 
3 Benzene Nickel 
4 Ethylene (as oxide) Ethylene (as oxide) 
5 Formaldehyde 1,3-Butadiene 
6 1,3-Butadiene Formaldehyde 
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Figure 36:  Rankings for class 1 substances obtained from HEIDI II and TRACI correspond 
relatively well. (Only two trendlines are shown since the rank order for indicent cases and simple 
DALYs are identical) 
 For class 2 substances, the top-ranked substances in HEIDI II were consistently 
vanadium, BTEX, and sulphuric acid, regardless of ranking method used. As shown in 
Table 35, TRACI also ranks vanadium as a top priority in terms of health impacts. 
However, TRACI does not evaluate BTEX as a mixture, and does not include a 
characterization factor for sulphuric acid. The individual components of BTEX are 
ranked, 3rd, 7th, 13th, and 20th, suggesting that unless the total impacts interact in an 
antagonistic way (unlikely), the minimum rank achieved by the mixture should be third, 
which is consistent with HEIDI II. Mercury and zinc both achieve relatively high 
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prioritizations from the two models, and many of the same substances were ranked as 
being low priority (higher rank than 10). Class 2 substances for which the HEIDI II and 
TRACI rankings seemed divergent included diethanolamine, MIBK, and MEK which 
achieved ranks of 4, 6, and 8 with TRACI, but were associated with zero predicted 
incidence in HEIDI II and thus a last-place ranking. 
Table 35: Rank order resulting from application of TRACI's characterization factors to class 2 
substances at the hypothetical worst-case refinery 
Rank Order from Deterministic version of HEIDI II 
(using simple DALYs) 
Order from TRACI based on 
HH noncancer air 
1 Vanadium Vanadium 
2 Sulphuric Acid Zinc 
3 BTEX Benzene 
4 Mercury Diethanolamine 
5 Phenol Mercury 
6 Zinc MIBK 
7 Hydrogen Sulphide Toluene 
8 n-hexane MEK  
9 Naphthalene 1,2,4-trimethylbenzene 
10 Ammonia Naphthalene 
11 1,2,4-trimethylbenzene, cyclohexane, 
dicyclopentadiene, diethanolamine, isoprene,  
methanol, methyl ethyl ketone, methyl isobutyl 
ketone, methyl tert-butyl ether, propylene, styrene 
Ammonia 
12  n-hexane  
13 MTBE 
14 
**All substances ranked in 11th place were 
associated with predicted incidence of zero Xylene 
15  Methanol 
16  Hydrogen Sulphide 
17  Cyclohexane 
18  Propylene 
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Figure 37: Rankings for class 2 substances obtained from HEIDI II and TRACI do not correspond 
well. Only substances with predicted indience (in HEIDI II)  greater than zero were included to avoid 
multiple substances being given the same rank. (Only two trendlines are shown since the rank order 
for indicent cases and simple DALYs are identical) 
 
Table 36: Rank order resulting from application of TRACI's characterization factors to class 3 
substances at the hypothetical worst-case refinery 
Rank Order from Deterministic version of 
HEIDI II (using simple DALYs) 
Order from TRACI based on HH criteria 
air contaminant-air point source 
1 PM2.5 from SOx Primary PM2.5 
2 PM2.5 from NOx NOx 
3 Primary PM2.5 SOx 
 
Table 36 indicates some divergence between priorities predicted by each of the models 
for class 3 substances. This is because TRACI provides characterization factors for SOx 
in the acidification category only and not in the human health criteria air contaminant 
impact category. There is an essential difference in what HEIDI II is evaluating compared 
to TRACI: HEIDI II considers the potential transformation of SOx and NOx to PM, 
which TRACI apparently does not. Thus comparing results predicted by HEIDI II and 
TRACI is invalid. 
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2.3.3.2 Across-class comparisons 
 In order to maintain proper units for relative comparison in TRACI, the 
contributions from cancer, noncancer, and criteria air contaminants impacts must be 
considered for each substance. This is not equivalent to the way that HEIDI II ranked the 
substances: by considering only the critical endpoint, regardless of whether there might 
be multiple endpoints. Table 37 suggests that although some substances are consistently 
identified as having the highest health impacts (i.e., nickel, PM2.5, ethylene oxide, and 
benzene), there is little overall consistency about which substances cause the greatest 
health impacts. 
Table 37: rank order resulting from application of TRACI's characterization factors across classes 
(omitting class 3, for which comparison of ranking is invalid) at the hypothetical worst-case refinery 
Rank Order from Deterministic version of 
HEIDI II (using simple DALYs) 
Order from TRACI based on HH 
cancer air+HH noncancer air + HH 
criteria air-point source 
1 Nickel Vanadium 
2 PAH Nickel  
3 Benzene Zinc 
4 Ethylene oxide Ethylene oxide 
5 Formaldehyde Benzene 
6 1,3-butadiene Diethanolamine 
7 Acetaldehyde Mercury 
8 Vanadium PAH 
9 Sulphuric Acid MIBK 
10 BTEX Toluene 
11 Mercury Formaldehyde 
12 Phenol MEK 
13 Zinc Acetaldehyde 
14 Hydrogen Sulphide 1,2,4-Trimethylbenzene 
15 n-hexane Naphthalene 
16 Naphthalene Ammonia 
17 Ammonia n-hexane 
18 1,2,4-trimethylbenzene, diethanolamine, 
dicyclopentadiene, cyclohexane, 










**All substances ranked in 18th place 
were associated with predicted incidence 
of zero 
Phenol 
26  Styrene 
27  Ethylbenzene, Isoprene 
Unranked Benzene, Toluene, Ethylbenzene, Xylene 
as individual substances 
Dicyclopentadiene, Sulphuric acid, 




2.3.4 Applying HEIDI II in other contexts 
 To see whether HEIDI II could be easily adapted to other industrial contexts, an 
effort was made to use HEIDI II to prioritize emissions from the Nanticoke Power 
Generation facility near Toronto, Canada. Table 38 provides a list of tasks that had to be 
accomplished to adapt HEIDI II to prioritize emissions from Nanticoke, and commentary 
on the relative ease of accomplishing the tasks. 
 Adapting HEIDI II to a coal-fired power generation facility was relatively easy 
for modules two and three, but difficult for model one as a result of the “black-box” 
nature of the dispersion modeling. The Nanticoke example was particularly easy since the 
population data was already in place within HEIDI II and the meteorology implied by 
HEIDI II is appropriate for the geographic location of the facility.  
 The main difficulty in applying HEIDI II to the Nanticoke power generation 
facility resulted from the stack height. While stack heights available in HEIDI II were 5 
metres, 15 metres, and 30 metres, the actual stack height at the Nanticoke power 
generation facility is 198 metres(Environment Canada 2005). The dispersion modeling in 
Module 1 of HEIDI II was applied through a series of transfer factors which are specific 
to the stack heights available in HEIDI II. Thus, a stack height of 200 metres could not be 
appropriately represented.  
 The full adaptation of HEIDI II was completed despite this restriction, using 30 
metres as the stack height for the modeling predictions. This was done (i) to test the 
difficulty of applying modules 2 and 3 to another context, and (ii) since, in the context of 
a screening tool, the ranking results could still indicate substances which might warrant 
further investigation.   
 HEIDI II could not easily be adapted to any industrial emissions for which 
exposure is mainly through non-inhalation sources. Even if emissions occur to the air, 
this limitation includes any industry that emits mostly organic emissions or any other 
emissions that they partition easily into soil and vegetation. As well, the assumptions 
about data values included in the Nanticoke model for substances that were not originally 
a part of HEIDI II have not been vetted by a multistakeholder group, and may be 





Table 38: Tasks involved in adapting HEIDI II to another industrial context 
Task Comments 
Obtain annual emissions for 
Nanticoke 
Relatively easy. They were obtained through the NPRI in the same way that the refinery emissions were 
obtained 
Check whether data used for stack 
height in HEIDI II are relevant for 
power facilities. 
HEIDI II uses stack heights of 5, 15, and 30 metres. The height of Nanticoke’s stack is 198 metres 
(Environment Canada 2005). Thus the dispersion modeling transfer factors used in HEIDI II are unlikely to 
apply to dispersion of pollutants from the Nanticoke Power generation facility. However, all of the petroleum 
refinery stacks are actually higher than 30 metres as well (heights range from ~50-110 metres). Thus the 
application of HEIDI II was continued as a proof-of-concept to test its feasibility. 
Check whether toxicity data was 
available in HEIDI II for any of the 
substances emitted at Nanticoke 
Toxicity data was available in HEIDI II for only 9 out of 27 substances 
Check for toxicity data from the 
major agencies (Health Canada, 
EPA) 
Air Toxics: 
Toxicity data was readily available from either HC or EPA for 6 of the 14 air toxic substances with missing 
data; toxicity data was available for a further 6 of the air toxics from Cal OEHHA or RIVM.  
 
CACs: 
HEIDI handles SOx, NOx, and primary PM2.5. Nanticoke also emits PM10 and total PM.  Although 
epidemiological data is available for PM10 from the original source of information (C-R functions are 
available for PM10 and chronic bronchitis, hospital admissions for COPD and pneumonia, and ER visits from 
asthma), HEIDI II is intentionally designed not to estimate the dispersion of PM10. Health effects from PM10 
and PM2.5 are highly correlated and including both would result in double-counting. 
 
Summary: 
Data is not easily available for the following substances: aluminum, copper, carbon monoxide, total PM, and 
“VOCs”. 
Make assumptions about 
substances and C-R data to include 
The following substances were not included in the adaptation of HEIDI II to the Nanticoke coal-fired power 
generation emissions: 
• Aluminum: is a suspected toxin, but no chronic C-R data was available. The amount released is 266 
tonnes annually.  
• Copper: is a suspected toxicant, no chronic C-R data could be found and the annual emissions are 
very small (1.07 tonnes annually) 
• Carbon monoxide appears to be mainly an acute toxicant. HEIDI II was designed to assess chronic 




• Total PM and PM10: HEIDI II is not able to predict the dispersion of these substances. The original 
PM and dispersion data came from an AERMOD model and was dropped into HEIDI II as a ”black 
box”.  PM2.5 was assumed to be representative of the health effects of all CAC emissions, which are 
highly correlated with each other (this includes emissions of gaseous co-pollutants). I.e., PM10 and 
total PM are emitted from refineries as well and were not included in HEIDI II. They are excluded 
here for similar reasons. 
• “VOCs” -: toxicity is suspected but not confirmed. VOCs were included as harmful based mainly on 
their ability to cause ozone formation. Ozone was omitted from the original HEIDI II model and so is 
omitted again here. Additionally, VOCs are likely to partition quickly into organic media such as 
vegetation and soil, and so inhalation is likely to be a minor route of exposure. 
Check for population data In the case of the Nanticoke power generation facility, it is within the same postal code as the Imperial Oil 
Nanticoke refinery, so the population data for the facility is already available within HEIDI II. 
Check for background data Difficult for substances that were not included in HEIDI II; background data for most substances is not 
readily available from Environment Canada or Ontario Ministry sources; values were derived based on 
those cited in federal or provincial documents, or in some cases were assumed to be zero. For metals, 
ambient levels where available often refer to the amounts bound to PM rather than gas-phase 
concentrations, suggesting that metals may be more properly treated as components of the PM phase, or 
class 3 substances. 
Check for DALY Data Moderately easy. Given the relative crudeness of the DALYs already being used  in HEIDI II, it was possible 
to follow up on the references used during development of  HEIDI II and substitute appropriate DALY values 
in most cases 
Recode in Excel Time required for someone experienced in Excel: one day. Major tasks were replacing the substance and 
data lists that feed into the formulas. Many sheets were deleted which simplified the overall model.  
Identify probabilistic data for each 
variable 
Moderately difficult: sources used to derive distributions for HEIDI II were well-documented and typically 
provided data for substances not previously included in HEIDI II. The exception was for the Background 
variable, which had relied on data from several locations to develop a distribution. In this case, a simple 
standard deviation  equivalent to 10% of the mean value was implemented 










































































































Histogram indicating probability that each class 1 substance 
will achieve a rank from 1-8 for the Nanticoke power generation plant
Number of times ranked #1
Number of times ranked #2
Number of times ranked #3
Number of times ranked #4
Number of times ranked #5
Number of times ranked #6
 
Figure 38: Frequency with which each class 1 substance achieved each possible rank during the 
Monte Carlo simulation. A fairly clear priority order is apparent from the simulation 
 
 Figure 38, Figure 39, and Figure 40 show the ranking results of the Monte Carlo 
simulation for the Nanticoke coal-fired power facility. The results from this analysis 
(which is based on predicted incidence) suggest that of the class 1 substances emitted 
from the Nanticoke facility, chromium and arsenic are of greatest concern, that of the 
class 2 substances, vanadium and selenium may be of concern, and that the order of 
priority for the three class 3 substances included in the model is clearly PM from SOx, 
PM from NOx, and then primary PM. 
 If desired, it should be possible to conduct further in-depth analysis for this 
















































































































































Histogram indicating probability that each 
class 2 substance will achieve each rank 
at the Nanticoke coal-fired power generation facility
Number of times ranked #1
Number of times ranked #2
Number of times ranked #3
Number of times ranked #4
Number of times ranked #5
Number of times ranked #6
Number of times ranked #7
Number of times ranked #8
Number of times ranked #9
Number of times ranked #10
Number of times ranked #11
 
Figure 39: Frequency with which each class 2 substance achieved each possible rank during the 
Monte Carlo simulation. For some substances, zero incidence was predicted throughout the 






















































Histogram indicating probability that 
each class 3 substance will achieve a rank from 1-3 
Number of times ranked #1
Number of times ranked #2
Number of times ranked #3
 
Figure 40: Frequency with which each class 3 substance achieved each possible rank during the 




 Use of a measure such as impact equivalents adds little to the current 
understanding of priority substances as predicted by HEIDI II, but may be a useful 
communications tool. Impact equivalents provide a sense of relative toxicity of emissions 
within a class, using well-known substances as a baseline. This allows easy comparison 
of substances across impact measures and straightforward identification of substances 
with relatively high impacts, such as nickel, PAH, BTEX, sulphuric acid, and vanadium 
(for the hypothetical refinery scenario). However, because any sense of absolute impact is 
lost, the impact equivalents must be presented with contextual information indicating 
whether the high values are of concern, perhaps relative to a standard risk level such as 
the de minimis risk. The values are also strongly dependent on the emissions selected by 
the HEIDI II model, and must be determined separately for each location. 
 The analysis of the refineries in Sarnia suggests that HEIDI II’s approach of 
treating refineries in isolation is not appropriate for cases where the same population is 
exposed to emissions from multiple refineries. However, identifying emissions for 
reduction and responsibility, or “ownership” of these emissions becomes complex, 
particularly for class 2 substances, where there is assumed to be a level of exposure 
below which adverse effects will not occur. 
 Comparison of HEIDI’s rankings to those which would be generated by TRACI 
suggested some correlation between priorities for class 1 and class 2 substances, with less 
concordance for class 2 substances. Comparing health impacts for class 3 substances was 
found to be invalid. 
 Analysis shows that it is technically not too difficult to adapt HEIDI II to other 
sets of emissions. However, the validity of making this adaptation must be assessed on a 
case-by case basis. HEIDI II could only be adapted to emissions that emanate from a 
point source. Only three stack heights are available within HEIDI II, and may not 
adequately represent emissions scenarios from other contexts. Additionally, HEIDI II 
assesses only exposure through inhalation. This is valid for HEIDI II by virtue of the 
specific emissions considered – none of which are expected to have significant 
persistence in the organic fraction. The exposure pathways for substances which are 
likely to partition into soil, vegetation and water would not be adequately represented by 
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HEIDI II. It would therefore be inappropriate to attempt to adapt HEIDI II to many other 
industries. Emissions from coal-fired power plants are similar to emissions from 
petroleum refineries in this way, which is why an effort was made to adapt HEIDI II to 
the Nanticoke coal-fired power generation facility. Additionally, Nanticoke is the largest 
coal-fired generating station in Ontario, and has been targeted by environmental groups 
as “Canada’s number 1 polluter”(Ontario Clean Air Alliance 2003). As with refineries, 
most public attention focuses on CAC emissions from power plants, rather than air 
toxics, but the analyses presented above suggests that HEIDI II can distinguish priorities 
within the air toxics classes.
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3 Part 3: Discussion  
3.1 Model Predictions 
 When the CCME initiated the National Framework for Petroleum Refinery 
Emission Reductions (NFPRER), its goal was to gather information that would aid 
jurisdictions in setting facility emissions caps for Canadian petroleum refineries. 
Development of a ranking model such as HEIDI was not an initial component of the 
framework, but was identified by the Health Prioritization Subgroup (HSP) as a 
potentially useful tool to inform jurisdictional decision-making about allowable 
emissions for local refineries. The HSP recommended that the HEIDI II model be used as 
one of a suite of information sources, including information about local concerns.   
The predictions from HEIDI II suggest that air toxics emissions of concern at 
petroleum refineries across Canada include nickel, PAH, BTEX, hydrogen sulphide, 
sulphuric acid, and vanadium. Given the uncertainty and assumptions inherent in HEIDI 
II it is premature to suggest that efforts to reduce air toxics refinery emissions should 
target these particular substances and no others; however, further analysis of the potential 
for adverse health impacts from these emissions is warranted at refineries where they are 
emitted. Given the diverse types of health impacts that are predicted for the substances 
included in HEIDI II and the vastly different annual emissions associated with each 
refinery, a cost-benefit analysis might be appropriate to compare emissions on the basis 
of how much reduction can be achieved, the associated costs, and the associated health 
benefits.  
In HEIDI II, vanadium and nickel were frequently co-identified as being 
emissions of concern. Nickel was treated as a carcinogen (lung cancer), and vanadium 
was treated as an upper respiratory tract irritant, based on occupational and 
environmental evidence (i.e., (WHO (World Health Organization) 2000)). However, the 
toxicity of vanadium is uncertain and pure vanadium is not distinguished from vanadium 
pentoxide. Transition metals have previously been associated with oxidative stress-
related damage to DNA, suggesting a biological mechanism for carcinogenesis (Valko, 
Rhodes et al. 2006), and chronic irritation is known to generate oxidant stress in the lung 
and induce basal cell hyperplasia in chronic lung disorders. The low-level induction of 
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respiratory tract irritation documented for vanadium could signal pre-carcinogenic 
activity. California listed vanadium pentoxide as a carcinogen for the purpose of drinking 
water safety in 2005 (Office of Environmental Health Hazard Assessment 2005), 
confirming that it is considered a carcinogen under other exposure conditions, and also 
suggesting that its characterization by regulators is in flux. This year, the IARC reviewed 
vanadium pentoxide and classified it as “possibly carcinogenic to humans” based on 
sufficient evidence for carcinogenicity in mice but insufficient evidence about its effects 
in humans (IARC (International Agency for Research on Cancer) 2006). They also note 
that vanadium pentoxide is rapidly absorbed when inhaled, which suggests that airborne 
sources may be of particular concern. 
Both nickel and vanadium are impurities (less than 1 % of the mixture) frequently 
found in crude oils. However, whether or not the emissions concentrations of Ni and V 
are correlated depends on the source and composition of the crude oil refined at each 
refinery. The proportionality of vanadium to nickel is not consistent over all crude oils; it 
depends on the geographic origin of the crude (Lewan 1984). Typically rocks with high 
sulfur content expel crude with high vanadium to nickel ratios, while rocks with low 
sulfur content expel crude with a wide variety of V/(V+ Ni) ratios. Jurisdictions 
regulating refineries that process crude containing both impurities may choose to 
implement stringent emissions caps regarding transition metals as a precautionary 
strategy.  
In general, the largest health effects appear to be attributable to particulates (both 
primary and secondary), which aligns well with the current federal regulatory focus on 
NOx and SOx as priority ambient pollutants for reduction (Bilateral Air Quality 
Committee 2004; Farnsworth 2005; Canadian Council for Ministers of the Environment 
2006). HEIDI II does not analyse health impacts of O3 or VOC emissions, both of which 
contribute to smog formation, a known risk factor for impaired cardiovascular and 
respiratory health (i.e., (Dockery, Pope et al. 1993; Pope, Thun et al. 1995; Brauer and 
Vedal 1999; Kunzli 2002; Dominici and Burnett 2003; World Health Organization 
(WHO) 2003; Cohen, Anderson et al. 2004)). The potential for smog formation from 
refineries emissions was not included in HEIDI II because of the problem of “double-
counting”, where health impacts of emissions such as NOx, O3, and VOCs might be 
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accounted for twice: as primary pollutants and as secondary pollutants. Instead, PM2.5 
was assumed to be an indicator of overall air quality, and the concentration-response 
functions used in HEIDI II were assumed to be representative of co-exposure of PM with 
gaseous pollutants (McColl, Gower et al. 2004).  
Using time-series techniques, Burnett found that for co-exposure to PM and 
gaseous pollutants in 11 Canadian cities, improvements in health from reduction of some 
gaseous co-pollutants may be significantly greater than what would be predicted by PM2.5 
alone (Burnett, Cakmak et al. 1998). In a multipollutant model examining daily mortality 
in eight Canadian cities, exposure to PM2.5 explained only 28% of variation, with the 
remaining effects accounted for by gases (Burnett, Brook et al. 2000). Canadian results 
suggest that substance-specific dose-response functions derived from multipollutant 
models are the most accurate method of estimating impacts such as respiratory and 
cardiac hospitalizations (Burnett, Smith-Doiron et al. 1999). Although time-series 
research is most relevant for short-term relationships between ambient air pollution and 
health outcomes, it is still considered valuable for demonstrating the adverse effects of 
pollution, identifying the toxic components, and providing indirect evidence of the 
plausibility of long-term health effects (European Centre for Environment and Health 
2000; Bell, Samet et al. 2004). Although complex to implement, explicit consideration of 
the impacts of individual emissions from refineries that contribute to smog formation as 
well as the impacts of smog itself would improve HEIDI II. 
The model also suggests that there are several emissions which are unlikely to be 
associated with significant health impacts even at the limit of uncertainty in worst-case 
scenarios. These substances can therefore be regarded as low priority for emissions 
reduction strategies unless new toxicological evidence emerges or there are dramatic 
changes in emissions. 
3.1.1 Emissions reduction 
Two distinct approaches to adjusting emissions profiles from point sources exist. 
Proportional reduction implies that the total mass emitted is reduced, with peak, average, 
and minimum concentrations being simultaneously and proportionally reduced. This 
approach would always be beneficial for reducing health effects of class 1 and class 3 
emissions, where predicted incidence is directly related to delivered concentration. 
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However, since class 2 substances only initiate an effect above a particular threshold, and 
the magnitude of effects is not linearly related to delivered concentration, proportional 
reduction would be useful for class 2 substances only in cases where exposure above the 
threshold occurs. The extent of benefits achieved would depend on the extent to which 
emissions reduction reduced the gap between exposure and threshold concentration. As 
well, because HEIDI II predicts only chronic health effects, proportional reduction of 
emissions would really only be beneficial in cases where the emissions levels do not 
fluctuate significantly.  
In the case of class 2 substances which exhibit large fluctuations in emissions 
levels over time, peak-shaving might be a more practical approach. This approach 
focuses on reducing emissions during periods of high release so that all (or most) 
emissions fall below the threshold level. Although this approach does not require a total 
emissions reduction (periods of minimum emission could theoretically simultaneously be 
adjusted upwards without exceeding the threshold), an ideal adjustment to the emissions 
profile would be part of a strategy to reduce emissions overall. For threshold-acting 
substances, emissions reduction is useful only if the toxicity threshold is being exceeded 
as a result of current emissions. The probability that this might occur depends on the 
relative proximity of (i) average annual emissions, (ii) peak emissions concentration (iii) 
threshold concentration. 
Actual emissions reduction approaches used depend strongly on technologies 
available. Often, emissions reduction technologies can be implemented at varying points 
in the refining process, with varying results and costs (Baukal, Hayes et al. 2004). Some 
substances may be reduced in concordance with each other. Most emissions are a result 
of incomplete combustion, and advanced burner technologies appear to be a cost-
effective solution for reducing some emissions including NOx (Baukal, Hayes et al. 
2004). Many emissions control technologies target specific emissions (such as SOx). By 
implementing technologies to reduce SOx losses at the fluid catalytic cracker and SOx 
recovery unit as well as SOx reduction additives, the Chevron Burnaby refinery has 
reduced its SOx emissions by over 50% from 2002-2004 (Environment Canada 2006). 
This might be useful given the predictions of HEIDI II which suggest that several 
sulphur-containing agents may be harmful, including HS, H2S, and SOx. 
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3.1.2 Probability Distributions for Model Variables 
 Although most if not all model variables are subject to both variability and 
uncertainty, a single probability distribution was assigned to each in an attempt to capture 
the dominant source of variation pertaining to each parameter. A more sophisticated 
approach might have been to conduct a two-dimensional Monte Carlo Simulation, where 
the sensitivity of the model predictions resulting from variability and uncertainty of each 
input was separately assessed. Limitations in data availability prevented this, but the 
implications for the ranking output should be acknowledged. If the overlap in rankings 
was due primarily to uncertainty, better data might be able to resolve the area of overlap 
in rankings and thus clearly define priority substances. However, if inherent variability is 
responsible for the overlap in rankings, the implication is that substances with “adjacent” 
ranks might be of equal concern for protection of the most susceptible members of the 
population. 
3.1.3 Characterizing PM exposure-response  
HEIDI II used a linear nonthreshold dose-response function to predict health 
impacts from PM2.5. While this form of the exposure-response relationship is broadly 
accepted and supported by research (Daniels, Dominici et al. 2000; Schwartz, Laden et 
al. 2002; Samoli, Analaits et al. 2005), the evidence base relies primarily on multicity 
analyses correlating daily PM levels with health outcomes, which are not ideally suited 
for assessing exposure-response for chronic outcomes (Pope 2000).  Limited evidence for 
nonlinear exposure-response relationships does exist (Health Effects Institute 2000), and 
current regulatory approaches to PM imply the existence of a threshold, suggesting that 
the possibility of a threshold was worth exploring with HEIDI II.  
Delivered concentrations of refinery emissions of primary or secondary PM were 
consistently predicted to be lower than the Canada-Wide Standard for PM2.5 (30 μg/m3) 
for zones within 25 km of any refinery.  A sensitivity analysis that implemented a low 
threshold of 1 μg/m3 indicated that the effect of including a threshold on the cumulative 
distribution for predicted incidence due to refinery emissions would be to narrow it and 
shift it to the left.  Environment Canada data suggests, however, that fine PM is 
ubiquitous in most urban and industrial environments and that one third of Canadians 
were exposed to average concentrations of PM2.5 above the CWS during 2001-2003 
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(Farnsworth 2005). If this is true then even if a threshold does exist for PM, it is probably 
consistently exceeded in jurisdictions containing refineries, even before the refinery 
emissions are considered. 
The possibility that a threshold exists for any chemical emitted from multiple 
sources invokes thorny issues of responsibility. Combined emissions from multiple 
sources may clearly exceed the toxicity threshold for a particular agent, but any 
individual emitter contributing concentrations below the toxicological threshold may not 
feel compelled to reduce emissions as a result. Determining how emissions reductions 
should be regulated and implemented across sources in cases like this is complex. In the 
case of PM in particular, emissions result not only from various industries but also from 
privately-owned vehicles, meaning that “ownership” of the emissions is widely 
distributed across the affected population. Additionally, the ownership profile for 
emissions likely will not match the exposure profile for emissions across the affected 
population, leading to complicated issues of social and environmental justice. 
3.1.4 Model structure and interesting questions of valuation, equality, 
fairness, and ethics 
HEIDI II was designed with a particular purpose in mind and was not intended to 
address complex issues of valuation and ethics. The assumptions inherent in the model 
and the intended use of the model are clearly documented (McColl and Gower 2004; 
McColl, Gower et al. 2004). However, the structure of the model raises some interesting 
questions about scientific perceptions and valuation implied by the model design. These 
questions may appear to be beyond the scope of HEIDI II, but issues of perception and 
communication must also be considered by modellers. Air pollution and health is an 
important issue and the concerned public is a principal stakeholder. Even with extensive 
documentation, the possibility for misuse and misinterpretation of the model structure, 
intent and assumptions exists. Additionally, exploring the implications of the model form 
may identify issues of interest for future modeling efforts.  
The predicted health impact value in HEIDI II depends on the number of people 
affected. Since the total number of people affected at a particular refinery is the same for 
each emission, this approach is useful for comparing emissions from an individual 
refinery. HEIDI II was not intended to be used for comparisons between refineries, but 
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the method of valuation raises questions about how we perceive individual risk: this 
approach implies that a refinery in a rural area with high emissions could have less of an 
impact than a low-emissions refinery in a densely population area. Certainly the 
population health impact and direct and indirect economic costs are higher when more 
people are affected, but the individual-level risk may be a more important number to 
members of a community. Focusing emissions reduction strategies on large urban centres 
may convey to smaller centres that they are less important. The social costs of perceived 
inferiority and irrelevance are unclear. 
An approach that suggests that the cumulative impact of refinery emissions is 
almost totally dependent on the number of people living nearby rather than the magnitude 
of emissions also has important implications for application of regulations. Does it mean 
that regulation should preferentially target refineries in densely populated areas? Would 
this affect competitive fairness in the refining sector? 
Finally, this analysis evaluates individual refinery emissions at each location but 
does not look at the cumulative impact of living near a refinery. Generating a rank order 
suggests that sufficient protection may be offered to the public by reducing only those 
emissions with the greatest health impacts. Given that many of the substances included in 
HEIDI II were selected on the basis on their toxicity and biopersistence, the ethics of 
defining “harmful” vs. “harmless” seem important. Is this an ethical approach when there 
is evidence that all emissions could potentially cause harm? In scientific risk assessment, 
a de minimis risk level of 10-5 or 10-6 is usually applied to signify a “virtually safe” level. 
However a simple rank order does not communicate a sense of risk to a public user of 
HEIDI II and the HEIDI II documentation suggests that the predicted incidence values 
are not representative of reality. For users of HEIDI II trying to understand the level of 
risk in their community resulting from refinery emissions, the lack of “grounding” of the 
ranking information with either reliable predicted incidence values or cost-benefit 





 Many limitations associated with characterizing variables in HEIDI II are 
identified and discussed in Appendix C. Although these limitations must be considered to 
understand the contexts for which HEIDI II is valid, not all points will be discussed here. 
3.2.1 Stack heights 
HEIDI II offers users three separate stack heights (5 m, 15 m, 30 m) to model 
dispersion of emissions away from petroleum refineries. This allows users flexibility in 
characterizing emissions. The 5 metre stack height in particular was intended to represent 
dispersion patterns for fugitive emissions. In reality, a single stack located in the centre of 
the refinery property does not represent the location or height of emissions. On most 
refinery properties, emissions originate from several stacks of varying heights and are 
combined with fugitive emissions. It may therefore be more appropriate to estimate an 
“average stack height” which is less than the actual stack height, to account for the 
contribution from fugitive emissions. 
During the validation process, it was determined that the real stack heights of 
refineries across Canada are all 50 metres or higher (See Table 39). While a model stack 
height of 30 metres may appropriately represent an “average stack height” for some 
petroleum refineries (it is not possible to determine to what degree this is true, or for 
which refineries it would be most appropriate), it is certainly not uniformly applicable, 
and if this was the intended usage for the term “stack height”, it is not well-
communicated to potential users.  
Table 39: Stack heights for refineries in Canada as reported in the NPRI database for 
2004(Environment Canada 2005). 
Refinery 
Stack height (metres). A range is 
provided where more than one stack is 
present. 
Chevron Canada Limited - Burnaby Refinery 50.3 
Consumer's Co-operative Refineries 
Ltd./NewGrade Energy Inc. 71.6-76.2 
Husky Oil Operations Limited - Prince George 
Refinery No longer operational (no data) 
Imperial Oil - Dartmouth Refinery 50.9-61.9 
Imperial Oil - Nanticoke Refinery 50-111.9 
Imperial Oil - Sarnia Refinery Plan 61-106.7 
Imperial Oil - Strathcona Refinery 45.7-108.8 
Irving Oil Ltd - Irving Oil Ltd. - Refining 55.2-89 
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North Atlantic Refining - North Atlantic Refinery 50.3-76.2 
Nova Chemicals (Ltd.) - Nova Chemicals 
(Canada) Ltd. 60.96-106.7 
Parkland Refining Ltd. - Bowden Refinery No longer operational (no data) 
Petro-Canada - Edmonton Refinery 76.2-91.4 
Petro-Canada - Mississauga Lubricant Center 121.9 
Petro-Canada - Raffinerie de Montreal 60.96-100 
Petro-Canada - Oakville Refinery 61-100 
Produits Shell Canada - Raffinerie de Montreal-
est 51.8-68.3 
Shell Canada Products - Sarnia Manufacturing 
Centre 61-91.4 
Shell Canada Products - Shell Scotford Refinery 61.2 
Sunoco Inc. - Sarnia Refinery 60-99 
Ultramar Ltee - Raffinerie St. Romuald 54.9-85 
 
The height of the stack determines the dispersion pattern of emissions from the 
stack. Taller stacks typically result in dispersion to more distant locations. However, 
HEIDI II examines only populations within 25 km of the refinery. This suggests that for a 
real refinery with a tall stack, neither the population affected nor the dispersion pattern of 
pollution is appropriately represented in HEIDI II. This deficit means that exposure, and 
thus estimated health impact values are likely poorly estimated. 
3.2.2 Geographic Zones selected for Evaluation 
 The geographic division of areas around each refinery modelled in HEIDI II is 
also problematic. HEIDI II only examines health impacts within 25 km of each refinery. 
This may be valid for the air toxics, most of which have half lives on the order of several 
hours (McColl, Gower et al. 2004) and so experience significant degradation within the 
first 25 km of dispersion away from the refinery. However, research suggests that long-
range transport of secondary PM is significant, and that even in a catchment area of 500 
km around a point source, total population exposure is unlikely to be accounted for 
(Levy, Wilson et al. 2003). For releases from Chicago area power plants (which have 
taller stacks than refineries), 40% of primary PM2.5 exposure, 20% of exposure to PM2.5 
from sulfates and 25% of exposure to PM from nitrates occurred within 50 km of the 
source when a surrounding grid of 750 km2 was used to calculate total exposure (Levy, 
Spengler et al. 2002). The health impacts from PM are already predicted to be significant 
in HEIDI II, but this suggests that most of the impacts have not been accounted for. This 
is particularly important for regions such as southwest Ontario, where the population is 
 
 150
dense over a large geographic area, and is probably being simultaneously exposed to PM 
originating from several refineries. 
 Calculation of total exposure efficiency and exposure efficiency within-25 km 
intake fraction would be informative. This measure, sometimes called the “intake 
fraction” describes the proportion of PM emitted that is actually inhaled and describes the 
exposure efficiency of a particular source (Evans, Wolff et al. 2002). Its use would 
provide a sense of how much of the health impact of PM is actually captured by HEIDI 
II. A comparison of intake fractions for each of the emissions included in HEIDI II might 
also clarify the where potential reductions might be most beneficial. 
3.2.3 Use of annual emissions data 
 HEIDI II uses annual emissions data for each refinery as reported to the NPRI. 
These values are usually modelled rather than measured and represent an estimated 
composite of point source, area, and volume emissions across the refinery property, and 
includes stack emissions, fugitive emissions, escape from containment, and evaporation 
from spills.  
There is some evidence that the method used to calculate emissions (Canadian 
Association of Petroleum producers (CAPP)-sanctioned method) may be inaccurate. A 
relatively new method of measuring emissions, Differential Absorption Light Detection 
and Ranging (DIAL) uses laser technology to make a remote measurement of the amount 
of hydrocarbons in an emissions plume. It is often used in combination with gas-leak 
cameras, which use infra-red technology to identify existing hydrocarbon leaks. VOC 
emissions measured at an Alberta refinery using the technology were 9970 tonnes per 
year, while the CAPP method had estimated ~670 tonnes per year of releases (from 
combined sources of stack/point, storage/handling, fugitive, and spills) (Chambers 2004). 
Separate DIAL estimates for methane, VOCs and benzene at a gas processing plant in 
Alberta was 4 to 8 times higher than detailed CAPP estimates (Chambers 2006). The 
source of the differences at appeared to be mainly related to fugitive emissions: leaks at 
storage tanks, valve stem packings, unions, pipe thread fittings, tank vents and hatches 




There is currently no remote technology sufficiently advanced to make remote 
measurements of airborne particulate concentrations. Additionally, some of the refinery 
emissions included in HEIDI II do not qualify as hydrocarbons (i.e., the metals). 
However, many of the emissions included in HEIDI II are organic.  
These results are troubling: they suggest the possibility that all fugitive emissions 
are potentially being underestimated by the CAPP-sanctioned method. The 5-metre stack 
scenario suggests that this error would mainly affect people living closest to the refinery. 
A possible solution would be increased use of DIAL or similar technologies to detect 
fugitive emissions from petroleum refineries.  
An explicit assumption in the deterministic version of HEIDI II was that 
emissions are continuous and uniform, but this assumption may be invalid and provides 
little sense of the most usual emissions level for each substance. It is possible that some 
emissions are not constant over time, but are periodic and fluctuate between peak levels 
and zero emissions. Others, emissions events, such as spills, may be one-time high-level 
releases that would be more properly associated with acute exposures. HEIDI II is not 
intended to address acute health impacts from refinery emissions, but understanding the 
extent to which fluctuations occur – and for which particular emissions – would be 
helpful.  
For class 1 and 3 substances, where dose-response is modelled in a linear-
nonthreshold manner, predicted health impact is not affected by periodic fluctuations in 
emissions as long as the total emissions are included in the model. However, for 
threshold-acting substances, adverse effects are only predicted by HEIDI II in cases 
where the average annual delivered concentration of the substance exceeds the threshold. 
This is problematic for the possible case where peak emissions are above the threshold 
but the annual average is below the threshold. If the threshold is exceeded for a portion of 
the year, it is possible that adverse health effects could result from the emission but not 
be predicted by HEIDI II. Additionally, in cases of fluctuating emissions, the background 
may be more important than it appears, “bumping” the delivered concentration over the 
threshold during periods when emissions are higher. 
 
 152
3.2.4 Exposure Model 
 HEIDI II determines the “delivered concentration” of each substance to twenty 
zones surrounding each refinery. This value, which accounts for dispersion and 
photodegradation of emissions and the ambient levels of pollutants in the region provides 
only a limited sense of the exposure of the population in the area. While it does account 
for the distribution of population relative to the predominant wind direction, the exposure 
of people affected is estimated based on residential address. In reality, people will move 
around the area, going to work, school, and recreational activities. As well, most people 
spend upwards of 90% of their time indoors, and the actual concentration reaching each 
person might depend on the degree to which pollutants are filtered out by building 
envelopes. Since filtration of chemicals into indoor environments depends on building 
construction, including age of the structure, ventilation, and presence of air conditioning, 
this may differ by neighbourhood, with people living or working in older buildings being 
more highly exposed. Children and elderly persons are assumed to be exposed to the 
same concentrations as adults, although activity patterns and amount of time spent 
outside depend on age. Additionally, since the dose-response function for class 1 and 
class 2 substances does not differentiate age groups, there is no accounting for potential 
accumulated exposure to air toxics in elderly persons. 
 The characterization of background levels may also be problematic: a single 
concentration was assigned to each refinery location, while in reality the background 
concentrations may vary over the geographic zones around the refinery depending on the 
presence and density of sources such as industry and automobiles. This issue is important 
for the class 2 substances where the ambient levels of pollutants affect whether or not the 
toxicity threshold might be exceeded as a result of added refinery emissions. 
 Finally, formation of photochemical smog from VOC emissions was not included 
in HEIDI II but could potentially be an important source of health impacts. 
3.2.5 Dose-response Models 
HEIDI II uses the USEPA’s IRIS (Integrated Risk Information System) database 
to access fully and consistently reviewed toxicological data for many substances. 
However, there is often a time lapse between availability of new information and its 
reflection in the database. Many toxicity scores in these databases are based on 
 
 153
extrapolation from animal data. (Bailar and Bailar 1999) note that where comparable data 
exist for humans and animals, they often agree that risk does exist; however, significant 
uncertainties apply to extrapolating animal data to humans. Additionally, the extensive 
review process required means that not all chemicals are included. As well, values such 
as unit risk may differ by an order of magnitude between well-respected organizations 
such as the EPA and the WHO.  
Characterizing impacts also requires decisions to be made about how specific 
substances are to be treated. Some substances, such as PAHs (polycyclic aromatic 
hydrocarbons) are often emitted together, and some assessors may opt to treat them as 
mixtures, applying only one toxicity score to the group, while others may treat them 
individually. Metals are also a source of difficulty, as their ionic state can affect 
properties such as toxicity. However, accounting for all the ionic states of different 
metals can increase the complexity of a model dramatically. Furthermore, toxicity scores 
are not available for all ionic species of all metals. The approach of HEIDI II was to treat 
PAH as one entity, and use the best available data for metals: toxicity data for the nearest 
ionic state of the most commonly emitted form of each metal was selected. HEIDI II also 
identified an additional mixture class: BTEX (benzene, toluene, ethylbenzene and xylene, 
which are frequently emitted together and whose critical health effects are similar), for 
which weighted concentration and toxicity values were derived. 
 The potential health impact of exposure to each substance was based on a critical 
endpoint for that substance. This was generally defined as the endpoint that would 
manifest at the lowest concentration. However, some substances may be related to 
multiple endpoints as concentrations increase. For example, the endpoint used for H2S 
was nasal lesions/nose irritation but studies have also found that at high levels of 
exposure animals may exhibit CNS (motor activity) effects (Environmental Protection 
Agency (EPA) 2003). Local air quality standards for H2S are being reviewed in Ontario 
because of this (Ontario Ministry of the Environment 2006). Toluene, generally 
associated with neurological deficits, has also been associated with respiratory tract 
irritation (Environmental Protection Agency (EPA) 2005). 
Similarly, sulphuric acid has been proposed as a carcinogen, but because there is 
no good concentration-response data available for the substance on which to base cancer 
 
 154
incidence predictions, it was treated as an irritant in HEIDI II. These endpoints are 
disparate and represent vastly diverging levels of impact on quality and length of life for 
an affected individual.  
Finally, the dose-response model used for class 1 and class 2 substances does not 
discriminate by age group. Thus, children who are undergoing rapid development are 
assumed to respond to toxic exposures in the same way as adults.  
3.2.6 Sensitivity Analysis 
 The sensitivity analysis was able to identify some variables that were important to 
predicting health impact – particularly the concentration-response / toxicity data. 
However, it was unable to evaluate the influence of the dispersion modelling approach 
the choice of meteorology or the choice of terrain. This was a major disadvantage since 
the dispersion model comprised all of module one. Because of the “black box” character 
of the dispersion model, there was no way to test how (or how much) changing the 
predominant wind direction or altering the geography could affect predictions of impact. 
Understanding these effects would be important for understanding the limitations of the 
model, but also for determining how policy might be made more relevant for specific 
locations. 
 If distinct distributions could have been chosen to characterize uncertainty vs. 
variability in input distributions, two dimensional Monte Carlo simulations could have 
been conducted to identify which was the more important source of variation in the 
predicted incidence values. For example, there may be both uncertainty and variability in 
the ED05 values used to anchor the dose-response function for class 2 substances. 
Uncertainty could arise from the extrapolations required to calculate human equivalent 
values from experimental animal data, and variability within a population, where some 
people may be more susceptible to disease development because of genetic profiles, 
previously existing diseases, or environmental or occupational co-exposures. If the 
contributions of uncertainty and specific sources of variability could be distinguished, the 
results of sensitivity analyses variables might provide useful insight into the utility of 
specific policy decisions.  
Gough (Gough 1997) identifies ‘indeterminacy’ as a type of uncertainty where 
causal links, networks, and processes cannot be predicted. It is possible that there are 
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relationships important for predicting impacts of refinery emissions which have not been 
identified by the scientific community. However - it is not possible to test for or identify 
these during modelling. Acknowledging the limitations of HEIDI II and describing the 
assumptions inherent in its design and its intended use are attempts to frame the use of 
HEIDI II within a context of known relationships. 
3.2.7 Valuation  
Valuation of human health impacts is a question of how best to represent human 
morbidity and mortality for the purpose of the tool or study. Powell (Powell, Pearce et al. 
1997) describes four main approaches to the valuation phase in LCIA: (i) distance-to-
target techniques, in which the magnitude of deviation in performance from some 
environmental target or standard forms the basis of the weight; (ii) environmental control 
costs, in which the expense of controlling environmental damage is used to develop 
weights; (iii) environmental damage costs, in which explicit or implicit willingness to pay 
(WTP) measures (to avoid environmental impacts) are developed; and (iv) scoring 
approaches, in which weightings are derived by experts. Each approach is subject to 
limitations. For example, the distance-to-target and environmental control costs approach 
may be based on standards that are politically achievable rather than scientifically 
defensible, while WTP is an emerging technique that relies on currently available 
economic estimates of damage. Scoring approaches may not be transparent, and while 
they are likely to be based on a high degree of expert knowledge, they may not accurately 
reflect the interests of the society to which they will be applied. 
 DALYs, or disability-adjusted life years, are an example of a scoring approach 
and assign disability weights to aggregate the severity of different non-lethal disease 
stages. They incorporate the number of years lived with a disabling illness (YLD, years 
lived disabled) and the number of years lost to premature mortality (YLL, years of life 
lost) (Mathers, Stein et al. 2002). DALYs have been developed by both de Hollander (de 
Hollander, Melse et al. 1999) and the World Health Organization (Murray and Lopez 
1996; Mathers, Stein et al. 2002) for a variety of health outcomes, and provide a 
practical, consistent metric for comparison of a wide range of illnesses of varying 
severity (Udo de Haes, Jolliet et al. 1999). As well, the metric is framed as a health loss, 
which may be intuitive for decision-makers.  
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DALYs are intended to account for the relative difference in quality and years of 
life lost from different types of impacts. They were incorporated into HEIDI II so that 
health endpoints of differing severity could be compared. Attempts to rank substances 
across classes using probabilistically generated DALYs resulted in collections of CDFs 
of very different shapes which overlapped extensively. It is difficult to extract a 
defensible prioritization order from such a comparison. A comparison of across-class 
ranking methods found that although PM (class 3) was frequently identified as a high 
priority substance, conclusions about class 1 and class 2 substances depended strongly on 
the method used to create the ranking.  
DALYs may be sensitive to mild health impacts, weighting them too heavily. 
They compare health loss to a hypothetical profile (Hofstetter 2001), and may therefore 
imply an unrealistic comparison with perfect health. As well, although age-weighting is 
included in DALYs, its implementation still requires refinement (Hofstetter 2001), and in 
the operationalization of DALYs in HEIDI II specifically, the age structure of the 
population, the average duration of disease, and the valuation of death and disability was 
assumed to be similar to a Dutch population. This is likely a reasonable proxy for a 
Canadian population in order to simplify the analysis but does introduce an additional 
source of uncertainty. DALYs may not yet be sufficiently evolved to appropriately 
characterize the potential consequences of noncancer toxicological effects (Pennington, 
Crettaz et al. 2002), which would affect their utility in predicting impacts from class 2 
substances in particular. Finally, DALYs may not account for cost of illness to 
individuals or to the community, which may be different for different types of outcomes 
and therefore be important for prioritization schemes.  
3.3 Use of HEIDI II 
HEIDI II was designed to be a transparent, publicly available ranking tool. It was 
developed with significant input from a variety of stakeholders, and was initially coded in 
a commonly used spreadsheet program. Code such as visual basic which prevented use of 
HEIDI II by several stakeholders due to agency-level security settings was avoided, and 




Currently, the probabilistic version of HEIDI II exists in Matlab code. The intent 
is to publish any relevant predictions or commentary resultant from development of this 
version of the model, but it can no longer be considered transparent or publicly available. 
The distributions used to represent each variable were selected by the researcher, 
sometimes in consultation with other academic personnel, but without input from a range 
of stakeholders. Matlab is not a program that is commonly used, limiting both the 
accessibility of the code and the results to interested parties with appropriate skills. 
Because some expertise is required to understand the code, run the program, and interpret 
the results, the model should be considered generally inaccessible.   
The research carried out does suggest that the deterministic, excel-based version 
of HEIDI II may be as useful for prediction within-class rank order of refinery emissions 
as the probabilistic version. This suggests that the excel version should remain in the 
public domain. However, issues of clarity are likely to frustrate users of this version as 
well. Although HEIDI II is constructed in a software environment that is (almost) 
universally available, and is well-annotated and documents, the tool is not simple to 
understand and use and the technological report describing the assumptions and 
limitations of the model is dense. Proper application of HEIDI II requires a high level of 
literacy, scientific knowledge, and computer skill. 
While the intent of HEIDI II was to develop a screening-level tool, the model 
provides predictions of annual case incidence. The current report uses these values of 
predicted incidence to investigate the model’s ability to function as well as its predictions 
for individual refineries and highlight substances that may be of concern – but 
simultaneously advises that these values are not reliable. This is likely to create confusion 
for anyone interested in understanding the results of HEIDI II. This report and the 
technical report that accompanies the original HEIDI II attempts to clarify the intent and 
limitations of the model, but cannot prevent its misuse or misinterpretation. In particular, 
it would not be surprising to find that incidence predicted by HEIDI II was cited by 
external sources such as community groups as if it was a valid prediction for a specific 
location. 
Communication with all stakeholders is important for health risk, and for a tool 
that has been made publicly available as HEIDI II has, the public must be included as a 
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stakeholder. The level of knowledge of interested members of the public should be 
explicitly considered when developing materials designed to help people use HEIDI II 
properly.  
One difficulty of using HEIDI II in conjunction with the other information 
gathered by the NFPRER, in particular, the benchmarking data, is that not all the same 
emissions are addressed by each analysis. The benchmarking is intended to identify 
whether emissions from Canadian refineries are converging with emissions levels from 
refineries in the U.S. However, the benchmarking examined SOx, NOx, CO, VOC, PM10, 
PM2.5, benzene and ammonia. It does not include analysis of several emissions that were 
identified as being potentially important by HEIDI II; in particular, the metals (Ni and V), 
BTEX, PAH, HS, and sulphuric acid.  
3.3.1 HEIDI II in a new political context? 
 
 The Canadian Government recently tabled a new Federal Clean Air Act (2006) 
which could change the way some of the pollutants included in HEIDI II are regulated. 
NOx, SOx, PM2.5, ammonia and mercury are among the pollutants which would be 
recategorized under the proposed legislation. Currently, all of these (and many other 
substances included in HEIDI II) are classified as “CEPA Toxic”, which means that they 
are recognized as having harmful effects on the environment or present a danger to 
human life or health. For these substances, the federal government must provide at least 
one tool or instrument to prevent pollution from emissions of these substances. These 
tools can address any aspect of the substance’s lifecycle, and range from regulations, 
pollution prevention plans, environmental emergency plans, and environmental codes of 
practise to environmental release guidelines. In practise, National Ambient Air Quality 
Objectives (NAAQOs) were set as non-binding guidelines for several of these substances 
in the 1970s. While it is now recognized that these guidelines are no longer appropriate, 
Canada-Wide Standards (CWS) have been developed to replace the NAAQOs for only 
two substances: PM2.5 and ozone. The CWS serve as numeric targets that jurisdictions 
(such as provinces) can choose to adopt as enforceable standards. 
 The new act defines new categories for air emissions: “air pollutants” and 
“greenhouse gases”, and would move several substances away from the CEPA Toxic list 
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and into these categories. The proposed act appears to align treatment of these substances 
with the US approach, which sets enforceable ambient air standards for “criteria air 
contaminants” – defined as those which are present in the air as a result of emissions 
from multiple point and/or area sources. This could result in more strict regulation of 
these pollutants and more stringent requirements for pollution prevention planning by 
provinces. It is unclear what the final content of the act will be – or if it will even be 
accepted by the House of Commons before another election is called. The proposed act 
was referred to committee for possible revisions, as a result of wide criticism when it was 
first tabled. 
3.4 Recommendations and Future Research 
The NFPRER described a ten year plan for reviewing emissions levels, data 
needs, and impacts of refinery emissions. The NFPRER Steering committee proposed a 
that the health prioritization tool be reviewed in 2008 as part of the ten-year plan to 
gather feedback and improve the framework (CCME (Canadian Council of Ministers of 
the Environment) 2005). Feedback about HEIDI II will be gathered from the jurisdictions 
and stakeholders who may have used it – and a decision about whether to update the tool 
will be made based on stakeholder input. It is unclear whether the information collected 
will be made public but it would be useful for developers of future policy analysis tools 
for industrial emissions. 
If HEIDI II was ever to be upgraded, an open source software development 
approach might be most beneficial. “Open source” means that the code for the software 
would be freely accessible to all users, such that anyone is able to copy it, modify it, and 
redistribute it back to the user community. This allows for a variety of approaches and 
agendas in development of a single software tool, and permits many people with adequate 
expertise and a vested interest in the product’s ability to perform to work on developing 
the product simultaneously. The model could then be wrapped in a user-friendly GUI, 
allowing people who are unfamiliar with the technical details required to understand the 
code to use it and obtain results easily. They would still have access to criticism and 
commentary about the model, and information and opinion about its limitations and 
assumptions from the open source community involved in its development.  
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 Future versions of HEIDI II should eliminate the Parkland and Oakville refineries, 
which were closed in 2001 and 2004, respectively. While their inclusion in the model 
does not affect model runtime or predictions for other jurisdictions, it does date the 
model, and add unnecessary complication and data. 
 If a viable methodology could be identified, future versions of HEIDI II should 
account for the impacts of emissions which contribute to smog formation, including O3, 
VOCs, and NOx. This must be done in a way that avoids double-counting. 
 As, well, the model should be continuously updated with new information about 
toxicity of each emission. Vanadium is an example of a substance which should be 
followed carefully as new evidence supporting or refuting its potential carcinogenicity 
becomes available. 
4 Conclusions 
Ultimately, science-based policy decisions all include a subjective element, and 
require inferences, extrapolations, and judgement (Sexton 1995). Regulators must decide 
what level of risk is protective, and how much uncertainty is acceptable. They often face 
significant pressure from corporations and the public and face difficult economic 
decisions. HEIDI II is one tool that may help identify emissions of concern from the 
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Appendix A: Common Probability Distributions 
Adapted from (Morgan and Henrion 1990) 

























Arises in many applications (in part because 
of the Central Limit Theorem). Commonly 






























Arises when the logarithm of the random 
variable is normally distributed; used to 
represent physical quantities constrained to 
be non-negative and positively skewed 








Describes times between successive events, 
when events are purely random. 
Poisson 













Describes discrete, non-negative events.  
Gamma 














Similar to lognormal but less positively 
skewed and less “tail-heavy” 



















Applies to non-negative physical quantities 









For use when a range of possible values has 
been identified, but there is no knowledge 









= ;2  
Values toward the middle of the distribution 
are more likely than those at each extreme; 
may also convey sense that knowledge about 
the distribution is imperfect 












Flexible means of representing variability 





Appendix B: Variables List and Description (HEIDI II deterministic) 
Variable Source for Data Data Description/Type Variable Description/Type Relationships to other variables 
Air Exposure Module 
Refinery Emissions Environment Canada’s 
2001 NPRI (National 
Pollutant Release 
Inventory) database 
Empirical Continuous; “left-centred” – 
i.e. continuous down to a 
regulatory guideline value 
 
Average annual emissions for 
each substance included in the 
HEIDI II model for each of 
Canada’s 20 refineries 
 
The estimate for each pollutant 
is a composite of point source 
(i.e. stack), area, and volume 
emissions from a variety of 
emission sources within a 
refinery location, or losses 
through spills evaporation and 
escape from containment 
Forms the basis for determining the 
exposure concentration in each of the 20 
quadrants around each refinery. It is 
adjusted using dispersion adjustment 





factors for each quadrant 
and zone were determined 
outside the HEIDI II 
model. These were based 
on a generic 
meteorological profile  
For the meteorological 
profile, 1996-2000 
meteorological data for 
the southwestern Ontario 
region are used.  
Default – although they 
were developed 
from application 
ISC3/AERMOD to generic 
meteorological profile for a 
vector of zones j at 
refineries i, values will be 
taken as “given” for the 
purpose of analyses carried 
out as a part of this project 
Continuous; 
 
These are applied to the raw 
emissions data to predict 
concentration of each 
substance in each of the 20 
quadrants/zones 
For Refinery i, zone j 
 
 
(NPRI emissions)i*Dispersion model 







 Continuous positive Calculated based on emitted SOx and 
NOx at source, wind speed, reaction rate, 




Stack Change Factor Provided by John Hicks Default Categorical 
 
Allows the dispersion in each 
of the 20 zones to be 
calculated for 15 metre and 5 
metre stack heights relative to 
a 30 metre stack height. 
For Refinery i, zone j, stack height k 
 
Concentration of substancei,j,k = 
Dispersed Concentrationi,j* Stack Change 
Factorj,k 
Stack Height (input) N/A – selected by user User-specified 
 
Choices are 5, 15, 30 metres 
Interval 
 
Allows the user to choose an 
appropriate stack height for 
his/her modeling needs 




N/A – selected by user User-specified 
 
Choices are 8, 12, 16 hours 
Interval 
 
Allows the user to choose an 
appropriate number of daylight 
hours appropriate for his/her 
modeling needs 
Determines format of photodegradation 
equation for calculating degraded, 
dispersed concentrationi,j,k: 
For 0 hours: 
 = dispersed concentration 
For 8 hours: 
=(2/3)*dispersedi,j,k+(1/3)* 
dispersedi,j,l*(e-kt) 
For 12 hours: 
=(1/2)* dispersedi,j,l +(1/2)* dispersedi,j,l 
*(e-kt) 
For 16 hours: 
=(1/3)* dispersedi,j,l +(2/3)* dispersedi,j,l 
*(e-kt) 
Atmospheric OH rate 
constant (used to 
calculate 
atmospheric half-
lives of chemicals) 
SRC (Syracuse Research 




which allows calculation of 
half-life of substances emitted 
to air 
 
For each substance: 






Assumed [OH] of 1.5e6 
molecules/cm3; follows 
conventions used by EPA 
Empirical Continuous 
Required in order to calculate 
half-life of substances emitted 
to air 
 









Based on empirical data 
collected by NAPS near 
each refinery  or surrogate 
values estimated using 
NAPS data 
Empirical Continuous; positive 
 
Is required for calculations 
where dose-response 
relationship is not linear – the 
background level of a 
substance may alter the 
probability that a given 
emission will/will not have an 
impact 
For Refinery i, zone j, stack height k 
Daylight hours l: 
 
Delivered Concentrationi,j,k,l = Degraded 
dispersed concentrationi,j,k,l + Background 
Concentrationi 
 
Also in the Health Effects Module, 
 
Discounted incidence = 
incidence(delivered concentration) – 
incidence (background concentration) 
Health Effects Module 
Toxicity/C-R data 
for air toxics (non-
threshold) 
Health Canada, USEPA, 
CalEPA, HEAST 
Default Continuous - linear 
 
Unit risk values – sometimes 
derived from Health Canada’s 
TC01 values 
For Refinery i, zone j, stack height k 
Daylight hours l, population subgroup m: 
 





for air toxics 
(threshold)  
Health Canada, USEPA, 
CalEPA, HEAST 
Default Continuous – nonlinear 
 
Dose-response is characterized 
using a log(dose):probit 
approach anchored on the 
ED05 
 
The special case of the 
log(dose):probit approach used 
is called the “Mantel Bryan 
approach”. However, a slope 
of 1.5 is used for the curve as 
opposed to the more 
conventional value of 1 for 
slope. 
For Refinery i, zone j, stack height k 
Daylight hours l, population subgroup m: 
 
Undiscounted case incidence =  
 
LOGNORMDIST(Delivered 
Concentrationi,j,k,l,                           
LN(ED05/1000) + (2.303*(1.6449/1.5)), 
(2.303/1.5))* Populationm) 
 
Discounted case incidence =  
 
Undiscounted case incidence - 
LOGNORMDIST(Background 







for CACs (Criteria 
Air Contaminants) 
American Cancer Society 
Study; Harvard Six Cities 
Study; HEI Reanalyses 
where appropriate 
Default Continuous - linear For Refinery i, zone j, stack height k 
Daylight hours l, population subgroup m: 
 
Predicted Case Incidencei,j,k,l,m = 
Delivered conc. (no background 
included),j,k,l*Epi risk 
coefficientm*Populationi,j,m 
BTEX toxicity data Weighted value calculated 
from individual toxicity 
values for Benzene, 
Toluene, Ethylbenzene 
and Xylene 
Derived Weighted by toxicity for sum 
of effects of individual 
components 
 


























































PAH toxicity data Used B[a]P as 
representative of PAH 
mixtures 
 
Potency estimates for the 
surrogate mixture have 
been developed by the 
MOE, the WHO, and in 
the Netherlands. 
Default value used was 2.3 
E-5 developed by the MOE 
(1997) 
The surrogate model, or whole 
mixture model (WMM) 
estimates the potency of a 
PAH fraction of a mixture as a 
whole, assuming that its 
potency is proportional to the 
B(a)P content of the mixture.  
An assumption inherent in this 
approach is that as the 
concentration of B(a)P 
increases, so does the 
concentration of all other 
PAHs. As a result, the potency 
value used represents the 
potency of the mixture as a 
whole, not just of B(a)P 
 
 
Potency of PAH fraction =  
 
[B[a]P](μg/m3)*Surrogate Mix  




Population data 2001 Statistics Canada 
Census data (To 
determine population 
profiles in the 20 quadrant 
zones around each 
refinery, census data at the 
DA (dissemination area) 
level was imported into 
ArcMap GIS software  
Empirical Continuous  
 
Number of children, adults, 
and seniors living in each of 
20 defined geographic zones 
surrounding each refinery 
See 3 cells above, also used to determine 
extent of discounting for disease 
endpoints that may not apply to all age 
groups. 
Age  Default separation into 
children, youth, seniors  
Categorical (based on 
continuous data) 
Population descriptor at zone level; may 
induce discounting for some endpoints 
Sex  Default separation into 
Male/Female 
Categorical Population descriptor at zone level; may 
induce discounting for some endpoints 
Fraction of 
population that is 
male/female 
Default Default value of 0.5 Default Determines extent of discounting for 
some disease endpoints that may not 
apply to all sex groups 
Age-sex discounting 
multiplier 
N/A – discounting was 
done for reproductive 
disease endpoints that 
could not physiologically 
apply to one gender or to 
pre-pubertal adolescents. 
Default Categorical “Weighting” – 
note subjectivity of decision to 
discount in certain cases 
 




0 if disease does not affect 
target group 
Applies a values of 0 to predicted 
incidence for age-gender subpopulations 
where it is impossible 
Health Impacts Module 




Divide health endpoints into 
three categories: (i) 
irreversible/life-shortening, 
(ii) may be reversible, could 






DALYs per person - an 
aggregrate indicator which 
assumes an average duration 
of disease and/or years of life 
lost within a population 











DALYs per person - an 
aggregrate indicator which 
assumes an average duration 
of disease and/or years of life 
lost within a population 






Appendix C: Variables List and Description 





Value(s) used in HEIDI II: 
Chevron Canada Limited - Burnaby Refinery 
Consumer's Co-operative Refineries Ltd./NewGrade Energy Inc. 
Husky Oil Operations Limited - Prince George Refinery 
Imperial Oil - Dartmouth Refinery 
Imperial Oil - Nanticoke Refinery 
Imperial Oil - Sarnia Refinery Plan 
Imperial Oil - Strathcona Refinery 
Irving Oil Ltd - Irving Oil Ltd. - Refining 
North Atlantic Refining - North Atlantic Refinery 
Nova Chemicals (Ltd.) - Nova Chemicals (Canada) Ltd. 
Parkland Refining Ltd. - Bowden Refinery 
Petro-Canada - Edmonton Refinery 
Petro-Canada - Mississauga Lubricant Center 
Petro-Canada - Raffinerie de Montreal 
Petro-Canada - Oakville Refinery 
Produits Shell Canada - Raffinerie de Montreal-est 
Shell Canada Products - Sarnia Manufacturing Centre 
Shell Canada Products - Shell Scotford Refinery 
Sunoco Inc. - Sarnia Refinery   
Ultramar Ltee - Raffinerie St. Romuald 
Hypothetical Worst Case Refinery  
Sensitivity Analysis: Comparison across refineries will indicate whether priorities for emissions reduction in the refining sector must be 
determined on a facility basis, or whether general recommendations can be made.   
Justifications/notes:  
“Hypothetical worst-case Refinery” uses the maximum observed emission from any real refinery for each substance 







Stack Height (input) 
 
Value(s) used in HEIDI II: 
 5 metres 
15 metres 
30 metres (default value) 
Sensitivity Analysis:  HEIDI II assumes that all emissions from a given refinery originate from one stack; however in reality refineries may 
have several stacks of varying heights, and some emissions may be fugitive (i.e., at locations close to the ground). The default value used in 
HEIDI II was 30 metres. Sensitivity analysis with 5, 15, 30 metre stack heights will provide information on the validity of the assumption of one 
stack height to represent all emissions.  
Justifications/notes:  
Stack is assumed to be located in the centre of the refinery property. Stack heights of 30 metres are probably most representative of a realistic 
situation; however 5 m was included to enable assessments for fugitive emissions. 
 
Unclear from HEIDI II documentation whether the stack height is a physical stack height or an “effective” stack height. 






Photodegradation time (input) 
 
Value(s) used in HEIDI II: 
 
0-24 hours (default value = 12 hours) 
 
Sensitivity Analysis:  Sensitivity analysis with values in range from 0-24 hours will provide some indication of whether the amount of sunlight 
– and therefore photodegradation could affect the relative importance of various emissions for health impact 
Justifications/notes:  
The photodegradation time variable is intended to account for the average amount of sunlight per day at the refinery location. The difference in 
amount of photodegradation that occurs at varying distances away from the refinery is not accounted for. Scenarios of either 0 or 24 hours are 
unlikely to ever occur in the Canadian locations specified by the refineries being observed. Values from 8-12 hours of daylight are probably most 
representative of reality for the locations under consideration.  
Possible Correlations:  
In the current setup, there are likely no correlations; however, if the model were revised to include a measure of ambient temperature (which 
would affect dispersion, formation of secondary PM, and reaction rates), this might correlate with photodegradation time. (All would be a 









Value(s) used in deterministic HEIDI II: 
 




Average and stdev was calculated based on were annual emissions 
for 2001-2003 extracted from NPRI26. (See Appendix D)  
 
Although probability distributions were used for sensitivity analyses, 
point estimates (using average emissions) were used to generate 
model prediction  
Potential sources of Uncertainty/Variability:  
Emissions are averaged annually; NPRI values do not provide information about variability in emission rates over time throughout the year. 
Emissions may change over time if the amount or type of refining changes. Three years of data may be insufficient to accurately characterize the 
variability in annual emissions. The data is also uncertain: it is unclear to what extent emissions below reporting guidelines are actually reported. 
Emissions are calculated based on a Canadian Association of Petroleum Producers (CAPP)-sanctioned formula that has been show to be 
inaccurate and imprecise for other upstream oil and gas applications (Chambers 2004). 
Level of Uncertainty:  Risk 
Level of  Evidence:  Strong 
Sensitivity Analysis: Sensitivity analysis can be performed using to assess the relative importance of emissions as a primary model input, and 
also to investigate the impact of variability in annual emissions on predicted incidence related to each substance. 
Justifications/notes:  
Emissions must be ≥0 
Emissions below the regulatory guideline probably exist. Therefore the distribution of actual rather than reported emissions may not be left-
centred. Emissions below reporting guidelines may not be accounted for in HEIDI II. However, since many emissions are reported at levels 
below the guidelines, it is unlikely that this type of non-reporting occurs frequently. For similar reasons it does not make sense to truncate a 
distribution at the reporting guideline – this would exclude most of the data.  
During the Monte Carlo simulation, average values for emissions across several reporting years were used, but the emissions variable was not 
described using a probability distribution. To check for trends in emissions, substance-specific emissions were plotted over time for each 
refinery. Only at the Shell Scotford refinery did there appear to be any overall trend (decrease in emissions of all reported substances). Reporting 
                                                 
26 Provisional 2004 emissions values were also available from the NPRI but as they were not confirmed by Environment Canada at the time of 




for sulphuric acid emissions may be unreliable: although sulphuric acid emissions are generally high (>100 tonnes/year), they are occasionally 
not reported or reported as zero, especially for the year 2001. Sulphuric acid is included in the NPRI substance lists for each 2001-2003 year, so 
the source of this discrepancy is unclear. 
Possible Correlations:  
Emissions of groups of substances are likely to be correlated with each other (i.e., increase and decrease in concert) – this may depend on the 
composition of the crude oil, including the specific impurities. Total emissions may be correlated to refinery, where some refineries emit higher 
amounts of all substances and others emit lower amounts. This will be mostly a function of the amount of refining that occurs at each facility and 





adjustment factors for air 
toxics.  
 
These are applied to 
annual average emissions 
values (of air toxics) to 
predict the concentration 
of any substances in each 
of 20 zones around the 
refinery based on 
meteorology 
 
Value(s) used in deterministic HEIDI II: 
 
Stack Height = 30 metres 
  Direction (degrees)     
Distance (km) 45 (NE) 135 (SE) 225 (SW) 315 (NW) 
1 0.33381 0.26981 0.10207 0.14900 
2.5 0.10423 0.08344 0.03717 0.05575 
5 0.04831 0.04508 0.02030 0.03128 
10 0.02905 0.03307 0.01491 0.02331 
25 0.01256 0.01622 0.00786 0.01286 
Stack Height = 15 metres 
Distance (km) 45 (NE) 135 (SE) 225 (SW) 315 (NW) 
1 0.78760  0.76521 0.33394 0.48564 
2.5 0.44230 0.54686 0.26287 0.39039 
5 0.22338 0.29487 0.14990 0.22803 
10 0.08624 0.11713 0.06077 0.09526 
25 0.01938 0.02682 0.01405 0.02290 
Stack Height = 5 metres 
Distance (km) 45 (NE) 135 (SE) 225 (SW) 315 (NW) 
1 3.51727 4.57842 2.37253 3.4416 
2.5 0.78282 1.03784 0.5347 0.79119 
5 0.24009 0.3209 0.16462 0.24931 
10 0.07077 0.09482 0.04849 0.07548 
25 0.01282 0.01696 0.00867 0.01398  
Parametric description: 
 





Potential sources of Uncertainty/Variability:  
Physical air distribution patterns are not site-specific: a generic meteorological profile representing the southern Ontario region is used as the 
default scenario. The modeling also assumes that the refinery is located in flat terrain. Steady state emissions are assumed over 365 days. 
Level of Uncertainty: Scientific uncertainty 
Level of  Evidence:  Medium 
Sensitivity Analysis:  None 
Justifications/notes:  
Determined by John Hicks using ISCLT3 technology. Creating distributions to represent these dispersion adjustment factors would be a complex 
process which would have to be carried out by someone familiar with the original derivation of the factors. Knowledge about these distributions 
may not add value to the probabilistic version of HEIDI in the policy context since the meteorology used for the model is not location specific, 
and cannot be controlled by policy in any case. Any parametric representations developed for these factors would be representative of the 
technological limitations of the dispersion estimation method. 
Possible Correlations:  







Value(s) used in deterministic HEIDI II: 
Values are calculated based on tonnes of NO2, SOx, 
and primary PM released from each refinery. These 
values are for a base-case of a 30-metre stack. For 
other stack heights, the “PM stack change factors” 
must be applied (see below) 
 
Parametric description: 
Average and stdev was calculated based on were annual emissions 
for 2001-2003 extracted from NPRI1. (See Appendix E)  
 
Although probability distributions were used for sensitivity 
analyses, point estimates (using average emissions) were used to 
generate model prediction.  
Potential sources of Uncertainty/Variability:  
HEIDI II does not perform nonlinear simulation modeling of photooxidant formation and secondary PM formation. Photooxidants and secondary 
PM are estimated using algebraic transfer functions and extrapolations based on conversion factors available in the research and technical 
literature -- primarily from controlled chamber studies. 
Predicted secondary PM concentration values are based on reported emissions of NO2, SO2, and primary PM to the NPRI. These values represent 
annual averages, and uncertainties inherent in using this type of data (see comments regarding air toxics data) are relevant for calculated 
concentrations of secondary PM. Three years of data may be insufficient to accurately characterize the uncertainty in annual emissions 
Level of Uncertainty: Scientific uncertainty 
Level of  Evidence:  Medium 




also to investigate the impact of variability in annual emissions on predicted incidence related to each substance. 
Justifications/notes:  
Because PM is not considered to photodegrade, the model variables k and OH are irrelevant to predicted incidence.  
Possible Correlations:  
Correlated to primary PM concentrations; may be related to amount of other emitted substances (i.e., total emissions at a refinery may change in 




PM Stack Change Factor 
 
This is used to predict the 
concentration of PM reaching each of 
20 zones around the refinery for 
different stack heights. 
 
Value(s) used in deterministic HEIDI II: 
 
 Stack change factor (30 m to 30 m) 
  Degrees from North 
Distance (km) 45.00 135.00 225.00 315.00 
0.5 1 1 1 1 
1 1 1 1 1 
2.5 1 1 1 1 
5 1 1 1 1 
10 1 1 1 1 
25 1 1 1 1 
 Distance (km) Stack change factor (30 m to 15 m) 
0.5 2.37 2.01 2.46 2.26 
1 2.36 2.83 3.27 3.26 
2.5 4.25 6.59 7.11 8.38 
5 4.65 6.56 7.50 7.35 
10 2.97 3.55 4.00 4.13 
25 1.46 1.69 2.00 1.77 
 Distance (km) Stack change factor (30 m to 5 m) 
0.5 14.68 18.64 30.59 27.59 
1 10.51 16.96 23.24 23.09 
2.5 7.53 12.51 14.46 13.64 
5 5.00 7.13 8.25 8.03 
10 2.45 2.88 3.20 3.26 








Potential sources of Uncertainty/Variability:  
Physical air distribution patterns are not site-specific: a generic meteorological profile representing the southern Ontario region is used as the 
default scenario. The modeling also assumes that the refinery is located in flat terrain. Steady state emissions are assumed over 365 days. 
Level of Uncertainty: Scientific uncertainty 
Level of  Evidence: Medium 
Sensitivity Analysis:  None 
Justifications/notes:  
Determined by John Hicks using ISCLT3 technology. Creating distributions to represent these dispersion adjustment factors would be a complex 
process which would have to be carried out by someone familiar with the original derivation of the factors. Knowledge about these distributions 
may not add value to the probabilistic version of HEIDI in the policy context since the meteorology used for the model is not location specific, 
and cannot be controlled by policy in any case. Any parametric representations developed for these factors would be representative of the 
technological limitations of the dispersion estimation method. 
Possible Correlations:  


















Value(s) used in deterministic HEIDI II: 
 
Substance  (cm3/molecule-sec) 
1,3-Butadiene 6.66E-11 
Benzene 1.23E-12 
Ethylene  8.52E-12 
Nickel  0.00E+00 





Benzene (as BTEX potentiator) 1.23E-12 
Cyclohexane 7.49E-12 
Dicyclopentadiene 1.19E-10 
Diethanolamine  9.27E-11 
Parametric description: 
 
Distributions were derived using values extracted from the NIST (National 
Institute of Standards and Technology) database (National Institute of 
Standards and Technology 2005). NIST values for 298 K are used. (See 
Appendix F) 
 
For xylene, which has three isomers, a conservative approach was used and 
the lowest value of k from among the three isomers was chosen. 
 












Hydrogen Sulphide 0.00E+00 
Isoprene 1.11E-10 
Mercury  0.00E+00 
Methanol 9.44E-13 
Methyl Ethyl Ketone (MEK) 1.15E-12 
Methyl Isobutyl Ketone (MIBK) 1.41E-11 










Zinc 0.00E+00  
 
 


















Potential sources of Uncertainty/Variability:  
Degradation is assumed to be a first-order process. Rate constants included in the NIST are based on experimental or estimation methods; the level 
of knowledge may depend on the individual substance. k is temperature-dependent in most if not all cases; k values used here are for 298 K, which 
is inappropriate for much of Canada most of the time. The rate constant for BaP was used to represent the PAH mixture since PAH toxicity was 
described in terms of “BaP-equivalents”. It is unclear how appropriate this is. 
Level of Uncertainty:  Risk 
Level of  Evidence:   Medium 
Sensitivity Analysis:  Performed to explore the implication of parametric uncertainty in k values. Atkinson’s values with associated error may 
be used to confirm the validity of values chosen for the sensitivity analysis.  
Justifications/notes:  
Depends on individual substance; must be ≥0. 
Many values for kOH are measured experimentally and are subject to experimental error and the limits of detection. Atkinson has developed values 
of k with associated uncertainty measures; these have been published in several places including the Journal of Physical and Chemical Reference 
Data (Atkinson, et al., 1999) for IUPAC (International Union of Pure and Applied Chemistry) and a book of which he is a co-author (Calvert, et 




which is dependent upon factors such as the number of independent investigations carried out and the number of different techniques used. On the 
whole, our assessment of uncertainty limits tends toward the cautious side.” (Atkinson, et al., 1999). kOH values are also available from other 
sources including NASA (Sander, et al., 2003), the NIST (National Institute of Standards and Technology, 2005) (National Institute of Standards 
and Technology (formerly National Bureau of Standards)), and the SRC database (Syracuse Research Corporation, 2005), which is where the 
original HEIDI II data was obtained. 
 
For the substances that do not appear in the Atkinson’s data or in the NIST (Benzo[a]pyrene, dicyclopentadiene, diethanolamine, sulphuric acid), 
the value from the SRC research database will be used in place of the arithmetic mean, and estimates for the other parameters will be derived using 
LOGNORM4 software (Strom 2001), based on the coefficients of variation from those substances for which adequate data is available. (The 
greyed-out parameters are those that were estimated using LOGNORM4). 
 
Substance Arithmetic mean variance stdev Cov GEO mean sigma GSD 
1,3-Butadiene 6.73E-11 9.25E-23 9.62E-12 1.43E-01 6.68E-11 1.42E-01 1.15E+00 
Benzene 1.17E-12 6.91E-26 2.63E-13 2.25E-01 1.14E-12 2.22E-01 1.25E+00 
Ethylene 6.96E-12 4.94E-24 2.22E-12 3.19E-01 6.52E-12 3.12E-01 1.37E+00 
Nickel  NO RXN NO RXN NO RXN NO RXN NO RXN NO RXN NO RXN 
PAHs (BaP surrogate class) 5.00E-11 1.28E-22 1.13E-11 2.26E-01 4.88E-11 2.23E-01 1.25E+00 
Formaldehyde 8.92E-12 2.82E-23 5.31E-12 5.96E-01 5.31E-12 5.51E-01 1.74E+00 
Acetaldehyde 1.50E-11 3.13E-24 1.77E-12 1.18E-01 1.49E-11 1.18E-01 1.12E+00 
1,2,4-Trimethylbenzene 3.45E-11 9.66E-24 3.11E-12 9.01E-02 3.44E-11 8.99E-02 1.09E+00 
Ammonia 1.51E-13 7.58E-27 8.70E-14 5.78E-01 1.27E-13 5.37E-01 1.71E+00 
Cyclohexane 7.05E-12 6.29E-25 7.93E-13 1.13E-01 7.00E-12 1.12E-01 1.12E+00 
Dicyclopentadiene 1.19E-10 7.23E-22 2.69E-11 2.26E-01 1.16E-10 2.23E-01 1.25E+00 
Diethanolamine  9.27E-11 4.29E-22 2.10E-11 2.26E-01 9.04E-11 2.23E-01 1.25E+00 
Ethylbenzene 7.28E-12 3.92E-25 6.26E-13 8.61E-02 7.25E-12 8.59E-02 1.09E+00 
Hydrogen Sulphide 4.64E-12 7.75E-25 8.81E-13 1.90E-01 4.56E-12 1.88E-01 1.21E+00 
Isoprene 8.77E-11 2.23E-22 1.49E-11 1.70E-01 8.66E-11 1.69E-01 1.18E+00 
Mercury No RXN No RXN No RXN No RXN No RXN No RXN No RXN 
Methanol 8.82E-13 8.79E-26 2.96E-13 3.36E-01 7.82E-13 3.27E-01 1.39E+00 
Methyl Ethyl Ketone (MEK) 1.90E-12 1.15E-24 1.07E-12 5.64E-01 1.64E-12 5.26E-01 1.69E+00 
Methyl Isobutyl Ketone (MIBK) 1.38E-11 7.43E-25 8.62E-13 6.23E-02 1.38E-11 6.22E-02 1.06E+00 




Naphthalene 2.34E-11 4.48E-24 2.12E-12 9.05E-02 2.33E-11 9.03E-02 1.09E+00 
n-Hexane 5.50E-12 6.29E-25 7.93E-13 1.44E-01 5.43E-12 1.44E-01 1.15E+00 
Phenol 2.96E-11 7.05E-24 2.66E-12 8.96E-02 2.96E-11 8.94E-02 1.09E+00 
Propylene 2.20E-11 6.21E-23 7.88E-12 3.58E-01 2.00E-11 3.48E-01 1.42E+00 
Styrene 6.27E-11 6.17E-22 2.48E-11 3.96E-01 5.96E-11 3.82E-01 1.46E+00 
Sulphuric Acid 2.80E-13 4.01E-27 6.33E-14 2.26E-01 2.73E-13 2.23E-01 1.25E+00 
Toluene 6.00E-12 5.57E-25 7.47E-13 1.24E-01 5.96E-12 1.24E-01 1.13E+00 
Vanadium No RXN No RXN No RXN No RXN No RXN No RXN No RXN 
Xylene - use ortho-isomer as a conservative assumption since 
it has the slowest degradation 1.31E-11 9.95E-25 9.98E-13 7.65E-02 1.30E-11 7.63E-02 1.08E+00 
Zinc No RXN No RXN No RXN No RXN No RXN No RXN No RXN 
Average                CoV  = 0.226; stdev of CoV = 0.17        
 
The distributions for kOH are likely lognormal: NASA suggests that the probability distribution of k values may not follow the normal Gaussian 
form (Sander, et al., 2003), and lognormal distributions have previously been assumed for gas-phase rate constants (Zador, Wagner et al. 2005). 
 
****Note that the reaction products are not accounted for in HEIDI at all – for example, reactions of aromatics with OH often produce ozone – a 
major contributor to formation of smog. The health effects that could result from exposure to these breakdown products are not accounted for in 
HEIDI II.  




















































Potential sources of Uncertainty/Variability:  
[OH] is highly variable locally over space and time and depends on level of biogenic emissions and levels of pollutants (Wang and Prinn, 1998) 
as well as solar intensity and prevailing concentration of ozone. Several estimations of the global levels of OH have been made, although even 
these are complicated by year-to-year variations of OH concentrations resulting from a complicated combination of meteorological variability 
and chemical concentration due to variable emissions and stratospheric O3 (Koumoutsaris and Bey, 2004). The most commonly used value of 
1.5*106 molecules/cm3 (which was the value used in HEIDI II) is adjusted to an average 12-hour period and therefore most applicable to spring 
and Fall. 
Level of Uncertainty: Risk 
Level of  Evidence:  Medium 
Sensitivity Analysis:  Values for sensitivity analysis (to assess impact of variability) include: 
5 *105 (night; below detection limit) to max of 2-10*106 (Hofzumahaus, Aschmutat et al. 1998) 
1.15 *106 in Toronto (Bunce, Liu et al. 1997) 
Global OH = 10.48*105 (Koumoutsaris) and 9.7 ± 0.6*105 (Prinn) 
Justifications/notes:  
Hofzmanhaus (Hofzumahaus, Aschmutat et al. 1998)suggests that OH radical concentrations can range from 5*105 at night (below detection 
limit) to a maximum of (2-10) *106 at noon during the summer (at peak photolysis). In Toronto specifically, peak values in 1988 (measured at 
midday in July) ranged from 1* 106 to 1.5*107 molecule/cm3 (Bunce, Liu et al. 1997). Some 1995 estimates of global [OH] include 10.4*105 




uncertainty in the rate constants used to deduce the value). In 2001, Prinn et al provided normal distributions for OH concentrations globally 
(9.43 ± 1.30 * 105 molecules/cm3), and for northern and southern hemispheres: 8.98 ± 2.02 * 105 molecules/cm3 and 9.93 ± 2.02* 105 
molecules/cm3, respectively (Prinn, Huang et al. 2001). 
Prinn’s (2001) value is for the northern hemisphere; it is slightly lower than values measured in Toronto in 1988. In general, [OH] is highly 
variable over space and time and depends on levels of biogenic emissions and levels of pollutants. 
Possible Correlations:  
It is difficult to know whether the level of background pollution would affect and therefore be correlated to atmospheric OH concentration. While 
the presence of CO and hydrocarbons tends to deplete the amount of OH in the atmosphere, presence of NOx can boost OH formation. All three 







(In HEIDI II, the term 
“background” implies 




Value(s) used in deterministic 
HEIDI II: 
 
Most background data was collected 
by NAPS (National Ambient 
Pollution Survey) monitors at the 
nearest Environment Canada 
location.Data on VOCs was provided 
by Tom Dann, otherwise, NAPS data 
was extracted from NAPS 2002 
Annual Report (Environment Canada 
2003)or from the document "Ambient 
Air Measurements of Polycyclic 
Aromatic Hydrocarbons (PAH), 
Polychlorinated Dibenzo-p-Dioxins 
(TCDD) and Polychlorinated 
Dibenzofurans in Canada (1987-
1997) (Dann 1998), or from data sent 
by Kristina Curran of Environment 
Canada (Curran 2004). 
 
For rural locations without 
monitoring data,  
Parametric description: 
 
Sensitivity analysis (described below) determined that division into 
high/medium/low is appropriate. Mean and standard deviations were 
derived from the values used across refineries in locations deemed “high”, 
“Medium”, and “low” background.  
Lognormal distributions truncated at zero; geometric means and standard 
deviations will be used to describe the distributions 
(See Appendix H) 
 





50% of lowest monitored value for 
each chemical was used. In special 
cases such as for MTBE, values were 
based on specific measurements or 
set to zero   
  
(See Appendix G for details) 



















Potential sources of Uncertainty/Variability:  
Limited data – some site specific concentrations are based on 1 month’s worth of measurement data. Technical limitations of the equipment used 
to measure concentrations. Assumptions were made where data was lacking (i.e., the ideal location for a monitor is nearby and upwind. This was 
not always available, so the closest geographic monitor was selected.) Assumptions made where no data existed, i.e. for rural locations with no 
monitoring data, 50% of the lowest observed value at a monitor was used. 
Level of Uncertainty:  Risk 
Level of  Evidence:  Weak 
Sensitivity Analysis:   
HEIDI II used site-specific measures of background concentrations for each chemical; however, due to the nature of the data this may be an 
overparameterization, or the data used may be inappropriate. Background data for many of the urban sites was based on nearby monitors; 
however these may not have been upwind of the refineries. For example, many of the values used for “background” in Sarnia were from monitors 
in Windsor, and background levels used for the Scotford refinery were often actually measured in Edmonton. The most rural sites did not have 
site-specific monitoring data. As well, although data was generally provided on a monthly basis, the amount of available data was variable, and 
annual averages were occasionally calculated using as few as one month of the year, which is not truly representative of an annual average.
   
With these limitations in mind, it was felt more appropriate to create a limited number of background scenarios, with refineries assigned to the 
most relevant scenario. Selected scenarios are:  
Geometric mean = 0.21 




Low – background levels are calculated based on half of the lowest observed concentration at any of the monitors originally considered in the 
HEIDI II model. (In most cases refineries designated as “low” do not have any nearby monitoring data.)  
Medium - for refineries located in smaller communities where industrial penetration is minimal, and would be calculated based on the average 
background levels observed across the designated communities.   
High: for refineries located in the largest cities or in smaller cities with a strong industrial presence and would be calculated based on the average 
background levels observed across the designated communities   
The population scenarios used were also considered when developing the background scenarios. For example, a large population combined with 
a rural background scenario would be inappropriate. 
 
Classification of the Refineries:  
Use weighted sum of background levels across substances to rank refineries; use population as secondary basis for classification divisions. This method also 
tends to group refineries geographically, so that refineries in the same location (urban centre) will be represented as having the same background levels 
Rank based on Background Rank based on site-specific background levels (identical rank = same background levels) Population Rank based on Population Classification 
Chevron -Burnaby 1 1694061 3 High 
Petro-Canada - Oakville 2 1095580 5 High 
Petro-Canada - Montreal 3 2560328 2 High 
Shell - Montreal East 3 2612269 1 High 
Imperial - Strathcona 5 929299 7 High 
Petro-Canada - Edmonton 5 929431 6 High 
Shell - Scotford 7 31231 18 High 
Petro-Canada - Mississauga 8 1572665 4 Medium 
Ultramar - St. Romuald 9 631211 8 Medium 
Imperial - Sarnia 10 98730 13 Medium 
NOVA - Corunna 10 102094 12 Medium 
Shell - Sarnia 10 96725 15 Medium 
Sunoco - Sarnia 10 96977 14 Medium 
Imperial - Dartmouth 14 317113 9 Medium 
Consumers' Co-operative - Regina 15 193214 10 Low 
Irving - Saint John 16 109203 11 Low 
Imperial - Nanticoke 17 47143 17 Low 
North Atlantic Refining - Come by Chance 18 4710 20 Low 
Parkland - Bowden 18 25933 19 Low 





Values must be ≥ 0. 
Bortnick and Stetzer (2002) detail the types of uncertainty inherent in ambient air toxics monitoring data, suggesting that a coefficient of 
variation of 10-15% is reasonable given monitoring capacities. The uncertainty in the estimates included in HEIDI II is much higher, reflecting 
the limited data on which the estimates were made.  Distribution for background  is likely lognormal (Limpert, Stahel et al. 2001). 
Possible Correlations:  










Value(s) used in deterministic 
HEIDI II: 
 
Substance Unit Risk Value 
1,3-Butadiene 5.88E-06 
Benzene 3.50E-06 
Ethylene Oxide (as 
ethylene metabolite) 2.27E-05 













Sigma GSD SD 
1,3-Butadiene 5.88E-06 2.40 11 1.04E-04 
Benzene 3.50E-06 2.40 11 6.19E-05 
Ethylene (as oxide) 2.27E-05 2.40 11 4.01E-04 
Nickel (and its 
compounds) 1.25E-03 
2.40 11 2.21E-02 
PAH (as 
benzo(a)pyrene) 2.30E-02 
2.40 11 4.07E-01 
Formaldehyde 5.30E-06 2.40 11 9.38E-05 
Acetaldehyde 5.80E-07 2.40 11 1.03E-05 
 












0.00E+00 2.00E-06 4.00E-06 6.00E-06 8.00E-06 1.00E-05






Potential sources of Uncertainty/Variability:  
Using the unit risk value as a central value for toxicity when cancer potency actually represents the 95% upper confidence limit of the cancer 
potency value; extrapolating from animal data to human data, extrapolating from high to low dose, assumption that the dose-response shape is 
linear at low doses, and variability within a population - interindividual susceptibility to cancer is generally acknowledged based on genetic and 
environmental factors (such as concurrent exposures to other carcinogens). Assumption that the evidence for carcinogenicity is clear and that it is 
equally compelling for all substances included in HEIDI.  
Level of Uncertainty: Risk 
Level of  Evidence:  Medium 
Sensitivity Analysis:  Required for individual chemicals: those for which values are controversial or difficult to identify. These include 
 
PAH: values from WHO = 80–100×10-3 (μg/m3)-1; RIVM = 100×10-3 (μg/m3)-1; MOE = 23 ×10-3 (μg/m3)-1 
Vanadium: values from WHO = 20 μg/m3 , values from IIEQ = 100 μg/m3 , 1-20 μg/m3 
Nickel: values from Health Canada = 1.25 ×10-3 (μg/m3)-1, EPA(nickel subsulfide) =4.8E-4 (μg/m3)-1 , EPA (refinery dust) = 2.4E-3 (μg/m3)-1 
Justifications/notes:  
The toxicity values used to characterize the dose-response relationship for nonthreshold air toxics were unit risk values (although 
occasionally, these were derived from TC05 values). 





based on a previously derived uncertainty distribution for cancer potency factors and interindividual parameters which affect 
susceptibility. All inputs were specified as being lognormal. Outputs were tabulated as percentiles for various levels of susceptibility. 
Hattis’ predicted distributions were anchored on a hypothetical 1/106 cancer risk, the shape and spread of the distribution should 
equally apply to the levels of risk observed in HEIDI II. The Hattis distributions, however, would have to be adapted such that the 
mean centered on the unit risk values for the individual chemicals included in HEIDI II. This method only applies to genetically-
acting metabolically activated carcinogens; also the experiments on which it is based were not limited to inhalation – so some aspects 
of metabolism which were modeled are not relevant. 
 
 





If we assume that the unit risk value applies to the median sensitivity individual and is situated at the median of the range of 
uncertainty, then a comparison between Hattis’ “median individual” value and the 95% confidence level for a 95th percentile of 
sensitivity in individuals will provide a basis to calculate the level of spread in the distribution (assuming lognormality).  
The freeware program “LOGNORM4” (Strom and Stansbury 2000) allows calculation of any parameters of a lognormal distribution 
given any two. Thus, based on the median and the 95th percentile value, the coefficient of variance can be determined. This, in turn, 
can be applied to the unit risks in HEIDI II (which can be considered chemical-specific median values) and used to calculate the 
characteristics of the chemical-specific distributions. 
 
I.e., given:        median = 2.6*10-7,  and   95th percentile = 1.2e-5 
 
LOGNORM calculates: 
GSD sigma SD CV variance skewness kurtosis 
10.27434 2.32965 5.90E-05 15.0508 3.48E-09 3454.562 2.70E+09
 
This value of GSD is close to a GSD of ~11 that was calculated by both Crouch (Crouch 1996) and Gaylor, and later and used by 
Brand (Brand, Gray et al. 1997) to account for interspecies scaling including variability across chemicals and experiments. Therefore, 
HEIDI II will adopt a constant GSD of 11 to apply to cancer potency/unit risk values in the model. 
 
 Applying this coefficient of variance to the chemical-specific unit risk values gives, using LOGNORM4: 
 
Substance Inhalation unit risk 
 (assume equivalent to arithmetic 
mean) 




1,3-Butadiene 5.88E-06 2.40 11 3.32E-07 1.04E-04 
Benzene 3.50E-06 2.40 11 1.97E-07 6.19E-05 
Ethylene (as oxide) 2.27E-05 2.40 11 1.28E-06 4.01E-04 
Nickel (and its compounds) 1.25E-03 2.40 11 7.05E-05 2.21E-02 
PAH (as benzo(a)pyrene) 2.30E-02 2.40 11 1.30E-03 4.07E-01 
Formaldehyde 5.30E-06 2.40 11 2.99E-07 9.38E-05 
Acetaldehyde 5.80E-07 2.40 11 3.27E-08 1.03E-05  




















Value(s) used in deterministic HEIDI II: 
 













Mixture value calculated; value 
depends on relative concentrations 
at specific site 
BTEX Mixture value calculated; value 
depends on relative concentrations 
at specific site 




2000 LOAEL ug/m3 
Diethanolamine 
(and its salts) 
2700 LOAEL adj 
(ug/m3) 
Ethylbenzene Mixture value calculated; value 
depends on relative concentrations 
at specific site 
Hydrogen 
sulphide 
640 NOAEL (HEC) 
ug/m3) 
Isoprene 3748793 LOAEL 
Mercury 9 LOAEL (HEC) 
ug/m3 
Methanol 1910000 LOAEL (adj) 
Parametric description: 
 
ED05 values (or values used in place of ED05s where data was not 
available, as discussed below) were assigned a lognormal 
distribution and  GSD of 7.5 if the value was based on animal data 



























1517000 LEC (HEC) ug/m3 
Methyl isobutyl 
ketone 




368,000 NOAEL (adj) 
ug/m3 
Naphthalene 9300 LOAEL (HEC) 
ug/m3 
n-Hexane 73000 LOAEL (HEC) 
ug/m3 





Propylene 326000 LOAEL (adj) 
(ug/m3) 
Styrene 46000 LOEL (adj) ug/m3 
Sulphuric acid 380 LOAEL (ug/m3) 
Toluene Mixture value calculated; value 
depends on relative concentrations 
at specific site 
Vanadium 
(except when in 
an alloy) and its 
compounds 
20 LOAEL ug/m3 
Xylene (all 
isomers) 
Mixture value calculated; value 
depends on relative concentrations 
at specific site 
Zinc (and its 
compounds) 
350 RELx10 (ug/m3) 
 
Potential sources of Uncertainty/Variability:  
Extrapolating from animal data to human data, assumption that the dose-response shape invoked by the Mantel-Bryan formulation is appropriate 
at low doses for all chemicals, and variability within a population. In HEIDI II specifically, NOAELs and LOAELs are treated as being 
equivalent to ED05s. Assumption that the evidence for adverse health effects is clear and that it is equally compelling for all substances included 
in HEIDI. Variability within a population likely exists -  interindividual susceptibility is probable and would result from genetic factors and/or 




Level of Uncertainty:  Risk 
Level of  Evidence:   Medium 
Sensitivity Analysis:  Vanadium: 20 μg/m3 provisional LOAEL from WHO; limits of distribution could be 1 μg/m3 (WHO value to which a 
10-fold UF was applied); up to 50μg/m3 which is the ACGIH limit value Note special case of BTEX; other substances for which sensitivity 
analysis might be necessary, i.e., V, Zn etc. 
Justifications/notes:  
Where the data is available, HEIDI II uses TC05 values to predict case incidence for endpoints associated with each chemical. In practice, 
however, the best available toxicity data for many substances is in the form of a NOAEL or benchmark dose. (As Hattis (Hattis and Anderson 
1999) suggests, NOAELS are not incompatible with the concept of ED05 or TC05). 
 The preliminary testing of HEIDI II suggested that it will be important to characterize uncertainty and variability that exists in the 
toxicity data used. The uncertainties associated with the use of values such as NOAELs are widely recognized, and include experimental 
limitations arising from the selected spacing of doses and detection limits of instrumentation as well as issues such as interspecies extrapolation, 
intraspecies extrapolation, extrapolation from subchronic to chronic studies, and relevance for sensitive subpopulations (See, for example 
(Kalberlah, Schneider et al. 2003)). Typically, uncertainty/adjustment factors are applied to NOAELs to account for some of this lack of 
knowledge.  
 In general, it appears that lognormal distributions for the values will be a generally accepted format for the family of distributions (Hattis, 
Banati et al. 1999):  
“Such a distribution would be expected if there are many factors, each contributing modestly to the individual variability in threshold doses, and 
if each factor tends to act multiplicatively to affect individual thresholds. This assumption of log-normality of population distributions of 
thresholds is by no means new—it is the basis for traditional probit analysis of toxicological data that predates Lehman and Fitzhugh”  
(Hattis and Anderson 1999). 
The “non-threshold-acting” substances in HEIDI II were assessed individually to determine which uncertainty factors were relevant to each one. 
If the EPA applied a particular type of uncertainty factor when developing and RfC, this was taken as an indicator that the associated type of 
uncertainty was relevant in determining a range of possible values for the threshold. However, it is noted that the central NOAEL/LOAEL/TC05 
values used in HEIDI have already been adjusted to account for the animal to human extrapolation, and for subchronic to chronic extrapolations 
(but the uncertainty inherent in these extrapolations was not described). 
          Attempts were made to characterize the uncertainty in the adjustment factors by calculating ratios of values found in different experiments; 
i.e., collating values of NOAELs calculated for rats and mice and using the ratios between the results to describe the interspecies adjustment 
factor, or similar approaches to compare chronic and subchronic results, with the mean representing the “true” difference in NOAELs between 
the species and the spread of the values intended to represent heterogeneity in response across chemicals. While intuitively, this approach makes 
sense, there is evidence that use of the ratios can invoke systematic errors (Brand, Rhomberg et al. 1999). Other efforts have developed 






Type of Uncertainty Estimated GSD Method Reference 






Database-derived (ratios comparison) (Baird, Cohen et al. 1996) 






Theoretical distributions developed to be consistent with 
default factor of 10 (Price, Keenan et al. 1997) 






Theoretical distributions developed to be consistent with 
default factor of 10 (Slob and Pieters 1998) 






Theoretical distributions developed to be consistent with 
default factor of 10 (Swartout, Price et al. 1988)
interindividual 2.95 Estimated aggregate GSD for inhaled chronic systemic toxicant based on variability in pharmacokinetic parameters (Hattis, Banati et al. 1999) 






Database-derived (ratios comparison) (Vermeire, Stevenson et al. 1999) 
LOAEL ->NOAEL 







Compilation of previous ratios comparisons by various authors (Kodell and Gaylor 1999) 
LOAEL ->NOAEL 











3 historical data 
(Evans, Rhomberg et al. 
2001) 
Combined 7.5 Regulatory agency (RIVM) review of evidence (Vermeire, Pieters et al. 2001a) 
 




values used to derive the distributions suggests that the distributions may not be representative of reality. However, in the context of HEIDI II 
and the uncertainties present throughout the model, using a GSD of 7.5 chosen by a regulatory agency after reviewing the available data seems 
reasonable. This value encompasses both uncertainty and variability in the available data. However - not all of the toxicological values in HEIDI 
II are subject to the same uncertainties. While the data is not mature enough to differentiate between all types of uncertainty and assign a GSD to 
each, studies that are based on epidemiologic evidence are likely to be less uncertain. Hattis’ value of GSD~3 will be used in those cases. 
 
(Note:”y” (=yes) indicates that uncertainty factor applies) 



















y y y y 
No UFs have 
been applied; 









   y y (database deficiencies) 3 1259 3521 1.10 
Benzene 14700 TC05 (ug/m3) y  y y 
y (database 
deficiencies) 
7.5 1931 1.1*105 2.01 








 y  y y (database deficiencies) 
7.5 




ug/m3 y y y y 
Assume since 
known to be 
10 000 in total 
7.5 
263 15095 2.01 
Diethanolam






y y y y  
7.5 






 y  y y (database deficiencies) 
7.5 
57004 3.3*106 2.01 






Isoprene 3748793 LOAEL  y y y  





  y  y (database deficiencies) 
7.5 





 y  y  
7.5 










 y  y y 
7.5 










 y  y y 
7.5 








y y y y  
7.5 





 y y y y 
7.5 





  y y y 
7.5 
9588 5.5*105 2.01 
Phenol 19245 NOAEL (ug/m3) y y  y  





 y y y  
7.5 





 y y y  
7.5 
6042 3.5*105 2.01 









   y  
3 
20509 5.7*104 1.10 
Vanadium 20 LOAEL ug/m3   y y  





 y y y  
7.5 
23642 1.4*106 2.01 
Zinc 350 RELx10 (ug/m3)    y  
3 191 536 1.10 
 
LOGNORM4 was used to derive various parameters of the lognormal distribution for each substance’s ED05 (or value used to represent the 
ED05 as described above). 





Toxicity/C-R data for air 
toxics (“threshold” – modeled 
using Mantel-Bryan 









Based on Mantel Bryan method 
where slope represents change in 
probits (number of standard 
deviations) relative to log of the 
dose. 1 is a conservative estimate 
and a value of 1.5 appeared to 
represent the data well. 
Parametric description: 
A rectangular distribution with the endpoints at values of 1 and 3.  


















Potential sources of Uncertainty/Variability:  
The Mantel-Bryan dose-probit method is just one way of carrying out low-dose extrapolations for systemic toxicants. A comparison of 
extrapolations using (i) a linearized unit risk approach (ii) the Mantel Bryan formulation with the default slope of 1, and (iii) a steep probit 
(Mantel Bryan-type) approach using a slope of 1.5 indicated that the concentration of a hypothetical contaminant with an ED05 of 500 μg/m3 
associated with a de minimis risk level of 10-5 would range from 0.1-5 μg/m3 depending on the approach. The steep Mantel Bryan formulation 
predicted that the air concentration corresponding to a 10-5 risk is roughly equivalent to the ED05/100 (e.g the ED05=500 μg/3, and the 10-5 risk 
concentration=5 μg/m3). Hence the LN(dose)-probit function with slope=1.5 produces the same tolerable concentration (TC) level as the 
ED05/100 (or NOAEL/100) formula for deriving the default TC values for threshold-acting agents (McColl 2003). 
Alternative methods of extrapolating to low doses for “threshold-acting” toxins might predict different values or incidence. 
Level of Uncertainty:  Risk 
Level of  Evidence:   Medium 
Sensitivity Analysis:  The Mantel-Bryant slope can be varied to determine its importance for the predictions of HEIDI II; this is essence tests 
various exposure-response functions within the probit family. Investigation of any interaction between the ED05 and the slope value can also be 
accomplished through response surface analysis. 
Justifications/notes:  
The preliminary testing of HEIDI II suggested that it will be important to characterize uncertainty and variability that exists in the toxicity data 
used.  
Mantel and Bryan (Mantel and Bryan 1961; Mantel, Bohidar et al. 1975) note that with systemic poisons, rather steep dose-response slopes are 
observed (even up to 10-50 probits per tenfold dose). However, for therapeutic agents and virus assays, slopes tend to be lower; within the range 
of 2-3. For this reason they select 1 as an (arbitrary) conservative estimate. While it is possible to create a distribution for the dose-response slope 
that contains higher values the following points indicate that that this is unnecessary: 
In HEIDI, natural log rather than log10 is used, so all slopes should be adjusted by an order of 2.303, which leads to slopes of ~5-25 
a steeper dose-response will likely lead to lower predicted incidence in the low exposure region, and likely cause underflow of predicted 
cases to zero in any case. 
Values ranging up to three were chosen for the uniform distribution because preliminary local sensitivity analyses indicated that responses 
disappeared to zero at values of 3 and so extending the distribution to 5 does not add any information 
















Value(s) used in deterministic HEIDI II: 
The reference documentation for PM health 
effects endpoints and concentration-response 
function information was obtained from the 





































Arithmetic Normal truncated below zero (formula for calculation provided 
below) 
Outcome Concentration-
response factor (β) 
Standard error 




of β (using lower 
bound of 
reported RR) 




















Example of concentration-response factor (which is used alongside death 













2.0E-03 4.0E-03 6.0E-03 8.0E-03 1.0E-02 1.2E-02 1.4E-02 1.6E-02






Potential sources of Uncertainty:  
 
For the asthma outcomes, the RR is based on PM10, but the formula is not adjusted to represent only PM2.5, which it was for the case of chronic 
bronchitis. From the discussions and literature review it was not clear why the analysis was inconsistent. 
Level of Uncertainty:  Risk 
Level of  Evidence:  Medium 
Sensitivity Analysis:   
Justifications/notes:  
The epidemiological concentration-response (C-R) functions are linear non-threshold in form, so that the C-R function is based on a linear risk 
coefficent that incorporates a slope factor according to the following equation: 
Incident Cases = Risk Coefficient * Conc PM2.5 * at-risk population (both population prevalence and C-R slope factors are accounted for in the 
risk coefficient) 
The C-R relationships used to predict incidence of mortality, chronic bronchitis, and asthma ER visits and hospital admissions were developed by 
Abt Associates (Abt Associates Nov. 2002) using widely accepted and used RR estimates. The approach also allows for calculation of the standard 
error associated with the mean RR, providing an estimate of the 5% and 95% confidence intervals. As applied in HEIDI I (following Abt)…: 
 



































There appears to be limited available research describing an appropriate shape for the probability distribution for the relative risks. 
Comparing the mean with 5% and 95% values indicates some skewness (to the right) in the distribution. The EPA elicited distributions for 
PM C-R functions from experts in its “Final Regulatory Analysis: Control of Emissions from Nonroad Diesel Engines”, published in 2004 
(Environmental Protection Agency (EPA) 2004). They found that most C-R functions were slightly skewed, although they did not 
generalize a specific distribution type that might be appropriate. Clearly, the distributions for relative risk must be bounded on the lower 
end, such that exposure to PM2.5 should not predict a gain in health status.  
 
Either a Weibull or a lognormal distribution may best represent the uncertainty in the PM C-R functions. Alternately, a normal distribution 
bounded at zero may be appropriate. 
 
It has been suggested that epidemiologic data should only be used in risk assessment when certain conditions are met: a moderate to strong 
positive association exists, strong biases can be ruled out, confounding is well-controlled or limited, and exposures have been well-characterized 
(in) (Stayner, Bailar et al. 1999). Use of epidemiologic data should consider 
Study design (i.e., sample size, follow-up timeframe, confounding) 
Choice of data, choice of D-R model 
Exposure estimates 
Using exposure rather than dose (is exposure proportional to dose?) 
Variations in susceptibility 






Value(s) used in HEIDI II: 
 
Population living in each of 20 zones 




None – it is most appropriate to perform 
sensitivity analysis with various patterns of 





Potential sources of Uncertainty:  
Movement of people into/out of areas 
Changes in population since the 2001 census for other reasons – births, deaths, aging (which would affect the number of people in each age group) 
Uncertainties introduced by ArcMAP – I.e., resolution is at average level of census dissemination areas. Where these are geographically large, 
there is no way of knowing where in the area people are living. 
Level of Uncertainty: Risk 
Level of  Evidence:  Strong 
Sensitivity Analysis:  To address variability, it was performed with a variety of patterns: homogeneous population density, dense close to 
refinery, dense at 20-25 km from refinery, dense in the four cardinal directions (N, S, E, and W) from refinery 
Justifications/notes:  
For policy analysis, it is most useful to know what patterns of population density surrounding refinery are associated with greatest impacts. Unless 
new developments are built or rezoning occurs, the patterns of population around a refinery are likely to remain relatively stable. Characterizing 
the uncertainty in the number of people living around each refinery is not likely to affect the prioritization of refinery emissions 
Possible Correlations:  






Value(s) used in HEIDI II: 
Child: 0-18 years 
Adult: 19-59 years 




Level of Uncertainty: N/A – assigned 
Sensitivity Analysis:  N/A 
Justifications/notes:  
Age distinctions are only used to predict incidence from exposure to CACs (primary and secondary PM2.5) 
















Potential sources of Uncertainty: N/A – assigned 
Sensitivity Analysis:  N/A 
Justifications/notes:  
Switching variable only 




Fraction of population that is male/female 
Value(s) used in HEIDI II: 
0.5 
Parametric description: 
None – to be taken as “given” 
Sensitivity Analysis:  None 
Justifications/notes:  
Approximate value for the population in Canada. Potential to affect predictions exists only for disease endpoints which apply to only one gender 




Age-sex discounting multiplier 
 
Value(s) used in HEIDI II: 
0 if specific age-sex group is not a target; 1 if 
group is a target 
Parametric description: 
None – to be taken as “given” 
Sensitivity Analysis:  None 
Justifications/notes: Potential to affect predictions exists only for disease endpoints which apply to only specific age groups 





DALYp values (simple) 
 
Value(s) used in HEIDI II: 
 
ILSI definition for selection of 




(cancer, mutagenicity, teretogenic 6.7 
Parametric description: 
 
None was used. DALY values were treated as 
point values due to a lack of information. 
Including distributions of DALYs could only 
have attempted to describe the uncertainty 




or reproductive effects) 
May be irreversible/life-shortening 
effects (immunotoxicity, 
neurotoxicity, kidney damage, liver 
damage, heart disease, pulmonary 
disease) 
0.67 
Reversible/ not life-shortening 
effects (irritation, sensitization) 0.067  
deemed to be large.  
 
Data collected in an effort to identify potential 
distributions is retained below. 
Potential sources of Uncertainty:  
These are derived values and allow for only three categories; imply valuation for aspects of life and illness which may be difficult to justify. 
Values used in HEIDI are aggregate values of DALYs per person, which assumed that the population in Canada can be represented by the 
populations in the reference study: in terms of age structure, average age at onset of illness, duration of illness and severity weights/valuation of 
disability or death. 
Level of Uncertainty: Scientific Uncertainty 
Level of  Evidence:  Weak 
Sensitivity Analysis:  None 
Justifications/notes:  
A range of values has been calculated for various disease endpoints. For example, for cancer endpoints, Charles and Jolliet (Charles and Jolliet 
2003) suggest that different cancers have more or less the same severity, calculate an average DALYp = 6.6 [yr lost/pers], and suggest this as a 
default. However, the various DALYp values calculated for different cancers range from 2.1 for prostate cancer to 14.6 for leukemia. These could 
be used to create a triangular distribution for the simple DALY framework, having a mode at 6.7, the simple DALYp value used in HEIDI II for 
cancer endpoints, and bounded at 2.1 at the low end and 14.6 at the high end. As the ILSI “simple DALYs” are simply divisions by ten of each 
other to account for varying degrees of uncertainty, it should be appropriate to adapt this triangular (or maybe even uniform) distribution in a 
similar manner. 
 
ILSI definition for selection of simple DALY Mode Proposed endpoints for triangular distribution 
Irreversible/Life-shortening effects (cancer, mutagenicity, teretogenic or reproductive effects) 6.7 Low: 2.1 High: 14.6 




Reversible/ not life-shortening effects (irritation, sensitization) 0.067 Low: 0.021 High:0.146 
 
Example: 
















Limitations: the endpoint/exposure list in de Hollander is by no means inclusive of all endpoints, so the coefficients of variance will reflect 
primarily DALYs calculated for exposures to particulates or inhaled carcinogens. Also, since an average CV will be used, the level of uncertainty 
will be over- or under- estimated in the case of many endpoints. Finally, the uncertainty estimate does not include any assessment of the broader 
uncertainty associated with this method, such as the “correctness” of the severity weights, the uncertainty imposed by social preferences and 
cultural contexts. 




DALYp values (complex) 
 
Value(s) used in HEIDI II: 
 
Substance DALYp Substance DALYp 






None was used. DALY values were 
treated as point values due to a lack of 
information. Including distributions of 








Nickel (and its compounds) 14.75 
Methyl tert-
butyl ether 0.72 
PAH (as benzo(a)pyrene) 14.75 Naphthalene 1.29 
Formaldehyde 14.75 n-Hexane 0.72 
Acetaldehyde 14.75 Phenol 0.97 
1,2,4-Trimethylbenzene 0.01 Propylene 0.07 
Ammonia (Total) 0.07 Styrene 1.40 












Diethanolamine (and its salts) 0.07 
Zinc (and its 
compounds) 0.01 
Ethylbenzene (as BTEX component) 0.97 PM death  10.9 






Mercury (and its compounds) 11.44 
PM asthma 
ER visits 0.018  
describe the uncertainty currently 
associated with these values, which is 
deemed to be large.  
 
Data collected in an effort to identify 
potential distributions is retained below. 
Potential sources of Uncertainty:  
These are derived values; imply valuation for aspects of life and illness which may be difficult to justify. Values used in HEIDI are aggregate 
values of DALYs per person, which assumed that the population in Canada can be represented by the populations in the reference study: in terms 
of age structure, average age at onset of illness, duration of illness and severity weights/valuation of disability or death. 
Level of Uncertainty: Scientific Uncertainty 




Sensitivity Analysis:   
Justifications/notes:  
           The complex DALYs used in HEIDI II originate from a variety of sources, including de Hollander (de Hollander, Melse et al. 1999), Melse 
(Melse, Essink-Bot et al. 2000), and the Global Burden of Disease (Murray and Lopez 1996). de Hollander’s estimates are provided alongside 5th 
and 95th percentile values derived from Monte Carlo simulations. It is not specified whether the central estimate presented is the mode, median, or 
mean, however, and there is no information provided about the characteristics of the input distributions. A superficial examination of the point 
estimates alongside the 5th and 95th percentiles indicates that most of the distributions are skewed to the right, although the degree of skew appears 
to vary. Calculation of the coefficients of variation (assuming a normal distribution for the sake of investigation) reveal varying degrees of 
variation among the predicted DALYs for the various environmental factor/outcome combinations. 
 The input variables used to calculate these DALY values are: a set of functions which includes exposure and the associated relative risk to 
represent the population attributable fraction of the condition, annual incidence of response, and a severity factor discounting time spent with the 
condition, and the duration of the condition (or loss of life expectancy). It would be anticipated that both exposure and duration of the condition 
would be characterized by skewed distributions. Determining whether RR distributions are likely to be skewed is less intuitive, but even if both 
RR and the severity weighting factor had been assigned normal distributions, the output DALY distributions would likely be skewed to the right.  
 Therefore, the following was initially proposed to develop a distribution for the complex DALYp values: lognormal distributions centred 
at the DALYp value previously selected in HEIDI II. An average coefficient of variance will be derived using the DALY and 95th and DALY and 
5th percentile values reported in de Hollander for exposures and endpoints that are also included in HEIDI II. 
The proposed approach leads to the following parameters for the various complex DALYp values used (LOGNORM4 was used to calculate the 
coefficients of variation from the original de Hollander data under the assumption of lognormal distribution, and was also used to extract the 
following data): 
 
DALYp CV GSD sigma SD variance skewness kurtosis
0.01 0.92 2.19 0.78 0.01 0.00 3.54 28.40 
0.02 0.92 2.19 0.78 0.02 0.00 3.54 28.40 
0.02 0.92 2.19 0.78 0.02 0.00 3.54 28.40 
0.07 0.92 2.19 0.78 0.06 0.00 3.54 28.40 
0.47 0.92 2.19 0.78 0.43 0.19 3.54 28.40 
0.72 0.92 2.19 0.78 0.66 0.44 3.54 28.40 
0.95 0.92 2.19 0.78 0.87 0.76 3.54 28.40 
0.97 0.92 2.19 0.78 0.89 0.80 3.54 28.40 
1.29 0.92 2.19 0.78 1.19 1.41 3.54 28.40 
1.40 0.92 2.19 0.78 1.29 1.66 3.54 28.40 




11.44 0.92 2.19 0.78 10.52 110.69 3.54 28.40 
14.75 0.92 2.19 0.78 13.57 184.01 3.54 28.40 
23.44 0.92 2.19 0.78 21.56 464.70 3.54 28.40 
35.00 0.92 2.19 0.78 32.19 1036.09 3.54 28.40  











acting 2001 2002 2003 mean std dev 2001 2002 2003 mean std dev 2001 2002 2003 mean std dev
1,3-Butadiene
Benzene 1.33 2.60 2.13 2.02 0.64 14.89 9.62 11.31 11.94 2.69 0.00 0.00 0.00 0.00 0.00
Ethylene 0.12 0.19 0.37 0.23 0.13 38.87 19.33 18.71 25.63 11.47 1.90 1.98 1.93 1.94 0.04
Nickel (and its compounds) 0.22 0.25 0.23 0.02 0.01 0.00 0.10 0.04 0.06




1,2,4-Trimethylbenzene 0.42 0.80 0.82 0.68 0.22 9.78 15.13 16.58 13.83 3.58 0.00 0.00 0.00 0.00 0.00
Ammonia (Total) 0.00 0.00 0.00 0.00 0.00 8.78 8.78 8.78 8.78 0.00
Benzene (as BTEX potentiator) 1.33 2.60 2.13 2.02 0.64 14.89 9.62 11.31 11.94 2.69 0.00 0.00 0.00 0.00 0.00
Cyclohexane 0.53 1.11 1.47 1.04 0.47 31.95 16.61 17.54 22.03 8.60 1.29 1.27 1.40 1.32 0.07
Dicyclopentadiene
Diethanolamine (and its salts) 0.00 0.00 0.00 0.00 0.00
Ethylbenzene 0.48 0.64 0.67 0.60 0.11 8.22 8.69 10.67 9.19 1.30 0.00 0.00 0.00 0.00 0.00
Hydrogen sulphide 2.33 3.54 1.59 2.49 0.98 26.09 26.23 29.81 27.38 2.11 1.80 1.87 1.87 1.85 0.04
Isoprene
Mercury (and its compounds) 0.00 0.00
Methanol 0.01 0.02 0.02 0.01
Methyl ethyl ketone
Methyl isobutyl ketone
Methyl tert-butyl ether 9.95 10.25 10.10 0.22
Naphthalene 0.07 0.12 0.12 0.11 0.03 0.92 2.58 2.94 2.15 1.08 0.00 0.00 0.00 0.00 0.00
n-Hexane 2.80 6.00 5.33 4.71 1.69 23.64 29.22 26.43 3.95 3.93 4.24 4.25 4.14 0.18
Phenol (and its salts) 0.01 0.02 0.02 0.02 0.00 0.03 0.03 0.04 0.03 0.00
Propylene 1.93 1.68 2.27 1.96 0.30 10.27 11.34 11.69 11.10 0.74 2.00 1.98 1.94 1.97 0.03
Styrene
Sulphuric acid 0.00 6.22 6.49 4.24 3.67 0.21 0.21 #DIV/0!
Toluene 2.41 5.55 3.37 3.77 1.61 31.46 34.24 36.53 34.08 2.54 1.12 1.16 1.10 1.13 0.03
Vanadium (except when in an alloy) an 0.76 1.01 0.89 0.17 0.02 0.00 0.00 0.01 0.01
Xylene (all isomers) 0.98 1.71 1.35 1.35 0.36 27.14 48.84 63.02 46.33 18.07 0.00 0.00 2.20 0.73 1.27
Zinc (and its compounds) 0.00 0.00 0.00 0.00 0.00
SOx 1165.85 1149.98 2736.80 2640.51 1439.30 1197.97
NOx 646.99 556.17 1157.61 1271.38 65.70 50.70
primary PM2.5 18.70 21.98 0.00 0.00 0.85 1.73







acting 2001 2002 2003 mean std dev 2001 2002 2003 mean std dev 2001 2002 2003 mean std dev
1,3-Butadiene 0.068 0.06 0.015 0.05 0.03
Benzene 5.64 5.47 3.80 4.97 1.02 3.81 5.11 4.09 4.34 0.68 10.76 11.04 9.70 10.50 0.71
Ethylene 2.29 2.61 2.15 2.35 0.24 1.68 1.59 1.76 1.68 0.09 3.42 2.55 3.12 3.03 0.44
Nickel (and its compounds) 30.33 26.57 28.28 28.39 1.88




1,2,4-Trimethylbenzene 2.44 2.29 1.72 2.15 0.38 1.75 2.47 1.62 1.94 0.46 4.39 3.71 2.67 3.59 0.87
Ammonia (Total) 9.86 2.87 11.79 8.17 4.70 3.79 20.74 1.19 8.57 10.62 0.39 7.31 5.07 4.26 3.53
Benzene (as BTEX potentiator) 5.64 5.47 3.80 4.97 1.02 3.81 5.11 4.09 4.34 0.68 10.76 11.04 9.70 10.50 0.71
Cyclohexane 5.04 5.60 3.97 4.87 0.83 2.85 3.10 2.52 2.82 0.29 12.15 10.77 7.62 10.18 2.32
Dicyclopentadiene 0.00 0.00 0.00 0.00 0.00
Diethanolamine (and its salts) 0.58 0.56 0.25 0.46 0.19 0.51 0.51 1.06 0.69 0.32
Ethylbenzene 2.10 1.80 1.69 1.86 0.21 1.44 1.98 1.34 1.59 0.34 4.36 3.89 3.36 3.87 0.50
Hydrogen sulphide 2.94 4.03 3.36 3.44 0.55 8.55 28.18 11.47 16.07 10.59 10.42 3.62 6.70 6.91 3.41
Isoprene
Mercury (and its compounds) 0.002 0.002 0.002 0.002 0.000 0.004 0.004 0.004 0.004 0.000 0.003 0.003 0.003 0.003 0.000
Methanol 1.17 1.04 1.92 1.38 0.47 0.82 0.76 0.71 0.77 0.06 30.61 9.47 4.99 15.02 13.68
Methyl ethyl ketone 50.60 44.90 57.74 51.08 6.43
Methyl isobutyl ketone 72.49 65.00 64.98 67.49 4.33
Methyl tert-butyl ether
Naphthalene 0.60 0.80 0.74 0.71 0.10 0.37 0.48 0.33 0.39 0.08 0.85 0.85 0.54 0.75 0.18
n-Hexane 16.67 16.94 12.73 15.44 2.35 7.62 8.96 7.25 7.95 0.90 38.89 34.06 25.29 32.75 6.90
Phenol (and its salts) 0.36 0.28 0.29 0.31 0.04 0.15 0.06 0.06 0.09 0.06 1.71 1.67 3.68 2.36 1.15
Propylene 3.47 3.44 3.91 3.61 0.27 15.85 14.49 24.48 18.27 5.42 31.64 92.44 42.17 55.42 32.49
Styrene
Sulphuric acid 125.11 107.69 116.40 12.32 103.81 103.64 105.39 104.28 0.96 421.29 421.29 164.43 335.67 148.29
Toluene 11.03 9.41 8.76 9.73 1.17 6.26 9.82 7.29 7.79 1.83 19.07 17.87 14.38 17.11 2.44
Vanadium (except when in an alloy) and its compounds 61.55 67.18 70.52 66.42 4.53
Xylene (all isomers) 11.16 10.04 10.07 10.42 0.64 6.54 9.62 6.74 7.63 1.73 19.20 15.98 13.04 16.07 3.08
Zinc (and its compounds) 9.11 8.71 0.43 6.08 4.90
SOx 4778.90 5967.94 3955.87 5819.97 24735.27 20704.35
NOx 3525.55 3593.31 2001.38 2096.78 2752.17 2628.46
primary PM2.5 294.92 282.18 160.16 157.08 402.09 443.79







acting 2001 2002 2003 mean std dev 2001 2002 2003 mean std dev 2001 2002 2003 mean std dev
1,3-Butadiene 0.05 0 0 0.02 0.03
Benzene 3.70 3.70 3.53 3.64 0.10 1.26 0.00 23.44 8.23 13.19 16.38 11.71 7.00 11.70 4.69
Ethylene 6.14 6.57 7.09 6.60 0.47 16.94 14.67 0.00 10.54 9.20
Nickel (and its compounds) 0.33 0.20 0.21 0.25 0.07 13.80 13.99 14.53 14.11 0.38




1,2,4-Trimethylbenzene 2.96 2.98 2.64 2.86 0.20 0.68 0.00 2.26 0.98 1.16 9.12 4.87 4.74 6.24 2.49
Ammonia (Total) 0.02 4.02 0.07 1.37 2.29 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Benzene (as BTEX potentiator) 3.70 3.70 3.53 3.64 0.10 1.26 0.00 23.44 8.23 13.19 16.38 11.71 7.00 11.70 4.69
Cyclohexane 1.52 2.27 1.33 1.71 0.50 2.41 1.66 14.60 6.22 7.26 15.40 9.88 6.08 10.45 4.68
Dicyclopentadiene
Diethanolamine (and its salts) 0.00 0.00 0.00 0.00 2.02 1.32 9.33 4.22 4.44
Ethylbenzene 1.92 2.30 2.38 2.20 0.24 0.84 0.00 16.13 5.66 9.08 4.12 3.79 2.95 3.62 0.61
Hydrogen sulphide 3.65 3.88 3.25 3.60 0.32 0.17 0.00 6.04 2.07 3.44 4.18 4.68 4.43 0.35
Isoprene
Mercury (and its compounds) 0.006 0.005 0.006 0.005 0.000 0.000 0.000 0.000 0.000
Methanol 0.01 0.01 0.00 0.01 0.00 0.00 0.00 0.00 0.00 0.00
Methyl ethyl ketone 22.07 18.96 29.74 23.59 5.55
Methyl isobutyl ketone 17.04 14.04 23.40 18.16 4.78
Methyl tert-butyl ether 9.21 6.94 8.08 1.61 93.29 65.29 99.84 86.14 18.35
Naphthalene 1.22 1.23 1.42 1.29 0.11 0.08 0.00 0.00 0.03 0.05
n-Hexane 9.20 13.60 11.18 11.33 2.21 3.24 3.64 35.40 14.09 18.46 11.70 15.08 30.43 19.07 9.98
Phenol (and its salts) 0.29 0.16 0.10 0.18 0.09 0.00 0.00 0.00 0.00 0.00 0.13 0.13 0.00 0.09 0.08
Propylene 7.92 8.11 7.49 7.84 0.32 34.90 32.44 5.71 24.35 16.19
Styrene 0.02 0.00 0.01 0.01
Sulphuric acid 138.04 138.04 174.66 150.25 21.14 0.00 0.00 0.00 0.00 0.00
Toluene 10.44 10.99 11.07 10.83 0.34 3.57 3.24 42.87 16.56 22.79 31.26 29.17 19.39 26.60 6.34
Vanadium (except when in an alloy) and its compounds 0.51 0.17 0.56 0.41 0.21 40.00 37.30 39.78 39.03 1.50
Xylene (all isomers) 13.22 13.32 12.99 13.17 0.17 3.74 2.63 19.09 8.49 9.20 21.04 19.65 18.78 19.82 1.14
Zinc (and its compounds) 8.16 9.20 0.37 5.91 4.83 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.47 0.49 0.02
SOx 4824.00 5330.21 4452.00 7474.36 14658.00 14136.00
NOx 1845.33 1989.38 4211.00 4424.46 1260.00 1346.25
primary PM2.5 221.21 227.08 194.80 237.31 173.00 184.57







acting 2001 2002 2003 mean std dev 2001 2002 2003 mean std dev 2001 2002 2003 mean std dev
1,3-Butadiene 11.33 17.63 11.16 13.37 3.69
Benzene 46.84 56.43 11.98 38.41 23.39 4.15 NO DATANO DATA 4.15 2.48 0.48 2.06 1.67 1.06
Ethylene 80.01 50.98 23.72 51.57 28.15 2.55 0.00 0.00 0.85 1.47
Nickel (and its compounds) 0.03 0.00 0.00 0.01 0.02




1,2,4-Trimethylbenzene 1.51 3.78 1.35 2.21 1.36 1.89 1.89 1.07 0.00 5.77 2.28 3.07
Ammonia (Total) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Benzene (as BTEX potentiator) 46.84 56.43 11.98 38.41 23.39 4.15 4.15 2.48 0.48 1.48 1.42
Cyclohexane 3.26 2.70 2.66 2.87 0.34 2.53 2.53 3.21 0.00 1.85 1.69 1.61
Dicyclopentadiene 4.97 17.12 0.16 7.42 8.74
Diethanolamine (and its salts) 0.51 0.00 0.00 0.17 0.29
Ethylbenzene 5.05 5.89 1.19 4.04 2.51 0.81 0.81 1.16 0.68 3.84 1.89 1.70
Hydrogen sulphide 0.11 0.10 0.07 0.09 0.02 2.53 1.39 2.11 2.01 0.57
Isoprene 1.87 6.59 1.81 3.42 2.74





Naphthalene 1.44 3.73 0.73 1.97 1.57
n-Hexane 7.72 5.85 23.30 12.29 9.58 12.08 12.08 9.09 13.41 17.14 13.21 4.03
Phenol (and its salts) 13.31 13.31 0.00 0.00 0.00 0.00 0.00
Propylene 46.48 28.45 30.88 35.27 9.79 2.53 1.34 0.00 1.29 1.27
Styrene 2.46 3.84 0.29 2.20 1.79
Sulphuric acid 257.26 266.74 262.00 6.70 0.00 127.62 175.31 100.98 90.64
Toluene 22.84 24.79 6.97 18.20 9.78 7.71 7.71 5.67 2.65 19.72 9.35 9.11
Vanadium (except when in an alloy) and its compounds 0.01 0.00 0.00 0.00 0.01
Xylene (all isomers) 9.37 8.94 5.42 7.91 2.17 4.41 4.41 4.09 0.75 17.83 7.56 9.05
Zinc (and its compounds) 0.00 1.79 0.00 0.60 1.03
SOx 5730.62 5990.80 1907.85 1788.01
NOx 2458.16 2890.20 1661.41 1547.90
primary PM2.5 244.84 219.80 220.71 86.20







acting 2001 2002 2003 mean std dev 2001 2002 2003 mean std dev 2001 2002 2003 mean std dev
1,3-Butadiene 0.005 0 0 0.002 0.003 0.093 0 0 0.031 0.054
Benzene 3.42 3.43 3.38 3.41 0.02 18.03 8.74 10.55 12.44 4.92 1.06 2.14 2.17 1.79 0.63
Ethylene 1.25 0.00 0.00 0.42 0.72 6.17 6.13 6.15 0.03
Nickel (and its compounds) 0.00 0.00 0.00 0.00 1.47 1.32 1.15 1.32 0.16 0.34 0.00 0.40 0.25 0.21




1,2,4-Trimethylbenzene 3.16 2.34 2.36 2.62 0.47 2.19 1.31 1.47 1.66 0.47 0.58 0.00 0.00 0.19 0.33
Ammonia (Total) 0.00 0.00 0.00 0.00 0.00 0.06 0.06 0.00 0.04 0.03
Benzene (as BTEX potentiator) 3.42 3.43 3.38 3.41 0.02 18.03 8.74 10.55 12.44 4.92 1.06 2.14 2.17 1.79 0.63
Cyclohexane 0.38 0.00 0.58 0.32 0.29 2.01 1.66 1.72 1.80 0.19 1.57 1.24 1.30 1.37 0.18
Dicyclopentadiene
Diethanolamine (and its salts) 0.00 0.00 0.67 0.22 0.39 0.00 0.00 0.00 0.00 0.00 0.45 0.00 0.00 0.15 0.26
Ethylbenzene 0.92 3.47 0.85 1.75 1.49 3.14 1.54 1.54 2.07 0.92 0.50 0.00 0.00 0.17 0.29
Hydrogen sulphide 0.16 0.15 0.13 0.15 0.01 4.90 3.61 3.77 4.09 0.70 2.19 1.99 1.95 2.04 0.13
Isoprene
Mercury (and its compounds) 0.003 0.005 0.004 0.004 0.001 0.001 0.002 0.002 0.002 0.001
Methanol 2.36 0.00 0.00 0.79 1.36
Methyl ethyl ketone 16.96 22.85 7.96 15.92 7.50
Methyl isobutyl ketone
Methyl tert-butyl ether
Naphthalene 2.33 1.75 1.72 1.93 0.35 0.41 0.00 0.00 0.14 0.24 0.34 0.00 0.00 0.11 0.19
n-Hexane 5.41 5.03 4.92 5.12 0.26 9.22 7.46 7.85 8.18 0.92 6.31 5.47 5.60 5.79 0.45
Phenol (and its salts) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Propylene 7.76 3.33 5.54 3.13 14.49 8.73 13.41 12.21 3.06 39.29 36.87 43.92 40.03 3.58
Styrene
Sulphuric acid 0.00 58.30 49.77 36.02 31.49 0.06 159.43 135.19 98.23 85.88 0.63 261.98 231.20 164.60 142.84
Toluene 18.45 23.99 11.00 17.81 6.52 21.88 12.09 12.24 15.40 5.61 2.92 3.43 3.45 3.27 0.30
Vanadium (except when in an alloy) and its compounds 4.82 3.44 2.68 3.65 1.09 1.03 0.00 0.79 0.61 0.54
Xylene (all isomers) 5.21 14.59 4.19 7.99 5.73 15.70 2.80 2.60 7.03 7.50 1.92 1.72 1.79 1.81 0.10
Zinc (and its compounds) 0.00 6.23 0.42 2.22 3.48
SOx 1293.19 1096.12 3393.90 4027.30 5984.20 5580.78
NOx 747.01 436.73 1311.80 1413.20 625.89 605.89
primary PM2.5 77.82 47.10 151.90 173.00 138.67 189.16







acting 2001 2002 2003 mean std dev 2001 2002 2003 mean std dev 2001 2002 2003 mean std dev
1,3-Butadiene
Benzene 7.89 3.62 4.01 5.17 2.36 32.67 12.85 11.19 18.90 11.95 11.17 6.66 3.63 7.15 3.79
Ethylene 4.81 4.07 5.31 4.73 0.62 9.17 5.86 5.02 6.68 2.20
Nickel (and its compounds) 0.00 0.00 #DIV/0! 6.97 6.61 6.63 6.74 0.20 0.00 0.01 0.00 0.00 0.00




1,2,4-Trimethylbenzene 2.68 1.43 1.76 1.96 0.65 3.66 1.85 1.63 2.38 1.11 2.68 2.95 2.24 2.62 0.36
Ammonia (Total) 1.58 3.39 1.60 2.19 1.04 0.02 0.05 0.03 0.03 0.02 0.02 0.00 0.00 0.01 0.01
Benzene (as BTEX potentiator) 7.89 3.62 4.01 5.17 2.36 32.67 12.85 11.19 18.90 11.95 11.17 6.66 3.63 7.15 3.79
Cyclohexane 2.24 1.16 2.03 1.81 0.57 7.37 5.58 4.90 5.95 1.27 0.18 0.12 0.18 0.16 0.03
Dicyclopentadiene
Diethanolamine (and its salts) 1.59 1.41 1.59 1.53 0.10 4.62 4.50 4.62 4.58 0.07
Ethylbenzene 3.92 2.98 2.85 3.25 0.58 9.87 6.36 6.32 7.52 2.04 3.08 1.94 1.15 2.06 0.97
Hydrogen sulphide 2.86 1.21 1.29 1.79 0.93 3.16 3.86 3.26 3.43 0.38 2.57 0.97 0.97 1.51 0.92
Isoprene
Mercury (and its compounds) 0.003 0.003 0.003 0.003 0.000 0.004 0.002 0.002 0.002 0.001 0.000 0.001 0.005 0.002 0.003
Methanol 2.10 0.16 0.15 0.80 1.12
Methyl ethyl ketone 16.73 6.44 7.29 10.15 5.71
Methyl isobutyl ketone 6.81 2.34 2.73 3.96 2.48
Methyl tert-butyl ether
Naphthalene 0.91 0.49 0.58 0.66 0.22 0.69 0.30 0.32 0.44 0.22 0.44 0.32 0.25 0.33 0.10
n-Hexane 15.15 8.98 9.36 11.16 3.46 9.05 9.49 6.08 8.21 1.85 8.49 5.98 5.69 6.72 1.54
Phenol (and its salts) 0.02 0.06 0.01 0.03 0.03 0.00 0.00 0.00 0.00 0.00
Propylene 16.72 5.40 6.70 9.61 6.19 24.31 8.81 7.03 13.39 9.50 2.57 2.57 #DIV/0!
Styrene
Sulphuric acid 111.40 110.20 110.80 0.85 263.88 278.74 271.31 10.51 0.00 0.00 0.00 0.00 0.00
Toluene 50.42 18.05 22.31 30.26 17.59 54.95 37.21 35.41 42.53 10.80 22.07 13.54 7.24 14.28 7.45
Vanadium (except when in an alloy) and its compounds 14.70 13.93 14.10 14.24 0.40
Xylene (all isomers) 26.02 9.21 12.77 16.00 8.86 29.27 14.47 13.20 18.98 8.93 17.80 12.78 7.98 12.85 4.91
Zinc (and its compounds) 0.00 0.00 0.00 0.00 0.00
SOx 5273.00 5401.00 12527.89 12212.98 368.00 91.30
NOx 1869.00 1820.00 1853.69 1750.09 865.80 844.00
primary PM2.5 178.12 174.17 379.00 403.17 11.70 10.72







acting 2001 2002 2003 mean std dev 2001 2002 2003 mean std dev 2001 2002 2003 mean std dev
1,3-Butadiene 11.554 17.69 11.175 13.473 3.65694
Benzene 22.28 11.84 11.32 15.15 6.19 4.15 4.15 3.19 3.83 0.55 211.64 159.57 128.48 166.56 42.02
Ethylene 12.35 3.52 1.64 5.83 5.72 188.57 120.05 70.81 126.48 59.14
Nickel (and its compounds) 53.29 48.92 51.55 51.25 2.20
Benzo(a)pyrene 0.01 0.00 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.19 3.47 0.24 1.30 1.88
Formaldehyde 15.37 11.98 13.67 2.39 15.37 11.98 13.67 2.39
Acetaldehyde 0.00 0.00 0.00 0.00
0.00 0.00 0.00 0.00
Sublinear threshold-acting 0.00 0.00 0.00 0.00
1,2,4-Trimethylbenzene 3.65 3.64 3.48 3.59 0.09 0.30 0.21 0.23 0.25 0.05 54.66 49.76 53.33 52.58 2.53
Ammonia (Total) 0.00 0.00 0.00 0.00 0.00 1.18 0.36 0.36 0.63 0.47 25.68 47.56 28.89 34.04 11.82
Benzene (as BTEX potentiator) 22.28 11.84 11.32 15.15 6.19 4.15 4.15 3.19 3.83 0.55 211.64 159.57 126.41 165.88 42.96
Cyclohexane 3.87 2.98 3.21 3.35 0.46 3.80 4.19 3.98 3.99 0.19 102.89 71.90 78.94 84.57 16.25
Dicyclopentadiene 4.97 17.12 0.16 7.42 8.74
Diethanolamine (and its salts) 0.00 0.00 0.00 0.00 0.00 10.36 8.31 17.51 12.06 4.83
Ethylbenzene 22.23 15.16 13.77 17.05 4.53 0.52 0.46 0.46 0.48 0.03 74.43 61.56 71.15 69.04 6.69
Hydrogen sulphide 0.84 2.27 1.58 1.56 0.71 15.17 5.35 5.62 8.71 5.60 92.67 96.43 89.51 92.87 3.46
Isoprene 1.87 6.59 1.81 3.42 2.74
Mercury (and its compounds) 0.000 0.000 0.000 0.000 0.000 0.03 0.03 0.04 0.03 0.01
Methanol 0.20 0.20 0.21 0.20 0.00 37.28 11.66 7.98 18.97 15.96
Methyl ethyl ketone 106.36 93.16 102.73 100.75 6.82
Methyl isobutyl ketone 96.34 81.38 91.11 89.61 7.59
Methyl tert-butyl ether 112.45 75.54 106.78 98.25 19.87
Naphthalene 0.53 0.47 0.46 0.48 0.04 0.05 0.05 0.05 0.05 0.00 11.25 13.15 10.20 11.53 1.49
n-Hexane 11.22 10.32 9.66 10.40 0.78 17.47 15.03 12.67 15.06 2.40 203.74 213.18 263.35 226.76 32.04
Phenol (and its salts) 0.00 0.00 0.00 0.00 0.00 2.70 2.40 17.51 7.54 8.63
Propylene 14.25 16.33 15.29 1.47 20.72 5.59 4.17 10.16 9.17 248.90 283.11 228.00 253.34 27.83
Styrene 2.48 3.84 0.29 2.20 1.79
Sulphuric acid 0.00 171.81 183.07 118.29 102.60 0.00 56.94 57.39 38.11 33.00 2.80 2262.90 2046.27 1437.32 1247.05
Toluene 48.72 51.62 28.58 42.97 12.55 4.22 4.51 4.20 4.31 0.17 375.40 313.31 295.86 328.19 41.80
Vanadium (except when in an alloy) and its compounds 107.95 122.78 129.44 120.06 11.00
Xylene (all isomers) 92.72 67.10 46.19 68.67 23.30 2.77 2.55 2.60 2.64 0.12 311.49 256.70 261.83 276.67 30.26
Zinc (and its compounds) 17.77 26.43 1.70 15.30 12.55
SOx 2404.10 2599.96 3499.93 3783.34
NOx 939.85 964.58 1789.29 1846.59
primary PM2.5 104.29 105.03 193.37 129.61
Grand TotalUltramar - St. RomualdSunoco - Sarnia
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Appendix E – Secondary PM Concentrations 
1 km 
NE SE SW NW  Refinery and PM type 
mean stdev mean stdev mean stdev mean stdev 
Chevron - Burnaby 
PM2.5 from SOx (NH4SO4) 0.21 0.00 0.17 0.00 0.06 0.00 0.09 0.00 
PM2.5 from NOx (NH4NO3) 0.08 0.02 0.06 0.02 0.02 0.01 0.04 0.01 
primary PM2.5 0.72 0.87 0.58 0.71 0.22 0.27 0.32 0.39 
Consumer's Co-operative Refineries Ltd./NewGrade Energy Inc. 
PM2.5 from SOx (NH4SO4) 0.59 0.19 0.48 0.16 0.18 0.06 0.27 0.09 
PM2.5 from NOx (NH4NO3) 0.17 0.02 0.14 0.02 0.05 0.01 0.08 0.01 
primary PM2.5 0.53 0.92 0.43 0.74 0.16 0.28 0.24 0.41 
Husky Oil Operations Limited - Prince George Refinery 
PM2.5 from SOx (NH4SO4) No data!27 No data No data No data No data No data No data No data 
PM2.5 from NOx (NH4NO3) No data No data No data No data No data No data No data No data 
primary PM2.5 No data No data No data No data No data No data No data No data 
Imperial Oil - Dartmouth Refinery 
PM2.5 from SOx (NH4SO4) 0.97 0.11 0.79 0.09 0.30 0.03 0.44 0.05 
PM2.5 from NOx (NH4NO3) 0.52 0.02 0.42 0.02 0.16 0.01 0.24 0.01 
primary PM2.5 3.49 0.76 2.82 0.61 1.07 0.23 1.57 0.34 
Imperial Oil - Nanticoke Refinery 
PM2.5 from SOx (NH4SO4) 1.00 0.27 0.81 0.22 0.31 0.08 0.45 0.12 
PM2.5 from NOx (NH4NO3) 0.31 0.01 0.25 0.01 0.09 0.00 0.14 0.00 
primary PM2.5 2.01 0.58 1.63 0.47 0.61 0.18 0.90 0.26 
Imperial Oil - Sarnia Refinery Plan 
PM2.5 from SOx (NH4SO4) 4.13 0.38 3.34 0.31 1.26 0.12 1.86 0.17 
PM2.5 from NOx (NH4NO3) 0.41 0.01 0.33 0.01 0.12 0.00 0.18 0.00 
primary PM2.5 5.86 2.40 4.73 1.94 1.79 0.73 2.63 1.08 
Imperial Oil - Strathcona Refinery 
PM2.5 from SOx (NH4SO4) 0.89 0.05 0.72 0.04 0.27 0.02 0.40 0.02 
PM2.5 from NOx (NH4NO3) 0.27 0.03 0.22 0.03 0.08 0.01 0.12 0.01 
primary PM2.5 3.76 2.40 3.04 1.94 1.15 0.73 1.69 1.08 
Irving - Saint John 
PM2.5 from SOx (NH4SO4) 1.04 0.27 0.84 0.22 0.32 0.08 0.47 0.12 
PM2.5 from NOx (NH4NO3) 0.66 0.02 0.53 0.02 0.20 0.01 0.30 0.01 
primary PM2.5 3.09 1.41 2.50 1.14 0.94 0.43 1.39 0.63 
North Atlantic Refining - North Atlantic Refinery 
PM2.5 from SOx (NH4SO4) 2.75 0.31 2.22 0.25 0.84 0.09 1.24 0.14 
PM2.5 from NOx (NH4NO3) 0.21 0.03 0.17 0.02 0.06 0.01 0.10 0.01 
primary PM2.5 4.20 3.99 3.39 3.22 1.28 1.22 1.88 1.79 
Nova Chemicals (Ltd.) - Nova Chemicals (Canada) Ltd. 
PM2.5 from SOx (NH4SO4) No data No data No data No data No data No data No data No data 
PM2.5 from NOx (NH4NO3) No data No data No data No data No data No data No data No data 
primary PM2.5 No data No data No data No data No data No data No data No data 
Parkland – Bowden 
PM2.5 from SOx (NH4SO4) No data No data No data No data No data No data No data No data 
PM2.5 from NOx (NH4NO3) No data No data No data No data No data No data No data No data 
                                                 
27 Where “no data” is displayed, PM emissions records were not available for all three years 
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primary PM2.5 No data No data No data No data No data No data No data No data 
 
 
         
1 km 
NE SE SW NW  Refinery and PM type 
mean stdev mean stdev mean stdev mean stdev 
Petro-Canada - Edmonton Refinery 
PM2.5 from SOx (NH4SO4) 0.40 0.13 0.33 0.10 0.12 0.04 0.18 0.06 
PM2.5 from NOx (NH4NO3) 0.23 0.03 0.18 0.02 0.07 0.01 0.10 0.01 
primary PM2.5 1.80 0.77 1.46 0.63 0.55 0.24 0.81 0.35 
Petro-Canada - Mississauga Lubricant Center 
PM2.5 from SOx (NH4SO4) 0.24 0.05 0.19 0.04 0.07 0.01 0.11 0.02 
PM2.5 from NOx (NH4NO3) 0.09 0.02 0.08 0.02 0.03 0.01 0.04 0.01 
primary PM2.5 0.86 0.38 0.70 0.31 0.26 0.12 0.39 0.17 
Petro-Canada - Raffinerie de Montreal 
PM2.5 from SOx (NH4SO4) 0.68 0.07 0.55 0.05 0.21 0.02 0.31 0.03 
PM2.5 from NOx (NH4NO3) 0.21 0.01 0.17 0.01 0.06 0.00 0.09 0.01 
primary PM2.5 2.00 0.51 1.62 0.41 0.61 0.15 0.90 0.23 
Petro-Canada - Oakville Refinery 
PM2.5 from SOx (NH4SO4) 1.04 0.04 0.84 0.03 0.32 0.01 0.47 0.02 
PM2.5 from NOx (NH4NO3) 0.10 0.01 0.08 0.00 0.03 0.00 0.04 0.00 
primary PM2.5 2.81 1.87 2.27 1.51 0.86 0.57 1.26 0.84 
Produits Shell Canada - Raffinerie de Montreal-est 
PM2.5 from SOx (NH4SO4) 1.01 0.10 0.82 0.08 0.31 0.03 0.46 0.05 
PM2.5 from NOx (NH4NO3) 0.28 0.01 0.23 0.01 0.09 0.00 0.13 0.01 
primary PM2.5 2.75 1.53 2.22 1.24 0.84 0.47 1.23 0.69 
Shell Canada Products - Sarnia Manufacturing Centre 
PM2.5 from SOx (NH4SO4) 2.22 0.03 1.79 0.03 0.68 0.01 1.00 0.01 
PM2.5 from NOx (NH4NO3) 0.24 0.05 0.20 0.04 0.07 0.02 0.11 0.02 
primary PM2.5 5.76 2.81 4.66 2.27 1.76 0.86 2.59 1.26 
Shell Canada Products - Shell Scotford Refinery 
PM2.5 from SOx (NH4SO4) 0.04 0.02 0.03 0.02 0.01 0.01 0.02 0.01 
PM2.5 from NOx (NH4NO3) 0.12 0.01 0.10 0.01 0.04 0.00 0.05 0.01 
primary PM2.5 0.26 0.25 0.21 0.20 0.08 0.08 0.12 0.11 
Sunoco Inc. - Sarnia Refinery 
PM2.5 from SOx (NH4SO4) 0.43 0.04 0.34 0.03 0.13 0.01 0.19 0.02 
PM2.5 from NOx (NH4NO3) 0.14 0.00 0.11 0.00 0.04 0.00 0.06 0.00 
primary PM2.5 1.72 1.06 1.39 0.86 0.53 0.32 0.77 0.48 
Ultramar Ltee - Raffinerie St. Romuald 
PM2.5 from SOx (NH4SO4) 0.66 0.03 0.54 0.03 0.20 0.01 0.30 0.02 
PM2.5 from NOx (NH4NO3) 0.24 0.06 0.20 0.05 0.07 0.02 0.11 0.03 
primary PM2.5 1.62 0.37 1.31 0.30 0.49 0.11 0.73 0.17 
Hypothetical Worst Case Refinery (Imperial Sarnia for PM) 
PM2.5 from SOx (NH4SO4) 4.13 0.38 3.34 0.31 1.26 0.12 1.86 0.17 
PM2.5 from NOx (NH4NO3) 0.41 0.01 0.33 0.01 0.12 0.00 0.18 0.00 





2.5  km 
NE SE SW NW  Refinery and PM type 
mean stdev mean stdev mean stdev mean stdev 
Chevron - Burnaby 
PM2.5 from SOx (NH4SO4) 0.16 0.00 0.13 0.00 0.06 0.00 0.09 0.00 
PM2.5 from NOx (NH4NO3) 0.06 0.02 0.05 0.01 0.02 0.01 0.03 0.01 
primary PM2.5 0.22 0.27 0.18 0.22 0.08 0.10 0.12 0.15 
Consumer's Co-operative Refineries Ltd./NewGrade Energy Inc.         
PM2.5 from SOx (NH4SO4) 0.46 0.15 0.37 0.12 0.16 0.05 0.25 0.08 
PM2.5 from NOx (NH4NO3) 0.13 0.02 0.11 0.01 0.05 0.01 0.07 0.01 
primary PM2.5 0.16 0.29 0.13 0.23 0.06 0.10 0.09 0.15 
Husky Oil Operations Limited - Prince George Refinery         
PM2.5 from SOx (NH4SO4) No data No data No data No data No data No data No data No data 
PM2.5 from NOx (NH4NO3) No data No data No data No data No data No data No data No data 
primary PM2.5 No data No data No data No data No data No data No data No data 
Imperial Oil - Dartmouth Refinery         
PM2.5 from SOx (NH4SO4) 0.76 0.08 0.60 0.07 0.27 0.03 0.41 0.05 
PM2.5 from NOx (NH4NO3) 0.41 0.02 0.32 0.01 0.14 0.01 0.22 0.01 
primary PM2.5 1.09 0.24 0.87 0.19 0.39 0.08 0.59 0.13 
Imperial Oil - Nanticoke Refinery         
PM2.5 from SOx (NH4SO4) 0.78 0.21 0.62 0.17 0.28 0.08 0.42 0.11 
PM2.5 from NOx (NH4NO3) 0.24 0.01 0.19 0.00 0.09 0.00 0.13 0.00 
primary PM2.5 0.63 0.18 0.50 0.14 0.22 0.06 0.34 0.10 
Imperial Oil - Sarnia Refinery Plan         
PM2.5 from SOx (NH4SO4) 3.21 0.30 2.56 0.24 1.14 0.11 1.73 0.16 
PM2.5 from NOx (NH4NO3) 0.32 0.01 0.25 0.01 0.11 0.00 0.17 0.00 
primary PM2.5 1.82 0.75 1.46 0.60 0.65 0.27 0.98 0.40 
Imperial Oil - Strathcona Refinery         
PM2.5 from SOx (NH4SO4) 0.69 0.04 0.55 0.03 0.25 0.01 0.37 0.02 
PM2.5 from NOx (NH4NO3) 0.21 0.03 0.17 0.02 0.07 0.01 0.11 0.01 
primary PM2.5 1.17 0.75 0.93 0.60 0.42 0.27 0.63 0.40 
Irving - Saint John         
PM2.5 from SOx (NH4SO4) 0.80 0.21 0.64 0.17 0.29 0.08 0.43 0.11 
PM2.5 from NOx (NH4NO3) 0.51 0.02 0.41 0.01 0.18 0.01 0.27 0.01 
primary PM2.5 0.96 0.44 0.77 0.35 0.34 0.16 0.52 0.24 
North Atlantic Refining - North Atlantic Refinery         
PM2.5 from SOx (NH4SO4) 2.13 0.24 1.70 0.19 0.76 0.09 1.15 0.13 
PM2.5 from NOx (NH4NO3) 0.16 0.02 0.13 0.02 0.06 0.01 0.09 0.01 
primary PM2.5 1.31 1.24 1.04 0.99 0.46 0.44 0.70 0.67 
Nova Chemicals (Ltd.) - Nova Chemicals (Canada) Ltd.         
PM2.5 from SOx (NH4SO4) No data No data No data No data No data No data No data No data 
PM2.5 from NOx (NH4NO3) No data No data No data No data No data No data No data No data 
primary PM2.5 No data No data No data No data No data No data No data No data 
Parkland - Bowden         
PM2.5 from SOx (NH4SO4) No data No data No data No data No data No data No data No data 
PM2.5 from NOx (NH4NO3) No data No data No data No data No data No data No data No data 
primary PM2.5 No data No data No data No data No data No data No data No data 
 
 




2.5  km 
NE SE SW NW  Refinery and PM type 
mean stdev mean stdev mean stdev mean stdev 
Petro-Canada - Edmonton Refinery         
PM2.5 from SOx (NH4SO4) 0.31 0.10 0.25 0.08 0.11 0.03 0.17 0.05 
PM2.5 from NOx (NH4NO3) 0.18 0.02 0.14 0.02 0.06 0.01 0.10 0.01 
primary PM2.5 0.56 0.24 0.45 0.19 0.20 0.09 0.30 0.13 
Petro-Canada - Mississauga Lubricant Center         
PM2.5 from SOx (NH4SO4) 0.19 0.04 0.15 0.03 0.07 0.01 0.10 0.02 
PM2.5 from NOx (NH4NO3) 0.07 0.02 0.06 0.02 0.03 0.01 0.04 0.01 
primary PM2.5 0.27 0.12 0.21 0.09 0.10 0.04 0.14 0.06 
Petro-Canada - Raffinerie de Montreal         
PM2.5 from SOx (NH4SO4) 0.53 0.05 0.42 0.04 0.19 0.02 0.29 0.03 
PM2.5 from NOx (NH4NO3) 0.16 0.01 0.13 0.01 0.06 0.00 0.09 0.00 
primary PM2.5 0.62 0.16 0.50 0.13 0.22 0.06 0.34 0.08 
Petro-Canada - Oakville Refinery         
PM2.5 from SOx (NH4SO4) 0.81 0.03 0.64 0.02 0.29 0.01 0.43 0.02 
PM2.5 from NOx (NH4NO3) 0.07 0.00 0.06 0.00 0.03 0.00 0.04 0.00 
primary PM2.5 0.87 0.58 0.70 0.47 0.31 0.21 0.47 0.31 
Produits Shell Canada - Raffinerie de Montreal-est         
PM2.5 from SOx (NH4SO4) 0.79 0.08 0.63 0.06 0.28 0.03 0.42 0.04 
PM2.5 from NOx (NH4NO3) 0.22 0.01 0.18 0.01 0.08 0.00 0.12 0.00 
primary PM2.5 0.86 0.48 0.68 0.38 0.30 0.17 0.46 0.26 
Shell Canada Products - Sarnia Manufacturing Centre         
PM2.5 from SOx (NH4SO4) 1.72 0.02 1.38 0.02 0.61 0.01 0.93 0.01 
PM2.5 from NOx (NH4NO3) 0.19 0.04 0.15 0.03 0.07 0.01 0.10 0.02 
primary PM2.5 1.79 0.87 1.43 0.70 0.64 0.31 0.97 0.47 
Shell Canada Products - Shell Scotford Refinery         
PM2.5 from SOx (NH4SO4) 0.03 0.02 0.03 0.02 0.01 0.01 0.02 0.01 
PM2.5 from NOx (NH4NO3) 0.09 0.01 0.08 0.01 0.03 0.00 0.05 0.00 
primary PM2.5 0.08 0.08 0.07 0.06 0.03 0.03 0.04 0.04 
Sunoco Inc. - Sarnia Refinery         
PM2.5 from SOx (NH4SO4) 0.33 0.03 0.26 0.03 0.12 0.01 0.18 0.02 
PM2.5 from NOx (NH4NO3) 0.11 0.00 0.09 0.00 0.04 0.00 0.06 0.00 
primary PM2.5 0.54 0.33 0.43 0.26 0.19 0.12 0.29 0.18 
Ultramar Ltee - Raffinerie St. Romuald         
PM2.5 from SOx (NH4SO4) 0.52 0.03 0.41 0.02 0.18 0.01 0.28 0.01 
PM2.5 from NOx (NH4NO3) 0.19 0.04 0.15 0.04 0.07 0.02 0.10 0.02 
primary PM2.5 0.50 0.12 0.40 0.09 0.18 0.04 0.27 0.06 
Hypothetical Worst Case Refinery (Imperial Sarnia for PM) 
PM2.5 from SOx (NH4SO4) 3.21 0.30 2.56 0.24 1.14 0.11 1.73 0.16 
PM2.5 from NOx (NH4NO3) 0.32 0.01 0.25 0.01 0.11 0.00 0.17 0.00 





5  km 
NE SE SW NW  Refinery and PM type 
mean stdev mean stdev mean stdev mean stdev 
Chevron - Burnaby 
PM2.5 from SOx (NH4SO4) 0.15 0.00 0.14 0.00 0.06 0.00 0.09 0.00 
PM2.5 from NOx (NH4NO3) 0.05 0.02 0.05 0.01 0.02 0.01 0.04 0.01 
primary PM2.5 0.10 0.13 0.10 0.12 0.04 0.05 0.07 0.08 
Consumer's Co-operative Refineries Ltd./NewGrade Energy Inc.         
PM2.5 from SOx (NH4SO4) 0.41 0.14 0.39 0.13 0.17 0.06 0.27 0.09 
PM2.5 from NOx (NH4NO3) 0.12 0.01 0.11 0.01 0.05 0.01 0.08 0.01 
primary PM2.5 0.08 0.13 0.07 0.12 0.03 0.05 0.05 0.09 
Husky Oil Operations Limited - Prince George Refinery         
PM2.5 from SOx (NH4SO4) No data No data No data No data No data No data No data No data 
PM2.5 from NOx (NH4NO3) No data No data No data No data No data No data No data No data 
primary PM2.5 No data No data No data No data No data No data No data No data 
Imperial Oil - Dartmouth Refinery         
PM2.5 from SOx (NH4SO4) 0.68 0.08 0.64 0.07 0.28 0.03 0.44 0.05 
PM2.5 from NOx (NH4NO3) 0.37 0.02 0.34 0.01 0.15 0.01 0.24 0.01 
primary PM2.5 0.50 0.11 0.47 0.10 0.21 0.05 0.32 0.07 
Imperial Oil - Nanticoke Refinery         
PM2.5 from SOx (NH4SO4) 0.70 0.19 0.66 0.18 0.29 0.08 0.45 0.12 
PM2.5 from NOx (NH4NO3) 0.22 0.01 0.20 0.00 0.09 0.00 0.14 0.00 
primary PM2.5 0.29 0.08 0.27 0.08 0.12 0.03 0.19 0.05 
Imperial Oil - Sarnia Refinery Plan         
PM2.5 from SOx (NH4SO4) 2.89 0.27 2.71 0.25 1.20 0.11 1.87 0.17 
PM2.5 from NOx (NH4NO3) 0.28 0.01 0.27 0.01 0.12 0.00 0.18 0.00 
primary PM2.5 0.84 0.34 0.79 0.32 0.35 0.14 0.54 0.22 
Imperial Oil - Strathcona Refinery         
PM2.5 from SOx (NH4SO4) 0.62 0.04 0.58 0.04 0.26 0.02 0.40 0.02 
PM2.5 from NOx (NH4NO3) 0.19 0.02 0.18 0.02 0.08 0.01 0.12 0.01 
primary PM2.5 0.54 0.35 0.51 0.32 0.23 0.14 0.35 0.22 
Irving - Saint John         
PM2.5 from SOx (NH4SO4) 0.73 0.19 0.68 0.18 0.30 0.08 0.47 0.12 
PM2.5 from NOx (NH4NO3) 0.46 0.01 0.43 0.01 0.19 0.01 0.30 0.01 
primary PM2.5 0.44 0.20 0.42 0.19 0.18 0.08 0.29 0.13 
North Atlantic Refining - North Atlantic Refinery         
PM2.5 from SOx (NH4SO4) 1.92 0.22 1.80 0.20 0.80 0.09 1.24 0.14 
PM2.5 from NOx (NH4NO3) 0.15 0.02 0.14 0.02 0.06 0.01 0.10 0.01 
primary PM2.5 0.60 0.57 0.57 0.54 0.25 0.24 0.39 0.37 
Nova Chemicals (Ltd.) - Nova Chemicals (Canada) Ltd.         
PM2.5 from SOx (NH4SO4) No data No data No data No data No data No data No data No data 
PM2.5 from NOx (NH4NO3) No data No data No data No data No data No data No data No data 
primary PM2.5 No data No data No data No data No data No data No data No data 
Parkland - Bowden         
PM2.5 from SOx (NH4SO4) No data No data No data No data No data No data No data No data 
PM2.5 from NOx (NH4NO3) No data No data No data No data No data No data No data No data 
primary PM2.5 No data No data No data No data No data No data No data No data 
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5  km 
NE SE SW NW  Refinery and PM type 
mean stdev mean stdev mean stdev mean stdev 
Petro-Canada - Edmonton Refinery      
PM2.5 from SOx (NH4SO4) 0.28 0.09 0.26 0.08 0.12 0.04 0.18 0.06 
PM2.5 from NOx (NH4NO3) 0.16 0.02 0.15 0.02 0.07 0.01 0.10 0.01 
primary PM2.5 0.26 0.11 0.24 0.10 0.11 0.05 0.17 0.07 
Petro-Canada - Mississauga Lubricant Center         
PM2.5 from SOx (NH4SO4) 0.17 0.03 0.16 0.03 0.07 0.01 0.11 0.02 
PM2.5 from NOx (NH4NO3) 0.07 0.02 0.06 0.02 0.03 0.01 0.04 0.01 
primary PM2.5 0.12 0.05 0.12 0.05 0.05 0.02 0.08 0.04 
Petro-Canada - Raffinerie de Montreal         
PM2.5 from SOx (NH4SO4) 0.48 0.05 0.45 0.04 0.20 0.02 0.31 0.03 
PM2.5 from NOx (NH4NO3) 0.15 0.01 0.14 0.01 0.06 0.00 0.09 0.01 
primary PM2.5 0.29 0.07 0.27 0.07 0.12 0.03 0.19 0.05 
Petro-Canada - Oakville Refinery         
PM2.5 from SOx (NH4SO4) 0.73 0.03 0.68 0.02 0.30 0.01 0.47 0.02 
PM2.5 from NOx (NH4NO3) 0.07 0.00 0.06 0.00 0.03 0.00 0.04 0.00 
primary PM2.5 0.40 0.27 0.38 0.25 0.17 0.11 0.26 0.17 
Produits Shell Canada - Raffinerie de Montreal-est         
PM2.5 from SOx (NH4SO4) 0.71 0.07 0.66 0.07 0.30 0.03 0.46 0.05 
PM2.5 from NOx (NH4NO3) 0.20 0.01 0.19 0.01 0.08 0.00 0.13 0.01 
primary PM2.5 0.39 0.22 0.37 0.21 0.16 0.09 0.26 0.14 
Shell Canada Products - Sarnia Manufacturing Centre         
PM2.5 from SOx (NH4SO4) 1.55 0.02 1.46 0.02 0.65 0.01 1.00 0.01 
PM2.5 from NOx (NH4NO3) 0.17 0.04 0.16 0.03 0.07 0.01 0.11 0.02 
primary PM2.5 0.83 0.40 0.78 0.38 0.35 0.17 0.53 0.26 
Shell Canada Products - Shell Scotford Refinery         
PM2.5 from SOx (NH4SO4) 0.03 0.02 0.03 0.02 0.01 0.01 0.02 0.01 
PM2.5 from NOx (NH4NO3) 0.07 0.02 0.07 0.01 0.03 0.01 0.05 0.01 
primary PM2.5 0.06 0.05 0.05 0.04 0.02 0.02 0.04 0.03 
Sunoco Inc. - Sarnia Refinery         
PM2.5 from SOx (NH4SO4) 0.30 0.03 0.28 0.03 0.12 0.01 0.19 0.02 
PM2.5 from NOx (NH4NO3) 0.10 0.00 0.09 0.00 0.04 0.00 0.06 0.00 
primary PM2.5 0.25 0.15 0.23 0.14 0.10 0.06 0.16 0.10 
Ultramar Ltee - Raffinerie St. Romuald         
PM2.5 from SOx (NH4SO4) 0.46 0.02 0.44 0.02 0.19 0.01 0.30 0.02 
PM2.5 from NOx (NH4NO3) 0.17 0.04 0.16 0.04 0.07 0.02 0.11 0.03 
primary PM2.5 0.23 0.05 0.22 0.05 0.10 0.02 0.15 0.03 
Hypothetical Worst Case Refinery (Imperial Sarnia for PM) 
PM2.5 from SOx (NH4SO4) 2.89 0.27 2.71 0.25 1.20 0.11 1.87 0.17 
PM2.5 from NOx (NH4NO3) 0.28 0.01 0.27 0.01 0.12 0.00 0.18 0.00 





10  km 
NE SE SW NW  Refinery and PM type 
mean stdev mean stdev mean stdev mean stdev 
Chevron - Burnaby 
PM2.5 from SOx (NH4SO4) 0.17 0.00 0.19 0.00 0.09 0.00 0.13 0.00 
PM2.5 from NOx (NH4NO3) 0.06 0.02 0.07 0.02 0.03 0.01 0.05 0.01 
primary PM2.5 0.06 0.08 0.07 0.09 0.03 0.04 0.05 0.06 
Consumer's Co-operative Refineries Ltd./NewGrade Energy Inc.      
PM2.5 from SOx (NH4SO4) 0.48 0.16 0.55 0.18 0.25 0.08 0.38 0.12 
PM2.5 from NOx (NH4NO3) 0.14 0.02 0.16 0.02 0.07 0.01 0.11 0.01 
primary PM2.5 0.05 0.08 0.05 0.09 0.02 0.04 0.04 0.06 
Husky Oil Operations Limited - Prince George Refinery      
PM2.5 from SOx (NH4SO4) No data No data No data No data No data No data No data No data 
PM2.5 from NOx (NH4NO3) No data No data No data No data No data No data No data No data 
primary PM2.5 No data No data No data No data No data No data No data No data 
Imperial Oil - Dartmouth Refinery      
PM2.5 from SOx (NH4SO4) 0.79 0.09 0.90 0.10 0.41 0.05 0.63 0.07 
PM2.5 from NOx (NH4NO3) 0.43 0.02 0.49 0.02 0.22 0.01 0.34 0.01 
primary PM2.5 0.30 0.07 0.35 0.07 0.16 0.03 0.24 0.05 
Imperial Oil - Nanticoke Refinery      
PM2.5 from SOx (NH4SO4) 0.81 0.22 0.93 0.25 0.42 0.12 0.64 0.18 
PM2.5 from NOx (NH4NO3) 0.25 0.01 0.29 0.01 0.13 0.00 0.20 0.00 
primary PM2.5 0.17 0.05 0.20 0.06 0.09 0.03 0.14 0.04 
Imperial Oil - Sarnia Refinery Plan      
PM2.5 from SOx (NH4SO4) 3.36 0.31 3.83 0.35 1.74 0.16 2.67 0.25 
PM2.5 from NOx (NH4NO3) 0.33 0.01 0.38 0.01 0.17 0.00 0.26 0.01 
primary PM2.5 0.51 0.21 0.58 0.24 0.26 0.11 0.40 0.16 
Imperial Oil - Strathcona Refinery      
PM2.5 from SOx (NH4SO4) 0.73 0.04 0.83 0.05 0.38 0.02 0.58 0.03 
PM2.5 from NOx (NH4NO3) 0.22 0.03 0.25 0.03 0.11 0.01 0.17 0.02 
primary PM2.5 0.33 0.21 0.37 0.24 0.17 0.11 0.26 0.17 
Irving - Saint John      
PM2.5 from SOx (NH4SO4) 0.84 0.22 0.96 0.25 0.44 0.12 0.67 0.18 
PM2.5 from NOx (NH4NO3) 0.54 0.02 0.61 0.02 0.28 0.01 0.42 0.01 
primary PM2.5 0.27 0.12 0.31 0.14 0.14 0.06 0.21 0.10 
North Atlantic Refining - North Atlantic Refinery      
PM2.5 from SOx (NH4SO4) 2.24 0.25 2.55 0.29 1.16 0.13 1.78 0.20 
PM2.5 from NOx (NH4NO3) 0.17 0.02 0.20 0.03 0.09 0.01 0.14 0.02 
primary PM2.5 0.36 0.35 0.41 0.39 0.19 0.18 0.29 0.27 
Nova Chemicals (Ltd.) - Nova Chemicals (Canada) Ltd.      
PM2.5 from SOx (NH4SO4) No data No data No data No data No data No data No data No data 
PM2.5 from NOx (NH4NO3) No data No data No data No data No data No data No data No data 
primary PM2.5 No data No data No data No data No data No data No data No data 
Parkland - Bowden      
PM2.5 from SOx (NH4SO4) No data No data No data No data No data No data No data No data 
PM2.5 from NOx (NH4NO3) No data No data No data No data No data No data No data No data 
primary PM2.5 No data No data No data No data No data No data No data No data 
  
      
 
226 
10  km 
NE SE SW NW  Refinery and PM type 
mean stdev mean stdev mean stdev mean stdev 
 
Petro-Canada - Edmonton Refinery 
PM2.5 from SOx (NH4SO4) 0.33 0.10 0.37 0.12 0.17 0.05 0.26 0.08 
PM2.5 from NOx (NH4NO3) 0.19 0.02 0.21 0.02 0.10 0.01 0.15 0.02 
primary PM2.5 0.16 0.07 0.18 0.08 0.08 0.03 0.12 0.05 
Petro-Canada - Mississauga Lubricant Center 
PM2.5 from SOx (NH4SO4) 0.20 0.04 0.22 0.04 0.10 0.02 0.15 0.03 
PM2.5 from NOx (NH4NO3) 0.08 0.02 0.09 0.02 0.04 0.01 0.06 0.02 
primary PM2.5 0.07 0.03 0.09 0.04 0.04 0.02 0.06 0.03 
Petro-Canada - Raffinerie de Montreal 
PM2.5 from SOx (NH4SO4) 0.55 0.05 0.63 0.06 0.29 0.03 0.44 0.04 
PM2.5 from NOx (NH4NO3) 0.17 0.01 0.19 0.01 0.09 0.00 0.14 0.01 
primary PM2.5 0.17 0.04 0.20 0.05 0.09 0.02 0.14 0.03 
Petro-Canada - Oakville Refinery 
PM2.5 from SOx (NH4SO4) 0.84 0.03 0.96 0.03 0.44 0.02 0.67 0.02 
PM2.5 from NOx (NH4NO3) 0.08 0.00 0.09 0.01 0.04 0.00 0.06 0.00 
primary PM2.5 0.24 0.16 0.28 0.19 0.13 0.08 0.19 0.13 
Produits Shell Canada - Raffinerie de Montreal-est 
PM2.5 from SOx (NH4SO4) 0.82 0.08 0.94 0.10 0.43 0.04 0.65 0.07 
PM2.5 from NOx (NH4NO3) 0.23 0.01 0.26 0.01 0.12 0.00 0.18 0.01 
primary PM2.5 0.24 0.13 0.27 0.15 0.12 0.07 0.19 0.11 
Shell Canada Products - Sarnia Manufacturing Centre 
PM2.5 from SOx (NH4SO4) 1.81 0.03 2.06 0.03 0.93 0.01 1.43 0.02 
PM2.5 from NOx (NH4NO3) 0.20 0.04 0.22 0.05 0.10 0.02 0.16 0.03 
primary PM2.5 0.50 0.24 0.57 0.28 0.26 0.13 0.40 0.19 
Shell Canada Products - Shell Scotford Refinery 
PM2.5 from SOx (NH4SO4) 0.03 0.02 0.04 0.02 0.02 0.01 0.03 0.02 
PM2.5 from NOx (NH4NO3) 0.10 0.01 0.11 0.01 0.05 0.00 0.08 0.01 
primary PM2.5 0.02 0.02 0.03 0.02 0.01 0.01 0.02 0.02 
Sunoco Inc. - Sarnia Refinery 
PM2.5 from SOx (NH4SO4) 0.35 0.03 0.39 0.04 0.18 0.02 0.27 0.03 
PM2.5 from NOx (NH4NO3) 0.11 0.00 0.13 0.00 0.06 0.00 0.09 0.00 
primary PM2.5 0.15 0.09 0.17 0.10 0.08 0.05 0.12 0.07 
Ultramar Ltee - Raffinerie St. Romuald 
PM2.5 from SOx (NH4SO4) 0.54 0.03 0.61 0.03 0.28 0.01 0.43 0.02 
PM2.5 from NOx (NH4NO3) 0.20 0.05 0.22 0.05 0.10 0.02 0.16 0.04 
primary PM2.5 0.14 0.03 0.16 0.04 0.07 0.02 0.11 0.03 
Hypothetical Worst Case Refinery (Imperial Sarnia for PM) 
PM2.5 from SOx (NH4SO4) 3.36 0.31 3.83 0.35 1.74 0.16 2.67 0.25 
PM2.5 from NOx (NH4NO3) 0.33 0.01 0.38 0.01 0.17 0.00 0.26 0.01 






25  km 
NE SE SW NW  Refinery and PM type 
mean stdev mean stdev mean stdev mean stdev 
Chevron - Burnaby 
PM2.5 from SOx (NH4SO4) 0.16 0.00 0.21 0.00 0.09 0.00 0.16 0.00 
PM2.5 from NOx (NH4NO3) 0.06 0.02 0.08 0.02 0.03 0.01 0.06 0.02 
primary PM2.5 0.03 0.03 0.03 0.04 0.02 0.02 0.03 0.03 
Consumer's Co-operative Refineries Ltd./NewGrade Energy Inc.         
PM2.5 from SOx (NH4SO4) 0.44 0.14 0.59 0.19 0.26 0.08 0.44 0.14 
PM2.5 from NOx (NH4NO3) 0.13 0.02 0.17 0.02 0.08 0.01 0.13 0.02 
primary PM2.5 0.02 0.03 0.03 0.04 0.01 0.02 0.02 0.03 
Husky Oil Operations Limited - Prince George Refinery         
PM2.5 from SOx (NH4SO4) No data No data No data No data No data No data No data No data 
PM2.5 from NOx (NH4NO3) No data No data No data No data No data No data No data No data 
primary PM2.5 No data No data No data No data No data No data No data No data 
Imperial Oil - Dartmouth Refinery         
PM2.5 from SOx (NH4SO4) 0.73 0.08 0.97 0.11 0.42 0.05 0.73 0.08 
PM2.5 from NOx (NH4NO3) 0.39 0.02 0.52 0.02 0.23 0.01 0.39 0.02 
primary PM2.5 0.13 0.03 0.17 0.04 0.07 0.02 0.13 0.03 
Imperial Oil - Nanticoke Refinery         
PM2.5 from SOx (NH4SO4) 0.75 0.21 1.00 0.27 0.44 0.12 0.75 0.21 
PM2.5 from NOx (NH4NO3) 0.23 0.01 0.31 0.01 0.14 0.00 0.23 0.01 
primary PM2.5 0.07 0.02 0.10 0.03 0.04 0.01 0.07 0.02 
Imperial Oil - Sarnia Refinery Plan         
PM2.5 from SOx (NH4SO4) 3.09 0.29 4.12 0.38 1.80 0.17 3.09 0.29 
PM2.5 from NOx (NH4NO3) 0.30 0.01 0.41 0.01 0.18 0.00 0.30 0.01 
primary PM2.5 0.21 0.09 0.28 0.11 0.12 0.05 0.21 0.09 
Imperial Oil - Strathcona Refinery         
PM2.5 from SOx (NH4SO4) 0.67 0.04 0.89 0.05 0.39 0.02 0.67 0.04 
PM2.5 from NOx (NH4NO3) 0.20 0.02 0.27 0.03 0.12 0.01 0.20 0.02 
primary PM2.5 0.14 0.09 0.18 0.12 0.08 0.05 0.14 0.09 
Irving - Saint John         
PM2.5 from SOx (NH4SO4) 0.78 0.21 1.03 0.27 0.45 0.12 0.78 0.21 
PM2.5 from NOx (NH4NO3) 0.49 0.02 0.66 0.02 0.29 0.01 0.49 0.02 
primary PM2.5 0.11 0.05 0.15 0.07 0.06 0.03 0.11 0.05 
North Atlantic Refining - North Atlantic Refinery         
PM2.5 from SOx (NH4SO4) 2.06 0.23 2.74 0.31 1.20 0.14 2.06 0.23 
PM2.5 from NOx (NH4NO3) 0.16 0.02 0.21 0.03 0.09 0.01 0.16 0.02 
primary PM2.5 0.15 0.14 0.20 0.19 0.09 0.08 0.15 0.14 
Nova Chemicals (Ltd.) - Nova Chemicals (Canada) Ltd.         
PM2.5 from SOx (NH4SO4) No data No data No data No data No data No data No data No data 
PM2.5 from NOx (NH4NO3) No data No data No data No data No data No data No data No data 
primary PM2.5 No data No data No data No data No data No data No data No data 
Parkland - Bowden         
PM2.5 from SOx (NH4SO4) No data No data No data No data No data No data No data No data 
PM2.5 from NOx (NH4NO3) No data No data No data No data No data No data No data No data 








25  km 
NE SE SW NW  Refinery and PM type 
mean stdev mean stdev mean stdev mean stdev 
Petro-Canada - Edmonton Refinery         
PM2.5 from SOx (NH4SO4) 0.30 0.09 0.40 0.13 0.18 0.05 0.30 0.09 
PM2.5 from NOx (NH4NO3) 0.17 0.02 0.23 0.03 0.10 0.01 0.17 0.02 
primary PM2.5 0.06 0.03 0.09 0.04 0.04 0.02 0.06 0.03 
Petro-Canada - Mississauga Lubricant Center         
PM2.5 from SOx (NH4SO4) 0.18 0.04 0.24 0.05 0.10 0.02 0.18 0.04 
PM2.5 from NOx (NH4NO3) 0.07 0.02 0.09 0.02 0.04 0.01 0.07 0.02 
primary PM2.5 0.03 0.01 0.04 0.02 0.02 0.01 0.03 0.01 
Petro-Canada - Raffinerie de Montreal         
PM2.5 from SOx (NH4SO4) 0.51 0.05 0.68 0.07 0.30 0.03 0.51 0.05 
PM2.5 from NOx (NH4NO3) 0.16 0.01 0.21 0.01 0.09 0.01 0.16 0.01 
primary PM2.5 0.07 0.02 0.10 0.02 0.04 0.01 0.07 0.02 
Petro-Canada - Oakville Refinery         
PM2.5 from SOx (NH4SO4) 0.78 0.03 1.03 0.04 0.45 0.02 0.78 0.03 
PM2.5 from NOx (NH4NO3) 0.07 0.00 0.10 0.01 0.04 0.00 0.07 0.00 
primary PM2.5 0.10 0.07 0.13 0.09 0.06 0.04 0.10 0.07 
Produits Shell Canada - Raffinerie de Montreal-est         
PM2.5 from SOx (NH4SO4) 0.76 0.08 1.01 0.10 0.44 0.05 0.76 0.08 
PM2.5 from NOx (NH4NO3) 0.21 0.01 0.28 0.01 0.12 0.00 0.21 0.01 
primary PM2.5 0.10 0.05 0.13 0.07 0.06 0.03 0.10 0.05 
Shell Canada Products - Sarnia Manufacturing Centre         
PM2.5 from SOx (NH4SO4) 1.66 0.02 2.21 0.03 0.97 0.01 1.66 0.02 
PM2.5 from NOx (NH4NO3) 0.18 0.04 0.24 0.05 0.11 0.02 0.18 0.04 
primary PM2.5 0.21 0.10 0.28 0.13 0.12 0.06 0.21 0.10 
Shell Canada Products - Shell Scotford Refinery         
PM2.5 from SOx (NH4SO4) 0.03 0.02 0.04 0.02 0.02 0.01 0.03 0.02 
PM2.5 from NOx (NH4NO3) 0.09 0.01 0.12 0.01 0.05 0.01 0.09 0.01 
primary PM2.5 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 
Sunoco Inc. - Sarnia Refinery         
PM2.5 from SOx (NH4SO4) 0.32 0.03 0.42 0.04 0.19 0.02 0.32 0.03 
PM2.5 from NOx (NH4NO3) 0.11 0.00 0.14 0.00 0.06 0.00 0.11 0.00 
primary PM2.5 0.06 0.04 0.08 0.05 0.04 0.02 0.06 0.04 
Ultramar Ltee - Raffinerie St. Romuald         
PM2.5 from SOx (NH4SO4) 0.50 0.03 0.66 0.03 0.29 0.01 0.50 0.03 
PM2.5 from NOx (NH4NO3) 0.18 0.04 0.24 0.06 0.11 0.02 0.18 0.04 
primary PM2.5 0.06 0.01 0.08 0.02 0.03 0.01 0.06 0.01 
Hypothetical Worst Case Refinery (Imperial Sarnia for PM) 
PM2.5 from SOx (NH4SO4) 3.09 0.29 4.12 0.38 1.80 0.17 3.09 0.29 
PM2.5 from NOx (NH4NO3) 0.30 0.01 0.41 0.01 0.18 0.00 0.30 0.01 
primary PM2.5 0.21 0.09 0.28 0.11 0.12 0.05 0.21 0.09 
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Appendix F – NIST data for calculation of Atmospheric 
OH values 
 
Substance NIST: values for ~289 K extracted;  2nd order rxn  
 Atkinson (book) (Calvert, Atkinson et al. 
2002) 































































Likely to associate with particles 
 
estimated half-life for reaction with 
photochemically produced hydroxyl 
radicals is 21.49 hr 
http://speclab.com/compound/c50328.htm 
 























































Dicyclopentadiene No match Boiling point ~ 400 K   
Diethanolamine 
(and its salts) 
No match 























































































































































5.8x10-11 ± 20% 



















5.63*10-12 ± 20% 
























































13.6 *10-12 ±25%–orth 
23.1 *10-12 ±15%–met 
14.3 *10-12 ±25%–para 
 
 
For xylene – use the most conservative 
estimate – which will imply choosing one of 
the isomers and using that one (i.e. the one 
with the slowest degradation).  
Zinc (and its 
compounds) NO RXN 
  
PM2.5 from SOx CACs considered by alternate method   
PM2.5 from NOx CACs considered by alternate method   

































































































1,3-Butadiene 5.00E-01 3.00E-01 5.00E-02 3.00E-01 1.00E-01 
Benzene 2.70E+00 1.20E+00 4.00E-01 1.50E+00 2.30E+00 
Ethylene (as 5% Ethylene 
Oxide) 3.10E+00 2.70E+00 4.50E-01 2.90E+00 1.70E+00 
Nickel (Elements totals bound 
to PM) 2.47E-03 2.03E-03 7.11E-04 4.90E-03 1.95E-03 
PAHs (BaP surrogate class) 
BaP 9.00E-05 2.00E-05 1.00E-05 4.00E-05 4.00E-05 
Formaldehyde 1.60E+00 2.64E+00 8.00E-01 2.64E+00 2.70E+00 
Acetaldehyde 1.90E+00 1.70E+00 6.50E-01 1.70E+00 1.30E+00 
1,2,4-trimethylbenzene 5.00E-01 4.00E-01 5.00E-02 6.00E-01 1.00E-01 
Ammonia 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 
Benzene (as BTEX potentiator) 2.70E+00 1.20E+00 4.00E-01 1.50E+00 2.30E+00 
BTEX  Special Case – derived using a combination of B, T, E, X 
Cyclohexane 6.40E+00 2.00E-01 5.00E-02 3.00E-01 1.00E-01 
Dicyclopentadiene 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 
Diethanolamine (and its salts) 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 
Ethylbenzene 2.30E+00 6.00E-01 1.00E-01 7.00E-01 3.00E-01 
Hydrogen Sulphide 6.97E-04 6.97E-04 2.79E-04 6.97E-04 6.97E-04 
Isoprene 4.00E-01 3.00E-01 5.00E-02 3.00E-01 1.00E-01 
Mercury (Elements totals 
bound to PM) 1.70E-03 3.45E-03 6.67E-04 3.94E-03 2.63E-03 
Methanol 1.43E+01 1.43E+01 3.57E+00 1.43E+01 1.43E+01 
Methyl Ethyl Ketone (MEK) 1.10E+00 1.49E+00 2.50E-01 1.49E+00 8.00E-01 
Methyl Isobutyl Ketone (MIBK) 2.00E-01 2.42E-01 5.00E-02 2.42E-01 1.00E-01 
Methyl Tert-Butyl Ether 
(MTBE) 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 
Naphthalene 9.00E-01 8.00E-01 1.00E-01 7.00E-01 5.00E-01 
n-Hexane 8.00E+00 8.00E-01 2.00E-01 9.00E-01 7.00E-01 
Phenol 4.05E+00 4.05E+00 2.03E+00 4.05E+00 4.05E+00 
Propylene 3.40E+00 1.10E+00 3.00E-01 1.20E+00 1.30E+00 
Styrene 2.00E-01 1.00E-01 0.00E+00 1.00E-01 1.00E-01 
Sulphuric Acid 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 
Toluene 1.53E+01 3.60E+00 7.00E-01 3.80E+00 1.40E+00 
Vanadium (Elements totals 
bound to PM) 9.71E-03 7.46E-03 2.62E-03 2.93E-02 6.65E-03 
Xylene 1.07E+01 2.70E+00 4.00E-01 3.20E+00 9.00E-01 
Zinc (Elements totals bound to 
PM) 1.37E-02 2.89E-02 2.38E-03 4.76E-03 2.29E-02 
or PM2.5 (DC)p 8.00E+00 8.00E+00 9.00E+00 8.00E+00 1.10E+01 
(from precursors)      
Ammonia 0 0 0 0 0 
Nox (NO2, ppb) 11 13 11 17 8 



























































































1,3-Butadiene 2.00E-01 2.00E-01 1.00E-01 5.00E-02 2.00E-01 
Benzene 1.20E+00 1.70E+00 8.00E-01 4.00E-01 1.20E+00 
Ethylene (as 5% Ethylene 
Oxide) 4.40E+00 3.70E+00 9.00E-01 4.50E-01 4.40E+00 
Nickel (Elements totals bound 
to PM) 1.62E-03 1.64E-03 2.16E-03 7.11E-04 1.62E-03 
PAHs (BaP surrogate class) 
BaP 2.60E-04 3.00E-05 1.50E-04 1.00E-05 2.60E-04 
Formaldehyde 2.90E+00 2.64E+00 1.60E+00 8.00E-01 2.90E+00 
Acetaldehyde 1.80E+00 1.70E+00 1.50E+00 6.50E-01 1.80E+00 
1,2,4-trimethylbenzene 3.00E-01 9.00E-01 2.00E-01 5.00E-02 3.00E-01 
Ammonia 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 
Benzene (as BTEX potentiator) 1.20E+00 1.70E+00 8.00E-01 4.00E-01 1.20E+00 
BTEX  Special Case – derived using a combination of B, T, E, X 
Cyclohexane 1.10E+00 1.40E+00 4.00E-01 5.00E-02 1.10E+00 
Dicyclopentadiene 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 
Diethanolamine (and its salts) 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 
Ethylbenzene 5.00E-01 8.00E-01 2.00E-01 1.00E-01 5.00E-01 
Hydrogen Sulphide 6.97E-04 6.97E-04 6.97E-04 2.79E-04 6.97E-04 
Isoprene 3.00E-01 9.00E-01 2.00E-01 5.00E-02 3.00E-01 
Mercury (Elements totals 
bound to PM) 1.91E-03 1.33E-03 3.44E-03 6.67E-04 1.91E-03 
Methanol 1.43E+01 1.43E+01 1.43E+01 7.14E+00 1.43E+01 
Methyl Ethyl Ketone (MEK) 2.40E+00 1.49E+00 5.00E-01 2.50E-01 2.40E+00 
Methyl Isobutyl Ketone (MIBK) 4.00E-01 2.42E-01 1.00E-01 5.00E-02 4.00E-01 
Methyl Tert-Butyl Ether 
(MTBE) 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 
Naphthalene 6.00E-01 6.00E-01 7.00E-01 1.00E-01 6.00E-01 
n-Hexane 2.40E+00 5.30E+00 4.00E-01 2.00E-01 2.40E+00 
Phenol 4.05E+00 4.05E+00 4.05E+00 2.03E+00 4.05E+00 
Propylene 1.50E+00 1.10E+00 8.40E+00 3.00E-01 1.50E+00 
Styrene 1.00E-01 6.00E-01 0.00E+00 0.00E+00 1.00E-01 
Sulphuric Acid 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 
Toluene 3.30E+00 3.40E+00 1.50E+00 7.00E-01 3.30E+00 
Vanadium (Elements totals 
bound to PM) 5.23E-03 6.56E-03 6.60E-03 2.62E-03 5.23E-03 
Xylene 1.60E+00 3.50E+00 8.00E-01 4.00E-01 1.60E+00 
Zinc (Elements totals bound to 
PM) 7.59E-02 1.76E-02 3.22E-02 2.38E-03 7.59E-02 
or PM2.5 (DC)p 1.10E+01 8.00E+00 6.00E+00 2.50E+00 1.10E+01 
(from precursors)      
Ammonia 0 0 0 0 0 
Nox (NO2, ppb) 17 24 5 1.54E+01 17 








































































































1,3-Butadiene 5.00E-02 2.00E-01 1.00E-01 2.00E-01 1.00E-01 
Benzene 4.00E-01 1.70E+00 1.10E+00 3.00E+00 1.40E+00 
Ethylene (as 5% Ethylene 
Oxide) 4.50E-01 3.70E+00 1.40E+00 3.70E+00 1.40E+00 
Nickel (Elements totals bound 
to PM) 7.11E-04 1.64E-03 1.42E-03 3.97E-03 1.42E-03 
PAHs (BaP surrogate class) 
BaP 1.00E-05 3.00E-05 1.90E-04 5.70E-04 1.90E-04 
Formaldehyde 8.00E-01 2.64E+00 3.50E+00 2.80E+00 3.50E+00 
Acetaldehyde 6.50E-01 1.70E+00 1.50E+00 2.00E+00 1.50E+00 
1,2,4-trimethylbenzene 5.00E-02 9.00E-01 5.00E-01 5.00E-01 5.00E-01 
Ammonia 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 
Benzene (as BTEX potentiator) 4.00E-01 1.70E+00 1.10E+00 3.00E+00 1.40E+00 
BTEX  Special Case – derived using a combination of B, T, E, X 
Cyclohexane 5.00E-02 1.40E+00 6.00E-01 7.00E-01 6.00E-01 
Dicyclopentadiene 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 
Diethanolamine (and its salts) 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 
Ethylbenzene 1.00E-01 8.00E-01 1.00E+00 1.20E+00 7.00E-01 
Hydrogen Sulphide 2.79E-04 6.97E-04 6.97E-04 6.97E-04 6.97E-04 
Isoprene 5.00E-02 9.00E-01 2.00E-01 2.00E-01 5.00E-01 
Mercury (Elements totals 
bound to PM) 6.67E-04 1.33E-03 1.81E-03 1.82E-03 1.81E-03 
Methanol 7.14E+00 1.43E+01 1.43E+01 1.43E+01 1.43E+01 
Methyl Ethyl Ketone (MEK) 2.50E-01 1.49E+00 1.50E+00 1.20E+00 1.50E+00 
Methyl Isobutyl Ketone (MIBK) 5.00E-02 2.42E-01 2.00E-01 2.00E-01 2.00E-01 
Methyl Tert-Butyl Ether 
(MTBE) 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 
Naphthalene 1.00E-01 6.00E-01 2.00E-01 7.00E-01 7.00E-01 
n-Hexane 2.00E-01 5.30E+00 9.00E-01 1.90E+00 3.30E+00 
Phenol 2.03E+00 4.05E+00 4.05E+00 4.05E+00 4.05E+00 
Propylene 3.00E-01 1.10E+00 6.00E-01 1.60E+00 1.01E+01 
Styrene 0.00E+00 6.00E-01 3.00E-01 4.00E-01 1.00E-01 
Sulphuric Acid 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 
Toluene 7.00E-01 3.40E+00 6.60E+00 5.90E+00 6.50E+00 
Vanadium (Elements totals 
bound to PM) 2.62E-03 6.56E-03 5.47E-03 1.17E-02 5.47E-03 
Xylene 4.00E-01 3.50E+00 3.90E+00 4.40E+00 3.00E+00 
Zinc (Elements totals bound to 
PM) 2.38E-03 1.76E-02 3.30E-02 3.24E-02 3.30E-02 
or PM2.5 (DC)p 5.00E+00 8.00E+00 9.00E+00 1.00E+01 9.00E+00 
(from precursors)      
Ammonia 0 0 0 0 0 
Nox (NO2, ppb) 14 24 26 14 16 












































































1,3-Butadiene 2.00E-01 2.00E-01 2.00E-01 2.00E-01 3.00E-01 
Benzene 1.20E+00 1.70E+00 3.00E+00 1.20E+00 1.31E+00 
Ethylene (as 5% Ethylene 
Oxide) 4.40E+00 3.70E+00 3.70E+00 4.40E+00 9.00E-01 
Nickel (Elements totals bound 
to PM) 1.62E-03 1.64E-03 3.97E-03 1.62E-03 2.19E-02 
PAHs (BaP surrogate class) 
BaP 2.60E-04 3.80E-04 5.70E-04 2.60E-04 1.50E-04 
Formaldehyde 2.90E+00 2.64E+00 2.80E+00 2.90E+00 1.60E+00 
Acetaldehyde 1.80E+00 1.70E+00 2.00E+00 1.80E+00 1.50E+00 
1,2,4-trimethylbenzene 3.00E-01 9.00E-01 5.00E-01 3.00E-01 2.00E-01 
Ammonia 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 
Benzene (as BTEX 
potentiator) 1.20E+00 1.70E+00 3.00E+00 1.20E+00 8.00E-01 
BTEX  Special Case – derived using a combination of B, T, E, X 
Cyclohexane 1.10E+00 1.40E+00 7.00E-01 1.10E+00 4.00E-01 
Dicyclopentadiene 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 
Diethanolamine (and its salts) 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 
Ethylbenzene 5.00E-01 8.00E-01 1.20E+00 5.00E-01 2.00E-01 
Hydrogen Sulphide 6.97E-04 5.58E-04 6.97E-04 6.97E-04 6.97E-04 
Isoprene 3.00E-01 9.00E-01 2.00E-01 3.00E-01 2.00E-01 
Mercury (Elements totals 
bound to PM) 1.91E-03 1.33E-03 1.82E-03 1.91E-03 2.19E-03 
Methanol 1.43E+01 1.43E+01 1.43E+01 1.43E+01 1.43E+01 
Methyl Ethyl Ketone (MEK) 2.40E+00 1.49E+00 1.20E+00 2.40E+00 5.00E-01 
Methyl Isobutyl Ketone 
(MIBK) 4.00E-01 2.42E-01 2.00E-01 4.00E-01 1.00E-01 
Methyl Tert-Butyl Ether 
(MTBE) 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 
Naphthalene 6.00E-01 6.00E-01 7.00E-01 6.00E-01 7.00E-01 
n-Hexane 2.40E+00 5.30E+00 1.90E+00 2.40E+00 4.00E-01 
Phenol 4.05E+00 4.05E+00 4.05E+00 4.05E+00 4.05E+00 
Propylene 1.50E+00 1.10E+00 1.60E+00 1.50E+00 8.40E+00 
Styrene 1.00E-01 6.00E-01 4.00E-01 1.00E-01 0.00E+00 
Sulphuric Acid 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 
Toluene 3.30E+00 3.40E+00 5.90E+00 3.30E+00 5.10E+00 
Vanadium (Elements totals 
bound to PM) 5.23E-03 6.56E-03 1.17E-02 5.23E-03 1.32E-02 
Xylene 1.60E+00 3.50E+00 4.40E+00 1.60E+00 8.00E-01 
Zinc (Elements totals bound 
to PM) 7.59E-02 1.76E-02 3.24E-02 7.59E-02 1.36E-01 
or PM2.5 (DC)p 1.10E+01 6.00E+00 1.00E+01 1.10E+01 8.00E+00 
(from precursors)      
Ammonia 0 0 0 0 0 
Nox (NO2, ppb) 17 14 14 17 14 






Appendix H – Parametric Background Concentrations  
 
 Background levels 














1,3-Butadiene 0.21 1.60 0.20 1.44 0.08 2.02 
Benzene 2.08 1.38 1.24 1.10 0.72 2.07 
Ethylene (as 5% Ethylene 
Oxide) 3.14 1.44 2.81 1.93 0.85 2.18 
Nickel (Elements totals bound 
to PM) 0.00 1.55 0.00 2.76 0.00 1.79 
PAHs (BaP surrogate class) 
BaP 0.00 3.62 0.00 1.99 0.00 2.97 
Formaldehyde 2.60 1.27 2.70 1.28 1.34 1.82 
Acetaldehyde 1.78 1.11 1.69 1.09 0.98 1.59 
1,2,4-trimethylbenzene 0.64 1.37 0.34 1.45 0.10 2.40 
Ammonia 0.00 0.00 0.00 0.00 0.00 0.00 
Benzene (as BTEX 
potentiator) 2.08 1.38 1.15 1.21 0.72 2.07 
BTEX  0.00 
Cyclohexane 1.26 2.24 0.73 1.75 0.10 2.40 
Dicyclopentadiene 0.00 0.00 0.00 0.00 0.00 0.00 
Diethanolamine (and its salts) 0.00 0.00 0.00 0.00 0.00 0.00 
Ethylbenzene 1.02 1.51 0.51 1.63 0.18 2.10 
Hydrogen Sulphide 0.00 1.09 0.00 1.00 0.00 1.65 
Isoprene 0.48 1.97 0.27 1.22 0.10 2.20 
Mercury (Elements totals 
bound to PM) 0.00 1.17 0.00 1.32 0.00 2.35 
Methanol 14.27 1.00 14.27 1.00 8.99 1.76 
Methyl Ethyl Ketone (MEK) 1.34 1.15 1.68 1.78 0.46 2.12 
Methyl Isobutyl Ketone 
(MIBK) 0.22 1.11 0.28 1.70 0.08 1.88 
Methyl Tert-Butyl Ether 
(MTBE) 0.00 0.00 0.00 0.00 0.00 0.00 
Naphthalene 0.68 1.16 0.54 1.55 0.26 2.83 
n-Hexane 3.92 1.75 1.40 2.06 0.35 1.92 
Phenol 4.05 1.00 4.05 1.00 2.86 1.46 
Propylene 1.97 2.28 1.63 2.22 0.83 3.75 
Styrene 0.35 1.98 0.00 0.00 0.00 0.00 
Sulphuric Acid 0.00 0.00 0.00 0.00 0.00 0.00 
Toluene 5.41 1.72 3.96 1.32 1.17 1.93 
Vanadium (Elements totals 
bound to PM) 0.01 1.37 0.01 1.98 0.00 1.70 
Xylene 4.29 1.53 1.82 1.69 0.71 2.13 
Zinc (Elements totals bound to 





Appendix I: Proportion of predicted incidence below the 





















Benzene 1.00 0.00 Leukemia 4 
Ethylene (as 5% 
ethylene oxide) 1.00 0.00 Leukemia 3 
Nickel 0.91 0.09 Lung cancer 1 
PAH (using 
Benzo[a] pyrene) 1.00 0.00 Lung cancer 2 
     
1,2,4-
trimethylbenzene 1.00 0.00 
Moderate 
anemia 9 
BTEX 0.64 0.36 CNS neurotoxicity 1 
Cyclohexane 1.00 0.00 Reduced bodyweight 6 
Hydrogen sulphide 1.00 0.00 Nose irritation 8 
MTBE 1.00 0.00 PNS neurotoxicity 5 
Naphthalene 1.00 0.00 Benign lung tumors 10 
n-hexane 1.00 0.00 PNS neurotixicity 4 















Zinc 1.00 0.00 Moderate anemia 11 
 


















Benzene 0.96 0.04 Leukemia 1 
                                                 
28 Rank may be based on differences at the 10-8 level or less 
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Ethylene (as 5% 
ethylene oxide) 0.98 0.02 Leukemia 2 
Nickel 0.98 0.02 Lung cancer 3 
     
1,2,4-
trimethylbenzene 1.00 0.00 
Moderate 
anemia 9 
Ammonia 1.00 0.00 skin and nose irritation 10 
BTEX 0.83 0.17 CNS neurotoxicity 1 
Cyclohexane 1.00 0.00 Reduced bodyweight 4 
Hydrogen sulphide 0.92 0.08 Nose irritation 2 
Naphthalene 0.99 0.01 Benign lung tumors 3 
n-hexane 1.00 0.00 PNS neurotoxicity 8 
Phenol 1.00 0.00 Mild CNS neurotoxicity 11 


































BTEX 0.83 0.17 CNS neurotoxicity 1 
Cyclohexane 1.00 0.00 Reduced bodyweight 2 
Hydrogen 
sulphide 1.00 0.00 Nose irritation 4 
n-hexane 1.00 0.00 PNS neurotoxicity 5 
Propylene 1.00 0.00 























Benzene 0.99 0.01 Leukemia 2 





Benzo[a] pyrene) 0.98 0.02 Lung cancer 1 
     
1,2,4-
trimethylbenzene 1.00 0.00 
Moderate 
anemia 12 
Ammonia 1.00 0.00 skin and nose irritation 13 
BTEX 0.81 0.19 CNS neurotoxicity 2 
Cyclohexane 1.00 0.00 Reduced bodyweight 8 
Diethanolamine 1.00 0.00 Throat irritation 9 
Hydrogen sulphide 0.99 0.01 Nose irritation 3 
Mercury 1.00 0.00 severe CNS neurotoxicity 9 
Methanol 1.00 0.00 Benign lung tumors 6 
Naphthalene 1.00 0.00 PNS neurotoxicity 4 
n-hexane 1.00 0.00 Mild CNS neurotoxicity 5 
Phenol 1.00 0.00 Mild CNS neurotoxicity 7 





























Benzene 1.00 0.00 Leukemia 3 
Ethylene (as 5% 
ethylene oxide) 1.00 0.00 Leukemia 2 
PAH (using 
Benzo[a] pyrene) 0.98 0.02 Lung cancer 1 
     
1,2,4-
trimethylbenzene 1.00 0.00 
Moderate 
anemia 10 
Ammonia 1.00 0.00 skin and nose irritation 12 
BTEX 0.83 0.17 CNS neurotoxicity 2 
Cyclohexane 1.00 0.00 Reduced bodyweight 4 
Diethanolamine 1.00 0.00 Throat irritation 5 
Hydrogen sulphide 0.96 0.04 Nose irritation 3 
Mercury 1.00 0.00 severe CNS neurotoxicity 6 
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Methanol 1.00 0.00 physical teratogenesis 9 
Naphthalene 1.00 0.00 Benign lung tumors 11 
n-hexane 1.00 0.00 PNS neurotoxicity 8 
Phenol 1.00 0.00 mild CNS neurotoxicity 13 
Propylene 1.00 0.00 




























1,3-butadiene 1.00 0.00 Leukemia 4 
Benzene 0.96 0.04 Leukemia 3 
Ethylene (as 5% 
ethylene oxide) 1.00 0.00 Leukemia 5 
Nickel 0.16 0.84 Lung cancer 1 
PAH (using 
Benzo[a] pyrene) 0.65 0.35 Lung cancer 2 
     
1,2,4-
trimethylbenzene 1.00 0.00 
Moderate 
anemia 13 
Ammonia 1.00 0.00 skin and nose irritation 14 
BTEX 0.81 0.19 CNS neurotoxicity 3 
Cyclohexane 1.00 0.00 Reduced bodyweight 11 
Hydrogen sulphide 0.97 0.03 Nose irritation 4 
Mercury 1.00 0.00 severe CNS neurotoxicity 10 
Methanol 1.00 0.00 physical teratogenesis 8 
Naphthalene 0.99 0.01 Benign lung tumors 6 
n-hexane 0.99 0.01 PNS neurotoxicity 5 
Phenol 1.00 0.00 mild CNS neurotoxicity 9 
Propylene 1.00 0.00 













Zinc 0.99 0.01 Moderate anemia 7 
 


















Benzene 1.00 0.00 Leukemia 3 
Ethylene (as 5% 
ethylene oxide) 1.00 0.00 Leukemia 2 
PAH (using 
Benzo[a] pyrene) 0.99 0.01 Lung cancer 1 
     
1,2,4-
trimethylbenzene 1.00 0.00 Moderate anemia 13 
Ammonia 1.00 0.00 skin and nose irritation 12 
BTEX 0.65 0.35 CNS neurotoxicity 1 
Cyclohexane 1.00 0.00 Reduced bodyweight 9 
Hydrogen sulphide 1.00 0.00 Nose irritation 5 
Mercury 1.00 0.00 severe CNS neurotoxicity 8 
MEK 1.00 0.00 developmental retardation 10 
MIBK 1.00 0.00 developmental retardation 7 
Naphthalene 0.99 0.01 Benign lung tumors 4 
n-hexane 0.99 0.01 PNS neurotoxicity 3 
Phenol 1.00 0.00 mild CNS neurotoxicity 6 
Propylene 1.00 0.00 




Sulphuric Acid 0.71 0.29 




Zinc 1.00 0.00 Moderate anemia 14 
 


















1,3-butadiene 1.00 0.00 Leukemia 4 
Benzene 0.98 0.02 Leukemia 1 
Ethylene (as 5% 
ethylene oxide) 1.00 0.00 Lung cancer 2 
 
242 
Nickel 0.88 0.12 Lung cancer 2 
     
1,2,4-
trimethylbenzene 1.00 0.00 Moderate anemia 7 
BTEX 0.83 0.17 CNS neurotoxicity 1 
Cyclohexane 1.00 0.00 Reduced bodyweight 3 
Hydrogen sulphide 1.00 0.00 Nose irritation 8 
MTBE 1.00 0.00 PNS neurotoxicity 4 
Naphthalene 1.00 0.00 Benign lung tumors 9 
n-hexane 1.00 0.00 PNS neurotoxicity 6 
Propylene 1.00 0.00 









Vanadium 1.00 0.00 Nasal and upper airway irriatation 7 
 


















Benzene 0.96 0.04 Leukemia 2 
Nickel 0.27 0.73 Lung cancer 1 
PAH (using 
Benzo[a] pyrene) 1.00 0.00 Lung cancer 3 
     
1,2,4-
trimethylbenzene 1.00 0.00 
Moderate 
anemia 8 
BTEX 0.82 0.18 CNS neurotoxicity 2 
Cyclohexane 1.00 0.00 Reduced bodyweight 4 
Diethanolamine 1.00 0.00 Throat irritation 6 
Hydrogen sulphide 0.99 0.01 Nose irritation 3 
MTBE 1.00 0.00 PNS neurotoxicity 5 
n-hexane 1.00 0.00 PNS neurotoxicity 7 
Phenol 1.00 0.00 mild CNS neurotoxicity 10 



























1,3-butadiene 0.97 0.03 Leukemia 3 
Benzene 0.92 0.08 Leukemia 1 
Ethylene (as 5% 
ethylene oxide) 0.97 0.03 Leukemia 2 
PAH (using 
Benzo[a] pyrene) 1.00 0.00 Lung cancer 4 
     
1,2,4-
trimethylbenzene 1.00 0.00 
Moderate 
anemia 12 
BTEX 0.80 0.20 CNS neurotoxicity 2 
Cyclohexane 1.00 0.00 Reduced bodyweight 8 
Dicyclopentadiene 1.00 0.00 chronic renal disease 10 
Hydrogen sulphide 1.00 0.00 Nose irritation 7 
Isoprene 1.00 0.00 benign lung tumours 5 
Mercury 1.00 0.00 severe CNS neurotoxicity 6 
Naphthalene 0.99 0.01 Benign lung tumors 3 
n-hexane 1.00 0.00 PNS neurotoxicity 4 
Phenol 1.00 0.00 mild CNS neurotoxicity 9 
Propylene 1.00 0.00 





























trimethylbenzene 1.00 0.00 
Moderate 
anemia  
BTEX 0.83 0.17 CNS neurotoxicity 1 
Cyclohexane 1.00 0.00 Reduced bodyweight  
n-hexane 1.00 0.00 PNS neurotoxicity  
 




















Benzene 1.00 0.00 Leukemia 4 
Ethylene (as 5% 
ethylene oxide) 1.00 0.00 Leukemia 2 
Nickel 1.00 0.00 Lung cancer 3 
PAH (using 
Benzo[a] pyrene) 1.00 0.00 Lung cancer 1 
     
1,2,4-
trimethylbenzene 1.00 0.00 
Moderate 
anemia 10 
BTEX 0.65 0.35 CNS neurotoxicity 1 
Cyclohexane 1.00 0.00 Reduced bodyweight 7 
Diethanolamine 1.00 0.00 Throat irritation 5 
Hydrogen sulphide 1.00 0.00 Nose irritation 8 
Mercury 1.00 0.00 severe CNS neurotoxicity 6 
n-hexane 0.99 0.01 PNS neurotoxicity 4 
Propylene 1.00 0.00 









Vanadium 0.96 0.04 nasal and upper airway irritation 3 
Zinc 1.00 0.00 Moderate anemia 11 
 


















Benzene 1.00 0.00 Leukemia 1 
     
1,2,4-
trimethylbenzene 1.00 0.00 Moderate anemia 9 
BTEX 0.81 0.19 CNS neurotoxicity 1 
Cyclohexane 1.00 0.00 Reduced bodyweight 5 
Diethanolamine 1.00 0.00 Throat irritation 4 
Hydrogen 
sulphide 1.00 0.00 Nose irritation 6 
MEK 1.00 0.00 developmental retardation 7 




n-hexane 1.00 0.00 PNS neurotoxicity 10 
Propylene 1.00 0.00 




Sulphuric Acid 0.90 0.10 
























1,3-butadiene 1.00 0.00 Leukemia 4 
Benzene 0.98 0.02 Leukemia 2 
Ethylene (as 5% 
ethylene oxide) 1.00 0.00 Leukemia 5 
Nickel 0.76 0.24 Lung cancer 1 
PAH (using 
Benzo[a] pyrene) 0.99 0.01 Lung cancer 3 
     
1,2,4-
trimethylbenzene 1.00 0.00 
Moderate 
anemia 9 
BTEX 0.64 0.36 CNS neurotoxicity 1 
Cyclohexane 1.00 0.00 Reduced bodyweight 6 
Hydrogen sulphide 1.00 0.00 Nose irritation 5 
Mercury 1.00 0.00 severe CNS neurotoxicity 6 
Methanol 1.00 0.00 physical teratogenesis 12 
Naphthalene 1.00 0.00 Benign lung tumors 10 
n-hexane 1.00 0.00 PNS neurotoxicity 4 
Propylene 1.00 0.00 









Vanadium 0.72 0.28 nasal and upper airway irritation 2 
Zinc 1.00 0.00 Moderate anemia 11 
 




















1,3-butadiene 1.00 0.00 Leukemia 3 
Benzene 1.00 0.00 Leukemia 5 
Ethylene (as 5% 
ethylene oxide) 1.00 0.00 Leukemia 4 
Nickel 0.92 0.08 Lung cancer 2 
PAH (using 
Benzo[a] pyrene) 0.29 0.71 Lung cancer 1 
     
1,2,4-
trimethylbenzene 1.00 0.00 
Moderate 
anemia 11 
Ammonia 1.00 0.00 skin and nose irritation 5 
BTEX 0.64 0.36 CNS neurotoxicity 1 
Cyclohexane 1.00 0.00 Reduced bodyweight 8 
Diethanolamine 1.00 0.00 Throat irritation 6 
Hydrogen sulphide 1.00 0.00 Nose irritation 9 
Mercury 1.00 0.00 severe CNS neurotoxicity 7 
Naphthalene 1.00 0.00 Benign lung tumors 12 
n-hexane 1.00 0.00 PNS neurotoxicity 4 
Propylene 1.00 0.00 





























Benzene 1.00 0.00 Leukemia 2 
Ethylene (as 5% 
ethylene oxide) 1.00 0.00 Leukemia 3 
PAH (using 
Benzo[a] pyrene) 0.95 0.05 Lung Cancer 1 
     
1,2,4-
trimethylbenzene 1.00 0.00 Moderate anemia 14 
Ammonia 1.00 0.00 skin and nose irritation 13 
BTEX 0.64 0.36 CNS neurotoxicity 1 
Cyclohexane 1.00 0.00 Reduced bodyweight 8 
Diethanolamine 1.00 0.00 Throat irritation 8 
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Hydrogen sulphide 1.00 0.00 Nose irritation 11 
Mercury 1.00 0.00 severe CNS neurotoxicity 6 
MEK 1.00 0.00 developmental retardation 10 
MIBK 1.00 0.00 developmental retardation 7 
Naphthalene 1.00 0.00 Benign lung tumors 4 
n-hexane 0.99 0.01 PNS neurotoxicity 3 
Phenol 1.00 0.00 mild CNS neurotoxicity 5 
Propylene 1.00 0.00 




Sulphuric Acid 0.74 0.26 























Benzene 0.95 0.05 Leukemia 2 
Ethylene (as 5% 
ethylene oxide) 1.00 0.00 Leukemia 4 
Nickel 0.43 0.57 Lung Cancer 1 
PAH (using 
Benzo[a] pyrene) 0.95 0.05 Lung Cancer 3 
     
1,2,4-
trimethylbenzene 1.00 0.00 
Moderate 
anemia 10 
Ammonia 1.00 0.00 skin and nose irritation 6 
BTEX 0.80 0.20 CNS neurotoxicity 3 
Cyclohexane 1.00 0.00 Reduced bodyweight 7 
Diethanolamine 1.00 0.00 Throat irritation 9 
Hydrogen sulphide 0.99 0.01 Nose irritation 4 
Mercury 1.00 0.00 severe CNS neurotoxicity 8 
Methanol 1.00 0.00 physical teratogenesis 13 
Naphthalene 1.00 0.00 Benign lung tumors 5 
n-hexane 1.00 0.00 PNS neurotoxicity 12 
Propylene 1.00 0.00 









Vanadium 0.55 0.45 nasal and upper airway irritation 2 
 


















Benzene 1.00 0.00 Leukemia 2 
Nickel 1.00 0.00 Lung Cancer 3 
PAH (using 
Benzo[a] pyrene) 0.75 0.25 Lung Cancer 1 
     
1,2,4-
trimethylbenzene 1.00 0.00 
Moderate 
anemia 7 
Ammonia 1.00 0.00 skin and nose irritation 8 
BTEX 0.64 0.36 CNS neurotoxicity 1 
Cyclohexane 1.00 0.00 Reduced bodyweight 4 
Hydrogen sulphide 1.00 0.00 Nose irritation 5 
Mercury 1.00 0.00 severe CNS neurotoxicity 3 
Naphthalene 1.00 0.00 Benign lung tumors 8 
n-hexane 1.00 0.00 PNS neurotoxicity 2 
Propylene 1.00 0.00 
























Benzene 0.95 0.05 Leukemia 3 
PAH (using 
Benzo[a] pyrene) 0.93 0.07 Lung Cancer 1 
Formaldehyde 0.94 0.06 nasal and lung cancer 2 
     
1,2,4-
trimethylbenzene 1.00 0.00 
Moderate 
anemia 8 
BTEX 0.80 0.20 CNS neurotoxicity 2 
Cyclohexane 1.00 0.00 Reduced bodyweight 5 
Hydrogen sulphide 1.00 0.00 Nose irritation 6 
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Naphthalene 1.00 0.00 Benign lung tumors 3 
n-hexane 1.00 0.00 PNS neurotoxicity 4 
Propylene 1.00 0.00 




























Benzene 1.00 0.00 Leukemia 1 
Ethylene (as 5% 
ethylene oxide) 1.00 0.00 Leukemia 3 
PAH (using 
Benzo[a] pyrene) 1.00 0.00 Lung Cancer 2 
     
1,2,4-
trimethylbenzene 1.00 0.00 
Moderate 
anemia 9 
Ammonia 1.00 0.00 skin and nose irritation 7 
BTEX 0.81 0.19 CNS neurotoxicity 1 
Cyclohexane 1.00 0.00 Reduced bodyweight 6 
Hydrogen sulphide 0.98 0.02 Nose irritation 3 
Mercury 1.00 0.00 severe CNS neurotoxicity 5 
Naphthalene 1.00 0.00 Benign lung tumors 10 
n-hexane 1.00 0.00 PNS neurotoxicity 4 
Propylene 1.00 0.00 




























1,3-Butadiene 0.97 0.03 Leukemia 6 
Benzene 0.92 0.08 Leukemia 3 
Ethylene (as 5% 
ethylene oxide) 0.97 0.03 Leukemia 5 
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Nickel 0.24 0.76 Lung Cancer 1 
PAH (using 
Benzo[a] pyrene) 0.26 0.74 Lung Cancer 2 
Formaldehyde 0.96 0.04 nasal and lung cancer 4 
     
1,2,4-
trimethylbenzene 0.99 0.01 Moderate anemia 7 
Ammonia 1.00 0.00 skin and nose irritation 20 
BTEX 0.64 0.36 CNS neurotoxicity 3 
Cyclohexane 1.00 0.00 Reduced bodyweight 12 
Dicyclopentadiene 1.00 0.00 chronic renal disease 17 
Diethanolamine 1.00 0.00 Throat irritation 16 
Hydrogen sulphide 0.94 0.06 Nose irritation 4 
Isoprene 1.00 0.00 benign lung tumours 9 
Mercury 1.00 0.00 severe CNS neurotoxicity 14 
Methanol 1.00 0.00 physical teratogenesis 8 
MEK 1.00 0.00 developmental retardation 13 
MIBK 1.00 0.00 developmental retardation 10 
MTBE 1.00 0.00 PNS neurotoxicity 11 
Naphthalene 0.99 0.01 Benign lung tumors 6 
n-hexane 0.98 0.02 PNS neurotoxicity 5 
Phenol 1.00 0.00 mild CNS neurotoxicity 15 
Propylene 1.00 0.00 









Sulphuric Acid 0.57 0.43 




Vanadium 0.43 0.57 nasal and upper airway irritation 1 






Appendix J: Predicted Case Incidence and Rates for 








Refinery: Chevron Burnaby (population = 1 694 061 ) 
PM from SOx - Mortality 0.8 8.2 15.7 4.9E-06 
          Chronic bronchitis 1.5 15.4 29.3 9.2E-06 
          Asthma hospitalizations 0.1 1.0 1.8 5.7E-07 
          Asthma ER visits 0.2 1.7 3.3 1.0E-06 
PM from NOx - Mortality  0.3 3.1 5.9 1.8E-06 
         Chronic bronchitis 0.6 5.7 10.8 3.4E-06 
         Asthma hospitalizations 0.0 0.4 0.7 2.3E-07 
         Asthma ER visits 0.1 0.6 1.1 3.6E-07 
Primary PM - Mortality 0.2 2.1 3.9 1.2E-06 
        Chronic bronchitis 0.4 3.9 7.4 2.3E-06 
        Asthma hospitalizations 0.0 0.2 0.5 1.5E-07 
        Asthma ER visits 0.0 0.4 0.8 2.5E-07 
Refinery: Consumer’s Co-operative (population = 193 214) 
PM from SOx - Mortality 0.2 2.0 3.8 1.0E-05 
          Chronic bronchitis 0.4 4.0 7.6 2.1E-05 
          Asthma hospitalizations 0.0 0.2 0.4 1.2E-06 
          Asthma ER visits 0.0 0.4 0.7 2.0E-06 
PM from NOx - Mortality  0.1 0.6 1.1 3.0E-06 
         Chronic bronchitis 0.1 1.1 2.1 5.7E-06 
         Asthma hospitalizations 0.0 0.1 0.1 3.9E-07 
         Asthma ER visits 0.0 0.1 0.2 6.1E-07 
Primary PM - Mortality 0.0 0.3 0.5 1.3E-06 
        Chronic bronchitis 0.1 0.5 1.0 2.8E-06 
        Asthma hospitalizations 0.0 0.0 0.1 1.6E-07 
        Asthma ER visits 0.0 0.1 0.1 2.9E-07 
Refinery: Husky Prince-George 
No emissions reported 
Refinery: Imperial-Dartmouth (population = 317 113) 
PM from SOx - Mortality 0.7 7.0 13.4 2.2E-05 
          Chronic bronchitis 1.3 13.3 25.2 4.2E-05 
          Asthma hospitalizations 0.1 0.9 1.7 2.8E-06 
          Asthma ER visits 0.1 1.5 2.8 4.6E-06 
PM from NOx - Mortality  0.4 3.9 7.4 1.2E-05 
         Chronic bronchitis 0.8 8.1 15.4 2.6E-05 
         Asthma hospitalizations 0.0 0.4 0.9 1.4E-06 
         Asthma ER visits 0.1 0.7 1.4 2.3E-06 
Primary PM - Mortality 0.3 2.6 5.0 8.3E-06 
        Chronic bronchitis 0.5 5.0 9.4 1.6E-05 
        Asthma hospitalizations 0.0 0.3 0.6 9.5E-07 
        Asthma ER visits 0.1 0.5 1.0 1.7E-06 
Refinery: Imperial Nanticoke (population = 47 143) 
PM from SOx - Mortality 0.1 1.1 2.0 2.2E-05 
          Chronic bronchitis 0.2 2.0 3.7 4.1E-05 
          Asthma hospitalizations 0.0 0.1 0.2 2.5E-06 
          Asthma ER visits 0.0 0.2 0.4 4.3E-06 
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PM from NOx - Mortality  0.0 0.3 0.7 7.3E-06 
         Chronic bronchitis 0.1 0.7 1.4 1.5E-05 
         Asthma hospitalizations 0.0 0.0 0.1 8.0E-07 
         Asthma ER visits 0.0 0.1 0.1 1.4E-06 
Primary PM - Mortality 0.01 0.13 0.25 2.8E-06 
        Chronic bronchitis 0.02 0.24 0.45 5.0E-06 
        Asthma hospitalizations 0.00 0.01 0.03 3.1E-07 
        Asthma ER visits 0.00 0.02 0.05 5.3E-07 
Refinery: Imperial Sarnia (population = 98 730) 
PM from SOx - Mortality 1.0 10.1 19.2 1.0E-04 
          Chronic bronchitis 2.0 19.8 37.6 2.0E-04 
          Asthma hospitalizations 0.1 1.2 2.3 1.2E-05 
          Asthma ER visits 0.2 2.0 3.8 2.0E-05 
PM from NOx - Mortality  0.1 1.1 2.1 1.1E-05 
         Chronic bronchitis 0.2 2.0 3.7 2.0E-05 
         Asthma hospitalizations 0.0 0.1 0.2 1.2E-06 
         Asthma ER visits 0.0 0.2 0.4 2.0E-06 
Primary PM - Mortality 0.2 2.0 3.7 2.0E-05 
        Chronic bronchitis 0.4 3.6 6.9 3.7E-05 
        Asthma hospitalizations 0.0 0.2 0.4 2.2E-06 
        Asthma ER visits 0.0 0.4 0.8 4.2E-06 
Refinery: Imperial Strathcona (population =  929 299) 
PM from SOx - Mortality 1.7 17.1 32.5 1.8E-05 
          Chronic bronchitis 3.2 32.4 61.5 3.5E-05 
          Asthma hospitalizations 0.2 1.9 3.6 2.0E-06 
          Asthma ER visits 0.3 3.4 6.5 3.7E-06 
PM from NOx - Mortality  0.5 5.0 9.5 5.4E-06 
         Chronic bronchitis 1.0 9.6 18.3 1.0E-05 
         Asthma hospitalizations 0.1 0.5 1.0 5.9E-07 
         Asthma ER visits 0.1 1.0 1.9 1.1E-06 
Primary PM - Mortality 0.5 4.8 9.2 5.2E-06 
        Chronic bronchitis 0.9 9.0 17.1 9.7E-06 
        Asthma hospitalizations 0.1 0.5 1.0 5.9E-07 
        Asthma ER visits 0.1 1.0 1.9 1.1E-06 
Refinery: Irving Saint-John (population = 109 203) 
PM from SOx - Mortality 0.2 2.3 4.4 2.1E-05 
          Chronic bronchitis 0.4 4.4 8.3 4.0E-05 
          Asthma hospitalizations 0.0 0.3 0.6 2.7E-06 
          Asthma ER visits 0.0 0.4 0.8 4.0E-06 
PM from NOx - Mortality  0.1 1.4 2.8 1.3E-05 
         Chronic bronchitis 0.3 2.8 5.3 2.6E-05 
         Asthma hospitalizations 0.0 0.2 0.3 1.5E-06 
         Asthma ER visits 0.0 0.3 0.5 2.6E-06 
Primary PM - Mortality 0.08 0.81 1.54 7.4E-06 
        Chronic bronchitis 0.14 1.44 2.73 1.3E-05 
        Asthma hospitalizations 0.01 0.10 0.19 9.0E-07 
        Asthma ER visits 0.02 0.16 0.31 1.5E-06 
Refinery: North Atlantic Come-by-Chance (population = 4710) 
PM from SOx - Mortality 0.0 0.3 0.6 7.2E-05 
          Chronic bronchitis 0.1 0.7 1.2 1.4E-04 
          Asthma hospitalizations 0.0 0.0 0.1 8.0E-06 
          Asthma ER visits 0.0 0.1 0.1 1.4E-05 
PM from NOx - Mortality  0.0 0.0 0.1 6.0E-06 
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         Chronic bronchitis 0.0 0.1 0.1 1.1E-05 
         Asthma hospitalizations 0.0 0.0 0.0 6.6E-07 
         Asthma ER visits 0.0 0.0 0.0 1.1E-06 
Primary PM - Mortality 0.0 0.1 0.1 1.3E-05 
        Chronic bronchitis 0.0 0.1 0.2 2.4E-05 
        Asthma hospitalizations 0.0 0.0 0.0 1.4E-06 
        Asthma ER visits 0.0 0.0 0.0 2.3E-06 
Refinery: NOVA Corunna (population = 102 094) 
No reported emissions 
Refinery: Parkland-Bowden (population = 25 933) 
Missing reported emissions 
Refinery: Petro-Canada Edmonton (population = 929 431) 
PM from SOx - Mortality 0.8 7.6 14.5 8.2E-06 
          Chronic bronchitis 1.4 14.5 27.5 1.6E-05 
          Asthma hospitalizations 0.1 0.9 1.8 1.0E-06 
          Asthma ER visits 0.1 1.5 2.8 1.6E-06 
PM from NOx - Mortality  0.4 4.4 8.4 4.7E-06 
         Chronic bronchitis 0.8 7.9 15.0 8.5E-06 
         Asthma hospitalizations 0.0 0.5 0.9 5.1E-07 
         Asthma ER visits 0.1 0.9 1.7 9.4E-07 
Primary PM - Mortality 0.2 2.4 4.5 2.5E-06 
        Chronic bronchitis 0.4 4.3 8.1 4.6E-06 
        Asthma hospitalizations 0.0 0.3 0.5 2.9E-07 
        Asthma ER visits 0.0 0.5 0.9 5.0E-07 
Refinery: Petro-Canada Mississauga (population= 1 572 665) 
PM from SOx - Mortality 0.9 9.1 17.4 5.8E-06 
          Chronic bronchitis 1.8 18.1 34.3 1.1E-05 
          Asthma hospitalizations 0.1 1.1 2.1 7.0E-07 
          Asthma ER visits 0.2 1.7 3.2 1.1E-06 
PM from NOx - Mortality  0.3 3.5 6.6 2.2E-06 
         Chronic bronchitis 0.7 6.8 12.9 4.3E-06 
         Asthma hospitalizations 0.0 0.4 0.8 2.8E-07 
         Asthma ER visits 0.1 0.7 1.3 4.4E-07 
Primary PM - Mortality 0.2 2.1 3.9 1.3E-06 
        Chronic bronchitis 0.4 3.6 6.8 2.3E-06 
        Asthma hospitalizations 0.0 0.2 0.4 1.5E-07 
        Asthma ER visits 0.0 0.4 0.7 2.5E-07 
Refinery: Petro-Canada Montreal (population = 2 560 328) 
PM from SOx - Mortality 3.6 35.5 67.5 1.4E-05 
          Chronic bronchitis 6.7 66.7 126.8 2.6E-05 
          Asthma hospitalizations 0.4 4.2 8.0 1.7E-06 
          Asthma ER visits 0.7 6.8 12.9 2.7E-06 
PM from NOx - Mortality  1.1 10.9 20.7 4.3E-06 
         Chronic bronchitis 2.1 21.2 40.4 8.3E-06 
         Asthma hospitalizations 0.1 1.2 2.3 4.7E-07 
         Asthma ER visits 0.2 2.1 3.9 8.0E-07 
Primary PM - Mortality 0.7 6.8 13.0 2.7E-06 
        Chronic bronchitis 1.3 13.0 24.8 5.1E-06 
        Asthma hospitalizations 0.1 0.8 1.5 3.1E-07 
        Asthma ER visits 0.1 1.4 2.6 5.3E-07 
Refinery: Petro-Canada Oakville (population = 1 095 580) 
PM from SOx - Mortality 2.3 23.1 43.9 2.1E-05 
          Chronic bronchitis 4.2 42.3 80.5 3.9E-05 
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          Asthma hospitalizations 0.3 3.0 5.7 2.7E-06 
          Asthma ER visits 0.5 5.0 9.5 4.6E-06 
PM from NOx - Mortality  0.2 2.3 4.3 2.1E-06 
         Chronic bronchitis 0.4 4.2 7.9 3.8E-06 
         Asthma hospitalizations 0.0 0.3 0.5 2.5E-07 
         Asthma ER visits 0.0 0.5 0.9 4.1E-07 
Primary PM - Mortality 0.4 4.3 8.2 3.9E-06 
        Chronic bronchitis 0.9 8.5 16.2 7.8E-06 
        Asthma hospitalizations 0.1 0.5 1.0 4.6E-07 
        Asthma ER visits 0.1 0.9 1.7 8.1E-07 
Refinery: Shell Montreal (population = 2 612 269) 
PM from SOx - Mortality 8.7 86.7 164.7 3.3E-05 
          Chronic bronchitis 16.1 160.9 305.6 6.2E-05 
          Asthma hospitalizations 1.1 11.3 21.4 4.3E-06 
          Asthma ER visits 1.6 16.5 31.3 6.3E-06 
PM from NOx - Mortality  2.5 24.7 46.9 9.4E-06 
         Chronic bronchitis 4.5 44.7 85.0 1.7E-05 
         Asthma hospitalizations 0.3 2.6 5.0 1.0E-06 
         Asthma ER visits 0.4 4.4 8.4 1.7E-06 
Primary PM - Mortality 1.5 14.8 28.2 5.7E-06 
        Chronic bronchitis 2.5 25.2 47.8 9.6E-06 
        Asthma hospitalizations 0.2 1.5 2.9 5.8E-07 
        Asthma ER visits 0.3 2.6 4.9 9.9E-07 
Refinery: Shell Sarnia (population = 96 725) 
PM from SOx - Mortality 0.6 5.7 10.9 5.9E-05 
          Chronic bronchitis 1.1 10.8 20.5 1.1E-04 
          Asthma hospitalizations 0.1 0.7 1.3 7.0E-06 
          Asthma ER visits 0.1 1.1 2.1 1.1E-05 
PM from NOx - Mortality  0.1 0.6 1.2 6.4E-06 
         Chronic bronchitis 0.1 1.2 2.2 1.2E-05 
         Asthma hospitalizations 0.0 0.1 0.1 7.1E-07 
         Asthma ER visits 0.0 0.1 0.2 1.2E-06 
Primary PM - Mortality 0.1 1.3 2.4 1.3E-05 
        Chronic bronchitis 0.2 2.2 4.2 2.3E-05 
        Asthma hospitalizations 0.0 0.1 0.3 1.4E-06 
        Asthma ER visits 0.0 0.2 0.4 2.4E-06 
Refinery: Shell Scotford (population = 31 231) 
PM from SOx - Mortality 0.0 0.0 0.1 8.8E-07 
          Chronic bronchitis 0.0 0.0 0.1 1.6E-06 
          Asthma hospitalizations 0.0 0.0 0.0 1.2E-07 
          Asthma ER visits 0.0 0.0 0.0 1.8E-07 
PM from NOx - Mortality  0.0 0.1 0.2 2.5E-06 
         Chronic bronchitis 0.0 0.2 0.3 5.0E-06 
         Asthma hospitalizations 0.0 0.0 0.0 3.1E-07 
         Asthma ER visits 0.0 0.0 0.0 5.5E-07 
Primary PM - Mortality 0.0 0.0 0.0 3.1E-07 
        Chronic bronchitis 0.0 0.0 0.0 5.5E-07 
        Asthma hospitalizations 0.0 0.0 0.0 4.0E-08 
        Asthma ER visits 0.0 0.0 0.0 6.2E-08 
Refinery: Sunoco Sarnia (population = 96 977) 
PM from SOx - Mortality 0.1 1.1 2.0 1.1E-05 
          Chronic bronchitis 0.2 2.0 3.8 2.1E-05 
          Asthma hospitalizations 0.0 0.1 0.2 1.3E-06 
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          Asthma ER visits 0.0 0.2 0.4 2.3E-06 
PM from NOx - Mortality  0.0 0.4 0.7 3.7E-06 
         Chronic bronchitis 0.1 0.7 1.3 7.2E-06 
         Asthma hospitalizations 0.0 0.0 0.1 4.2E-07 
         Asthma ER visits 0.0 0.1 0.2 8.2E-07 
Primary PM - Mortality 0.0 0.5 0.9 4.9E-06 
        Chronic bronchitis 0.1 0.9 1.7 9.5E-06 
        Asthma hospitalizations 0.0 0.1 0.1 5.2E-07 
        Asthma ER visits 0.0 0.1 0.2 8.8E-07 
Refinery: Ultramar St. Romuald (population = 631 211) 
PM from SOx - Mortality 1.1 10.7 20.3 1.7E-05 
          Chronic bronchitis 1.9 18.7 35.5 3.0E-05 
          Asthma hospitalizations 0.1 1.2 2.2 1.9E-06 
          Asthma ER visits 0.2 1.9 3.7 3.1E-06 
PM from NOx - Mortality  0.4 3.7 6.9 5.8E-06 
         Chronic bronchitis 0.7 7.3 13.9 1.2E-05 
         Asthma hospitalizations 0.0 0.4 0.8 6.3E-07 
         Asthma ER visits 0.1 0.7 1.4 1.1E-06 
Primary PM - Mortality 0.2 1.8 3.4 2.9E-06 
        Chronic bronchitis 0.3 3.4 6.5 5.4E-06 
        Asthma hospitalizations 0.0 0.2 0.4 3.3E-07 
        Asthma ER visits 0.0 0.3 0.7 5.4E-07 
Refinery: Hypothetical Worst-Case (population = 2 612 269) 
PM from SOx - Mortality 34.9 348.9 662.9 1.3E-04 
          Chronic bronchitis 71.0 709.5 1348.1 2.7E-04 
          Asthma hospitalizations 3.8 37.8 71.8 1.4E-05 
          Asthma ER visits 6.5 64.7 123.0 2.5E-05 
PM from NOx - Mortality  3.3 33.3 63.3 1.3E-05 
         Chronic bronchitis 6.5 64.5 122.6 2.5E-05 
         Asthma hospitalizations 0.4 3.8 7.2 1.5E-06 
         Asthma ER visits 0.6 6.5 12.3 2.5E-06 
Primary PM - Mortality 2.8 28.0 53.1 1.1E-05 
        Chronic bronchitis 5.4 53.9 102.4 2.1E-05 
        Asthma hospitalizations 0.3 3.2 6.2 1.2E-06 






ADI   Acceptable Daily Intake 
ATSDR  Agency for Toxic Substances and Disease Registry 
BTEX   Benzene, Toluene, Ethylbenzene and Xylene 
CAC   Criteria Air Contaminants 
CalEPA  California Environmental Protection Agency 
CB   Crystal BallTM 
CCME   Canadian Council for Ministers of the Environment 
CDF   Cumulative Distribution Function 
CEPA   Canadian Environmental Protection Act 
CPPI   Canadian Petroleum Producers Institute 
CNS   Central Nervous System 
C-R   Concentration-Response Parameter 
CWS   Canada-Wide Standards 
DALY   Disability Adjusted Life Years 
DALYp  DALYs per person 
ED05   Estimated Dose Affecting 5% of the Population 
GIS   Geographic Information System 
GSD   Geometric Standard Deviation 
HEAST  Health Effects Assessment Summary Tables 
HEIDI   Health Effects Indicators Decision Index 
HPS   Health Prioritization Subgroup 
IARC   International Agency for Research on Cancer 
ILSI   International Life Science Institute 
IRIS   Integrated Risk Information System 
IUPAC  International Union of Pure and Applied Chemistry 
k   Rate Constant for Reaction with OH (substance-specific) 
LCA   Life Cycle Analysis 
LCIA   Life Cycle Impact Analysis 
LHS   Latin Hypercube Sampling 
LOAEL  Lowest Observed Adverse Effect Level 
MEK   Methyl Ethyl Ketone 
MIBK   Methyl iso-butyl Ketone 
MTBE   Methyl tert-butyl Ether 
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NAPS   National Air Pollutant Survey (Network) 
NERAM  Network for Environmental Risk Assessment and Management 
NFPRER  National Framework for Petroleum Refinery Emissions Reductions 
NIST   National Institute of Science and Technology 
NOAEL  No-Observed Adverse Effects Level 
NPRI   National Pollutant Release Inventory 
OH   Ambient Concentration of OH 
PAH   Polycyclic Aromatic Hydrocarbons 
PDF   Probability Density Function 
PM   Particulate Matter 
PSL   Priority Substances List 
RfC   Reference Concentration 
SETAC  Society of Environmental Toxicology and Chemistry  
SR   Sensitivity Ratio 
TC05   Tolerable Concentration Affecting 5% of the Population 
TERA   Toxicology Excellence for Risk Assessment 
TRACI Tool for the Reduction and Assessment of Chemical and Other 
Environmental Impacts 
USEPA  United States Environmental Protection Agency 
WTP   Willingness to Pay 
YLD   Years of Life Disabled 
YLL   Years of Life Lost 
 
 
  
